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Introduction
Ever since human beings have been walking in an erect position, abdominal 
wall hernias have likely been a problem. A hernia is a protrusion of abdominal 
content (preperitoneal fat, omentum, or abdominal organs) through an 
abdominal wall defect. Hernias usually develop in anatomically congenitally 
weak locations (e.g. inguinal, umbilical, and hiatal hernias) or as a result of prior 
surgery (incisional, parastomal, and trocar site hernias). After the discovery 
and introduction of asepsis and general anesthesia in the 19th century, there 
was a significant increase in the number of surgical interventions, and in the 
likelihood of surviving intra-abdominal surgery. As abdominal surgery became 
more common, the incidence of incisional hernia (IH) increased. In the present 
day, IH remains a common complication of surgery, and represents a large 
proportion of all ventral abdominal wall hernias; therefore, the subject of this 
thesis is IH. IH develops when the fascial tissue fails to heal at the incision site 
of a prior laparotomy. IHs are symptomatic in the vast majority of patients and 
associated with pain and discomfort, often resulting in a decreased quality 
of life and perception of body image(1). Additionally, incarceration and 
strangulation of abdominal contents can occur, for which emergency surgery 
is indicated, with associated morbidity and mortality(2). Furthermore, IHs are 
costly to treat(1, 3, 4) and recurrences do occur(5). 
In decreasing order of incidence, IH can be diagnosed after upper 
midline incisions, lower midline incisions, transverse incisions, and subcostal 
incisions. Although midline incision is the type most associated with a high 
incidence of IH, it is still the incision most frequently used by abdominal 
surgeons. The midline incision provides surgeons with a rapid and wide 
access to the abdominal cavity, with minimal damage to the nerves, vascular 
structures, and muscles of the abdominal wall. IHs are also found to occur after 
paramedian, McBurney, Pfannenstiel, and flank incisions. Approximately 10-
25% of all patients will develop IH after midline laparotomy(6-9). This incidence 
rises to 35% in patients with an aneurysm of the abdominal aorta(10-12); 
and incidences as high as 69% have been reported in high-risk patients after 
prospective long-term follow-up(13). During laparotomy, the creation of a 
stoma through the abdominal wall is necessary in approximately 25% of 
patients. A parastomal hernia (PSH) – a kind of IH – is a frequent complication 
following stoma creation, with a reported incidence of up to 48%(14, 15). 
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As far back as 1901, Eads recognized the high frequency of IH, and 
stated in the Annals of Surgery: “The occurrence of ventral hernia as a sequence 
of abdominal section is so common that it should command our thoughtful 
consideration”(16). Since then, extensive research on the aetiology and risk 
factors of abdominal wall hernias has been performed. During the 20th century, 
it was discovered that pathologic changes in connective tissue may render 
certain individuals particularly liable to hernia – a condition described as 
“herniosis”(17). The role of genetics, the collagen type 1 and 3 ratio, and matrix 
metalloproteinases in herniosis has been uncovered(18). 
However, it is not only the patient characteristics and genetics that 
impair wound-healing that make patients susceptible to the development 
of IH. The effect of increased intra-abdominal pressure on the development 
and aggravation of abdominal wall hernias has also been recognized. In the 
last century, Jenkins focussed his research on a mechanical approach to IH 
development(19). During the postoperative period, abdominal distension 
can present as a problem, due, for example, to paralytic ileus. Almost all 
patients experience some period of paralysis, and approximately 40% of 
patients experience a paralytic ileus lasting more than five days(20). Jenkins’ 
measurements showed that abdominal girth and the xiphoid-pubic distance 
may lengthen by up to 30% during abdominal distension. An adequate 
reserve of suture length in the wound is therefore necessary to allow for this 
lengthening to occur, to ensure the minimal resulting rise in tension between 
the sutures and the tissues. Jenkins calculated a suture length to wound length 
(SL:WL) ratio of 4:1 to be sufficient for a patient with postoperative abdominal 
distension and a 30% increase in wound length(19). Suturing the fascia of a 
midline laparotomy with a SL:WL of 4:1 reduces the tension on the suture, and, 
in turn, the risk of suture pull-out through the fascia. Applying an adequate 
SL:WL ratio significantly lowers the risk of IH(21, 22). In daily practice, most 
surgeons perform a continuous suture technique with slowly-absorbable 
suture material to close a midline laparotomy. 
Conditions that impair wound healing and make patients susceptible 
to the development of IH include: wound infection, diabetes mellitus, obesity, 
immunosuppressive drugs, and smoking(4, 12, 23). Taking into account patient 
factors and surgical technique, the incidence of IH at the present time remains 
high, and prevention seems, therefore, of uttermost importance. 
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Despite the advances made in the prevention of IH, this still represents 
a common issue in general surgical practice. Non-surgical treatment for IH is 
mostly applied to patients that are unfit for surgery, and consists of abdominal 
binders to reduce the hernia and support the abdominal wall. The vast majority 
of IHs are symptomatic and require repair(1). In contrast to asymptomatic 
inguinal hernias, a watchful waiting strategy might not be a safe option for 
IHs(24). The risk of incarceration is high, and emergency repair is associated 
with a greater incidence of intraoperative bowel perforations, the development 
of enterocutaneous fistulas, and mortality(24). Elective surgical repair should 
be considered if: the hernia is symptomatic; the increased risk for incarceration 
outweighs the risk of the operation; when the size of the hernia complicates 
dressing or activities of daily living; or when decreased quality of life and 
perception of body image are a factor. 
The surgical treatment of abdominal wall hernias has been performed 
since Hellenistic times, when Celsus performed hernial sac extirpations(18). 
Since then, many new surgical techniques, or modifications of established 
techniques, have been introduced. These repair techniques can broadly be 
divided into repair techniques without mesh (suture repair and autoplasty), 
and repair with mesh reinforcement. In 1899, Mayo described a transverse 
overlapping technique for repair of umbilical hernias(25), which was soon 
adopted as the standard technique for closing incisional and umbilical hernias. 
This technique was well adopted, but recurrence rates continued to frustrate 
surgeons. These procedures could not be performed for large abdominal 
wall defects, and new surgical techniques needed to be developed. With the 
introduction by Albanese and Ramirez of releasing incisions of the external 
oblique muscle, there was development of the components separation 
technique (CST) for large abdominal wall defects(26, 27). Besides several 
surgical techniques, transplantations of autologous or homologous materials 
were also explored. However, recurrence rates for hernia repair remained 
unsatisfactory high, and surgeons started to realize that ventral hernia repair 
might require the use of a foreign body. 
Since 1859, when Edwin Drake first successfully obtained oil from the 
ground by drilling, the oil industry has flourished, and several new polymers 
have been developed and introduced to medicine. Perlon and nylon meshes 
(1944) were developed, and implanted during hernia repair. However, perlon 
was found to provoke an extreme inflammatory response, and nylon tended 
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to lose its strength and fall apart. American vascular surgeon Michael DeBakey 
discovered a new fabric called dacron (polyester) and used it to develop long-
lasting vascular grafts. In 1956, the polyester vascular grafts were modified into 
synthetic meshes for hernia repair, and introduced to the market under the 
brand names Dacron and Mersilene. Around the same time, another American 
surgeon, Francis Usher, instigated collaboration with a petroleum company 
and developed a hernia mesh from the polymer Marlex. This first polyethylene 
Marlex mesh was further improved, and in 1963 the second generation Marlex 
mesh – of knitted polypropylene – was introduced, this compound being 
strong, biocompatible, and cheap. Over the following few years, Usher and 
other dedicated surgeons published good results for these synthetic meshes 
on recurrence rates and complications. But despite the positive reports, the 
surgical community, largely influenced by the high complication rates of earlier 
metal and plastic prostheses, saw little or no need for the routine use of these 
new meshes in hernia surgery. 
In the following years, a third kind of synthetic mesh, made from 
expanded-polyetrafluoroethylene (e-PTFE), was developed by Gore. This new 
e-PTFE mesh was first used clinically in hernia repair in 1983. Although surgeons 
were starting to use meshes more and more in hernia repair, implantation was 
still reserved for complex or recurrent cases – particularly in ventral hernia 
repair. It took the publication of a randomized controlled trial from the Dutch 
REPAIR-group in 2000(23), for the worldwide surgical community to start to 
accept the use of meshes as the standard of care for ventral hernia repair. The 
impressive results of this RCT were published in The New England Journal of 
Medicine in 2000(23). Three-year follow-up revealed recurrence rates of 43% for 
suture repair, and 24% for mesh repair. Several years later, the long-term follow-
up of this RCT showed a 10-year cumulative recurrence rate of 63% for suture 
repair, and 32% for mesh repair(5). In the following years, clinical trials were 
conducted on the different repair techniques and mesh prostheses for small 
and medium-sized ventral hernias, but the treatment of large IHs (over 10cm) 
has not yet been properly addressed. To improve the evidence-base for IH-
surgery, the EHS developed a classification for IH which takes into account the 
location, size, and possible recurrence of the IH(28). This classification system 
has, since its introduction in 2009, been widely accepted and used in scientific 
publications about IH. However, a solid base of comparative research material 
on abdominal wall surgery has remained elusive, due to a strong heterogeneity 
in reported study population characteristics and outcome measurements.
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The early meshes of polyester, polyethylene, polypropylene, and e-PTFE 
provided solid repair of the abdominal wall. However, these meshes were 
sometimes found to induce infectious complications, and adhesion formation 
when in contact with abdominal viscera. For these reasons, composite meshes 
with antibacterial and anti-adhesion coatings were developed, generating 
promising results. The anti-adhesive layer, added to a synthetic mesh, was 
designed to function as a barrier between the viscera and the mesh, reducing 
the risk of adhesion formation. However, implantation of synthetic meshes 
in infected environments remained problematic, with a high rate of mesh 
infections. Over the last decade, in response to this challenging indication, 
biological meshes of collagen have been developed, derived from animal or 
human donor tissue. These biological meshes were especially developed to be 
implanted in a contaminated or infected environment requiring closure. These 
biological collagen meshes are thought to be replaced by the patient’s own 
collagen in time (remodeling), with associated low adhesion-formation, and a 
low infection risk. They are less suitable for bridging, however, because gradual 
absorption occurs, the risk of recurrence possibly being higher in such a case. The 
short-term results of biological mesh use for complicated abdominal wall repair 
seem promising, but long-term results on recurrence rates are not yet available. 
The Ventral Hernia Working Group have developed an incisional hernia grading 
system based on the characteristics of both the patient and the wound. It advises 
the use of a biological mesh in potentially contaminated environments (grade 
3, i.e. patients with a previous wound infection, a stoma present, or involving an 
operation with violation of the gastrointestinal tract); and infected environments 
(grade 4, i.e. patients with an infected mesh or septic dehiscence)(29). Since 
long-term results are not yet available, and the cost of biological meshes is very 
high compared to synthetic meshes, evidence of superiority is necessary before 
widespread use of biological meshes can be justified. 
Outline of the thesis
The first aim of this thesis is to determine the current incidence of IH, and the 
best surgical technique to prevent it. The second aim of this thesis is to study 
the treatment of IH, especially the repair of large IHs, and repair techniques 
using the novel biological and composite meshes. 
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In the first part, studies are presented on the current incidence of IH, and on 
the best surgical technique to prevent it. 
In Chapters 2 and 3, the influence of exact suture techniques on the incidence 
of IH is examined. These chapters present the design (Chapter 2) and outcomes 
(Chapter 3) of a randomized controlled trial (RCT) comparing a commonly used 
‘large bites’ technique (large tissue bites of at least a centimetre, with a stitch 
placed every centimetre) with a promising ‘small bites’ technique (small tissue 
bites of half a centimetre, with a stitch placed every half centimetre). 
In Chapter 4, there is presentation of a systematic review and meta-analysis 
to evaluate the evidence from published RCTs examining suture materials or 
suture techniques on the incidence of IH. 
In Chapter 5, the available evidence on the optimal materials and methods 
used to close abdominal wall incisions is used to report on European Hernia 
Society (EHS) guidelines.
In Chapter 6, a cross-sectional study on the incidence of IH and PSH in 150 
patients with end-colostomy and midline laparotomy, is presented. 
In Chapter 7, the aetiology of the combination of IH and PSH is further 
investigated. The effect of damage to the intercostal nerves due to herniation 
after colostomy formation with subsequent rectus atrophy and midline shift, is 
examined. 
In the second part of this thesis, studies are presented on the surgical treatment 
of IH. 
In Chapter 8, the results of a systematic review conducted to identify the 
best possible technique(s) for large IH repair, with regard to recurrence and 
complication rates, is reported on. 
In Chapter 9, the EHS recommendations for abdominal wall surgery, for 
describing hernia variables, treatment variables, and for reporting outcomes, 
are presented. 
In Chapter 10, several synthetic and biological meshes are compared in an 
animal experiment on adhesion formation and incorporation during long-term 
follow-up. 
In Chapter 11, an animal experiment is described in which several synthetic 
and collagen meshes are implanted in a contaminated environment, and mesh 
infection and adhesion formation are evaluated. 
In Chapter 12, the mesh-specific cellular responses are described.
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In Chapter 13, an in vitro model to study the biomaterial-dependent reaction 
of macro-phages in an inflammatory environment is described. 
In Chapter 14, the study of the infection susceptibility of several biological 
meshes in an experimental contaminated field is presented.
In Chapter 15, long-term results on the sustainability of abdominal wall repair 
with various biological meshes in an experimental setting, are presented. 
In Chapter 16, a clinical case of bulging of a polyester mesh due to expansion 
of the pores is reported on. 
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18
References
1. van Ramshorst GH, Eker HH, Hop WC, Jeekel J, Lange JF. Impact of incisional hernia on health-
related quality of life and body image: a prospective cohort study. American journal of surgery. 
2012;204(2):144-50.
2. Nieuwenhuizen J, van Ramshorst GH, ten Brinke JG, de Wit T, van der Harst E, Hop WC, et al. The use 
of mesh in acute hernia: frequency and outcome in 99 cases. Hernia. 2011;15(3):297-300.
3. Gillion JF, Sanders D, Miserez M, Muysoms F. The economic burden of incisional ventral hernia 
repair: a multicentric cost analysis. Hernia. 2016.
4. Fischer JP, Basta MN, Mirzabeigi MN, Bauder AR, Fox JP, Drebin JA, et al. A Risk Model and Cost 
Analysis of Incisional Hernia After Elective, Abdominal Surgery Based Upon 12,373 Cases: The Case 
for Targeted Prophylactic Intervention. Ann Surg. 2016;263(5):1010-7.
5. Burger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J. Long-term follow-up 
of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg. 
2004;240(4):578-83; discussion 83-5.
6. Bloemen A, van Dooren P, Huizinga BF, Hoofwijk AG. Randomized clinical trial comparing 
polypropylene or polydioxanone for midline abdominal wall closure. Br J Surg. 2011;98(5):633-9.
7. Deerenberg EB, Harlaar JJ, Steyerberg EW, Lont HE, van Doorn HC, Heisterkamp J, et al. Small bites 
versus large bites for closure of abdominal midline incisions (STITCH): a double-blind, multicentre, 
randomised controlled trial. Lancet. 2015;386(10000):1254-60.
8. Hoer J, Lawong G, Klinge U, Schumpelick V. [Factors influencing the development of incisional 
hernia. A retrospective study of 2,983 laparotomy patients over a period of 10 years] Einflussfaktoren 
der Narbenhernienentstehung. Retrospektive Untersuchung an 2.983 laparotomierten Patienten 
uber einen Zeitraum von 10 Jahren. Chirurg. 2002;73(5):474-80.
9. Millbourn D, Cengiz Y, Israelsson LA. Effect of stitch length on wound complications after closure of 
midline incisions: a randomized controlled trial. Archives of surgery. 2009;144(11):1056-9.
10. Adye B, Luna G. Incidence of abdominal wall hernia in aortic surgery. American journal of surgery. 
1998;175(5):400-2.
11. Bevis PM, Windhaber RA, Lear PA, Poskitt KR, Earnshaw JJ, Mitchell DC. Randomized clinical trial 
of mesh versus sutured wound closure after open abdominal aortic aneurysm surgery. Br J Surg. 
2010;97(10):1497-502.
12. Henriksen NA, Helgstrand F, Vogt KC, Jorgensen LN, Bisgaard T. Risk factors for incisional hernia 
repair after aortic reconstructive surgery in a nationwide study. J Vasc Surg. 2013;57(6):1524-30, 30 
e1-3.
13. Alnassar S, Bawahab M, Abdoh A, Guzman R, Al Tuwaijiri T, Louridas G. Incisional hernia postrepair of 
abdominal aortic occlusive and aneurysmal disease: five-year incidence. Vascular. 2012;20(5):273-
7.
14. Carne PW, Robertson GM, Frizelle FA. Parastomal hernia. Br J Surg. 2003;90(7):784-93.
15. Brandsma HT, Hansson BM, Aufenacker TJ, van Geldere D, Lammeren FM, Mahabier C, et al. 
Prophylactic Mesh Placement During Formation of an End-colostomy Reduces the Rate of 
Parastomal Hernia: Short-term Results of the Dutch PREVENT-trial. Ann Surg. 2016.
16. Eads BB. I. Ventral Hernia following Abdominal Section. Ann Surg. 1901;33(1):1-12.
17. Read RC. Inguinal herniation in the adult, defect or disease: a surgeon’s odyssey. Hernia. 
2004;8(4):296-9.
18. Deerenberg EB, Timmermans L, Jeekel J, Lange JF. Natural history of abdominal wall defects. In: 
Nahabedian M, Bhanot P, editors. Abdominal Wall Reconstruction. Woodbury, Canada: Ciné-Med 
Publishing, Inc. ; 2014.
19. Jenkins TP. The burst abdominal wound: a mechanical approach. Br J Surg. 1976;63(11):873-6.
20. Delaney CP. Clinical perspective on postoperative ileus and the effect of opiates. Neurogastroenterol 
Motil. 2004;16 Suppl 2:61-6.
21. Israelsson LA, Jonsson T. Suture length to wound length ratio and healing of midline laparotomy 
incisions. Br J Surg. 1993;80(10):1284-6.
1Introduction and outline of the thesis
19
22. Israelsson LA, Jonsson T, Knutsson A. Suture technique and wound healing in midline laparotomy 
incisions. The European journal of surgery = Acta chirurgica. 1996;162(8):605-9.
23. Luijendijk RW, Hop WC, van den Tol MP, de Lange DC, Braaksma MM, JN IJ, et al. A comparison of 
suture repair with mesh repair for incisional hernia. N Engl J Med. 2000;343(6):392-8.
24. Verhelst J, Timmermans L, van de Velde M, Jairam A, Vakalopoulos KA, Jeekel J, et al. Watchful 
waiting in incisional hernia: is it safe? Surgery. 2015;157(2):297-303.
25. Mayo WJ. IV. Remarks on the Radical Cure of Hernia. Ann Surg. 1899;29(1):51-61.
26. Albanese AR. [Gigantic median xipho-umbilical eventration; method for treatment]Eventracion 
mediana xifoumbilical gigante; metodo para su tratamiento. Rev Asoc Med Argent. 1951;65(709-
710):376-8.
27. Ramirez OM, Ruas E, Dellon AL. “Components separation” method for closure of abdominal-wall 
defects: an anatomic and clinical study. Plast Reconstr Surg. 1990;86(3):519-26.
28. Muysoms FE, Miserez M, Berrevoet F, Campanelli G, Champault GG, Chelala E, et al. Classification of 
primary and incisional abdominal wall hernias. Hernia. 2009;13(4):407-14.
29. Ventral Hernia Working G, Breuing K, Butler CE, Ferzoco S, Franz M, Hultman CS, et al. Incisional 
ventral hernias: review of the literature and recommendations regarding the grading and 
technique of repair. Surgery. 2010;148(3):544-58.

Part 1 
Prevention and incidence  
of incisional hernia
Chapter
A multicenter randomized 
controlled trial evaluating 
the effect of small stitches 
on the incidence of incisional 
hernia in midline incisions 
(STITCH trial, NCT01132209)
J.J. Harlaar
E.B. Deerenberg 
G.H. van Ramshorst 
H.E. Lont
E.C.M.H. van der Borst
W.R. Schouten 
J. Heisterkamp 
H.C. van Doorn
H.A. Cense 
F.J. Berends
H.B.A.C. Stockmann
W.W. Vrijland
E. Consten
R.T. Ottow
P.M.N.Y.H. Go
J.J. Hermans
E.W. Steyerberg
J.F. Lange 
BMC Surgery 2011;11:20.
Chapter 2
24
Abstract
Background
The median laparotomy is frequently used by abdominal surgeons to gain 
rapid and wide access to the abdominal cavity with minimal damage to nerves, 
vascular structures and muscles of the abdominal wall. However, incisional 
hernia remains the most common complication after median laparotomy, with 
reported incidences varying between 2-20%. Recent clinical and experimental 
data showed a continuous suture technique with many small tissue bites in the 
aponeurosis only, is possibly more effective in the prevention of incisional hernia 
when compared to the common used large bite technique or mass closure. 
Design
The STITCH trial is a double-blinded multicenter randomized controlled trial 
designed to compare a standardized large bite technique with a standardized 
small bites technique. The main objective is to compare both suture techniques 
for incidence of incisional hernia after one year. Secondary outcomes will include 
postoperative complications, direct costs, indirect costs and quality of life.
Methods
A total of 576 patients will be randomized between a standardized small bites 
or large bites technique. At least 10 departments of general surgery and two 
departments of oncological gynaecology will participate in this trial. Both techniques 
have a standardized amount of stitches per cm wound length and suture length 
wound length ratios are calculated in each patient. Follow up will be at 1 month 
for wound infection and 1 year for incisional hernia. Ultrasound examinations will 
be performed at both time points to measure the distance between the rectus 
muscles (at 3 points) and to objectify presence or absence of incisional hernia. 
Patients, investigators and radiologists will be blinded during follow up, although 
the surgeon can not be blinded during the surgical procedure.
Conclusion
The STITCH trial will provide level 1b evidence to support the preference 
for either a continuous suture technique with many small tissue bites in the 
aponeurosis only or for the commonly used large bites technique.
Trial registration: Clinicaltrials.gov NCT01132209
STITCH protocol
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Background
The median laparotomy is frequently used by abdominal surgeons to gain 
rapid and wide access to the abdominal cavity with minimal damage to nerves, 
vascular structures and muscles of the abdominal wall. However, incisional 
hernia remains the most common complication after median laparotomy, with 
reported incidences varying between 2-20%(1-5). Even higher incidences up 
to 30-35% have been reported in obese and aortic aneurysm patients(6-10). 
Incisional hernia can cause discomfort, impair quality of life or result in serious 
life-threatening conditions, such as incarceration or strangulation of the 
bowel(5). Median laparotomies and incisional hernias have been subject of 
investigation for a long period of time already. Although a lot is known about 
patient related risk factors and suture materials, technical risk factors such as 
suture techniques have not been investigated thoroughly(5, 11, 12).
For prevention of incisional hernia, many clinical trials and meta-analyses 
have demonstrated that a mass closure technique with a simple running suture 
is the best option to close a midline incision. A mass closure technique with a 
running suture is also easier and quicker to perform than layered techniques 
with interrupted sutures(5, 12-14). Furthermore, the use of slowly absorbable 
suture material compared with non-absorbable suture material decreases the 
incidence of incisional hernia, and it also lowers the incidence and intensity of 
postoperative pain and wound infection(12, 15, 16).
Suture length to wound length ratio and small bites
Several authors have stated that a suture length to wound length ratio (SL:WL) 
of four or more must be achieved, since a lower ratio is associated with an 
increased rate of incisional hernia(7, 17-20). It has often been recommended 
to place continuous stitches more than 10 mm from the wound edge in 
combination with a long stitch length(19, 21-28). A long stitch is the result of a 
large bite with the largest portion of fascia possible, aiming to increase tensile 
strength and to decrease the risk of fascial dehiscence. However, long stitches 
have been associated with high rates of both wound infection and incisional 
hernia(17, 29, 30). A long stitch length may be associated with higher risks of 
wound infection due to an increase in the amount of necrotic tissue within 
the wound. In experimental studies, the long stitch length has been found 
to compress or cut through soft tissue included in the stitch(31, 32). The risk 
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of incisional hernia may be higher because the stitch tends to slacken, which 
allows wound edges to separate. 
Small stitches, placed 4–6 mm from the wound edge, only cut through 
the aponeurosis and not through the rectus abdominis muscle. Recent 
experimental data show that the small bites technique results in stronger 
wounds and faster healing than the routine large bite technique(33). Our 
experiments in a porcine model showed a 47% increase in breaking strength 
when small bites were used compared to the routine technique(32). A recent 
randomized of randomised clinical study by Millbourn et al. reported a decrease 
of incidence of incisional hernia of 70% 18% to 5.6%, p<0.001) and a decrease 
of 50%, (10.2% to 5.2%, p=0.020) of wound infection (34, 35). These results are 
very promising with regard to the prevention of incisional hernia and wound 
infection. The benefits of this technique need to be confirmed in a multicenter 
double-blinded randomized controlled trial. 
 In daily practice, most surgeons in the Netherlands use the large bite 
technique with large suture distances. With large bites, SL:WL ratio depends 
on the thickness of the abdominal wall including the muscles, the bite size, the 
number of stitches and the traction on the sutures during suturing. With large 
bites, an unanswered question remains with regard to how the SL:WL ratio of 4 
should be reached. With a low traction force, fewer stitches are needed, but the 
slacking effect during the postoperative period may influence results. 
With small stitches, SL:WL ratio is mostly dependent on the number of 
stitches. There is no sufficient evidence to prefer one suture closure technique 
over the other in order to prevent incisional hernia and fascia dehiscence.
Objective
The objective of the STITCH trial (Suture Techniques to reduce the Incidence 
of The inCisional Hernia) is to compare the small bites technique described by 
Millbourn et al. with a standardized large bites technique. 
The overall objective of the study is reduction of the incidence of the 
most frequent complication of abdominal surgery, i.e., incisional hernia. We 
hypothesize that the small bites technique will result in a significant reduction 
of the incidence of incisional hernia, which may lead to a reduced morbidity 
and a better quality of life for patients and a significant reduction of costs.
Primary endpoint will be incisional hernia occurrence within one year 
after surgery, either clinically and/or ultrasonographically detected. Secondary 
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endpoints include postoperative complications, in particular surgical site 
infection, burst abdomen and wound pain in the first postoperative month.
Methods
Trial Design
The STITCH trial has been designed as a prospective, multicenter, double-
blind, randomized controlled trial, in which the large bites technique will be 
compared with the small bites technique. 
Participants
Patients scheduled for an elective abdominal operation through a midline 
incision will be asked for informed consent at the outpatient clinic or in hospital 
on the day preceding the day of surgery. Also, emergency laparotomies can 
be included in this trial if the patient is able to sign the informed consent. We 
intend to investigate the efficacy of the small bites technique in all risk groups. 
This also includes oncological gynaecological patients in centers with at least 
50 median laparotomies a year. 
Inclusion criteria:
• Signed informed consent
• Laparotomy through a midline incision 
• Age 18 years or older
Exclusion criteria:
• Previous incisional hernia or fascial dehiscence with secondary 
healing after a midline incision
• Abdominal surgery through a midline incision within the last three 
months
• Pregnancy
Since the STITCH trial is an intervention study, it is not considered desirable to 
combine this trial with other intervention studies. In case of non-intervention 
(registration) studies, it will be judged on individual basis whether it is suitable 
and ethically correct to include a patient in both the STITCH trial and in another 
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study. Patients will be included in the STITCH trial in combination with one 
other trial (registration trials only), provided that it is possible to organize the 
informed consent and the follow up in a proper way for the individual patient 
for both trials.
Registration procedure
Included patient are registrated before surgery in an online data base 
(designed and managed by HOVON data center, Rotterdam, the Netherlands,) 
after signed informed consent via the Internet via TOP (Trial Online Process; 
see www.stitchtrial.nl). The patient namecode, date of birth, name of caller, 
name of responsible physician, sex and eligible criteria will be registered. Every 
participating institution has its own login code. 
Randomisation procedure
The randomization process is started only 15 minutes before closure to prevent 
consequences due to the trial during the operation with the online TOP 
randomisation. 
Patients will be randomized between closure with the large tissue bites 
technique or with the small tissue bites technique. Randomisation is stratified 
by center, and between surgeon or resident with a minimization procedure, 
ensuring balance within each stratum and overall balance. The randomization 
result will be given immediately by TOP. A confirmation email without 
randomization result will be send to the investigator.
Patients will be kept unaware of the type of closure until the endpoint 
of the trial. Surgeons or residents blinded for the procedure will perform 
outpatient clinic controls. Postoperative ultrasonography will be performed by 
radiologists blinded for type of closure. The randomisation procedure, blinding 
and objectification of incisional hernia by ultrasound will provide the best 
possible data to support preference for the large bites technique or the small 
bites technique over the other for closure of the abdominal wall.
Interventions
In this trial the large bites technique will be compared with the small tissue bites 
technique as developed in Sundsvall Hospital, Sweden(18). In the first group, 
the conventional large bites technique will be applied with bite widths of 1 cm 
and intersuture spacing of 1 cm with the use of one PDS plus II loop with a 48 
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mm needle. In the second group, the small bites technique will be applied with 
bite widths of 0,5 cm and intersuture spacing of 0,5 cm with the use of PDS 
plus II 2-0 with a 31 mm needle. In the small bites technique, twice as many 
stitches will be placed per sutured cm, with a smaller needle and thinner suture 
material. In the Swedish hospital where the small bites techniques has been in 
use for many years, this combination proved the easiest and safest method to 
perform the small bites technique(18, 34). 
In both groups wound length is measured before closing of the fascia. 
After measurement of the wound length, the number of stitches is calculated. 
In the large bites technique at least one suture per cm wound length must be 
placed. In the small bites technique at least two sutures per cm wound length 
must be placed. The number of stitches is counted by the assistant during 
closure. 
In both arms, suturing is initiated at both ends of the incision towards 
the middle where an overlap will be created of at least 2 cm. The remaining 
sutures will be measured and the suture length used for closure of the fascia 
and the SL:WL ratio will be calculated by the scrub nurse. In both arms, suture 
length to wound length ratios (SL:WL) of 4:1 are aimed at. 
Implementation
In every hospital the OR nurses the surgeons or gynecologists and residents 
are instructed before the start of the trial in the individual institution during 
presentations and demonstration movies. During at least the first five inclusions 
the study coordinator will be present in the OR before randomization to assist 
randomization and control the correct applying of the standardized techniques. 
For every included patient a form with the detailed closing protocol in added to 
the clinical chart. Only when the surgeon is familiar with both the techniques, 
the nurses with the counting and measuring of the stitches and suture material 
and the study, centers are allowed to run the trial. Also for every included 
patient a form with the detailed closing protocol in added to the clinical chart. 
During the study unplanned audits are performed to control quality. 
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Outcome parameters
Primary outcome
• Primary outcome will be incisional hernia occurrence within one year 
after surgery, either clinically and/or ultrasonographically detected. 
Secondary outcome
• Postoperative complications
• Pain
• Quality of life 
• Cost effectiveness
We use the definition of the incisional hernia by the European Hernia Society: 
‘any abdominal wall gap with or without bulge in the area of a postoperative scar 
perceptible or palpable by clinical examination or imaging’. The classification 
made by the European Hernia Society is used. [35] The classification of incisional 
hernias: Incisional hernias will be classified according to their localization, size, 
reducibility and symptoms. 
Discharge dates and complications will be registered. Patients who fail 
to keep their annual clinic appointment will be given the option of a further 
appointment at a more suitable date or a visit to their home if they cannot 
make it to the outpatient clinic. The following data will be gathered at different 
points in time:
Preoperative data
• Date of birth
• Length and weight
• Current smoker (Yes or No).
• Medical history (including chronic obstructive pulmonary disease 
(COPD), diabetes mellitus, cardiac disease, prior laparotomies)
• Preoperative radiotherapy or chemotherapy
• Preoperative or perioperative corticosteroids
• Previous abdominal operations
• Other abdominal wall hernias 
• American Society of Anaesthesiologists (ASA) classification
• Width of linea alba (if preoperative Computed Tomography Imaging 
is available)
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Operation data
• Type of operation
• Suture length : wound length ratio
• Number of stitches
• Length of incision
• Closure time
• Blood loss
• Operation time
• Antibiotic prophylaxis 
• Drains and location
• Thrombosis prophylaxis
• Pain medication
• Peroperative complications (intestinal lesions, bleeding, other)
• Epidural catheter
Postoperative data
• Blood transfusion
• Postoperative ventilation and duration
• Postoperative corticosteroids
• Postoperative radiation therapy
• Postoperative pain medication
• Postoperative ileus and duration
• Postoperative complications:
o Centers for Disease Control criteria for Surgical Site Infection, 
according to the guidelines proposed by Mangram in 1999 (36). 
o Wound haematoma: accumulation of blood in the wound area, 
which warrants surgical exploration and intervention.
o Pulmonary infections
o Ventilation problems
o Re-admission and indication
o VAS pain score until day 6 postoperative
At 1 and 12 months, ultrasound imaging will be performed to examine the 
midline for any asymptomatic clinically not detectable incisional hernias. Size 
and location of any incisional hernias will be registered.
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Outpatient clinic follow up
• Outpatient clinic visit at 1 and 12 months
 o Incisional hernia
 o Wound infection
 o Seroma formation
 o Other wound problems
 o Other abdominal wall hernia
• Ultrasound at 1 and 12 months
• VAS pain scores and Quality of Life forms preoperatively (day of 
operation or the day before) and at 1,3, 6 and 12 months
Ultrasound examinations
During the 1 month and 1 year follow up an ultra sound examination will be 
performed to measure the distance between the rectus muscles at 3 point in 
the incision and control for incisional hernia. A specific score is used for the 
ultrasound examination. At ten points, which include 4 measurements of the 
distance between the rectus muscle, the quality of the scar in the abdominal 
wall is objectified. With this method the conclusion if there is an incisional 
hernia can also be made on the score list. In this list is controlled for:
• An intact linea alba?
• Bulging without Valsalva maneuver?
• Bulging with Valsalva maneuver?
• Distance between rectus muscles in scar on 1/3 cranial part in cm?
• Distance between rectus muscles in scar on 1/3 caudal part in cm?
• Maximum distance between rectus muscles in scar in cm?
• Maximum distance between rectus muscles at place of bulging or 
defect in cm?
• Is there a defect? If yes, the size of the defect and location
• Is there fatty tissue in the defect?
• Is there a bowel loop in the defect?
The radiologist is asked to make prints of every measurement and finding. 
Quality of life will be assessed based on standardized Quality of Life forms 
including the EuroQol-5D and Short Form-36 before and at 1 month, 3 months, 
6 months, and 12 months after surgery. 
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Economic evaluation
We will perform an ex-post economic evaluation in which a new suture 
technique using small bites is compared with the traditionally applied large 
bites technique, from a societal perspective. The economic evaluation will be 
performed in accordance with Dutch guidelines(37). 
To measure the economic impact of the new suture technique using 
small bites the cost-effectiveness will be assessed by calculating the incremental 
cost-effectiveness ratio, defined here as the difference in average costs between 
both suture techniques divided by the difference in average effects. The primary 
outcome measure will be the costs per reduced incisional hernia within 1 year. 
Secondary, a cost-utility analysis will be performed using costs per quality 
adjusted life year (QALY) as outcome measure, using the EQ-5D.
Costs for all separate actions and time used by all individual health 
care professionals, and all other materials will be measured from a societal 
perspective for both bites techniques, which means that both direct medical 
costs (e.g. intervention costs, intramural and extramural medical costs) and 
indirect costs (absence from work, patient costs) will be included in the analysis. 
For the most important cost items, unit prices will be determined by 
following the micro-costing method (Gold et al, 1996), which is based on a 
detailed inventory and measurement of all resources used. Resource costs 
arise within the hospital and consist of outpatient visits, inpatient days, use 
of the operation room, radiology examinations, blood tests, etc. Real medical 
costs will be calculated by multiplying the volumes of health care use with the 
corresponding unit prices. For instance, the calculation of the costs of both 
suture techniques will consist of detailed measurement of investments in 
manpower, equipment, materials, housing and overhead. The salary schemes 
of hospitals and other health care suppliers will be used to estimate costs per 
hour for each health care professional. Taxes, social securities and vacations will 
be included. 
Data on effects (reduction of incisional hernia), costs (time costs of new 
suture technique and material and development costs) and savings (reduced 
health care use of patients without incisional hernia) will all be collected in 
this study. Data on treatment (hospitalisation) and follow-up consultations 
will be collected retrospectively from (electronic) patient charts and hospital 
administration. This data will be collected by health care professionals using a 
data-collection form. Information will collected on:
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- length of hospital stay
- length of stay in ICU
- reinterventions
Data on extramural care, work absence and other patient costs will be gathered 
via questionnaires at each follow-up (1 and 12 months). 
For a description of the calculation of the effect measures see paragraph 
‘outcome parameters’. Discounting of future costs and effects is not relevant 
because of the limited time horizon of 1 year. When costs of a treatment 
are similar across subgroups, the absolute benefit determines the cost-
effectiveness of a treatment for a specific subgroup. Randomized controlled 
trials are designed to evaluate the effects of treatment at the group level, 
and cost-effectiveness is usually calculated for this group as a whole. There 
could however be substantial and relevant between subgroup variability. It 
is therefore common to consider subgroup specific effects of interventions. 
The subgroup specific cost-effectiveness will be estimated by first deriving 
a prognostic index, based on the predefined predictors of incisional hernia: 
abdominal aneurysm aorta (AAA), obesity, diabetes, COPD, corticosteroid 
usage, radiotherapy, cardiovascular disease, smoking, age, cancer, other 
abdominal wall hernias and collagen disorders.
Sample size calculation
Millbourn et al. found a decrease in the incidence of incisional hernia from 18% 
to 5,6% in a randomized controlled trial. [34] In this trial, follow-up consisted of 
clinical instead of radiological examination for incisional hernia occurrence. In 
this trial, ultrasound examination will be used in order to be able to diagnose 
incisional hernia with higher sensitivity. It is expected that a relative decrease 
of the incidence incisional hernia after one year of 50% is reasonable. The 
mean reported one year incidence of incisional hernia in literature is 15%(1-
5). In order to reduce the mean incidence of incisional hernia from 15 to 7.5%, 
power calculations showed that two groups of 259 evaluable patients each 
are needed (power=0.80, alfa=0.05). Loss to follow-up is estimated at 10% of 
included patients. A total of 576 patients (2 x 288) will be included in the study 
to correct for loss to follow-up. Overall effects will be calculated adjusted for 
predictive baseline characteristics, which will lead to a higher statistical power.
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Statistical analysis 
Descriptive statistics will include median and interquartile range for continuous 
variables, and absolute numbers (with %) for categorical variables. Randomized 
groups will be compared for imbalance without formal statistical testing. 
Analysis will be by intention-to-treat. Differences between randomized groups 
will be tested with appropriate statistical methods, including t-tests or Mann-
Whitney tests for continuous variables (considering whether the normality 
assumption is rejected by the Kolmogorov-Smirnov test with Lilliefors 
correction test), and chi-square tests for categorical variables. The primary 
outcome (incisional hernia) will be analyzed with Kaplan–Meier analysis and 
a Cox regression analysis, to adjust for any loss to follow up between 30 days 
and 1 year after surgery. The primary analysis is a covariate adjusted Cox 
model, which includes the following predefined, well-establihed predictors 
of incisional hernia: abdominal aneurysm aorta (AAA), obesity, diabetes, 
corticosteroid usage, radiotherapy, COPD, smoking, age, cancer, inguinal 
hernia, cardiovascular disease and collagen disorders. 
Subgroup effects will be assessed by tests of interaction to prevent 
overinterpretation of apparent differences in effectiveness. Quality of life 
data will be analyzed by paired T-tests, comparing baseline with follow-up 
measurements, and repeated measures analysis. A two-sided p<0•05 will be 
taken to indicate statistical significance.
Monitoring
The Erasmus University Medical center is the sponsor of this trial. Adverse 
events are defined as any undesirable experience occurring to a subject 
during a clinical trial, whether or not considered related to the investigational 
intervention. All adverse events reported spontaneously by the subject or 
observed by the investigator or his staff will be recorded. A serious adverse 
event (SAE) is any untoward medical occurrence or effect that at any dose results 
in death; is life threatening (at the time of the event); requires hospitalization 
or prolongation of existing inpatients’ hospitalization; results in persistent or 
significant disability or incapacity; is a new event of the trial likely to affect the 
safety of the subjects, such as an unexpected outcome of an adverse reaction, 
major safety finding from a newly completed animal study, etc. All SAEs will be 
reported to the accredited Medical Ethical Committee (MEC) that approved the 
protocol, according to the requirements of that MEC. Serious Adverse events are 
death and burst abdomen. Adverse Events are readmission and reoperations.
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An independent data and safety monitoring committee will evaluate 
the progress of the trial and will examine safety parameters every 3 months. 
The committee can unblind the data whenever deemed necessary based on 
reported adverse events. All involved physicians will repetitively be asked 
to report any potential adverse events caused by the study protocol. These 
adverse events will be listed and discussed with the monitoring committee. 
The monitoring committee can ask for a full report in order to discuss a specific 
adverse event. A copy of this report will be sent to the central ethics board and 
to the involved physicians. All deceased patients will be evaluated by the safety 
committee for cause of death and possible trial related serious adverse effects. 
Every death will be reported to the central ethics board and the local ethics 
board. The Data Safety Monitoring Board will consist of an epidemiologist/
statistician and two independent surgeons. 
Ethics
This study will be conducted in accordance with the principles of the 
Declaration of Helsinki and ‘good clinical practice’ guidelines. The Medical 
Ethical Committee of the Erasmus University Medical Center Rotterdam has 
approved the protocol. The Ethical Committees of the participating centers are 
applied for local feasibility. Prior to randomization, written informed consent 
will be obtained from all patients.
Discussion
A major issue in all suture studies is standardisation of technique. In a multicenter 
trial it is difficult to achieve standardisation because many surgeons and 
residents will contribute in this trial. The benefit of a large group of participants 
is that the results will be representable for daily practice. 
In this trial two major parameters have been standardized: the difference 
between small and large bites and the amount of stitches per running cm of 
wound resulting in an appropriate SL:WL ratio. 
In daily practice, most surgeons use the large bite technique with large 
suture distances. With large bites, SL:WL ratio depends on the thickness of the 
abdominal wall including the muscles, the bite size, the number of stitches 
and the traction on the sutures during suturing. With large bites there is an 
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unanswered question under which conditions an optimal SL:WL ratio of 4 
should be reachable. With low traction on the suture fewer stitches are needed, 
but the slacking effect during the postoperative period will influence the results. 
For this reason in a RCT on suture techniques it is necessary to standardize the 
amount of stitches per centimetre of wound length. 
Conclusion
The STITCH trial is a multicenter randomized trial (trialregister: http://clinicaltrials.
gov/ct2/show/NCT01132209) comparing the costs and effectiveness of a 
standardized small tissue bites suture technique with a standardized large 
tissue bites technique in midline incisions. This trial will provide the surgical 
society the evidence needed to optimize a surgical technique used to prevent 
common surgical complications. 
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Appendix 1
Criteria for defining a Surgical Site Infection (SSI) 
Superficial Incisional SSI
Infection occurs within 30 days after the operation and infection involves only skin 
or subcutaneous tissue of the incision and at least one of the following:
1. Purulent drainage, with or without laboratory confirmation, from the 
superficial incision.
2. Organisms isolated from an aseptically obtained culture of fluid or tissue 
from the superficial incision.
3. At least one of the following signs or symptoms of infection: pain or 
tenderness, localized swelling, redness or heat and superficial incision is 
deliberately opened by surgeon, unless incision is culture-negative.
4. Diagnosis of superficial incisional SSI by the surgeon or attending 
physician.
Do not report the following conditions as SSI:
1. Stitch abscess (minimal inflammation and discharge confined to the 
points of suture penetration).
2. Incisional SSI that extends into the fascial and muscle layers (see deep 
incisional SSI).
Deep Incisional SSI
Infection occurs within 30 days after the operation if no implant is left in place or 
within 1 year if implant is in place and the infection appears to be related to the 
operation and infection involves deep soft tissue (e.g., fascial and muscle tissue) of 
the incision and at least one of the following:
1. Purulent drainage from the deep incision but not from the organ / space 
component of the surgical site.
2. A deep incision spontaneously dehisces or is deliberately opened by 
a surgeon when the patient has at least one of the following signs or 
symptoms: fever (>38°C), localized pain, or tenderness, unless site is 
culture negative.
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3. An abscess or other evidence of infection involving the deep incision is 
found on direct examination, during re-operation, or by histopathological 
or radiological examination.
4. Diagnosis of a deep incisional SSI by a surgeon or attending physician.
Notes:
1. Report infection that involves both superficial and deep incision sites as 
deep incisional SSI.
2. Report an organ/space SSI that drains through the incision as a deep 
incisional SSI.
Organ/Space SSI
Infection occurs within 30 days after the operation if no implant is left in place or 
within 1 year if implant is in place and the infection appears to be related to the 
operation and infection involves any part of the anatomy (e.g., organs or spaces), 
other than the incision, which was opened or manipulated during an operation 
and at least one of the following:
1. Purulent drainage from drain that is placed through a stab wound into 
the organ / space.
2. Organisms isolated from an aseptically obtained culture of fluid or tissue 
in the organ space.
3. An abscess or other evidence of infection involving the organ / space that 
is found on direct examination, during reoperation, or by histopathologic 
or radiologic examination.
4. Diagnosis of a deep organ / space SSI by a surgeon or attending 
physician.
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Abstract 
Background
Incisional hernia is a frequent complication of midline laparotomy and is 
associated with high morbidity, decreased quality of life, and high costs. 
We aimed to compare the large bites suture technique with the small bites 
technique for fascial closure of midline laparotomy incisions.
Methods
We did this prospective, multicentre, double-blind, randomised controlled trial 
at surgical and gynaecological departments in ten hospitals in the Netherlands. 
Patients aged 18 years or older who were scheduled to undergo elective 
abdominal surgery with midline laparotomy were randomly assigned (1:1), via 
a computer-generated randomisation sequence, to receive small tissue bites 
of 5 mm every 5 mm or large bites of 1 cm every 1 cm. Randomisation was 
stratified by centre and between surgeons and residents with a minimisation 
procedure to ensure balanced allocation. Patients and study investigators 
were masked to group allocation. The primary outcome was the occurrence of 
incisional hernia; we postulated a reduced incidence in the small bites group. 
We analysed patients by intention to treat. This trial is registered at Clinicaltrials.
gov, number NCT01132209 and with the Nederlands Trial Register, number 
NTR2052.
Findings
Between Oct 20, 2009, and March 12, 2012, we randomly assigned 560 patients 
to the large bites group (n=284) or the small bites group (n=276). Follow-up 
ended on Aug 30, 2013; 545 (97%) patients completed follow-up and were 
included in the primary outcome analysis. Patients in the small bites group 
had fascial closures sutured with more stitches than those in the large bites 
group (mean number of stitches 45 [SD 12] vs 25 [10]; p<0•0001), a higher 
ratio of suture length to wound length (5•0 [1•5] vs 4•3 [1•4]; p<0•0001) and 
a longer closure time (14 [6] vs 10 [4] min; p<0•0001). At 1 year follow-up, 57 
(21%) of 277 patients in the large bites group and 35 (13%) of 268 patients in 
the small bites group had incisional hernia (p=0•0220, covariate adjusted odds 
ratio 0•52, 95% CI 0•31–0•87; p=0•0131). Rates of adverse events did not differ 
significantly between groups.
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Interpretation
Our findings show that the small bites suture technique is more effective 
than the traditional large bites technique for prevention of incisional hernia 
in midline incisions and is not associated with a higher rate of adverse events. 
The small bites technique should become the standard closure technique for 
midline incisions.
Funding
Erasmus University Medical Center and Ethicon.
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Introduction
Incisional hernia is a frequent complication of abdominal operations with an 
incidence of 10–23%, which can increase to 38% in specific risk groups(1-4). 
In the USA 4 million to 5 million laparotomies are done annually, suggesting 
that at least 400 000–500 000 incisional hernias can be expected to occur 
every year. Incisional hernia is associated with pain and discomfort, resulting 
in a decreased quality of life(5).Moreover, incarceration and strangulation of 
abdominal contents can take place, for which emergency surgery is indicated, 
with associated morbidity and mortality(6). About 348 000 operations for 
incisional hernia are done every year in the USA with US$3•2 billion in annual 
associated costs(7). Prevention of incisional hernia is therefore of paramount 
importance. Several suturing techniques for abdominal closure after a midline 
abdominal incision have been studied in the past few decades. Findings 
from meta-analyses have shown that a running technique with long-lasting 
monofilament suture material reduces the incidence of incisional hernia 
compared with interrupted suture techniques(3, 8). Nowadays, most surgeons, 
urologists, and gynaecologists use the running closure technique with large 
tissue bites to close midline incisions(9). In 2009, a study from Sweden(10) 
showed that a running suture technique with small tissue bites, developed 
by Israelsson, decreased the incidence of incisional hernia compared with a 
running suture technique with large tissue bites. In this study, small tissue bites 
were defined as placement of a stitch every 5–8 mm from the wound edge. 
This promising technique is contradictory to old surgical principles and needs 
to be thoroughly investigated before it can be widely implemented(11, 12). 
We did the STITCH study to compare the common conventional large bites 
suture technique with the small bites technique for fascial closure of midline 
laparotomy incisions.
Methods
Study design
We did this prospective, multicentre, double-blind, randomised controlled trial 
at surgical and gynaecological departments in ten hospitals in the Netherlands. 
The trial protocol has been previously published(13). Patients aged 18 years 
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or older and scheduled to undergo elective abdominal surgery through a 
midline incision were asked to participate in the trial at the outpatient clinic 
or in hospital on the day before surgery. We excluded patients with a history 
of incisional hernia or fascial dehiscence after midline laparotomy, those who 
had undergone abdominal surgery through a midline incision within the 
past 3 months, those who were pregnant, or those who had participated in 
another intervention trial. The study protocol was approved by the institutional 
review board of Erasmus University Medical Center, Rotterdam, and by the 
review boards of each study centre before start of inclusion. All participants 
gave written informed consent. An independent data and safety monitoring 
board was constituted before the start of the trial. This board consisted of two 
independent surgeons and one biomedical statistician. All serious adverse 
events, defined as death and burst abdomen that happened during the study, 
were reported to the institutional review board of Erasmus University Medical 
Center. The progress of the trial and all adverse events were reported every 3 
months to the data and safety monitoring board and the safety of the trial was 
examined.
Randomisation and masking
After provision of consent, patients were registered in an online database 
in which they were assigned a unique trial code. During surgery, about 15 
min before closure, patients were randomly assigned (1:1), via a computer-
generated randomisation sequence, to receive small tissue bites of 5 mm every 
5 mm, or large bites of 1 cm every 1 cm (control group), for fascial closure. 
Randomisation was stratified by centre and between surgeons and residents 
with a minimisation procedure to ensure balance within each group and 
overall. Patients and study investigators were masked to group allocation. The 
data and safety monitoring board had access to unmasked data whenever 
deemed necessary.
Procedures
The principle of the small bites technique constituted placement of at least twice 
as many stitches as the incision length in cm with USP 2-0 PDS Plus II (Ethicon, 
Somerville, NJ, USA) with a 31 mm needle(10, 13-15). The suture technique 
was applied with tissue bites of 5 mm and intersuture spacing of 5 mm. In all 
cases the stitch incorporated the aponeurosis only and incorporation of fat or 
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muscle tissue was avoided. The conventional large tissue bites or mass closure 
technique was applied with tissue bites of at least 1 cm and intersuture spacing 
of 1 cm with USP 1 double loop PDS Plus II (Ethicon) with a 48 mm needle. 
In both groups, suturing was started at both ends of the incision towards the 
centre where an overlap of at least 2 cm of both the cranial and caudal sutures 
was created and both sutures were separately knotted. An additional knot 
from both the cranial and caudal sutures was allowed. The number of stitches 
was counted, wound length and length of the remaining suture measured, and 
ratio of suture length to wound length calculated by dividing the length of the 
suture used to close the fascia by the wound length. For both suture techniques, 
we aimed for a suture length to wound length ratio of 4:1 or higher(14). Patients 
were invited for follow-up at the outpatient clinic 1 month and 1 year after 
surgery. The 1 year follow-up visit was defined as a follow-up visit up to month 
15 after surgery. During these visits patients underwent physical examination 
by a medical doctor and abdominal ultrasonography by a radiologist, both of 
whom were masked to group allocation. Any abdominal CT done after surgery 
was also used to identify the presence or absence of incisional hernia. Physical 
examination and assessment of CT of all patients was done by two medical 
doctors (EBD and JJH) specially trained for this trial. Patients who did not 
attend the outpatient clinic received a repeated invitation or were offered a 
home visit. In case of conflicting observations, the observation by radiological 
imaging was decisive. Patients were regarded as censored observations if 
they underwent re-laparotomy through midline incision, were deceased, 
or ended follow-up. Patients remained unaware of the type of closure until 
completion of follow-up. All participants were asked to fill out quality of life 
questionnaires preoperatively and at 1, 3, 6, and 12 months postoperatively. 
We assessed quality of life with the Short Form-36 (SF-36) and the EuroQoL-5D 
(EQ-5D) questionnaires(16, 17). EQ-5D includes a visual analogue scale to rate 
overall health status on a scale of 0 (worst imaginable health state) to 100 (best 
imaginable state). Additionally, in the first postoperative week, patients scored 
their pain on a visual analogue scale once a day.
Outcomes
The primary outcome was the occurrence of incisional hernia during follow-up. 
We used the definition of incisional hernia from the European Hernia Society 
(EHS): “any abdominal wall gap with or without bulge in the area of a postoperative 
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scar perceptible or palpable by clinical examination or imaging”(18). Secondary 
outcomes were short-term postoperative complications (eg, surgical site 
infection [scored as superficial, deep, or involving organ or space, as specified 
in the protocol(13)]), burst abdomen (fascia dehiscence), cardiac events, length 
of hospital stay, and health-related quality of life. Main endpoints regarding 
quality of life were differences between patients assigned to the small bites 
technique and those assigned to the large bites technique, and between 
patients with and without development of incisional hernia during follow-up.
Statistical analysis
We postulated a reduced incidence of incisional hernia in the small bites 
group. On the basis of the results of the Swedish trial(10), we calculated that 
259 patients would be needed in each group to provide 80% power to detect 
a reduction of 50% (15% vs 7•5%) in the incidence of incisional hernia at a two-
sided α level 0•05. We aimed for a total of 576 patients (n=288 per group) to 
correct for an estimated 10% loss to follow-up(10, 13). We analysed differences 
between groups with t tests for continuous variables and χ2tests for categorical 
variables. For continuous variables, we tested equality of variance with 
Levene’s test. Normal distribution of data was tested and confirmed by limited 
skewness and kurtosis. We analysed the primary outcome with cross-tables 
with χ2testing and logistic regression to adjust for baseline covariates(19). We 
estimated final treatment effects with stratum of randomisation as a random 
effect in a generalised linear mixed model. We used a binomial error and logit 
link function in the glmer function of the lme4 package in R statistical sofware 
(version 3.1.0).
Considered baseline covariates were predefined potential predictors 
of incisional hernia: abdominal aneurysm aorta, body-mass index, diabetes 
mellitus, corticosteroid usage, preoperative chemotherapy, preoperative 
radiotherapy, chronic obstructive pulmonary disease (COPD), smoking, 
age, collagen disorders, non-incisional hernias (including inguinal hernia), 
and cardiovascular disease(13). For patients with missing covariate data 
for BMI, we imputed the mean BMI value. We assessed subgroup effects by 
tests of interaction to prevent over-interpretation of apparent differences in 
effectiveness for all baseline characteristics. We chose not to do Cox-regression 
analysis as specified in the protocol. Because most patients had available 
two-time measurements (1 month and 1 year postoperatively), we defined 
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incisional hernia as a binary endpoint if it took place up to 15 months after 
randomisation, with cross-table and logistic regression as the natural analyses, 
rather than Kaplan-Meier and Cox-regression analyses. Statistical comparison 
of quality of life between patient groups (small vs large bites technique and 
with or without incisional hernia during follow-up) was done by multilevel 
analysis (linear mixed-effects model with random effect for each patient). Time, 
randomisation (small vs large bites), and the interaction between time and 
randomisation were main effects, with adjustment for age and sex. Analysis 
was by intention to treat. We did statistical analysis with SPSS (version 20.0) and 
R statistical software (version 3.1.0).
This trial is registered with Clinicaltrials.gov, number NCT01132209, and 
Nederlands Trial Register, number NTR2052.
Role of the funding source
The funders of the study had no role in study design, data collection, data 
analysis, data interpretation, or writing of the report. All authors had full access 
to all the data in the study and had final responsibility for the decision to submit 
for publication.
Results
The figure shows the trial profile. Between Oct 20, 2009, and March 12, 2012, we 
randomly assigned 560 patients to the large bites group (n=248) or the small 
bites group (n=276). Follow-up ended on Aug 30, 2013; 545 (97%) completed 
follow-up and were included in the primary outcome analysis (figure). Baseline 
characteristics were similar between groups, except that slightly more patients 
with COPD were included in the small bites group (table 1). Most surgical 
procedures were for gastrointestinal oncological diseases and consisted of 
opening or partial resection of the gastrointestinal tract (table 1).
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Figure: CONSORT flow-chart of study enrollment.(20) 
*Not operated through midline incision, need to (partly) resect the abdominal wall or incisional 
hernia detected during incision. **Logistical reasons, computer randomisation issues, or surgeon was 
unfamiliar with this study.
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Table 1: Baseline characteristics
Large bites group (n=284) Small bites group (n=276)
Sex 
• Male - n (%)
• Female - n (%)
139 (48%)
145 (51%)
137 (50%)
139 (50%)
Age - years (median, IQR) 63 (54-71) 62 (53-72)
BMI - kg/m2* (median, IQR) 24 (22-27) 24 (22-27)
Smoking - n (%) 65 (23%) 77 (28%)
Diabetes Mellitus - n (%) 39 (14%) 29 (11%)
COPD - n (%) 27 (10%) 44 (16%)
Cardiovascular disease - n (%) 116 (41%) 101 (37%)
Corticosteroid usage - n (%) 18 (6%) 28 (10%)
Non incisional hernias† - n (%) 34 (12%) 37 (13%)
Aneurysma abdominal aorta - n (%) 12 (4%) 13 (5%)
Previous laparotomy - n (%) 43 (15%) 49 (18%)
ASA classification - n (%)
• 1
• 2
• 3 or higher
58 (20%)
183 (64%)
43 (15%)
61 (22%)
162 (59%)
53 (19%)
Preoperative chemotherapy - n (%) 75 (26%) 62 (22%)
Preoperative radiotherapy - n (%) 55 (19%) 59 (21%)
Type of surgery - n (%)
• Gynecological
• Upper gastrointestinal
• Lower gastrointestinal
• Vascular
41 (14%)
89 (31%)
133 (47%)
21 (7%)
41 (15%)
74 (27%)
140 (51%)
21 (8%)
BMI=Body Mass Index. COPD=Chronic Obstructive Pulmonary Disease. ASA=American Society of 
Anesthesiologists. *Data for BMI were missing for 12 patients.†Eg, inguinal, umbilical, and epigastric 
hernias in history.
Peri-operative complications (gastrointestinal perforation, haemorrhage, or 
cardiopulmonary event) arose in 64 (11%) patients and were equally distributed 
between groups. The amount of blood loss and numbers of inserted drains were 
also equally distributed (data not shown). Approximation of subcutaneous 
tissue and method of skin closure did not differ between both groups (data not 
shown). Table 2 shows details of the suture techniques.
Table 2: Details of suture techniques
Large bites 
group(n=284)
Small bites 
group(n=276)
p value
Number of stitches (mean; SD) 25 (10) 45 (12) <0•0001
Total length of used sutures (cm) (mean; SD) 95 (34) 110 (39) <0•0001
Wound length (cm) (mean; SD) 22 (5) 22 (5) 0•982
Rati of suture length to wound length (SL:WL) (mean; SD) 4.3 (1.4) 5.0 (1.5) <0•0001
Time of fascial closure (minutes) (mean; SD) 10 (4) 14 (6) <0•0001
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Of 545 patients, follow-up assessments were done by clinical and radiological 
examination in 338 (62%) patients, by radiological examination in 76 (14%), 
and by physical examination in 131 (24%) patients. Follow-up methods were 
similar between groups. 1 year postoperatively, 57 (21%) of 277 patients had 
incisional hernia in the large bites group and 35 (13%) of 268 patients had 
incisional hernia in the small bites group (p=0•0220; adjusted odds ratio [OR] 
0•52, 95% CI 0•31–0•87; p=0•0131). No subgroup effects were identified; all p 
values for interaction tests were greater than 0•20. In patients followed-up by 
both physical and radiological examination, incisional hernia was identified in 
43 (49%) of 87 patients by both physical and radiological examination, in 41 
(47%) of 87 solely by radiological examination, and in 3 (3%) of 87 solely by 
physical examination. In patients with incisional hernia, the mean fascial defect 
was 3•4 cm (SD 4•4). The size of the hernia defects did not differ significantly 
between groups (data not shown). Incisional hernias diagnosed by radiological 
examination alone were not significantly smaller than those diagnosed by 
both physical and radiological examination (mean 2•4 cm [SD 4•0] vs 4•2 cm 
[0•5]; p=0•0650.
Almost half of patients had postoperative complications, the incidence 
of which did not differ significantly between groups (table 3). Readmission 
rates and adverse events did not differ significantly between groups (table 3). 
Pain scores on the visual analogue scale did not differ significantly between 
groups in the first postoperative week (data not shown). 452 (94%) of 483 
patients completed the SF-36 questionnaire and the EQ-5D questionnaire 
12 months post-operatively. None of the SF-36 subdomains, the mental 
component summary (MCS) score, the physical component summary (PCS), or 
EQ-5D dimensions differed significantly between groups at 12 months (data 
not shown). Patients who developed incisional hernia during follow-up had 
lower general health SF-36 scores than did those without incisional hernia 12 
months post-operatively (mean 60•16 [SD 18•27] vs 64•84 [48•70]; p=0•0326) 
and reported more problems in EQ-5D dimension of mobility (1•46 [1•06] vs 
1•36 [0•46]; p=0•0318). We noted no significant differences for the other SF-36 
domains, the MCS, the PCS, EQ-5D dimensions, or overall health status on VAS 
(data not shown).
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Table 3: Secondary outcome parameters
Large bites group 
(n=284)
Small bites group 
(n=276)
p value
Patients with postoperative complications - n (%) 129 (45%) 125 (45%) 1•000
Ileus - n (%) 33 (12%) 28 (10%) 0•590
Pneumonia - n (%) 40 (14%) 35 (1%) 0•710
Cardiac event - n (%) 30 (11%) 25 (9%) 0•573
Surgical Site Infection (SSI) - n (%)
• Superficial Incisional SSI*
• Deep incisional SSI*
• Organ/space SSI*
68 (24%)
33 (12%)
12 (4%)
23 (8%)
58 (21%)
23 (8%)
8 (3%)
27 (10%)
0•419
0•207
0•496
0•554
Burst abdomen - n (%) 2 (1%) 4 (1%) 0•444
Length of hospital stay (days) – mean (SE) 14 (24) 15 (35) 0•585
*detailed criteria for SSIs can be found in the published study protocol(13).
Discussion
Our findings show that suturing of the fascia after abdominal midline incision 
with a continuous small bites technique reduces the incidence of incisional 
hernia compared with suturing with the conventional large bites technique. 
The small bites technique with a single suture USP 2-0 is a safe technique in view 
of the low incidence of burst abdomen, and is easily learnt and performed with 
the small needle(15). With a mean additional closure time of 4 min, the small 
bites technique is not very time consuming; additionally, the technique is not 
associated with a difference in postoperative pain. Our results are generalisable 
to the general surgical population in view of the participation of residents and 
specialists of vascular, general, gastrointestinal and gynaecological surgical 
specialties.
Although the Swedish trial(10) was the first prospective trial comparing 
large and small bites, this study had methodological limitations. Patients were 
quasi-randomised (alternated per calendar week) and radiological examination 
of the abdominal wall was not done. As a diagnostic technique for the presence 
of incisional hernia, ultrasonography has a reported sensitivity of 70–98%; 
physical examination has a reported sensitivity of 58–74% in diagnosis of 
incisional hernia(21, 22). Furthermore, in 16–28% of patients with complaints 
of discomfort at their scar, but without a palpable defect during physical 
examination, an incisional hernia was diagnosed by ultrasonography(21, 22). 
Because almost half of incisional hernias in the present trial were diagnosed 
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solely during radiological examination, our results attest that radiological 
imaging is essential to assess the presence of incisional hernia. Guidelines on the 
closure of abdominal wall incisions from the European Hernia Society strongly 
recommend that prospective studies with incisional hernias as a primary 
outcome should integrate medical imaging in the follow-up(2, 9, 18, 21). In our 
trial, roughly three-quarters of patients received radiological imaging during 
follow-up. Some patients had such an obvious clinical incisional hernia that 
imaging would have added no extra information. In some patients, radiological 
imaging was not done, either because patients were visited at home or because 
of local logistical difficulties. We considered achievement of standardisation to 
be important. Two major parameters were standardised: the technique of small 
and large bites and the target number of stitches per running cm of wound 
length, resulting in an appropriate ratio of suture length to wound length.
Our study has some limitations. Our primary analysis was done after 1 
year of follow-up. Previous studies(2, 4) have shown that incidence of incisional 
hernia increases during longer follow-up. Our follow-up of both clinical and 
radiological examination resulted in an incidence of 21% in the large bites 
group. These results are similar to those of other groups with longer follow-up(2, 
4). Because radiological examination was done for the diagnosis of incisional 
hernia, small incisional hernias could have been diagnosed that would not 
have been detected by physical examination. We feel that the diagnosis of 
these smaller hernias explains the fairly high incidence in both groups at 1 year 
and might translate into a smaller increase in new hernias during longer follow-
up. We do not expect that the effectiveness of the small bites will be affected 
with longer follow-up.
Another limitation might be that our results do not differentiate between 
an effect of the smaller bites or the use of different suture material. In this trial, 
we investigated the small bites technique described by Israelsson(14). For the 
small bites technique the UPS 2-0 PDS Plus II (Ethicon) single suture thread with 
a 31 mm needle was used, whereas the large bites procedure was done with 
a thicker PDS 1 loop with a 48 mm needle. Therefore, analysis of whether the 
small bites or the thinner needle and suture material reduces the incisional 
hernias in the small bites group needs further research.
We included only patients undergoing elective surgery. Evidence about 
the best closure technique in emergency laparotomy incisions is scarce, even in 
the EHS guidelines no recommendation is given(9). Whether results obtained 
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by studies for elective laparotomies can be extrapolated to emergency 
laparotomies remains a topic of discussion.
We hypothesise that the small bite suture technique in our trial, with 
twice the amount of stitches including the aponeurosis only, provides close 
to ideal conditions for fascia healing because of avoidance of necrosis of the 
rectus abdominis muscles and of optimum distribution of forces leading to a 
reduced incidence of incisional hernia. Experimental studies show that a suture 
technique with an equal distribution of forces on the fascia is necessary to 
achieve an optimum ratio of collagen type 1 to type 3. Too high tensile force 
per suture will result in more scar tissue(23, 24). The holding force of a suture 
depends on the collagen that deposits in the suture, which is best achieved by 
suturing of the aponeurosis without muscle or fat tissue(25). Experimental data 
show that the small bites technique is stronger than the large bites technique, 
which is consistent with the results of this clinical study(26). 
In this era of minimally invasive and robotic surgery, many patients with 
high-risk profiles or undergoing major abdominal surgical procedures will still 
have to have open surgical procedures with midline incision. Compared with 
previous trials, we examined a relatively high-risk group, which is relevant and 
consistent with present surgical practice. Challenging patient and surgical 
characteristics could be an explanation of the overall complication rate and 
the fairly high incidence of surgical site infection in both groups. The higher 
incidence of surgical site infection in our trial than in the Swedish trial might be 
explained by the difference in patient condition (eg, previous midline incision, 
more patients with diabetes, perioperative chemoradiation, and malnutrition), 
more major surgical procedures, and use of a strict standardised wound scoring 
method in this trial(10, 27). Although surgical site infection was not the primary 
endpoint of our trial, our results emphasise that wound infection remains a 
frequent complication in this surgical population and should be monitored 
carefully.
We also reported health-related quality of life and pain of patients who 
received the small bites suture technique. Postoperative quality of life or pain 
did not differ between the two groups. Patients with incisional hernia in both 
groups had significantly lower scores on the general health dimension and 
had more mobility problems. Furthermore, most of our patients had malignant 
disease, which is associated with a reduced quality of life in general(5, 28, 29). 
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In conclusion, the small bites suture technique is more effective than 
the traditional large bites suture closure technique for prevention of incisional 
hernia in midline incisions. The small bites technique is not associated with 
more pain or adverse events and should be considered the standard closure 
technique for midline incisions.
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Abstract
Introduction
The aim of this systematic review and meta-analysis was to evaluate the 
evidence from published randomized controlled trials (RCT) comparing closure 
materials or suture techniques for emergency and elective laparotomies. The 
primary outcome was incisional hernia after 12 months and the secondary 
outcomes were burst abdomen and surgical site infection (SSI). 
Materials and methods
A systematic computerized literature search was conducted using Medline, 
EMBASE, the Cochrane library, CINAHL, Scopus and Web-of Science including 
publications until May 2016. The quality of the RCTs was evaluated by at least 
3 assessors using critical appraisal checklists from SIGN. Meta-analyses were 
performed with Review Manager v5.3.
Results
A total of 23 RCTs were included in the meta-analysis. There was no evidence 
from RCTs using the same suture technique in both study arms, that any suture 
material (fast absorbable/slowly absorbable/non-absorbable) is superior in 
reducing incisional hernias. There is no evidence that continuous suturing is 
superior in reducing incisional hernias compared to interrupted suturing (OR 
= 1.20 ; 95%CI : 0.84, 1.71). For continuous suturing in elective midline closure, 
the small bites technique results in significantly less incisional hernias than a 
large bites technique (OR = 0.41 ; 95%CI : 0.19, 0.86).
Conclusion
No suture material or suture technique was proven superior. This allows us to 
choose a continues suture (faster) technique using a slowly absorbable suture 
and small bites (or small needle) for closure of a midline laparotomy.
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Introduction
Incisional hernia is a frequent problem after abdominal surgery with an 
incidence varying from 10% to 69% depending on the type of surgery, length 
and method of follow-up and patient characteristics(1-5). Incisional hernias 
develop due to insufficient healing of the abdominal wall after surgery. The 
defect in the abdominal wall allows for protrusion of intra-peritoneal content 
causing a variety of symptoms ranging from discomfort and impaired body 
image to incarceration and ischemia of the contents of the hernia sac. Besides 
significant morbidity and impaired quality of life, incisional hernias are costly 
to treat(6, 7). Well-known patient related risk factors for incisional hernia 
formation are smoking, obesity, relaparotomy and postoperative wound 
complications(8, 9). Additionally, the suture material and the surgical technique 
used to close a laparotomy wound are important surgical determinants 
of the risk of developing an incisional hernia. To reduce the incidence of 
incisional hernia, an international group of experts developed the European 
Hernia Society guidelines on the closure of abdominal wall incisions(10). The 
recommendations in this guideline for closure of midline incisions included a 
continuous suture technique, performed with a small bites technique and a 
slowly-absorbable suture material. These recommendations were mainly based 
on the evidence from systematic reviews on the subject(11-13). However, 
the randomized controlled trials (RCTs) included in these reviews generally 
compare a continuous suture technique with a slowly- or non-absorbable 
suture to an interrupted suture technique with a fast-absorbable suture. A 
comparison limited to those studies evaluating only one variable between study 
arms (same technique performed with different suture materials or different 
techniques performed with same suture material) was not performed. It was 
the hypothesis that in order to evaluate a certain suture material or technique, 
the same suture material should be used in both arms with various techniques 
and vice versa. Therefore this systematic review and meta-analysis was done 
to assess the evidence from published RCTs comparing closure materials or 
techniques for laparotomies with a primary outcome of incisional hernia after 
12 months and with secondary outcomes of surgical site infection (SSI) and 
burst abdomen. 
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Materials and methods
A written study protocol was produced and registered on Prospero 
(CRD42015023689) before the initiation of the systematic review and meta-
analysis. The data are reported in accordance with the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) statement(14).
Inclusion and exclusion criteria 
The aim of the systematic review and meta-analysis was to evaluate published 
RCTs comparing techniques and materials for fascial closure of a laparotomy. 
The primary outcome was incisional hernia and the secondary outcomes were 
SSI, burst abdomen/wound dehiscence and suture sinus formation. A minimum 
of 12 months follow-up was required. All types of incisions (transverse/midline/ 
oblique/paramedian), all indications for surgery (both emergency and elective 
laparotomies) were included. Only human studies on adults > 18 years of 
age were included. Studies on mesh closure of laparotomies and studies 
including historic suture materials such as catgut and stainless steel sutures for 
comparison were excluded.
Search strategy
A systematic computerized search was done independently by two authors 
(NAH and FM) in the following databases: Medline, EMBASE, Cochrane, 
SCOPUS, CINAHL and Web-of-Science. The search was not restricted to 
certain languages or years of publication. The last search was performed the 
9th of May 2016. In Medline and EMBASE, the search strategy was based on 
the Medical Subject Heading (MeSH) terms: laparotomy, wound closure, 
sutures and abdominal wall hernias. The detailed search term for Medline 
was ((“Wound Closure Techniques”[Mesh] OR “Sutures”[Mesh] OR “Surgical 
Procedures, Operative”[Mesh] AND “Laparotomy”[Mesh] AND (Randomized 
Controlled Trial[ptyp] AND “humans”[MeSH Terms])) OR (“Wound Closure 
Techniques”[Mesh] OR “Sutures”[Mesh] OR “Surgical Procedures, Operative”[Mesh] 
AND “Laparotomy”[Mesh] AND “Hernia, Ventral”[Mesh] AND (Randomized 
Controlled Trial[ptyp] AND “humans”[MeSH Terms]))). 
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Evaluation of papers and data extraction
Firstly, the records were screened by title and abstract by two assessors 
independently (ED, LV). Secondly, the full-texts were divided into two groups 
and each group was evaluated by two authors (NAH, ED, LV, RF) independently 
for eligibility with the use of critical appraisal checklist for randomized 
controlled trials developed by the Scottish Intercollegiate Guidelines Network 
(SIGN). Only papers rated as ‘acceptable’ or ‘high quality’ by SIGN were included 
in order to limit the risk of bias. Any disagreement between the two assessors 
were settled by discussion with a third evaluator (FM, MM). Data was extracted 
by two authors independently with regard to the predefined outcomes (NAH, 
FM) and checked by co-authors (LV, RF). Non-English full-texts were handled 
with same procedure by two individual assessors outside the author group.
Selection of outcomes to be included in the meta-analysis
In the meta-analysis, sutures were divided into fast-absorbable/slowly-
absorbable and non-absorbable sutures regardless of whether the sutures were 
monofilament or multifilament. Suture methods were divided into interrupted 
versus continuous suturing and small bites versus big bites technique, 
regardless of a layered or mass closure technique was used. Emergency and 
elective laparotomies were pooled in the same analysis, as was all types of 
incisions (midline, transverse/oblique/paramedian). It was decided only to 
compare different suture types, when the same suture method was used in 
both arms. Likewise, suture methods were only compared, when the same type 
of sutures were used for both methods.
Statistical analysis
The outcomes were pooled in conventional meta-analyses and reported as 
weighted odds ratios (OR) with 95% confidence intervals (95% CI) using the 
random effects model and illustrated with forest plots. Heterogeneity was 
explored using I2 statistics. Funnel plots were used to assess possible publication 
bias. The Cochrane risk of bias tool was used to assess the risk of bias. Kappa 
statistics were used to assess the agreement between two assessors. Statistical 
analyses were performed with Review Manager Software version 5.3 (The 
Nordic Cochrane Centre, Copenhagen, Denmark).
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Results
Literature search
Out of 1,818 citations, a total of 23 RCTs with 10,130 patients were included in 
the meta-analyses (Figure 1). The level of agreement between the two assessors 
was moderate for screening abstracts and high for assessing eligibility of the 
full-texts. All studies were published in peer-reviewed journals from 1981 to 
2015. One study was in French, and the remaining 22 studies were English. 
Study characteristics are listed in Table 1.
Risk of bias
Seven of the studies were considered high quality with the SIGN critical appraisal 
checklist, and the overall risk of bias was low. The most frequent source of bias 
was performance bias, as 12 of the studies did not report whether participants 
or personnel were blinded to the allocation. The funnel plots revealed no signs 
of publication bias.
Type of laparotomy
A total of 6 studies included only elective midline laparotomies(4, 12, 15-18). Nine 
of the studies included both emergency and elective midline laparotomies(2, 
19-26), but none of them reported outcome data separately for the emergency 
or elective procedures. A total of 5 studies included emergency and elective 
procedures through all kinds of incisions(27-31), but again outcome data was 
not reported separately for emergency and elective procedures. Only two of 
the studies(30, 31) subgrouped the outcome data with regard to incision type 
and Sahlin et al. reported more incisional hernias and wound dehiscences in 
midline laparotomies, whereas Richards et al. found no significant differences 
regarding type of incision.
Reporting of suture technique
The suture technique differed widely between the studies, making it difficult 
to extract data on varying suture methods apart from continuous versus 
interrupted and small bites versus big bites technique. In 9 of the studies, 
the stitch size was not reported. Six studies(2, 4, 12, 15, 25, 32) reported that 
a 4:1 suture technique was used, but only half of them reported the specific 
measurements(4, 12, 25).
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Figure 1. PRISMA flow diagram of search strategy and study selection
Primary outcome – incisional hernia
The vast majority of the studies defined incisional hernia with clinical 
examination as a protrusion of the laparotomy scar with the use of Valsalva’s 
maneuver. Only five studies used radiological examination in the identification 
of incisional hernias(2, 4, 12, 15, 32). There was no reporting on differences of 
incisional hernia rates between elective and emergency laparotomies(2, 19-31). 
There were no significant differences on incisional hernia rates when comparing 
non-absorbable and slowly-absorbable sutures or slowly-absorbable and fast-
absorbable sutures (Figures 2and 3). There was a tendency towards fewer 
incisional hernias, when using non-absorbable sutures compared with fast-
absorbable sutures, but this was not significant (Figure 4). 
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Secondary outcome – surgical site infection, wound dehiscence/burst 
abdomen, suture sinus
Various criteria were used for definition of SSI ranging from the definition by 
Center of Disease Control and Prevention with the classification into superficial, 
deep and organ/space infection to the surgeon’s clinical assessment of the wound. 
Wound dehiscence and burst abdomen was poorly defined by the majority of the 
studies. Wound dehiscence seemed to include both skin dehiscence with intact 
fascia and fascial disruption. In the meta-analysis, we defined burst abdomen as 
cases where a fascial dehiscence was described. Only one study reported that 
SSI was more common after emergency laparotomy compared with elective 
laparotomy(27). Several studies found that the development of an incisional 
hernia was preceded by a SSI in up to 40% of the cases(25-29). 
There were no significant differences on SSI and burst abdomen, when 
comparing the use of non-absorbable, slowly-absorbable and fast-absorbable 
sutures. Further, there were no differences on SSI and burst abdomen using 
a continuous or interrupted suture technique. Millbourn et al.(25) reported 
significantly fewer SSIs when using a small bites suture technique, however, 
Deerenberg et al.(4) found no significant differences on SSI between small and 
big bites technique (Figure 8). There were no significant differences regarding 
burst abdomen between small and big bites technique(4, 25).
Suture sinus formation, palpable knots and wound pain was reported to 
be a problem with the use of non-absorbable sutures as compared with fast- 
and slowly-absorbable sutures in several studies(19, 21, 23, 26, 28), whereas 
only one study found no significant differences on suture sinus between non-
absorbable and slowly-absorbable sutures(20).
Discussion
The results of this systematic review and meta-analysis show that a small bites 
continuous suture technique with a slowly-absorbable polydioxanone (PDS) 
small sized suture decreases the incisional hernia rate compared to a large 
bite technique with a larger suture. There were no significant differences on 
incisional hernia rate when comparing non-absorbable, slowly-absorbable and 
fast absorbable sutures using the same suture technique. Furthermore, using 
an interrupted or continuous suture technique with the same kind of suture 
material did not affect incisional hernia rate. 
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Non-absorbable or slowly-absorbable sutures was not superior to fast-
absorbable sutures in decreasing incisional hernia rate in this meta-analysis. In 
accordance, a recent systematic review by Bosanquet et al(3). did also conclude 
that there is no evidence that suture type has an intrinsic effect on incisional 
hernia rate. However, this finding is controversial compared with previous 
meta-analyses concluding that slowly-absorbable sutures are superior to 
fast absorbable sutures(11, 13). These previous meta-analyses differ from the 
current meta-analysis, which may explain the different conclusions. Firstly, 
only RCTs on midline laparotomies were included. Further, RCTs comparing 
a continuous suture technique using slowly-absorbable sutures with an 
interrupted suture technique using rapid absorbable suture were compared 
in the forest plots(11). Lastly, both meta-analyses included papers that were 
rejected in the current meta-analysis because of inadequate quality judged by 
the critical appraisal checklists. 
Although no significant differences between sutures could be found 
on incisional hernia and SSI rate, we agree with the recommendations of the 
European Hernia Society to use a slowly-absorbable suture when closing the 
fascia(10). When considering the biology of wound healing, using a slowly or 
non-absorbable suture for fascial closure seems appropriate. Fascial healing 
starts by recruiting inflammatory cells. Two to five days after laparotomy 
fibroblasts enter the wound and start producing collagen. During the 
proliferation phase of the first three weeks, mainly type III collagen is produced 
and an extracellular matrix is created. Type III collagen consists of thin, weak 
fibers and is replaced by strong and thick type I collagen during the following 
maturation phase(35, 36). The last part of the maturation phase is remodeling 
or realignment of collagen fibers along tension lines and can take up to 
years. The half-life tensile strength of absorbable sutures like polyglactin 910 
(Vicryl®) and polyglycolid acid (Dexon®) is around 2-3 weeks(37), suggesting an 
insufficient support of the healing fascial tissue. The half-life tensile strength 
of slowly-absorbable suture polydioxanone (PDS®) is 6 weeks(37). Since fascia 
needs at least 14 days to regain its strength(35, 38), using a fast-absorbable 
suture might not provide long enough support to the healing fascia, although 
this is not supported by our data. Since suture sinus formation, palpable knots 
and wound pain was reported to be a problem with the use of non-absorbable 
sutures(19-21, 23, 26, 28), a slowly-absorbable suture is preferred over a non-
absorbable suture. 
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Although no significant differences could be found when comparing 
interrupted and continuous suture techniques using the same suture material, 
we agree with the recommendations of the European Hernia Society to use 
a continuous suture technique to close the fascia(10). The superiority of the 
combination of a continuous technique with a slowly-absorbable suture on the 
incidence of incisional hernia has been determined in high-quality systematic 
reviews and meta-analyses(11, 13). Furthermore, a continuous technique is 
faster than an interrupted technique thereby reducing the length of surgery(13).
Two RCTs proved that a small bites suture technique using 2-0 
monofilamented slowly-absorbable stuture material significantly reduces 
incisional hernia rate compared to a large bite 1-0 suture technique(4, 25). This 
suture method was firstly described by Israelsson et al. and is also referred to as 
the 4:1 suture method, as the suture length should be at least four times as long 
as the laparotomy incision(39). Using twice the amount of stitches including 
the aponeurosis only, provides close to ideal conditions for fascial healing 
due to avoidance of necrosis of the rectus abdominis muscles and to optimal 
distribution of forces leading to a lower incidence of incisional hernia(4, 25, 40). 
Whether it is the size of the bites or the size of the suture, that is important in 
decreasing hernia rate is still unknown. Hypothetically, it is technically more 
difficult to perform the small bites technique with a larger needle and thicker 
suture.
The incidences of SSI reported in the included RCTs emphasize that 
wound infection remains a frequent complication after laparotomy and should 
be scored carefully. Furthermore, it was reported in the RCTs that incisional 
hernias were preceded by SSI in up to 40% of the cases(25-29), stressing that 
SSI is an important risk factor for incisional hernia formation. However, in this 
meta-analysis the suture material or suture method did not seem to influence 
the rate of SSI and burst abdomen. 
Optimizing all surgical-technical factors in closing a midline laparotomy 
and the increasing use of minimally invasive surgery unfortunately does not 
reduce incisional hernia rate to zero. Patients undergoing open surgery for 
abdominal aortic aneurysm and obese patients have a higher risk of incisional 
hernia formation(8, 41). In these high-risk patients, other interventions might 
be needed to further reduce the incidence of incisional hernia. Patients with 
an abdominal aneurysm or obesity were found to benefit from prophylactic 
mesh augmentation with a significant reduction in the incisional hernia rate 
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with an odds ratio of 0.25(42, 43). Furthermore, many patients with high-
risk profiles such as many previous laparotomies, emergency surgery and/or 
major abdominal surgical procedures will still have to undergo open surgical 
procedures through midline incisions. In these high-risk groups the avoidance 
of incisional hernia remains a challenge. Further studies on the optimal closure 
technique in emergency laparotomies are still needed, and should include the 
small bites technique in one study arm. To the best of our knowledge, there 
is only one ongoing RCT on midline emergency laparotomies comparing 
continuous all-layer suturing with slowly-absorbable suture to an interrupted 
technique with fast-absorbable sutures(44). The meta-analysis design is limited 
by the fact that the results depend on the included studies. Furthermore, one 
could argue that only studies on elective midline laparotomies should be 
included in order to minimize heterogeneity. On the other hand, the reality 
rarely represents with only elective midline laparotomies. Yet this is the first 
systematic review and meta-analysis to compare studies on the suture material 
using the same technique in both arms, which is essential to conclude anything 
on type of sutures. Likewise, to evaluate the suture technique, the same suture 
type must be used in both arms. Further, to minimize risk of bias, the SIGN 
checklists were used by two independent assessors for evaluation of the RCTs.
In conclusion, no suture material proved superior to other in the meta-
analyses. However, a slowly-absorbable suture material seems wise to use as it 
keeps its strength until the fascial tissue is healed. Further, a slowly-absorbable 
suture does not increase the SSI rate compared to fast-absorbable sutures and 
decreases the risk of wound pain and suture sinus, which is a risk when using 
non-absorbable material. Moreover, there were no difference on an interrupted 
suture technique compared with a faster continuous technique. On the other 
hand, this meta-analysis significantly concludes that the best-evidenced 
technique for closure of a laparotomy incision is a small bites suture technique 
with a 2-0 slowly-absorbable suture including the aponeurosis only in a suture 
to wound length ratio of at least 4:1. 
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Abstract 
Background 
The material and the surgical technique used to close an abdominal wall 
incision are important determinants of the risk of developing an incisional 
hernia. Optimizing closure of abdominal wall incisions holds a potential to 
prevent patients suffering from incisional hernias and for important costs 
savings in health care. 
Methods
The European Hernia Society formed a Guidelines Development Group 
to provide guidelines for all surgical specialists who perform abdominal 
incisions in adult patients on the materials and methods used to close the 
abdominal wall. The guidelines were developed using the GRADE approach 
(Grading of Recommendations Assessment, Development and Evaluation) 
and methodological guidance was taken from SIGN (Scottish Intercollegiate 
Guidelines Network). The literature search included publications up to April 
2014. The guidelines were written using the AGREE II instrument. An update of 
these guidelines is planned for 2017.   
Results
For many of the Key Questions that were studied no high quality data was 
detected. Therefore, some strong recommendations could be made but, for 
many Key Questions only weak recommendations or no recommendations 
could be made due to lack of sufficient evidence.
Recommendations 
To decrease the incidence of incisional hernias it is strongly recommended to 
utilise a non-midline approach to a laparotomy whenever possible. For elective 
midline incisions, it is strongly recommended to perform a continuous suturing 
technique and to avoid the use of rapidly absorbable sutures. It is suggested 
using a slowly absorbable monofilament suture in a single layer aponeurotic 
closure technique without separate closure of the peritoneum. A small bites 
technique with a suture to wound length (SL/WL) ratio at least 4/1 is the 
current preferred method of fascial closure. Currently, no recommendations 
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can be given on the optimal technique to close emergency laparotomy 
incisions. Prophylactic mesh augmentation appears effective and safe and can 
be suggested in high-risk patients. For laparoscopic surgery it is suggested 
using the smallest trocar size adequate for the procedure and closure of the 
fascial defect if trocars larger or equal to 10 mm are used. For single incision 
laparoscopic surgery we suggest meticulous closure of the fascial incision to 
avoid an increased risk of incisional hernias.   
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Introduction
Background
Incisional hernias are a frequent complication of abdominal wall incisions, but 
a wide range of incisional hernia rates are reported(1-6). The weighted mean 
incisional hernia rate at 23.8 months was 12.8 % in a systematic review and meta-
regression study(7), but incidence rates up to 69 % have been reported in high-
risk patients with prospective long-term follow-up(8). The reported incidence 
is determined by several factors: the patient population studied, the type of 
abdominal wall incision, the length of follow-up and the method of incisional 
hernia diagnosis. Risk factors for incisional hernias include postoperative 
surgical site infection, obesity and abdominal aortic aneurysm(9-11). 
Nevertheless, it seems that the suture material and the surgical technique 
used to close an abdominal wall incision, are the most important determinants 
of the risk of developing an incisional hernia(4, 12). The development of an 
incisional hernia has an important impact on the patients’ quality of life and 
body image(13). Furthermore, the repair of incisional hernias still has a high 
failure rate with long term recurrence rates above 30 %, even when mesh repair 
is performed(14-16). Optimising the surgical technique to close abdominal wall 
incisions using evidence based principles, holds a potential to prevent patients 
suffering from incisional hernias and the potential sequelae of incisional hernia 
repairs(17). The mean direct and indirect costs for the repair of an average 
incisional hernia in an average patient in France in 2011 was € 7,089(18). Thus, 
reducing the incisional hernia rate by optimising the closure of abdominal 
wall incisions holds a great potential for costs savings in the use of health care 
facilities and in reducing postoperative disability.
The European Hernia Society (EHS) originated from the “Groupe de la 
recherche de la paroi abdominal” (GREPA), which was founded in 1979 with 
the aim: “The promotion of abdominal wall surgery, the study of anatomic, 
physiologic and therapeutic problems related to the pathology of the 
abdominal wall, the creation of associated groups which will promote research 
and teaching in this field, and the development of interdisciplinary relations”. 
During the autumn board meeting of the EHS in September 2013 in Italy it was 
decided to extend our mission to actively promote the prevention of incisional 
hernias by the Sperlonga statement: “Maybe we should first learn and teach 
how to prevent incisional hernias, rather than how to treat them?”
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Objective
The objective is to provide guidelines for all surgical specialists who perform 
abdominal incisions in adult patients on the optimal materials and methods 
used to close the abdominal wall. The goal is to decrease the occurrence of 
both burst abdomen and incisional hernia. The guidelines refer to patients 
undergoing any kind of abdominal wall incision, including visceral surgery, 
gynaecological surgery, aortic vascular surgery, urological surgery or 
orthopaedic surgery. Both open and laparoscopic surgeries are included in 
these guidelines.
Methods
As EHS secretary of Quality, Filip Muysoms, under the auspices of the European 
Hernia Society board, proposed the Guidelines Development Group. The 
project was presented to the EHS board and accepted during the board meeting 
in Sperlonga, Italy, on September 28th 2013. The members of the Guidelines 
Development Group were chosen to recruit key opinion leaders and researchers 
on the subject from Europe. A geographical distribution across European 
countries was attempted and some younger surgeons having performed 
research on the subject were included in the Guidelines Development Group. 
Many of the members have contributed previously in producing guidelines 
on a national and international level. The Guidelines Development Group 
included abdominal wall surgeons, upper gastro-intestinal surgeons, hepato-
biliary surgeons, colorectal surgeons and a vascular surgeon.
During a Kick Off meeting of the Guidelines Development Group 
in the Bonham Hotel in Edinburgh on October 28th 2013, the members 
attended a seminar on the methodological aspect of developing guidelines 
by Robin T Harbour, the Lead Methodologist of the Scottish Intercollegiate 
Guidelines Network (SIGN)(19). The AGREE II instrument was used from the 
start of the project to guide our methodology and structure of producing the 
guidelines(20). AGREE II gives as definition for the Quality of a guideline: “The 
confidence that the potential biases of guideline development have been 
addressed adequately and that the recommendations are both internally 
and externally valid, and are feasible for practice.” During this first meeting 
Key Questions were formulated and translated into 24 patients-intervention-
Chapter 5
90
comparison-outcome (PICO) formats. For each Key Question at least three 
Guidelines Development Group members were assigned as investigators and 
specific search terms were formulated. 
On November 11th 2013, a meeting in Glasgow at the SIGN headquarters 
was held with the steering committee of the Guidelines Development Group 
to discuss the search strategy. A clinical librarian working for SIGN performed 
the primary literature research for all Key Questions. This involved a search for 
systematic reviews and/or meta-analyses on the Key Questions in Medline, 
Embase, NIHR CRD, NICE and The Cochrane library. The PRISMA flow diagram is 
shown in Figure1. The Guidelines Development Group members evaluated the 
systematic reviews for their relevance to the Key Questions and a qualitative 
assessment was done using the SIGN checklist No 1 for systematic reviews 
and meta-analyses(19). Only systematic reviews of High Quality were used 
as basis for the guidelines development. A second search (no filters) on the 
Key Questions was performed for relevant RCT’s published after the end of 
the search performed for the systematic reviews involved. If no High Quality 
systematic review was identified for a Key Question, the working group 
members performed a separate systematic review using the PRISMA statement 
methodology(21). To avoid lengthening of this guidelines manuscript, the 
results of these systematic reviews will be submitted as a separate manuscript 
on behalf of “The Bonham Group”, which are the members of the Guidelines 
Development Group. The members working together on a Key Question 
provided a Summary of Findings table from the results of the literature search, 
which were presented and discussed during the second group meeting.
The second Guidelines Development Group meeting was held in 
Edinburgh on April 25th 2014. For evaluation of evidence, the Grading of 
Recommendations Assessment, Development and Evaluation (GRADE) 
approach was used(22). For each Key Question, a level of evidence was 
proposed using the GRADE approach and four levels of quality of the body 
of evidence were used: high, moderate, low, very low (Table 1). Based on the 
research evidence, the clinical experience and patient values the Guidelines 
Development Group formulated a recommendation for each Key Question. In 
the GRADE approach only three levels of recommendation are used: strong 
recommendation, weak recommendation and no recommendation.
The results of the guidelines proposed by the Guidelines Development 
Group were presented during the 36th Annual International Congress of the 
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European Hernia Society in Edinburgh on May 31st 2014. The manuscript 
was subsequently written by the first author in a uniform manner for all 
Key Questions and send for review and agreement by all co-authors. Prior 
to submission, the manuscript of the guidelines was externally reviewed by 
experts and evaluated using the AGREE II instrument.
Results
The results of the searches are shown in the PRISMA flow diagram in Figure 1. 
From the 97 records detected by the SIGN process, 69 records were excluded 
based on the title and abstract as not being relevant to the guidelines. The 
remaining 28 systematic reviews(4, 23-49) were assessed by full text for their 
relevance to the Key Questions and if retained were assessed qualitatively 
using the SIGN checklist No 1(19). Additional searches on PubMed and by 
checking the references of all manuscripts were performed by the members of 
the Guidelines Development Group assigned to each Key Question. Relevant 
studies published up until April 2014 were included to provide the Summary 
of Evidence tables.
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Figure 1. PRISMA flow diagram for the search for systematic reviews and/or meta-analyses performed 
by Scottish Intercollegiate Guidelines Network (SIGN) for the Guidelines Development Group of the 
European Hernia Society guidelines on the closure of abdominal wall incisions. The search was 
performed in November 2013 and included searches in Medline, Embase, NIHR CRD, NICE and The 
Cochrane library
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Table 1. Using the GRADE approach to guideline development(22) the Quality of the body of evidence 
is rated (high/moderate/low/very low) and the recommendations are graded as strong or weak
Grading the Quality of the body of evidence for each Key Questions using the GRADE approach 
Underlying methodology Quality rating Symbols Definitions
Randomized trials; 
or double-upgraded 
observational studies.
High ■■■■ Further research is very unlikely to 
change our confidence in the estimate 
of effect
Downgraded randomized 
trials; or upgraded 
observational studies.
Moderate ■■■□ Further research is likely to have an 
important impact on our confidence in 
the estimate of effect and may change 
the estimate
Double-downgraded 
randomized trials; or 
observational studies.
Low ■■□□ Further research is very likely to have 
an important impact on our confidence 
in the estimate of effect and is likely to 
change the estimate
Triple-downgraded 
randomized trials; or 
downgraded observational 
studies; or case series/case 
reports.
Very low ■□□□ Any estimate of effect is very uncertain.
Grading of recommendations using the GRADE approach
Strong recommendation Based on the available evidence, if clinicians are very certain that 
benefits do, or do not, outweigh risks and burdens they will make a 
strong recommendation.
Weak recommendation Based on the available evidence, if clinicians believe that benefits and 
risks and burdens are finely balanced, or appreciable uncertainty exists 
about the magnitude of benefits and risks, they must offer a weak 
recommendation.
No recommendation If based on the lit
Which diagnostic modality is the most suitable to detect incisional 
hernias?
No systematic reviews on diagnostic modalities for incisional hernias were 
found. Fifteen records were included in the qualitative analysis(1-3, 6, 50-60). 
Only four studies were retained as High Quality and are listed in the Summary 
of Findings table (Table 2)(3, 50, 51, 60).
The quality of most studies investigating the diagnostic accuracy of 
imaging techniques was low to very low. Only some provided a sensitivity 
analysis. Because no studies compared different diagnostic modalities in a 
similar methodology and with similar study arms, no pooling of data was useful 
or possible. In general, most studies show that medical imaging will increase the 
rate of detection of incisional hernias compared to physical examination. In an 
everyday clinical setting this is usually not important, because most asymptomatic 
hernias do not require treatment and their diagnosis is thus not necessary.
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CT scan is reliable and reproducible, whereas ultrasound is more 
operator-dependant. However, CT scan will induce a radiation load to the 
patients and ultrasound is more accessible in most health care settings. A good 
standardisation and dynamic evaluation by ultrasound of the abdominal wall is 
needed, as described by Beck et al.(51) as the dynamic abdominal sonography 
for hernia (DASH) technique.
The difference in accuracy between physical examination and imaging 
technique is most important in the context of comparative studies evaluating 
incisional hernia rate. Next to the method of incisional hernia diagnosis the 
length of follow-up is important. Fink et al.(5) reported in a follow-up study 
of two prospective trials an increase from 12.6 % at 12 months to 22.4 % at 
36 months (p < 0.001) and concluded that follow-up for 3 years should be 
mandatory in any study evaluating the rate of postoperative incisional hernia 
after midline laparotomy.
Statement It is recommended that prospective studies 
with incisional hernia as a primary outcome 
integrate medical imaging, either dynamic 
ultrasound or CT-scan, in the follow-up.
■■□□
strong
Statement It is recommended that studies with incisional 
hernia as a primary outcome include follow-
up of at least 24 months (and preferably 36 
months).
■■□□
strong
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Does the type of abdominal wall incision influence the incidence of 
incisional hernias or burst abdomen?
Laparotomy incisions can be classified as midline, transverse, oblique or 
paramedian incisions(61). Six systematic reviews have compared midline 
laparotomies to alternative incisions(26, 27, 31, 36, 38, 61), but only two were 
considered High Quality (26, 27). A recent systematic review by Bickenback 
et al.(26) compared midline, transverse (including oblique) and paramedian 
incisions. This review included all relevant studies from previous reviews and 
no additional RCT’s were detected that were published after this review. The 
literature search of this systematic review(26) identified studies published 
until 2009 and 24 RCT’s directly comparing different laparotomy incisions 
were included in the analysis. The incisional hernia rates after non-midline 
incisions were significantly lower compared to the incisional hernia rates after 
midline incisions, for both transverse incisions (RR = 1.77; 95 % CI:1.09–2.87) 
and paramedian incisions (RR = 3.41; 95 % CI: 1.02–11.45)(26). However, data 
on burst abdomen (deep wound dehiscence or fascial dehiscence) were not 
significantly different between the different incisions types.
A Cochrane review by Brown et al.(27) published in 2005 and updated 
in 2011, compared transverse versus midline incisions, but excluded studies 
comparing paramedian incisions. A decreased incisional hernia rate after 
transverse incisions was reported compared to midline incisions (OR = 0.49; 95 
% CI: 0.30–0.79).
Both reviews concluded that non-midline incisions significantly reduced 
the risk of incisional hernia compared to midline incisions, but did not influence 
the risk of burst abdomen. Interestingly, the Cochrane conclusions were more 
moderate, due to methodological and clinical heterogeneity of the studies and 
the risk of potential bias.
Statement Non-midline incisions are recommended where 
possible ■■■□
strong
What is the optimal technique to close a laparotomy incision? 
Ten systematic reviews on the techniques and/or the materials to close 
abdominal wall incisions were identified (4, 32, 34, 37, 38, 42, 43, 48, 62, 63). The 
data from the different systematic reviews are very incoherent and conclusions 
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are often completely contradictory. The overall quality of most systematic 
reviews is low and therefore, several should be rejected as evidence to create 
guidelines. A major problem to identify the evidence from the literature is the 
fact that most prospective studies compared several variables between the 
study arms. Moreover, the populations studied are often very different: midline 
only or including other incisions, emergency or elective surgery, and different 
operative indications.
The current guidelines on techniques and materials are based on the 
systematic reviews by Diener et al.(4) and van’t Riet et al.(48) which were 
evaluated as High Quality. Both systematic reviews included only studies 
involving midline laparotomies and the review by Diener et al. was the only 
one to distinguish between elective or emergency surgery. The systematic 
review by Sajid et al.(43) was used for the question on suture materials and a 
recent Cochrane review by Gurusamy et al.(62) was used for the question on 
peritoneal closure.
Using separate PICO’s the shortcoming of many study designs to deliver 
clear answers becomes obvious. Another shortcoming in most studies on 
closure of laparotomies is the failure to monitor the technical details of the 
suturing technique, like the SL/WL ratio and the stitch size. As demonstrated 
by Israelsson(64) this might be an important confounding factor in studies 
comparing different suture materials. An updated systematic review taking 
into account the mentioned shortcomings of individual studies might be 
performed, but for these guidelines the conclusions are based on the data 
from the currently available systematic reviews. The protocol for an ongoing 
Cochrane review(65) was published in 2006 but the final data have not yet 
been published.
Statement It is recommended that prospective 
randomized studies on the suture material 
to close abdominal wall incisions use the 
same suturing technique in both study 
groups.  
strong
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Statement It is recommended that prospective 
randomized studies assessing the 
technique to close abdominal wall 
incisions use the same suture material in 
both study groups.  
strong
Continuous suturing versus interrupted sutures 
Both meta-analyses concluded that continuous suturing for closure of midline 
laparotomies was beneficial compared to interrupted closure (4, 48). Diener et 
al.(4) found a significant lower incisional hernia rate for continuous suturing 
(OR 0.59: p = 0.001) in elective surgery. Most of the included studies were at 
high risk of bias because the interrupted study arm used rapidly absorbable 
multifilament sutures and the continuous arm used either non-absorbable 
or slowly absorbable monofilament sutures. van’t Riet et al.(48) included 
studies involving emergency laparotomies and did not find any difference 
in incisional hernia rate between interrupted and continuous suturing. 
Continuous suturing was recommended because it was significantly faster.
Statement Continuous suturing for closure of 
midline abdominal wall incisions in 
elective surgery is recommended  
■■□□
strong
Closure versus non-closure of the peritoneum
The Cochrane review by Gurusamy et al.(62) concluded that there was no short-
term or long-term benefit in peritoneal closure. Five studies were included but 
were heterogeneous in type of incision (midline and non-midline) and included 
both elective and emergency laparotomies. In all studies the peritoneum was 
closed as a separate layer in the study arm with peritoneal closure. 
Statement Closure of the peritoneum as a separate 
layer during closure of laparotomy 
incisions is NOT recommended
■■□□
weak
Mass closure versus single layer closure
The search for the most appropriate layers to be sutured when closing a 
laparotomy is hampered by the lack of good definitions on what constitutes a 
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mass closure, layered closure or single layer closure. No clinical studies directly 
comparing different closure methods were found. 
For future research the Guidelines Development Group proposes the following 
definitions: 
-  mass closure: the incision is closed with a suture bite including all 
layers of the abdominal wall except the skin.
-  layered closure: the incision is closed with more than one separate 
layer of fascial closure
-  single layer aponeurotic closure: the incision is closed by suturing only 
the abdominal fascia in one layer.
Statement For closure of midline abdominal wall 
incisions in elective surgery, a single 
layer aponeurotic closure is suggested
■□□□
weak
Suture length to wound length ratio (SL/WL)
The beneficial effect of a high SL/WL ratio on reducing the incidence of 
incisional hernias has been recognised for a long time(66), but evidence from 
clinical prospective studies remains scarce and most of the work addressing 
the topic comes from the Clinic of Sundsvall in Sweden(64, 67, 68). A RCT, 
performed in Sundsvall, demonstrated the importance of the SL/WL ratio in 
reducing incisional hernia rate. The critical value was determined to be at a 
ratio of 4/1(64). Although a SL/WL ratio ≥4 is often mentioned in the protocol of 
prospective studies, many fail to document that the SL/WL ratio was recorded 
for the individual study patients.
Statement A suture to wound length ratio (SL/WL) 
of at least 4/1 for continuous closure 
of midline abdominal wall incisions in 
elective surgery is suggested.
■■□□
weak
Statement It is recommended that all prospective 
studies on the closure of laparotomy 
incisions will document the suture to 
wound length ratio (SL/WL) in all patients, 
as well as the number of stitches.
strong
EHS guidelines
101
5
Small bites versus large bites
Millbourn et al.(69) demonstrated that closure of a midline laparotomy with a 
“small bites” technique resulted in significant less incisional hernias (5.6% vs 
18.0 %; p< 0.001) and less surgical site infections (SSIs) (5.2% vs 10.2%; p= 0.02). 
In the small bite technique the laparotomy wound is closed with a single layer 
aponeurotic suturing technique taking bites of fascia of 5 - 8 mm and placing 
stitches every 5 mm. 
Statement The “small bites technique” for continuous 
closure of midline incisions is suggested. ■■■□
weak
What is the optimal suture material to close a laparotomy incision? 
Despite significant heterogeneity and confounders in most SRs identified, a 
study by Sajid et al.(43) focused solely on the suture material. Table 3 defines 
the suture materials used in the included studies. 
Rapidly absorbable suture versus non-absorbable or slowly absorbable sutures
Diener et al. (4) reported a significantly lower incisional hernia rate with slowly 
absorbable sutures (OR 0.65: p= 0.009) in elective surgery. Subgroup analysis 
performed by van ‘t Riet et al.(48) comparing only continuous suturing studies, 
detected only one RCT by Wissing et al.(70) using continuous suturing in both 
study arms. This study, which included 21% of emergency operations, showed 
significantly more incisional hernias with rapidly absorbable sutures compared 
to non-absorbable sutures (p= 0.001) and compared to slowly absorbable 
sutures (p = 0.009). 
Statement The use of rapidly absorbable suture 
material for closure of midline abdominal 
wall incisions in elective surgery is NOT 
recommended. 
■■■□
strong
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Table 3 List of the most commonly used suture materials to close abdominal wall incisions and their 
characteristics
Suture Producer Material Absorbable Absorption 
time
Filaments Antibiotics 
impragnated
Prolene Ethicon Polypropylene Non Mono No
Surgipro Covidien Polypropylene Non Mono No
Ethilon Ethicon Nylon Non Mono No
Monosof Covidien Nylon Non Mono No
Ethibond Ethicon Polyethylene Non Multi No
Mersilene Ethicon Polyester Non Multi No
Surgilon Covidien Nylon Non Multi No
Maxon Covidien Polyglyconate Slowly 180 days Mono No
PDS Ethicon Polydioxanone Slowly 183–238 days Mono No
PDS plus Ethicon Polydioxanone + 
triclosan
Slowly 183–238 days Mono Yes
Monoplus B Braun Polydioxanone Slowly 180–201 days Mono No
Monomax B Braun Poly-4-
hydroxybutyrate
Slowly 390–1080 days Mono No
Vicryl Ethicon Polyglactin Rapidly 56–70 days Multi No
Vicryl plus Ethicon Polyglactin + 
triclosan
Rapidly 56–70 days Multi Yes
Polysorb Covidien Polyglycolic acid Rapidly 60–90 days Multi No
Dexon Covidien Polygglycolic 
acid
Rapidly 60–90 days Multi No
Non-absorbable versus slowly absorbable sutures
No difference in incisional hernia rate for continuous suturing of midline 
incisions with slowly absorbable versus non-absorbable sutures (p= 0.75) was 
identified(48). However, an increased incidence of prolonged wound pain (p< 
0.005) and suture sinus formation (p= 0.02) with non-absorbable sutures was 
reported(48). Another MA (which included non-midline incisions) identified no 
difference in incisional hernia rate between slowly-absorbable polydioxanone 
and non-absorbable sutures (OR 1.10: p= 0.43)(43). Once again, non-absorbable 
sutures had a significant higher risk of suture sinus formation (OR 0.49: p= 0.01)
(43).
Statement Using slowly-absorbable suture material 
instead of non-absorbable sutures for 
continuous closure of midline abdominal 
wall incisions in elective surgery is 
suggested. 
■■□□
weak
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Monofilament versus multifilament sutures
Monofilament sutures are believed to be associated with a lower SSI rate than 
multifilament sutures(12). However, none of the SRs commented on this issue 
specifically. If the previous recommendation to use slowly absorbable sutures 
for closure of elective midline laparotomies is followed, this question becomes 
superfluous because the slowly absorbable sutures are all monofilament 
sutures.
Statement We suggest using monofilament suture 
material for continuous closure of midline 
abdominal wall incisions in elective 
surgery. 
■□□□
weak
Concerning the size of the suture, no studies comparing directly the size of 
the sutures used to close abdominal wall incisions were identified during our 
searches. For the “small bites” technique, Isrealsson et al(12) suggest to use a 
suture size USP 2/0 (USP = United States Pharmacopeia). 
Statement No recommendation on the size of the 
sutures for closure of abdominal wall 
incisions can be given due to lack of data. 
■□□□
no
Sutures impregnated with antibiotics
Sutures coated with Triclosan as an antimicrobial agent have been introduced 
to decrease the rate of surgical site infection in surgery. A recent meta-analysis 
has demonstrated a significant beneficial effect in the prevention of surgical 
site infection after all kinds of surgery(71). Surgical site infection is a risk factor 
for subsequent development of incisional hernias and therefore the use of 
antibiotics impregnated sutures to close laparotomies might be beneficial 
in the prevention of incisional hernias. Recently Diener et al.(72) published 
a large RCT on 1,224 patients undergoing an elective midline laparotomy 
comparing polydioxanone sutures with versus without triclosan impregnation. 
No reduction in the incidence of surgical site infection was reported (OR 0.91: 
CI 0.66–1.25; p = 0.39). Four other RCT’s have compared sutures with or without 
triclosan in laparotomy closure, either with polyglactin sutures (Vicryl)(73, 74) or 
with polydioxanone (PDS)(75, 76). A meta-analysis on all five studies performed 
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by Diener et al. showed a significant decrease in surgical site infection (OR 0.67: 
CI 0.47–0.98). No data on incisional hernias are available from these studies.
Statement Monofilament sutures impregnated with 
antibiotics for closure of elective midline 
incisions is NOT advised, because of 
insufficient data on their efficiency on 
prevention of surgical site infections and 
the lack of data on incisional hernias or 
burst abdomen.
■■■□
weak
Limitations of the statements in these guidelines on suture technique and suture 
materials
The statements are limited by the quality of the data on which they are based. 
In total, 61 RCT’s have been identified that compared suture materials or 
techniques to close laparotomy incisions. Many studies have more than one 
variable between study arms and therefore analysing them in meta-analyses 
is difficult. Moreover, many studies have flaws in the methodology increasing 
the risk of bias. We would like to encourage researchers that plan studies on 
abdominal wall closure to improve the methodology of their study protocol. 
Preferably study arms are only different in the variable under investigation, 
either a suture technique or a suture material. Moreover we recommend 
documenting the technical details such as SL/WL ratio, the number of stitches 
used in the patients and to provide a follow up of at least 24 months.  
Although some of the systematic reviews detected included non-midline 
incisions(43) or emergency operations(48), these guidelines are currently 
limited to elective midline laparotomies. For emergency operations and non-
midline incisions there is currently not enough data available. 
Statement No recommendation on suture material 
or suturing technique for use in 
emergency surgery can be given due to 
lack of sufficient data.
■□□□
no
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Statement No recommendation on suture material 
or suturing technique for use in non-
midline incisions can be given due to 
lack of sufficient data
■□□□ no
Suture needles and retention sutures
Blunt tip versus sharp needles
Only one SR assessing the type of needle used to close the abdominal wall(23) 
and one RCT comparing blunt needles with sharp needles were identified. The 
RCT reported no difference in SSI rate between blunt and sharp needles(77). 
Statement No recommendation on the type or the 
size of needle to close a laparotomy can 
be given due to lack of data.
■□□□
no
Is there a place for retention sutures when closing a laparotomy?
No SR on the use of retention sutures was found. Eight records were screened by 
full text(78-85). Three RCTs on the prevention of burst abdomen by using either 
retention sutures or a reinforced tension line suture in patients with increased 
risk for wound dehiscence and burst abdomen were identified(78, 81, 85). Follow 
up was too short to evaluate incisional hernia rate. The Summary of Evidence is 
listed in Table 4. Two studies showed favourable results(78, 81), but one study 
reported a high number of adverse events when using retention sutures(85). 
Statement No recommendation on the use of 
retention sutures in patients with 
multiple risk factors for burst abdomen 
can be given due to insufficient data.
■■□□
no
Postoperative care
Postoperative management and instructions for patients are not supported by 
high quality prospective data, but rely mostly on surgeons’ habits, tradition and 
common beliefs (86-88). Long term follow up studies are needed to research 
the impact on the occurrence of incisional hernias of prescribing abdominal 
binders or restricting postoperative activity. The additional searches did not 
reveal any relevant study on long term outcome. Some studies on the short 
term benefits of abdominal binders were found.   
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Subcutaneous drains in laparotomy incisions
Prophylactic routine placement of subcutaneous drains after laparotomy is 
occasionally used to decrease wound complications: infection, hematoma, 
seroma or wound dehiscence(88). However, there are several disadvantages to 
the routine use of subcutaneous drains. Namely, they cause patient discomfort 
and pain at removal, they hinder early mobilisation and demand additional 
nursing care. Therefore their use should be driven by a proven benefit.   
One systematic review(89) and several RCTs (90-98) on the use of 
subcutaneous drains in abdominal surgery were found. They cover a wide range 
of operative indications: liver surgery, colorectal surgery, cholecystectomy, 
gynaecological surgery, caesarean section, and gastric bypass surgery. With few 
exceptions, most studies did not show a benefit for the use of subcutaneous 
drains. However, none of these studies had incisional hernias or burst abdomen 
as primary or secondary endpoint. 
Statement The routine placement of a 
subcutaneous drain during closure 
of abdominal wall incisions is NOT 
recommended. 
■■■□
strong
Postoperative binders
One systematic review on the use of abdominal binders was found(86). The 
review included four RCT’s (99-102) and a national survey by questionnaire on 
the use of abdominal binders in French surgical practice(86). One additional 
recent RCT was identified(103). The French survey reported that postoperative 
support of the wound with an abdominal binder is common practice after 
major laparotomies in many surgical departments (94% use them in some 
patients). It is expected to reduce postoperative pain and to improve early 
mobilisation of the patients. Moreover 83% of users expect a benefit in the 
prevention of abdominal wall dehiscence(86). No significant improvement for 
the short term benefits was found by the small RCTs from the review(98, 99, 
101, 102). The additional study by Clay et al.(100) found a significant lower VAS 
(Visual Analogue Scale) score for pain at the fifth postoperative day and no 
adverse effect on postoperative lung function. No studies were found that had 
burst abdomen or incisional hernias as a primary or secondary endpoints.   
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Statement No recommendation can be given on the 
use of postoperative abdominal binders 
due to lack of data on their effect on 
incisional hernias or burst abdomen rates.
■□□□ no
Postoperative restriction of activity
No prospective studies were found on the restriction of physical activity after 
abdominal incisions. Nevertheless, it is advocated by some surgeons in order 
to decrease the risk of incisional hernias, but there is no consensus on the level 
or the duration of the restriction(87). Postoperative restriction might have an 
adverse impact on the return to normal activity and delay the return to work.   
Statement No recommendation can be given 
on routine restriction of activity after 
abdominal surgery due to lack of data 
on the effect on incisional hernias or 
burst abdomen rates.
■□□□
no
Prophylactic mesh augmentation 
Three Systematic reviews on the topic were found(24, 39, 104). 
1. Nachappian et al.(39) did not assess of the quality of the individual 
studies and included non published data. Therefore this review did 
not qualify for inclusion in this guideline. 
2. The systematic review by Bhangu et al.(24) is of High Quality and 
offers a good and extensive evaluation of the quality of the individual 
studies included. However, the quality of the non RCTs was usually 
low and these studies were not be used as evidence for these 
guidelines. 
3. Timmermans et al.(104) published a good meta-analysis on five RCT’s 
using polypropylene mesh, including a RCT published in 2013 by 
Abo-Ryia et al.(105). 
One additional RCT published after the review by Timmermans et al.(106) was 
identified. In this RCT, one hundred and sixty patients were included. This is 
the first trial on non-selected elective midline laparotomies (with a majority of 
oncological patients). All the other trials have only included patients deemed 
EHS guidelines
109
5
at high risk for incisional hernias. In this RCT by Caro-Tarrago et al. the mesh 
augmentation was performed with a light weight polypropylene mesh in 
the onlay position. A significant reduction in incisional hernias at 12 months 
was observed clinically and with CT scan in favour of prophylactic mesh, 
1.5 vs 35.9 % (p < 0.0001). A significantly higher number of postoperative 
seroma was detected in the mesh group, 11.3 vs 28.8 % (p < 0.01). No major 
complications related to the mesh augmentation were reported.
The details of the six published RCT’s using polypropylene mesh 
including 506 patients are listed in Table 5(105-110). Using Review Manager 5.2 
software a new meta-analysis was performed. The data for this meta-analysis 
were extracted from the Timmermans et al. meta-analysis and the additional 
RCT(104, 106). A meta-analysis on the outcomes of incisional hernia, seroma 
and SSI was performed. The pooled analyses data are shown in a Forrest plot for 
each outcome in Figure 2. Prophylactic mesh augmentation is effective in the 
prevention of incisional hernias (RR 0.17: CI 0.08–0.37). An increased incidence 
of postoperative seroma is identified, but the majority of these are from the 
single study by Caro-Tarrago et al.(106) where the mesh was placed in an onlay 
position, with a weight of 45.9 % on the cumulative Risk Ratio for seroma (RR = 
1.71; 95 %CI: 1.06–2.76) (Figure 2c). 
Although the data are favourable and consistent for prophylactic mesh 
augmentation, the Guidelines Development Group decided that larger trials 
are needed to make a strong recommendation to perform prophylactic mesh 
augmentation for all patients within certain risk groups.
Statement Prophylactic mesh augmentation for an 
elective midline laparotomy in a high-
risk patient in order to reduce the risk of 
incisional hernia is suggested.
■■■□
Weak
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7) Figure 2: Forrest plots of a meta-analysis performed by the Guidelines Development Group on 
prophylactic mesh augmentation with polypropylene mesh after laparotomy on the outcomes 
incisional hernia (2A), seroma (2B) and wound infection (2C).
 
Fig 2.A   Incisional hernia 
 
 
Fig 2.B   Wound infection 
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32 
80 
257 
Weight 
4.9% 
14.6% 
10.0% 
28.2% 
42.3% 
100.0% 
M-H, Random, 95% CI 
1.00 [0.06, 15.49] 
Not estimable 
0.50 [0.10, 2.43] 
1.16 [0.17, 7.85] 
1.00 [0.32, 3.12] 
1.00 [0.39, 2.53] 
0.92 [0.50, 1.68] 
Year 
2003 
2006 
2009 
2010 
2013 
2014 
Mesh augmentation Suture Risk Ratio Risk Ratio 
M-H, Random, 95% CI 
0.01 0.1 1 10 100 
Favours mesh Favours suture 
Study or Subgroup 
Gutierrez 2003 
Strelczyk 2006 
El-Kadrawy 2009 
Bevis 2010 
Abo-Ryia 2013 
Caro-Tarrago 2014 
Total (95% CI) 
Total events 
Heterogeneity: Tau² = 0.18; Chi² = 6.17, df = 5 (P = 0.29); I² = 19% 
Test for overall effect: Z = 4.48 (P < 0.00001) 
Events 
0 
0 
1 
5 
1 
2 
9 
Total 
44 
36 
20 
37 
32 
80 
249 
Events 
5 
8 
3 
16 
9 
30 
71 
Total 
44 
38 
20 
43 
32 
80 
257 
Weight 
6.8% 
7.0% 
11.1% 
39.8% 
12.7% 
22.7% 
100.0% 
M-H, Random, 95% CI 
0.09 [0.01, 1.60] 
0.06 [0.00, 1.04] 
0.33 [0.04, 2.94] 
0.36 [0.15, 0.90] 
0.11 [0.01, 0.83] 
0.07 [0.02, 0.27] 
0.17 [0.08, 0.37] 
Year 
2003 
2006 
2009 
2010 
2013 
2014 
Mesh augmentation Suture Risk Ratio Risk Ratio 
M-H, Random, 95% CI 
0.01 0.1 1 10 100 
Favours mesh Favours suture 
Study or Subgroup 
Gutierrez 2003 
Strelczyk 2006 
El-Kadrawy 2009 
Bevis 2010 
Abo-Ryia 2013 
Caro-Tarrago 2014 
Total (95% CI) 
Total events 
Heterogeneity: Tau² = 0.00; Chi² = 4.66, df = 5 (P = 0.46); I² = 0% 
Test for overall effect: Z = 2.20 (P = 0.03) 
Events 
1 
5 
4 
2 
6 
23 
41 
Total 
44 
36 
20 
37 
32 
80 
249 
Events 
3 
4 
3 
0 
5 
9 
24 
Total 
44 
38 
20 
43 
32 
80 
257 
Weight 
4.6% 
15.0% 
12.3% 
2.5% 
19.6% 
45.9% 
100.0% 
M-H, Random, 95% CI 
0.33 [0.04, 3.08] 
1.32 [0.38, 4.53] 
1.33 [0.34, 5.21] 
5.79 [0.29, 116.89] 
1.20 [0.41, 3.54] 
2.56 [1.26, 5.17] 
1.71 [1.06, 2.76] 
Year 
2003 
2006 
2009 
2010 
2013 
2014 
Mesh augmentation Suture Risk Ratio Risk Ratio 
M-H, Random, 95% CI 
0.01 0.1 1 10 100 
Favours mesh Favours suture 
Which mesh type, which mesh position and which type of mesh fixation? 
No comparative studies are published between different mesh type, mesh 
position or method of mesh fixation. Pans et al.(111) found no significant 
protective effect on incisional hernia rate by intra-peritoneal augmentation 
with a polyglactin mesh (Vicryl; Ethicon) on incisional hernia rate in a RCT 
on obesity surgery (n = 288). Llaguna et al.(112) placed a biological mesh 
(Alloderm; LifeCell) in a retro-muscular position in bariatric patients. In this non-
randomised comparative study (n = 106 of which 44 with mesh) a significantly 
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lower incisional hernia rate was observed in the mesh group, 2.3 vs 17.7 % 
(p = 0.014). All other studies published used a polypropylene mesh, most 
often a small pore/heavy weight mesh: Prolene; Ethicon(107), Premilene; B. 
Braun(109), no name mentioned(105, 108, 110). Only Caro-Tarrago et al.(106) 
used a large pore/light weight mesh: Biomesh Light P8; Cousin Biotech.
There is a large variation between the studies on the mesh position for 
the prophylactic mesh augmentation. Onlay, retro-muscular and pre-peritoneal 
mesh positioning was performed in two studies each. No studies on the use 
of intra-peritoneal augmentation with a non absorbable synthetic mesh are 
reported. Only one study on the use of intra-peritoneal augmentation with an 
absorbable synthetic mesh is reported(111). The mesh was in all studies fixed 
with sutures to the fascia except for the study of Pans et al.(111) which used no 
fixation. No studies on mesh augmentation with glue or a self-fixating mesh 
are reported.
Statement No recommendation on the optimal 
mesh position for prophylactic mesh 
augmentation can be given due to lack 
of data.
■□□□
no
Statement No recommendation on the optimal 
method of mesh fixation for 
prophylactic mesh augmentation can 
be given due to lack of data.
■□□□
no
Statement No recommendation on the type 
of mesh for prophylactic mesh 
augmentation can be given due to lack 
of data.
■□□□
no
Trocar wounds for laparoscopic surgery and single port surgery
Trocar size and trocar type 
The first search for systematic reviews resulted in 5 records(33, 40, 41, 46, 49) 
and 25 additional records were screened by full text(113-136). Several studies 
comment on the incidence of trocar-site hernia for various trocar sizes. However 
the quality of many studies is insufficient and challenge the validity of results. 
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Shortcomings of the individual studies include retrospective study design, 
short or unclear length of follow up and inappropriate or no information on 
diagnostic methods to detect incisional hernias. Most importantly, available 
data derive from studies in which the same patient serves as case and control; 
i.e. the incidence of trocar-site hernia is measured for different sizes of trocars 
inserted at different abdominal sites in the same patient. This may impose 
significant bias, related to the strength of the abdominal wall and the wound 
repair mechanisms at varying sites of the abdominal wall, in particular the linea 
alba to other parts of the abdominal wall.
Helgstrand et al.(33) performed a systematic review on the incidence of 
trocar-site hernia. Although they found a risk reduction after sutured closure 
and a lower hernia rate for 5-mm versus larger diameter trocars, no meta-
analysis was undertaken. The poor quality and design of the majority of the 
included reports preclude further in-depth evaluation for supporting evidence. 
No RCT’s have investigated the incidence of trocar-site hernia after insertion 
of blunt versus bladed trocars and no RCT’s or case-control studies have 
investigated the incidence of trocar-site hernia with reference to trocar size 
or diameter. Available data derive from univariate and multivariate analyses 
of cohort studies, which have investigated the effect of potential risk factors 
for trocar-site hernia. Obesity, age above 60 years diabetes, long duration of 
surgery, and the need for fascia enlargement for specimen extraction were 
identified as risk factors for the development of trocar-site hernia(120, 136).
Statement For laparoscopic procedures, using the 
smallest trocar size adequate for the 
procedure is suggested.
■■□□
Weak
Statement For laparoscopic procedures, suturing 
the fascial defect, if trocars larger than 
or equal to 10 mm have been used, 
in the presence of established risk 
factors for incisional hernia formation 
is suggested. 
■□□□
weak
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Closure of trocar incisions
There are no good quality comparative studies investigating different suture 
materials or techniques for closure of trocar fascia defects. Armananzas 
et al.(113) reported in a recently published RCT a benefit for prophylactic 
intraperitoneal placement of a ventral patch at the umbilical site in high-risk 
patients to reduce the incidence of trocar-site hernia from 18.5% to 4.4% (OR 
10.1: CI 2.15-47.6; p< 0.001). Larger sample-sized studies with a good risk-
benefit assessment and longer follow-up are needed to confirm and support a 
stronger recommendation. 
Statement For laparoscopic procedures a mesh-
augmented closure may be applied 
in patients at high risk for trocar-site 
hernia.
■■■□
weak
Single incision laparoscopic surgery and incisional hernia
The incidence of trocar-site hernia after single port surgery has been mostly 
investigated as a secondary outcome measure in the setting of RCTs and 
3 High Quality MAs were found(137-139). Two MAs of RCTs have found no 
difference in the incidence of trocar-site hernia between single port and 
multiple port surgery, although a trend in favour of multiple port surgery was 
demonstrated(137, 139). The most recent MA included 19 RCTs involving 676 
patients and found a higher incidence of trocar site hernia following single port 
surgery(138).
Statement Emerging evidence suggests an 
increased incidence of trocar-site 
hernia for single-incision surgery as 
compared to conventional surgery; 
therefore meticulous closure of the 
incised fascia in single-port surgery is 
recommended.
■■■□
weak
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Discussion
Limitations
Not many strong recommendations could be made due to lack of sufficient 
evidence on many of the PICO questions. It is somewhat confusing to 
notice that the first strong recommendation in these guidelines is to avoid 
midline laparotomies in favour of alternative incisions and that all other 
recommendations are only valid for elective midline incisions. Indeed most 
research is focused on midline laparotomies. A midline laparotomy is still 
the favoured approach for most surgeons. It allows quick entrance to the 
abdominal cavity and extension of the incision is easy if this is required for the 
operation. Nevertheless, the linea alba is probably the most vulnerable and 
least vascularized part of the abdominal wall. Some refer to incisional hernias as 
“a midline crisis”. Optimising closure of abdominal wall incisions would appear 
to hold a large potential in reducing the incidence of incisional hernias and the 
subsequent need for incisional hernia repair. This has obvious benefits for the 
individual patient relating to an improved quality of life, avoidance of secondary 
operations and at a macro-economical level a significant reduction in costs for 
health care resources. It is not easy to see the impact of each recommendation 
separately. Therefore, implementation of the optimised abdominal wall closure 
is probably best done by teaching all involved specialists a standardised 
technique described as the “Principles” of abdominal wall closure(17). This 
incorporates all recommendations, although the Guidelines Development 
Group is aware that the level of evidence for the different aspects is sometimes 
low to very low. David Sackett, a pioneer in evidence-based medicine wrote: “…
any external guideline must be integrated with individual clinical expertise in 
deciding whether and how it matches the patient’s clinical state, predicament, 
and preferences, and thus whether it should be applied”(140). 
Discussions
For most Key Questions on the technique and material to close abdominal 
wall incisions, the grading of the Quality of Evidence and the choice of 
recommendation was straightforward. For several recommendations, 
while the quality of evidence was low, there was good consensus between 
the members of the Guidelines Development Group on the formulated 
statements. For prophylactic mesh augmentation there was disagreement 
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on the strength of recommendation (weak or strong). For this reason, an 
additional meta-analysis was performed (Figure 2). Although the effect size 
in favour of mesh augmentation is large and consistent over the studies, the 
Guidelines Development Group felt that larger trials are needed to support 
a strong recommendation for prophylactic mesh augmentation in high-risk 
patients. Indeed, the number of patients in the reported studies for each risk 
group separately (e.g. abdominal aortic aneurysm, obesity surgery, oncological 
surgery) seems too low to recommend prophylactic mesh augmentation in all 
these patient groups. Nevertheless, we are aware that several large RCT’s are 
on-going and this grade of recommendation might be changed in the light of 
future publications.
No recommendations could be made on non-midline incisions due to 
insufficient evidence. Nevertheless, it seems reasonable to promote similar 
material (slowly absorbable suture) and techniques (continuous aponeurotic 
closure with small bites and SL/WL >4/1) for closure of non-midline incisions.
No recommendations could be made on the type or the size of the 
needle used to close abdominal incisions. No studies comparing the size of the 
sutures were identified in our searches.
No recommendation could be made for emergency surgery, which is 
often a contaminated procedure. The Guidelines Development Group consider 
that the use of retention sutures or of reinforced tension line sutures, should 
be prospectively studied in patients at high risk for development of burst 
abdomen. A risk model and score for burst abdomen has been developed by 
van Ramshorst et al.(141) and could be used as basis for including patients in 
these studies.
No recommendations could be made on the postoperative care after 
laparotomies. Long-term follow-up studies are needed to assess the impact 
on the occurrence of incisional hernias of prescribing abdominal binders or 
restricting or indeed encouraging early postoperative activity.
Applicability
To adopt the guidelines and “evidence based principles” for abdominal wall 
closure, surgeons must be convinced that these are valid recommendations 
with a large impact on the outcome for the patients. These guidelines are 
an attempt to create awareness amongst surgeons about these principles. 
Adaptation can be done by systematic quality control of the suturing technique 
EHS guidelines
117
5
as described by van Ramshorst et al.(142). The EuraHS, European registry for 
abdominal wall hernias, has developed an online platform for registration and 
outcome measurement of abdominal wall surgery(140). An additional route in 
the database on the closure of abdominal wall incisions and for prophylactic 
mesh augmentation will be provided from 2015 onwards. It is hoped that such 
a registry database will facilitate the data collection for prospective studies.
Validity of the guidelines
Prior to submission of the manuscript the guidelines were evaluated and 
scored using the AGREE II instrument. Several large multi-centre studies on the 
closure of abdominal wall incisions are currently on-going. High Quality data 
on the use of the “small bites” technique in midline incisions, on the closure 
of laparotomies in emergency and on prophylactic mesh augmentation will 
be published in the coming years. The Guidelines Development Group has 
decided to update these guidelines in 2017 and present the results during the 
39th Annual Congress of the European Hernia Society in Vienna in May 2017.
Conclusions
To decrease the incidence of incisional hernias it is recommended to utilize 
a non-midline approach to a laparotomy whenever possible. For elective 
midline incisions, it is strongly recommended to perform a continuous 
suturing technique and to avoid the use of rapidly absorbable sutures. It 
is suggested that the use of a slowly absorbable monofilament suture in a 
single layer aponeurotic closure technique without separate closure of the 
peritoneum and using a small bites technique with a SL/WL ratio at least 
4/1 is the current recommended method of fascial closure. Currently, no 
recommendations can be given on the optimal technique to close emergency 
laparotomy incisions. Prophylactic mesh augmentation appears effective and 
safe and can be suggested in high-risk patients like, aortic aneurysm surgery 
and obese patients.
Chapter 5
118
References
1. Bloemen A, van Dooren P, Huizinga BF, Hoofwijk AG. Comparison of ultrasonography and physical 
examination in the diagnosis of incisional hernia in a prospective study. Hernia. 2012;16(1):53-7.
2. Claes K, Beckers R, Heindryckx E, Kyle-Leinhase I, Pletinckx P, Claeys D, et al. Retrospective 
observational study on the incidence of incisional hernias after colorectal carcinoma resection 
with follow-up CT scan. Hernia. 2014;18(6):797-802.
3. den Hartog D, Dur AH, Kamphuis AG, Tuinebreijer WE, Kreis RW. Comparison of ultrasonography 
with computed tomography in the diagnosis of incisional hernias. Hernia. 2009;13(1):45-8.
4. Diener MK, Voss S, Jensen K, Buchler MW, Seiler CM. Elective midline laparotomy closure: the 
INLINE systematic review and meta-analysis. Annals of surgery. 2010;251(5):843-56.
5. Fink C, Baumann P, Wente MN, Knebel P, Bruckner T, Ulrich A, et al. Incisional hernia rate 3 years after 
midline laparotomy. Br J Surg. 2014;101(2):51-4.
6. Pereira JA, Pera M, Grande L. [Incidence of incisional hernia after open and laparoscopic colorectal 
cancer resection] Elevada incidencia de hernia incisional tras reseccion abierta y laparoscopica por 
cancer colorrectal. Cir Esp. 2013;91(1):44-9.
7. Bosanquet D, Aboelrahman T, Ansell J, Cornish J, Davies L, Frewer K, et al. Systematic review and 
meta regression of factors affecting midline incisional hernia rates: an analysis of 14,618 patients. 
Hernia. 2014;18((suppl 2)):S12-S5.
8. Alnassar S, Bawahab M, Abdoh A, Guzman R, Al Tuwaijiri T, Louridas G. Incisional hernia postrepair of 
abdominal aortic occlusive and aneurysmal disease: five-year incidence. Vascular. 2012;20(5):273-
7.
9. Antoniou GA, Georgiadis GS, Antoniou SA, Granderath FA, Giannoukas AD, Lazarides MK. 
Abdominal aortic aneurysm and abdominal wall hernia as manifestations of a connective tissue 
disorder. J Vasc Surg. 2011;54(4):1175-81.
10. Henriksen NA, Helgstrand F, Vogt KC, Jorgensen LN, Bisgaard T. Risk factors for incisional hernia 
repair after aortic reconstructive surgery in a nationwide study. J Vasc Surg. 2013;57(6):1524-30, 30 
e1-3.
11. Hoer J, Lawong G, Klinge U, Schumpelick V. [Factors influencing the development of incisional 
hernia. A retrospective study of 2,983 laparotomy patients over a period of 10 years]. Der Chirurg; 
Zeitschrift fur alle Gebiete der operativen Medizen. 2002;73(5):474-80.
12. Israelsson LA, Millbourn D. Prevention of incisional hernias: how to close a midline incision. The 
Surgical clinics of North America. 2013;93(5):1027-40.
13. van Ramshorst GH, Eker HH, Hop WC, Jeekel J, Lange JF. Impact of incisional hernia on health-
related quality of life and body image: a prospective cohort study. American journal of surgery. 
2012;204(2):144-50.
14. Burger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J. Long-term follow-up of a 
randomized controlled trial of suture versus mesh repair of incisional hernia. Annals of surgery. 
2004;240(4):578-83; discussion 83-5.
15. Flum DR, Horvath K, Koepsell T. Have outcomes of incisional hernia repair improved with time? A 
population-based analysis. Annals of surgery. 2003;237(1):129-35.
16. Helgstrand F, Rosenberg J, Kehlet H, Strandfelt P, Bisgaard T. Reoperation versus clinical recurrence 
rate after ventral hernia repair. Annals of surgery. 2012;256(6):955-8.
17. Meijer EJ, Timmermans L, Jeekel J, Lange JF, Muysoms FE. The principles of abdominal wound 
closure. Acta chirurgica Belgica. 2013;113(4):239-44.
18. Gillion JF, Sanders D, Miserez M, Muysoms F. The economic burden of incisional ventral hernia 
repair: a multicentric cost analysis. Hernia. 2016.
19. (SIGN). SIGN.
20. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing 
guideline development, reporting and evaluation in health care. Cmaj. 2010;182(18):E839-42.
21. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for 
reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: 
explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1-34.
EHS guidelines
119
5
22. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an 
emerging consensus on rating quality of evidence and strength of recommendations. Bmj. 
2008;336(7650):924-6.
23. Anderson ER, Gates S. Techniques and materials for closure of the abdominal wall in caesarean 
section. Cochrane Database Syst Rev. 2004(4):CD004663.
24. Bhangu A, Fitzgerald JE, Singh P, Battersby N, Marriott P, Pinkney T. Systematic review and meta-
analysis of prophylactic mesh placement for prevention of incisional hernia following midline 
laparotomy. Hernia. 2013;17(4):445-55.
25. Bhangu A, Nepogodiev D, Futaba K, West Midlands Research C. Systematic review and meta-analysis 
of the incidence of incisional hernia at the site of stoma closure. World J Surg. 2012;36(5):973-83.
26. Bickenbach KA, Karanicolas PJ, Ammori JB, Jayaraman S, Winter JM, Fields RC, et al. Up and down or 
side to side? A systematic review and meta-analysis examining the impact of incision on outcomes 
after abdominal surgery. American journal of surgery. 2013;206(3):400-9.
27. Brown SR, Goodfellow PB. Transverse verses midline incisions for abdominal surgery. Cochrane 
Database Syst Rev. 2005(4):CD005199.
28. Cheng H, Rupprecht F, Jackson D, Berg T, Seelig MH. Decision analysis model of incisional hernia 
after open abdominal surgery. Hernia. 2007;11(2):129-37.
29. Finan KR, Kilgore ML, Hawn MT. Open suture versus mesh repair of primary incisional hernias: a 
cost-utility analysis. Hernia. 2009;13(2):173-82.
30. Friedrich M, Muller-Riemenschneider F, Roll S, Kulp W, Vauth C, Greiner W, et al. Health Technology 
Assessment of laparoscopic compared to conventional surgery with and without mesh for 
incisional hernia repair regarding safety, efficacy and cost-effectiveness. GMS Health Technol 
Assess. 2008;4:Doc01.
31. Grantcharov TP, Rosenberg J. Vertical compared with transverse incisions in abdominal surgery. Eur 
J Surg. 2001;167(4):260-7.
32. Gupta H, Srivastava A, Menon GR, Agrawal CS, Chumber S, Kumar S. Comparison of interrupted 
versus continuous closure in abdominal wound repair: a meta-analysis of 23 trials. Asian J Surg. 
2008;31(3):104-14.
33. Helgstrand F, Rosenberg J, Bisgaard T. Trocar site hernia after laparoscopic surgery: a qualitative 
systematic review. Hernia. 2011;15(2):113-21.
34. Hodgson NC, Malthaner RA, Ostbye T. The search for an ideal method of abdominal fascial closure: 
a meta-analysis. Annals of surgery. 2000;231(3):436-42.
35. Hynes DM, Stroupe KT, Luo P, Giobbie-Hurder A, Reda D, Kraft M, et al. Cost effectiveness of 
laparoscopic versus open mesh hernia operation: results of a Department of Veterans Affairs 
randomized clinical trial. J Am Coll Surg. 2006;203(4):447-57.
36. Mathai M, Hofmeyr GJ, Mathai NE. Abdominal surgical incisions for caesarean section. Cochrane 
Database Syst Rev. 2013(5):CD004453.
37. Jin JB, Jiang ZP, Chen S. [Meta-analysis of suture techniques for midline abdominal incisions]. 
Zhonghua Wai Ke Za Zhi. 2010;48(16):1256-61.
38. Le Huu Nho R, Mege D, Ouaissi M, Sielezneff I, Sastre B. Incidence and prevention of ventral 
incisional hernia. J Visc Surg. 2012;149(5 Suppl):e3-14.
39. Nachiappan S, Markar S, Karthikesalingam A, Ziprin P, Faiz O. Prophylactic mesh placement in high-
risk patients undergoing elective laparotomy: a systematic review. World J Surg. 2013;37(8):1861-
71.
40. Owens M, Barry M, Janjua AZ, Winter DC. A systematic review of laparoscopic port site hernias in 
gastrointestinal surgery. Surgeon. 2011;9(4):218-24.
41. Pemberton RJ, Tolley DA, van Velthoven RF. Prevention and management of complications in 
urological laparoscopic port site placement. Eur Urol. 2006;50(5):958-68.
42. Rucinski J, Margolis M, Panagopoulos G, Wise L. Closure of the abdominal midline fascia: meta-
analysis delineates the optimal technique. Am Surg. 2001;67(5):421-6.
43. Sajid MS, Parampalli U, Baig MK, McFall MR. A systematic review on the effectiveness of slowly-
absorbable versus non-absorbable sutures for abdominal fascial closure following laparotomy. 
International journal of surgery. 2011;9(8):615-25.
Chapter 5
120
44. Seiler CM, Bruckner T, Diener MK, Papyan A, Golcher H, Seidlmayer C, et al. Interrupted or 
continuous slowly absorbable sutures for closure of primary elective midline abdominal incisions: 
a multicenter randomized trial (INSECT: ISRCTN24023541). Annals of surgery. 2009;249(4):576-82.
45. Seiler CM, Deckert A, Diener MK, Knaebel HP, Weigand MA, Victor N, et al. Midline versus transverse 
incision in major abdominal surgery: a randomized, double-blind equivalence trial (POVATI: 
ISRCTN60734227). Annals of surgery. 2009;249(6):913-20.
46. Swank HA, Mulder IM, la Chapelle CF, Reitsma JB, Lange JF, Bemelman WA. Systematic review of 
trocar-site hernia. Br J Surg. 2012;99(3):315-23.
47. Takagi H, Sugimoto M, Kato T, Matsuno Y, Umemoto T. Postoperative incision hernia in patients 
with abdominal aortic aneurysm and aortoiliac occlusive disease: a systematic review. European 
journal of vascular and endovascular surgery : the official journal of the European Society for 
Vascular Surgery. 2007;33(2):177-81.
48. van ‘t Riet M, Steyerberg EW, Nellensteyn J, Bonjer HJ, Jeekel J. Meta-analysis of techniques for 
closure of midline abdominal incisions. Br J Surg. 2002;89(11):1350-6.
49. Yamamoto M, Minikel L, Zaritsky E. Laparoscopic 5-mm trocar site herniation and literature review. 
Jsls. 2011;15(1):122-6.
50. Baucom RB, Beck WC, Holzman MD, Sharp KW, Nealon WH, Poulose BK. Prospective evaluation of 
surgeon physical examination for detection of incisional hernias. J Am Coll Surg. 2014;218(3):363-
6.
51. Beck WC, Holzman MD, Sharp KW, Nealon WH, Dupont WD, Poulose BK. Comparative effectiveness 
of dynamic abdominal sonography for hernia vs computed tomography in the diagnosis of 
incisional hernia. J Am Coll Surg. 2013;216(3):447-53; quiz 510-1.
52. Bhangu A, Fletcher L, Kingdon S, Smith E, Nepogodiev D, Janjua U. A clinical and radiological 
assessment of incisional hernias following closure of temporary stomas. Surgeon. 2012;10(6):321-
5.
53. Cingi A, Cakir T, Sever A, Aktan AO. Enterostomy site hernias: a clinical and computerized 
tomographic evaluation. Dis Colon Rectum. 2006;49(10):1559-63.
54. Cingi A, Solmaz A, Attaallah W, Aslan A, Aktan AO. Enterostomy closure site hernias: a clinical and 
ultrasonographic evaluation. Hernia. 2008;12(4):401-5.
55. Hojer AM, Rygaard H, Jess P. CT in the diagnosis of abdominal wall hernias: a preliminary study. Eur 
Radiol. 1997;7(9):1416-8.
56. Lee L, Mappin-Kasirer B, Sender Liberman A, Stein B, Charlebois P, Vassiliou M, et al. High incidence 
of symptomatic incisional hernia after midline extraction in laparoscopic colon resection. Surg 
Endosc. 2012;26(11):3180-5.
57. Musella M, Milone F, Chello M, Angelini P, Jovino R. Magnetic resonance imaging and abdominal 
wall hernias in aortic surgery. J Am Coll Surg. 2001;193(4):392-5.
58. Rodriguez HE, Matsumura JS, Morasch MD, Greenberg RK, Pearce WH. Abdominal wall hernias 
after open abdominal aortic aneurysm repair: prospective radiographic detection and clinical 
implications. Vasc Endovascular Surg. 2004;38(3):237-40.
59. Young J, Gilbert AI, Graham MF. The use of ultrasound in the diagnosis of abdominal wall hernias. 
Hernia. 2007;11(4):347-51.
60. Schreinemacher MH, Vijgen GH, Dagnelie PC, Bloemen JG, Huizinga BF, Bouvy ND. Incisional 
hernias in temporary stoma wounds: a cohort study. Archives of surgery. 2011;146(1):94-9.
61. Burger JW, van ‘t Riet M, Jeekel J. Abdominal incisions: techniques and postoperative complications. 
Scand J Surg. 2002;91(4):315-21.
62. Gurusamy KS, Cassar Delia E, Davidson BR. Peritoneal closure versus no peritoneal closure 
for patients undergoing non-obstetric abdominal operations. Cochrane Database Syst Rev. 
2013(7):CD010424.
63. Weiland DE, Bay RC, Del Sordi S. Choosing the best abdominal closure by meta-analysis. American 
journal of surgery. 1998;176(6):666-70.
64. Israelsson LA. Bias in clinical trials: the importance of suture technique. Eur J Surg. 1999;165(1):3-7.
65. Nelson RL, Vedula SS. Closure methods for laparotomy incisions. Cochrane Database Syst Rev. 
2006(1).
EHS guidelines
121
5
66. Jenkins TP. The burst abdominal wound: a mechanical approach. Br J Surg. 1976;63(11):873-6.
67. Israelsson LA, Jonsson T. Suture length to wound length ratio and healing of midline laparotomy 
incisions. Br J Surg. 1993;80(10):1284-6.
68. Israelsson LA, Millbourn D. Closing midline abdominal incisions. Langenbecks Arch Surg. 
2012;397(8):1201-7.
69. Millbourn D, Cengiz Y, Israelsson LA. Effect of stitch length on wound complications after closure of 
midline incisions: a randomized controlled trial. Archives of surgery. 2009;144(11):1056-9.
70. Wissing J, van Vroonhoven TJ, Schattenkerk ME, Veen HF, Ponsen RJ, Jeekel J. Fascia closure after 
midline laparotomy: results of a randomized trial. Br J Surg. 1987;74(8):738-41.
71. Wang ZX, Jiang CP, Cao Y, Ding YT. Systematic review and meta-analysis of triclosan-coated sutures 
for the prevention of surgical-site infection. Br J Surg. 2013;100(4):465-73.
72. Diener MK, Knebel P, Kieser M, Schuler P, Schiergens TS, Atanassov V, et al. Effectiveness of triclosan-
coated PDS Plus versus uncoated PDS II sutures for prevention of surgical site infection after 
abdominal wall closure: the randomised controlled PROUD trial. Lancet. 2014;384(9938):142-52.
73. Nakamura T, Kashimura N, Noji T, Suzuki O, Ambo Y, Nakamura F, et al. Triclosan-coated sutures 
reduce the incidence of wound infections and the costs after colorectal surgery: a randomized 
controlled trial. Surgery. 2013;153(4):576-83.
74. Rasic Z, Schwarz D, Adam VN, Sever M, Lojo N, Rasic D, et al. Efficacy of antimicrobial triclosan-
coated polyglactin 910 (Vicryl* Plus) suture for closure of the abdominal wall after colorectal 
surgery. Coll Antropol. 2011;35(2):439-43.
75. Baracs J, Huszar O, Sajjadi SG, Horvath OP. Surgical site infections after abdominal closure in 
colorectal surgery using triclosan-coated absorbable suture (PDS Plus) vs. uncoated sutures (PDS 
II): a randomized multicenter study. Surg Infect (Larchmt). 2011;12(6):483-9.
76. Justinger C, Slotta JE, Ningel S, Graber S, Kollmar O, Schilling MK. Surgical-site infection after 
abdominal wall closure with triclosan-impregnated polydioxanone sutures: results of a randomized 
clinical pathway facilitated trial (NCT00998907). Surgery. 2013;154(3):589-95.
77. Stafford MK, Pitman MC, Nanthakumaran N, Smith JR. Blunt-tipped versus sharp-tipped needles: 
wound morbidity. J Obstet Gynaecol. 1998;18(1):18-9.
78. Agarwal A, Hossain Z, Agarwal A, Das A, Chakraborty S, Mitra N, et al. Reinforced tension line suture 
closure after midline laparotomy in emergency surgery. Trop Doct. 2011;41(4):193-6.
79. Hubbard TB, Jr., Rever WB, Jr. Retention sutures in the closure of abdominal incisions. American 
journal of surgery. 1972;124(3):378-80.
80. Irvin TT, Stoddard CJ, Greaney MG, Duthie HL. Abdominal wound healing: a prospective clinical 
study. Br Med J. 1977;2(6083):351-2.
81. Khorgami Z, Shoar S, Laghaie B, Aminian A, Hosseini Araghi N, Soroush A. Prophylactic retention 
sutures in midline laparotomy in high-risk patients for wound dehiscence: a randomized controlled 
trial. J Surg Res. 2013;180(2):238-43.
82. Makela JT, Kiviniemi H, Juvonen T, Laitinen S. Factors influencing wound dehiscence after midline 
laparotomy. American journal of surgery. 1995;170(4):387-90.
83. Matsuoka J, Gohchi A, Kamikawa Y, Sakagami K, Orita K. Chopstick retention suture for the closure 
of abdominal wounds. J Am Coll Surg. 1995;181(5):471-4.
84. Penninckx FM, Poelmans SV, Kerremans RP, Beckers JP. Abdominal wound dehiscence in 
gastroenterological surgery. Annals of surgery. 1979;189(3):345-52.
85. Rink AD, Goldschmidt D, Dietrich J, Nagelschmidt M, Vestweber KH. Negative side-effects of 
retention sutures for abdominal wound closure. A prospective randomised study. Eur J Surg. 
2000;166(12):932-7.
86. Bouvier A, Rat P, Drissi-Chbihi F, Bonnetain F, Lacaine F, Mariette C, et al. Abdominal binders after 
laparotomy: review of the literature and French survey of policies. Hernia. 2014;18(4):501-6.
87. Pommergaard HC, Burcharth J, Danielsen A, Angenete E, Haglind E, Rosenberg J. No consensus on 
restrictions on physical activity to prevent incisional hernias after surgery. Hernia. 2014;18(4):495-
500.
88. Rahbari NN, Knebel P, Diener MK, Seidlmayer C, Ridwelski K, Stoltzing H, et al. Current practice of 
abdominal wall closure in elective surgery - Is there any consensus? BMC Surg. 2009;9:8.
Chapter 5
122
89. Kosins AM, Scholz T, Cetinkaya M, Evans GR. Evidence-based value of subcutaneous surgical wound 
drainage: the largest systematic review and meta-analysis. Plast Reconstr Surg. 2013;132(2):443-50.
90. Baier PK, Gluck NC, Baumgartner U, Adam U, Fischer A, Hopt UT. Subcutaneous Redon drains do 
not reduce the incidence of surgical site infections after laparotomy. A randomized controlled trial 
on 200 patients. Int J Colorectal Dis. 2010;25(5):639-43.
91. Chowdri NA, Qadri SA, Parray FQ, Gagloo MA. Role of subcutaneous drains in obese patients 
undergoing elective cholecystectomy: a cohort study. International journal of surgery. 
2007;5(6):404-7.
92. Gallup DC, Gallup DG, Nolan TE, Smith RP, Messing MF, Kline KL. Use of a subcutaneous 
closed drainage system and antibiotics in obese gynecologic patients. Am J Obstet Gynecol. 
1996;175(2):358-61; discussion 62.
93. Kaya E, Paksoy E, Ozturk E, Sigirli D, Bilgel H. Subcutaneous closed-suction drainage does not affect 
surgical site infection rate following elective abdominal operations: a prospective randomized 
clinical trial. Acta chirurgica Belgica. 2010;110(4):457-62.
94. Loong RL, Rogers MS, Chang AM. A controlled trial on wound drainage in caesarean section. Aust 
N Z J Obstet Gynaecol. 1988;28(4):266-9.
95. Nakayama H, Takayama T, Okubo T, Higaki T, Midorikawa Y, Moriguchi M, et al. Subcutaneous 
drainage to prevent wound infection in liver resection: a randomized controlled trial. J Hepatobiliary 
Pancreat Sci. 2014;21(7):509-17.
96. Numata M, Godai T, Shirai J, Watanabe K, Inagaki D, Hasegawa S, et al. A prospective randomized 
controlled trial of subcutaneous passive drainage for the prevention of superficial surgical site 
infections in open and laparoscopic colorectal surgery. Int J Colorectal Dis. 2014;29(3):353-8.
97. Panici PB, Zullo MA, Casalino B, Angioli R, Muzii L. Subcutaneous drainage versus no drainage after 
minilaparotomy in gynecologic benign conditions: a randomized study. Am J Obstet Gynecol. 
2003;188(1):71-5.
98. Shaffer D, Benotti PN, Bothe A, Jr., Jenkins RL, Blackburn GL. A prospective, randomized trial of 
abdominal wound drainage in gastric bypass surgery. Annals of surgery. 1987;206(2):134-7.
99. Ali J, Serrette C, Khan TA. The effect of abdominal binders on postoperative pulmonary function. 
Infect in Surg. 1983;2:875-81.
100. Cheifetz O, Lucy SD, Overend TJ, Crowe J. The effect of abdominal support on functional outcomes 
in patients following major abdominal surgery: a randomized controlled trial. Physiother Can. 
2010;62(3):242-53.
101. Fagevik Olsen M, Josefson K, Wiklund M. Evaluation of abdominal binder after major upper 
gastrointestinal surgery. . Adv in Physiother. 2009;11:104-10.
102. Larson CM, Ratzer ER, Davis-Merritt D, Clark JR. The effect of abdominal binders on postoperative 
pulmonary function. Am Surg. 2009;75(2):169-71.
103. Clay L, Gunnarsson U, Franklin KA, Strigard K. Effect of an elastic girdle on lung function, intra-
abdominal pressure, and pain after midline laparotomy: a randomized controlled trial. Int J 
Colorectal Dis. 2014;29(6):715-21.
104. Timmermans L, de Goede B, Eker HH, van Kempen BJ, Jeekel J, Lange JF. Meta-analysis of primary 
mesh augmentation as prophylactic measure to prevent incisional hernia. Dig Surg. 2013;30(4-
6):401-9.
105. Abo-Ryia MH, El-Khadrawy OH, Abd-Allah HS. Prophylactic preperitoneal mesh placement in open 
bariatric surgery: a guard against incisional hernia development. Obes Surg. 2013;23(10):1571-4.
106. Caro-Tarrago A, Olona Casas C, Jimenez Salido A, Duque Guilera E, Moreno Fernandez F, Vicente 
Guillen V. Prevention of incisional hernia in midline laparotomy with an onlay mesh: a randomized 
clinical trial. World J Surg. 2014;38(9):2223-30.
107. Bevis PM, Windhaber RA, Lear PA, Poskitt KR, Earnshaw JJ, Mitchell DC. Randomized clinical trial 
of mesh versus sutured wound closure after open abdominal aortic aneurysm surgery. Br J Surg. 
2010;97(10):1497-502.
108. El-Khadrawy OH, Moussa G, Mansour O, Hashish MS. Prophylactic prosthetic reinforcement of 
midline abdominal incisions in high-risk patients. Hernia. 2009;13(3):267-74.
109. Gutierrez de la Pena C, Medina Achirica C, Dominguez-Adame E, Medina Diez J. Primary closure of 
laparotomies with high risk of incisional hernia using prosthetic material: analysis of usefulness. 
Hernia. 2003;7(3):134-6.
EHS guidelines
123
5
110. Strzelczyk JM, Szymanski D, Nowicki ME, Wilczynski W, Gaszynski T, Czupryniak L. Randomized clinical 
trial of postoperative hernia prophylaxis in open bariatric surgery. Br J Surg. 2006;93(11):1347-50.
111. Pans A, Elen P, Dewe W, Desaive C. Long-term results of polyglactin mesh for the prevention of 
incisional hernias in obese patients. World J Surg. 1998;22(5):479-82; discussion 82-3.
112. Llaguna OH, Avgerinos DV, Nagda P, Elfant D, Leitman IM, Goodman E. Does prophylactic biologic 
mesh placement protect against the development of incisional hernia in high-risk patients? World 
J Surg. 2011;35(7):1651-5.
113. Armananzas L, Ruiz-Tovar J, Arroyo A, Garcia-Peche P, Armananzas E, Diez M, et al. Prophylactic 
mesh vs suture in the closure of the umbilical trocar site after laparoscopic cholecystectomy in 
high-risk patients for incisional hernia. A randomized clinical trial. J Am Coll Surg. 2014;218(5):960-
8.
114. Bhoyrul S, Payne J, Steffes B, Swanstrom L, Way LW. A randomized prospective study of radially 
expanding trocars in laparoscopic surgery. J Gastrointest Surg. 2000;4(4):392-7.
115. Bonjer HJ, Hazebroek EJ, Kazemier G, Giuffrida MC, Meijer WS, Lange JF. Open versus closed 
establishment of pneumoperitoneum in laparoscopic surgery. Br J Surg. 1997;84(5):599-602.
116. Bowrey DJ, Blom D, Crookes PF, Bremner CG, Johansson JL, Lord RV, et al. Risk factors and the 
prevalence of trocar site herniation after laparoscopic fundoplication. Surg Endosc. 2001;15(7):663-
6.
117. Bunting DM. Port-site hernia following laparoscopic cholecystectomy. Jsls. 2010;14(4):490-7.
118. Chiu CC, Lee WJ, Wang W, Wei PL, Huang MT. Prevention of trocar-wound hernia in laparoscopic 
bariatric operations. Obes Surg. 2006;16(7):913-8.
119. Clark LH, Soliman PT, Odetto D, Munsell MF, Schmeler KM, Fleming N, et al. Incidence of trocar site 
herniation following robotic gynecologic surgery. Gynecol Oncol. 2013;131(2):400-3.
120. Comajuncosas J, Hermoso J, Gris P, Jimeno J, Orbeal R, Vallverdu H, et al. Risk factors for umbilical 
trocar site incisional hernia in laparoscopic cholecystectomy: a prospective 3-year follow-up study. 
American journal of surgery. 2014;207(1):1-6.
121. Eid GM, Collins J. Application of a trocar wound closure system designed for laparoscopic 
procedures in morbidly obese patients. Obes Surg. 2005;15(6):871-3.
122. Erdas E, Dazzi C, Secchi F, Aresu S, Pitzalis A, Barbarossa M, et al. Incidence and risk factors for 
trocar site hernia following laparoscopic cholecystectomy: a long-term follow-up study. Hernia. 
2012;16(4):431-7.
123. Feste JR, Bojahr B, Turner DJ. Randomized trial comparing a radially expandable needle system 
with cutting trocars. Jsls. 2000;4(1):11-5.
124. Helgstrand F, Rosenberg J, Kehlet H, Bisgaard T. Low risk of trocar site hernia repair 12 years after 
primary laparoscopic surgery. Surg Endosc. 2011;25(11):3678-82.
125. Holzinger F, Klaiber C. [Trocar site hernias. A rare but potentially dangerous complication of 
laparoscopic surgery] Trokarhernien Eine seltene, potenziell gefahrliche Komplikation nach 
laparoskopischen Eingriffen. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 
2002;73(9):899-904.
126. Hussain A, Mahmood H, Singhal T, Balakrishnan S, Nicholls J, El-Hasani S. Long-term study of port-
site incisional hernia after laparoscopic procedures. Jsls. 2009;13(3):346-9.
127. Johnson WH, Fecher AM, McMahon RL, Grant JP, Pryor AD. VersaStep trocar hernia rate in unclosed 
fascial defects in bariatric patients. Surg Endosc. 2006;20(10):1584-6.
128. Kadar N, Reich H, Liu CY, Manko GF, Gimpelson R. Incisional hernias after major laparoscopic 
gynecologic procedures. Am J Obstet Gynecol. 1993;168(5):1493-5.
129. Leibl BJ, Schmedt CG, Schwarz J, Kraft K, Bittner R. Laparoscopic surgery complications associated 
with trocar tip design: review of literature and own results. J Laparoendosc Adv Surg Tech A. 
1999;9(2):135-40.
130. Mayol J, Garcia-Aguilar J, Ortiz-Oshiro E, De-Diego Carmona JA, Fernandez-Represa JA. Risks of the 
minimal access approach for laparoscopic surgery: multivariate analysis of morbidity related to 
umbilical trocar insertion. World J Surg. 1997;21(5):529-33.
131. Moran DC, Kavanagh DO, Sahebally S, Neary PC. Incidence of early symptomatic port-site hernia: a 
case series from a department where laparoscopy is the preferred surgical approach. Ir J Med Sci. 
2012;181(4):463-6.
Chapter 5
124
132. Moreno-Sanz C, Picazo-Yeste JS, Manzanera-Diaz M, Herrero-Bogajo ML, Cortina-Oliva J, Tadeo-Ruiz 
G. Prevention of trocar site hernias: description of the safe port plug technique and preliminary 
results. Surg Innov. 2008;15(2):100-4.
133. Sanchez-Pernaute A, Perez-Aguirre E, Garcia Botella A, Rodriguez L, Antona EM, Cabeza J, et al. 
Prophylactic closure of trocar orifices with an intraperitoneal mesh (ventralex) in laparoscopic 
bariatric surgery. Obes Surg. 2008;18(11):1489-91.
134. Schmedt CG, Leibl BJ, Daubler P, Bittner R. Access-related complications - an analysis of 6023 
consecutive laparoscopic hernia repairs. Minim Invasive Ther Allied Technol. 2001;10(1):23-9.
135. Tonouchi H, Ohmori Y, Kobayashi M, Kusunoki M. Trocar site hernia. Archives of surgery. 
2004;139(11):1248-56.
136. Uslu HY, Erkek AB, Cakmak A, Kepenekci I, Sozener U, Kocaay FA, et al. Trocar site hernia after 
laparoscopic cholecystectomy. J Laparoendosc Adv Surg Tech A. 2007;17(5):600-3.
137. Garg P, Thakur JD, Garg M, Menon GR. Single-incision laparoscopic cholecystectomy vs. 
conventional laparoscopic cholecystectomy: a meta-analysis of randomized controlled trials. J 
Gastrointest Surg. 2012;16(8):1618-28.
138. Milas M, Devedija S, Trkulja V. Single incision versus standard multiport laparoscopic 
cholecystectomy: up-dated systematic review and meta-analysis of randomized trials. Surgeon. 
2014;12(5):271-89.
139. Trastulli S, Cirocchi R, Desiderio J, Guarino S, Santoro A, Parisi A, et al. Systematic review and meta-
analysis of randomized clinical trials comparing single-incision versus conventional laparoscopic 
cholecystectomy. Br J Surg. 2013;100(2):191-208.
140. Muysoms F, Campanelli G, Champault GG, DeBeaux AC, Dietz UA, Jeekel J, et al. EuraHS: the 
development of an international online platform for registration and outcome measurement of 
ventral abdominal wall hernia repair. Hernia. 2012;16(3):239-50.
141. van Ramshorst GH, Nieuwenhuizen J, Hop WC, Arends P, Boom J, Jeekel J, et al. Abdominal wound 
dehiscence in adults: development and validation of a risk model. World J Surg. 2010;34(1):20-7.
142. van Ramshorst GH, Klop B, Hop WC, Israelsson LA, Lange JF. Closure of midline laparotomies by 
means of small stitches: practical aspects of a new technique. Surg Technol Int. 2013;23:34-8.

Chapter
Parastomal hernia is an 
independent risk factor for 
incisional hernia in patients with 
end colostomy
L. Timmermans
E.B. Deerenberg
B. Lamme
J. Jeekel
J.F. Lange 
Surgery 2014;155(1):178-83.
Chapter 6
128
Abstract
Background
Incisional hernia (IH) is the most frequent complication after abdominal 
surgery with an incidence of 11-20% and up to 35% in risk groups. Known risk 
groups for IH are abdominal aortic aneurysm and obesity. Our hypothesis is 
that parastomal hernia (PSH) might also represent a risk factor for developing 
IH. Identifying risk factors can help determine the need for preventive 
measures like primary mesh augmentation.
Methods
In a multi-center cross-sectional study, all patients who were operated between 
2002 and 2010 by means of a Hartmann procedure or abdominoperineal 
resection were invited for a follow-up visit to our outpatient clinic. Primary 
outcome measures were the prevalence of IH and PSH. All possible risk factors 
for IH were scored. A physical examination was performed and, when available, 
CT-scans were scored for IH and PSH. 
Results
A total of 150 patients were seen in the outpatient clinic. The median follow-up 
was 49 months (30-75). IH had a prevalence of 37.1% and PSH had a prevalence 
of 52.3% during physical examination. During CT-scan examination prevalance 
was even higher, beeing 48.3% and 52.9%. IH and PSH were both present in the 
same patient in 30% of all examined, and in 35.6% after CT-scan examination. 
PSH was found to be a statistically significant risk factor for IH in univariate and 
multivariate logistic regression analyses of variance, with an Odds Ratio (OR) 
of 7.2 (95% CI 3.3 – 15.7). In addition, an emergency operation was found to be 
a risk factor for IH with an OR of 5.8 in the multivariate analyses. 
Conclusions 
Patients with a PSH have a seven times higher chance of developing an IH 
compared to patients without PSH. 
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Introduction
Patients diagnosed with abdominal pathology can be operated by open midline 
laparotomy. Incisional hernia (IH) is the most frequent complication following 
midline laparotomy, with an incidence of 11-20%(1-3). The presence of IH is 
associated with pain, impaired quality of life and potentially life-threatening 
complications such as incarceration or strangulation of the bowel(4, 5). In 25% 
of patients surgically treated for abdominal pathology, a stoma is necessary (6). 
Parastomal hernia (PSH) is a frequent complication following stoma creation, 
with an incidence of up to 48% (7). Clinical findings in our center suggest that 
PSH might be a risk factor for later IH. PSH disrupts the normal abdominal wall 
anatomy and might therefore induce a higher incidence of IH. Currently known 
risk factors for IH development are obesity and abdominal aortic aneurysm 
(AAA), with incidences of up to 35%(8-13).  Identification of risk groups 
gives surgeons the possibility to adapt or change their techniques such as 
primary mesh augmentation in order to prevent IH occurrence(9, 14). A better 
understanding of the etiology of IH may also be obtained with greater insight 
into the association between PSH and IH. We hypothesized that the presence 
of a PSH would be a risk factor for the occurrence of IH occurrence. 
Methods
A cross-sectional study was conducted at the Erasmus University Medical Center 
(EMC) in Rotterdam and the Albert Schweitzer Hospital (ASZ) in Dordrecht, The 
Netherlands. All patients who had been operated either using a Hartmann 
procedure (HMP) or abdominoperineal resection (APR) between 2002 and 
2010 were screened for eligibility. Patients with HMP and APR were included 
because the end colostomy created during these operations is permanent 
(APR) or is not restored in most cases (HMP)(15). Patients who died and patients 
with anastomosis created in a second operation to restore the natural faecal 
route were excluded.
Those patients willing to participate provided their informed consent 
and were seen in our outpatient clinic. Follow-up examination was conducted 
by two physicians experienced in hernia investigation. Physical examination 
was performed to determine the presence of IH and/or PSH. IH was defined as 
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any abdominal wall gap with or without a bulge in the area of a postoperative 
scar perceptible or palpable by clinical examination and/or imaging(16). PSH 
was defined as any palpable defect or bulge adjacent to the stoma when the 
patient is supine with elevated legs or erect and coughing or straining(17). The 
length of the incision scar was measured and, when present, the position and 
size of the hernia was measured and scored using the European Hernia Society 
(EHS) classification system(18). If present, postoperative CT scans were scored 
for PSH and IH independently by two investigators.
Information on possible risk factors for herniation was obtained: gender, 
age, weight, height, body mass index (BMI), current smoking (defined as 5 
cigarettes per day or more), corticosteroid use (current user of any dose), 
chronic obstructive pulmonary disease (COPD), diabetes mellitus (DM) (defined 
as current user of specific diabetic type of drugs or insuline use), previous 
midline incision, AAA, previous hernia (inguinal, umbilical, incisional, hiatal), 
postoperative complications (surgical site infection (SSI), burst abdomen, 
pneumonia, ileus), emergency operation, chemotherapy (defined as any type 
or dose of oral or intravenous chemotherapy), radiotherapy (defined as any 
type or dose of radiotherapy) and physical strenuous work. 
Chi-Square (X²) tests and Mann-Whitney U tests were used to compare 
risk factors for IH and PSH. Univariate and multivariate logistical regression 
analyses were conducted to predict Odds ratios (OR) of potential risk factors. 
Risk factors that were discovered in this study or are known in the literature 
will be added to the multivariate logistic regression analyses. All statistical 
calculations were done using IBM SPSS© 17 Software (SPSS, Chicago, Illinois, 
USA). Significance was assumed at P <0.05.
Results
Between 2002 and 2010, a total of 574 patients received either APR or HMP. At 
the moment of our study: 244 of these patients were deceased; 87 could not be 
reached due to relocation or invalid contact information; and 54 patients did 
not wish to participate due to diminished physical condition or other reasons. 
Of the remaining 189 patients who were thus willing to participate 23 were 
excluded due to removal of the stoma and 16 did not show up for follow-up 
(Figure 1). Of the 150 included patients, 118 (78.7%) patients had undergone 
APR, 89 (59.3%) were male, the mean age was 67.4 years (SD 10.2), mean BMI 
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was 25.9 (SD 5.1) and median time to follow-up was 49 months (IQR 30-75). Of 
all the 150 operations, 119 patients were operated due to malignant disease 
and 31 times due to disease of benign nature (diverticulitis, crohns disease, 
colitis ulcerosa, fistulas etc). Most patients (92.4%) treated for malignant disease 
were operated by means of APR. Most patients (68.7%) treated for a disease 
of benign nature were operated by means of a HMP. In all midline closures a 
continuous closure technique with a slowly absorbable suture was used. The 
suture length to wound length ratio was not measured. 
Risk factors
All possible risk factors were scored and the results are presented in Table 1. 
The presence of a PSH was a highly significant risk factor for IH occurrence (p 
<0.001). HMP, age and length of the incision were also significant risk factors 
for developing IH. AAA and emergency operation both showed a tendency to 
increase the risk for IH. No differences were discovered between hospitals or 
follow-up period. During univariate analysis an OR of 7.2 (95% CI 3.3 – 15.7) 
was found for PSH on IH occurrence. When possibly confounding variables 
were controlled for in the logistic regression analyses (BMI, age, length of 
the incision, type of operation, emergency operation and radiotherapy), PSH 
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remained a statistically significant predictor of IH. Age and length of incision 
also remained significant predictors but had clinically irrelevant ORs (OR 1.05 
and OR 1.1). In the logistic regression analysis an emergency operation was 
found to be a risk factor for IH with an OR of 5.8 (p = 0.016). HMP proved not to 
be a significant risk factor after controlling for possible confounding variables.
Table 1. Risk factors for incisional hernia.
General
(n=150)
No IH
(N=94)
IH
(N=56)
p-value***
Sex
- Male
- Female
89 (59%)
61 (41%)
57 (61%)
37 (39%)
32 (57%)
24 (43%)
0.732
BMI* 25.9 (5.1) 25.3 (4.1) 26.9 (6.2) 0.110
Age* 67.4 (10) 65.8 (10) 70.1 (10) 0.009
Follow-up (months)** 49 (30-75) 49.5 (28-67) 47.5 (31-81) 0.45
Hospital
- ASZ
- EMC
67 (45%)
83 (55%)
42 (45%)
52 (55%)
25 (45%)
31 (55%)
1
Surgery 
- APR 
- Hartmann
118 (79%)
32 (21%)
81 (86%)
13 (14%)
37 (66%)
19 (34%)
0.004
Reason Surgery
- Malignant
- Benign
119 (79%)
31 (21%)
78 (83%)
16 (17%)
41 (73%)
15 (27%)
0.21
Emergency operation 
Length incision*
Chemotherapy
Radiotherapy
17 (11%)
21.7 (5)
61 (41%)
113 (75%)
7 (7%)
20.9 (5)
38 (40%)
76 (81%)
10 (18%)
22.9 (5)
23 (41%)
37 (66%)
0.064
0.029
1
0.051
Medical history:
- DM
- COPD
- Inguinal 
hernia
- AAA
- Diverticulitis
- Previous 
midline 
- Smoking
25 (17%)
15 (10%)
20 (13%)
3 (2%)
16 (11%)
36 (24%)
38 (25%)
14 (15%)
10 (11%)
15 (16%)
0 (0%)
7 (7%)
21 (22%)
26 (28%)
11 (20%)
5 (9%)
5 (9%)
3 (5%)
9 (16%)
15 (27%)
12 (21%)
0.5
0.787
0.321
0.05
0.109
0.558
0.439
Postoperative 
complications
- Wound 
infection
- Burst 
abdomen
- Ileus
- Pneumonia
39 (26%)
21 (14%)
4 (3%)
12 (8%)
7 (5%)
20 (21%)
11 (12%)
1 (1%)
7 (7%)
3 (3%)
19 (34%)
10 (18%)
3 (5%)
5 (9%)
4 (7%)
0.123
0.335
0.297
0.763
0.425
PSH 79 (53%) 34 (36%) 45 (80%) < 0.001
* Values represent the mean and standard deviation. 
** Values represent the median and interquartile ranges. 
*** p-values are two-sided. For dichotomous variables Chi-square test was performed and for continuous 
variables Mann-Whitney.  
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Prevalence 
During physical examination, out of the total of 150 patients, 56 IHs (37.3%) and 
79 PSHs (52.7%) were diagnosed (Table 2). Both hernia types were present in the 
same patient in 45 cases (p < 0.001). In 87 patients, a CT-scan was available and 
an objective evaluation of hernia presence could be performed. The available 
CT scans had been requested as follow-up method related to the initial disease 
of the patient. The CT revealed 42 IHs (48.3%) and 46 PSHs (52.9%). Both were 
present in 31 of the CT scans (35.6%), which was also statistically significant (p 
< 0.001). Physical examination for the diagnosis of IH reached a sensitivity of 
0.79 and a specificity of 0.96. For PSH a sensitivity of 0.87 was reached with a 
specificity of 0.95.
Table 2. Physical examination and CT-scan examination.
Prevalence X² p-value*
Physical examination (n=150)
- IH
- PSH
- IH and PSH
56 (37%)
79 (53%)
45 (30%) < 0.001
CT-scan (n=87)
- IH
- PSH
- IH and PSH
42 (48%)
46 (53%)
31 (36%) < 0.001
*Association is tested by means of Chi-Square testing. 
Discussion
This study confirms our hypothesis that the presence of PSH represents a risk 
factor for the occurrence of IH. Patients who acquire a PSH had a seven times 
higher odds of developing an IH compared to patients without a PSH.
The prevalence of PSH in our study was 52.7%, which corresponds 
with existing literature and in our previous experience with colostomies (7). 
The incidence of PSH does not differ when open or laparoscopic colostomy 
creation are compared, suggesting that PSH is not affected by midline incision 
or hernia (7, 19, 20). A number of potential theories explaining the high rate 
of PSH have been suggested in the literature. Increased abdominal pressure 
can exit through the opening in the abdominal wall possibly promoting PSH. 
According to Laplace’s law, the tangential forces working on the colostomy 
may enlarge the fascial opening and cause PSH (21). Additionally the creation 
of the colostomy opening is not a standardized procedure. An overly small 
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stoma opening can lead to obstruction while an overly large stoma opening 
can perhaps incite a higher frequency of PSH. These mechanisms can explain 
the high incidence of PSH found in general and also in our study. However, with 
a prevalence of over 37% at 49 months, the IH rate in our population is one 
of the highest found in the literature (3, 22, 23). Examination of the CT scans 
showed this number to be even larger - up to 48.3%. This high prevalence can 
probably be attributed to the presence of a PSH. When looking at the location 
where the IH occurred, it is striking to see that 55% of the IHs occurred at 
exactly the same level as the colostomy. For instance, patients with a colostomy 
at the M3 level (EHS classification) developed IH in most cases between 3cm 
above and 3cm below the umbilicus (M3). It can thus be hypothesized that the 
mechanical forces during inspiration and expiration change after colostomy 
creation. The midline incision tends to shift to the contralateral side due 
to reduced restraining force at the site of the colostomy. This explanation is 
visualized in Figure 2. The midline shift increases the tensile force on part of the 
sutures and can thus create direct postoperative separation of wound edges, 
which is a major predictor of IH (24, 25). The tensiles force and the midline 
shift will increase further after PSH development, with a further reduction 
of the restraining force as a result. Another possible explanation is atrophy 
of the rectus muscles on the colostomy side due to the disruption of nerve 
innervation during placement of the colostomy. This atrophy can create a weak 
spot at the level of the colostomy and thus induce IH. In the literature, it is also 
stated that some patients may be subject to herniosis and thus biologically 
prone to herniation (26-30). However, in the present study, no other possible 
symptoms of herniosis were found except the strong association between PSH 
and IH: Patients with a PSH and/or IH did not have more inguinal, umbilical or 
other incisional hernias. One can also hypothesize that all patients with a PSH 
have a form of herniosis in light of the fact that PSH can often be attributed 
to technical failures. Further research should thus examine both the biological 
and biomechanical aspects of hernia as the etiology may very well be a 
combination of the two. 
In the present study, we found a difference in the hernia rates for the two 
types of surgery performed in our patient group. Surgical site infections have 
been shown to increase IH rates, which means that the nature of both of these 
operations could - in principle - contribute to the high incidence of hernias (31, 
32). APR and HMP are by definition potentially contaminated surgeries. 
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Figure 2. Midline shift after enterostomy creation.
However, the 21 patients identified with SSI were equally divided across the 
patients with and without hernia; SSI therefore cannot be responsible for the 
high rates of hernia which we found. HMP showed a higher incidence (59.4%) 
of hernia compared to APR (31.4%). However, the results of the multivariate 
regression analysis showed - not HMP - but the emergency setting in which 
the HMP usually took place to constitute a risk factor for IH. Patients operated 
in an emergency setting had a 5.8 times higher odds of IH than patients not 
operated in an emergency setting. Relatively few articles have been published 
on this subject regarding emergency operations and hernia formation(33, 34). 
Patients operated in an emergency setting are generally in a more weakened 
state both pre-operatively and post-operatively, are more often subject of 
intra-abdominal contamination than other patients and also generally have 
high intra-abdominal pressure; the possibility of tension-free closure is thus 
reduced strongly (35).
Limitations
There are several weaknesses with regard to this study and most of them are 
due to the cross-sectional design. For instance, as all patients were seen at the 
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same time and in most cases no documentation of either IH or PSH could be 
found, it is unclear whether PSH or IH occurred first. Nevertheless an assumption 
was made on the basis of the patients’ anamneses that PSH occurred first, but 
further prospective studies should be undertaken to confirm this assumed 
sequence. Also, no measurement of the suture length to wound length ratio 
was conducted, which could facilitate an increase in IH formation. In addition, 
in this study out of 574 patients only 150 patients were available for follow-up 
which could attribute to selection bias. The majority of these lost patients were 
due to death or due to them not being able to come to our outpatient clinic, 
possibly due a diminished physical state or to postoperative complications. 
A prospective trial could be able to control for this possible bias. Standard 
follow-up which includes radiological examination might also strengthen the 
results of future studies giving also give more insight into possible changes 
that occurred in the abdominal wall before and after operation and herniation. 
Conclusion
This study confirms our hypothesis that PSH increases the chances of IH 
occurrence by seven times. Furthermore, patients operated in an emergency 
setting also have a 5 times higher chance of IH, as shown in the multivariate 
analyses of variance. Thus, PSH and - to a lesser extent - operation in an 
emergency setting can be added to the already known risk factors of IH 
development, namely AAA and obesity. Patients who are known to be prone to 
herniation can thus be treated prophylactically. Primary mesh augmentation 
in patients at risk for herniation has been shown to reduce the incidence of IH 
and PSH (9, 12), (36-39). Although colostomy operations are considered clean-
contaminated or even contaminated operations, the contamination did not 
increase (mesh) infections in trials where mesh augmentation was used. In 
case of open colostomy creation it would be advisable to not only augment the 
midline or the colostomy with a mesh but augment both, in order to prevent 
IH and PSH formation. In case of PSH correction, an effort should be made to 
correct both the IH and PSH. Creating an mesh overlap over the midline, as 
demonstrated by Berger et al, would reduce the chance of IH development and 
PSH recurrence (40). Further research is nevertheless needed to identify other 
possible preventive measures to reduce postoperative hernias and better 
understand the mechanical and biological factors influencing the occurrence 
of IH. 
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Abstract
Introduction
Incisional hernia (IH) can be attributed to multiple factors. The presence of a 
parastomal hernia has shown to be a risk factor for IH after midline laparotomy. 
Our hypothesis is that this increased risk of IH might be caused by changes 
in biomechanical forces, such as midline shift to the contralateral side of the 
colostomy owing to decreased restraining forces at the site of the colostomy, 
and left abdominal rectus muscle (ARM) atrophy owing to intercostal nerve 
damage.
Methods
Patients were selected if they underwent an end-colostomy via open operation 
between 2004 and 2011. Patients were eligible if computed tomography (CT) 
had been performed postoperatively. If available, pre-operative CT-scans were 
collected for case-control analyses. Midline shift was measured using V-Scope 
application in I-Space®, a CAVETM-like virtual reality system. For the ARM atrophy 
hypothesis, measurements of ARM were performed at, the level of colostomy, 
and 3cm and 8 cm cranial and caudal of the colostomy. 
Results
Postoperative CT-scans were available for 77 patients; of these patients, 30 
also had received a preoperative CT-scan. Median follow-up was 19 months. A 
mean shift to the right side was identified after preoperative and postoperative 
comparison; from -1.3 +/- 4.6 to 2.1 +/-9.3(p = 0.043). Furthermore, during 
rectus muscle measurements, a thinner left abdominal rectus muscle was 
observed below the level of colostomy. 
Discussion
Creation of a colostomy alters the abdominal wall. Atrophy of the left ARM was 
seen caudal to the level of the colostomy, and a midline shift to the right side 
was evident on CT-scan. These changes may explain the increased rate of IH 
after colostomy creation.
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Introduction
Incisional hernia (IH) is one the most frequent postoperative complications 
after abdominal surgery (1-3). The reason for IH formation can be attributed 
to patient-related factors, such as high body mass index (BMI), smoking, 
corticosteroid use, abdominal aortic aneurysm (AAA), or other connective 
tissue disorders(4-8). Otherwise, IH formation can also be influenced by factors 
related to the surgeon or the surgical procedure, such as suture technique, 
surgical site infections and fascial dehiscence(9-11). More recently, we found 
that parastomal hernia appeared to be a risk factor for IH(12). Patients with a 
parastomal hernia had a 7.2 higher Odds Ratio for IH formation(12). In addition, 
55% of all IH developed at the level of the colostomy. We hypothesized that 
the biomechanical forces in the abdominal wall would change after colostomy 
creation, inducing a greater rate of IH. One hypothesis was that the midline 
incision would shift to the right (or contralateral side) due to reduced restraining 
forces at the site of the colostomy. A midline shift would increase the tensile 
force on a part of the sutures and this shift would then cause separation of 
the wound edges, which is a major predictor of IH (13, 14). In addition, we 
hypothesized that would induce atrophy of the abdominal rectus muscle (ARM) 
due to transection or injury to the intercostal or subcostal nerves innervating 
the ARM (15). A radiologic anatomic study was performed to determine if 
colostomy creation induces a midline shift and ARM atrophy. 
Methods
Inclusion and exclusion criteria
Patients were selected from the PACIFIC cohort, a multicenter study which was 
conducted at the Erasmus University Medical Center, Rotterdam, the Netherlands 
and the Albert Schweitzer Hospital, Dordrecht, the Netherlands(12). Patients 
were included in this cohort if they had undergone a left-sided, end-colostomy 
during an open Hartmann Procedure or abdominoperineal resection between 
2004 and 2011. Patients were selected for this study if a CT had been taken 
postoperatively. If available, pre-operative CT-scans were also collected for case-
control analyses. Patients were excluded if the time between operation and the 
postoperative CT was less than 1 month, if a patient had a transposition of the 
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ARM, if a patient had an ileostomy or, if a patient had multiple colostomies. 
Patients with a parastomal hernia or IH were not excluded from this study.
I-Space®
In order to evaluate a midline shift at the level of the colostomy, the I-Space®, 
a CAVETM like virtual reality system, and V-scope software were used (16). This 
system was previously used and validated in a gynecologic and orthopaedic 
studies (17, 18). The CT-scans were uploaded to the I-Space® PACS, format 
converted, and then three dimensionally visualised and projected using the 
V-Scope application. This results in a “hologram” of the dataset being visualised 
floating in front of the viewers. The viewers wore a pair of lightweight glasses 
with polarising lenses that allowed the hologram to be seen with depth. A 
virtual pointer was used to interact with this “hologram” which made it possible 
to move into the hologram and to perform measurements (Figure 1 and 2)
(19). The exact midline of the abdominal wall was determined by drawing a 
3-dimensional line between the xyphoid process and the pubic bone, parallel 
to the spine. The distance of the abdominal rectus muscles to this midline 
(dARM) was measured to determine how the exact midline corresponded with 
the position of the rectus muscles. The midline shift was calculated as follows: 
(left dARM + right dARM) / 2 – left dARM). For instance, if the distance of the 
right ARM to the exact midline was 4 millimeter (mm) and the distance of the 
left ARM to the exact midline was 6 mm, this would constitute to: (6 + 4) / 2 – 6 
= -1mm, which would mean that the rectus muscles have shifted 1mm to the 
left at the level of the colostomy. 
ARM measurements
Measurements were performed at 5 different points at both the colostomy (left) 
side and the contralateral (right) side in order to evaluate the ARM thickness. 
These measurements were taken at 8cm, 3 cm cranial and caudal to, and at the 
level of the colostomy. 
Statistical analysis was performed using the paired Student’s t-test, 
Mann-Whitney-U test and the Spearman correlation coefficient, whenever 
appropriate(SPSS 14.0, Chicago, IL, USA). Numbers are presented as means 
with standard deviations (SD) or medians with interquartile ranges (IQR). A 
p-value of <0.05 was considered statistically significant.
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Figure 1. The I-Space® installed at the Erasmus is a CAVETM-like virtual reality environment where images 
can be projected as 3-dimensional hologram. 
Figure 2. The distance between the ARM to the exact midline is being measured in a 3-dimensional 
hologram. 
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Figure 3. ARM thickness was measured at 8 centimetres (cm) above and below, 3 cm above and below 
and at colostomy level. 
Results
Inclusion and exclusion criteria
A total of 160 patients from the PACIFIC cohort who had given informed 
consent were screened if a postoperative CT was available. At the time of our 
study, 32 patients were excluded (due to removal of the colostomy, multiple 
enterostomies, flap transposition of ARM, or a burst abdomen), 49 did not 
receive a postoperative CT, and in 2 patients the postoperative CT was taken 
within 1 month after surgery, leaving 77 patients eligible for this study.
General
The median time between creation of the colostomy and the postoperative 
CT-scans was 19 months (range 1 to 96). Of all patients 44, (57%) were men, 
Abdominal wall changes and IH
147
7
the median age was 66 (range 32 to 81), the median BMI was 25 (range 17 
to 41), 10 patients (13%) had diabetes mellitus (DM), 10 (13%) had chronic 
obstructive pulmonary disease (COPD), 16 (21%) were current smokers and in 
7 (9%), the colostomy was placed lateral to ARM. Older patients had a decrease 
in ARM thickness (rs= -0.28 preoperatively, rs= - 0.25 postoperatively); also, in 
female patients a general decrease in ARM thickness (p < 0.001) was observed. 
However, female sex and age did not have an effect on the midline shift. DM, 
COPD, smoking and pararectal placement of the colostomy were also not 
associated with a change in ARM thickness or midline shift. 
I-Space®
The median preoperative midline shift was -0.8mm (n=30; IQR -4.8 to 0.9). 
Postoperatively the median postoperative shift was 4.5 mm (n=77; IQR -1.9 - 
9.8) corresponding with a shift to the right. Comparing the preoperative CT-
scans with the CT-scans that were taken postoperatively, there was a mean 
shift to the right side; from -1.3 +/-4.6 to 2.1 +/-9.3) (p = 0.043) (Table 1). 
ARM measurements
When comparing the preoperative CT-scans with the postoperative CT-scans a 
thickening of the left ARM was observed at 3cm cranial, 3cm caudal, and at the 
level of the colostomy (Table 1). This thickening of the ARM was not seen on the 
right/contralateral side. 
Table 1. Preoperative versus postoperative data.
Preoperative* Postoperative* P-Value**
Midline shift at stoma -1.3 (4.6) 2.1 (9.3) 0.043
Left ARM (n = 30)
ARM thickness 8cm above stoma 8.1 (2.4) 8.5 (2.1) 0.203
ARM thickness 3cm above stoma 8.8 (2.6) 9.8 (2.6) 0.010
ARM thickness at stoma level 9.1 (2.8) 10.2 (2.5) 0.024
ARM thickness 3cm below stoma 9.6 (2.7) 10.3 (2.7) 0.086
ARM thickness 8cm below stoma 10.8 (3.2) 10.4 (3.2) 0.466
Right ARM (n = 30)
ARM thickness 8cm above stoma 8.3 (2.4) 8.5 (2.6) 0.609
ARM thickness 3cm above stoma 8.9 (2.5) 9.6 (3.1) 0.081
ARM thickness at stoma level 9.3 (2.7) 9.6 (2.7) 0.448
ARM thickness 3cm below stoma 9.9 (2.7) 10.5 (3.3) 0.178
ARM thickness 8cm below stoma 10.9 (3.1) 11.1 (3.5) 0.609
* Values represent the means and standard deviation in mm
** p-values are two-sided. For continuous variables the paired student t-test was used.  
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When comparing the left and the right ARM, no difference was seen regarding 
ARM thickness preoperatively. However, postoperatively, a thickening of the 
left/ipsilateral ARM was seen at 8cm cranial, 3cm cranial and at the level of 
the colostomy (Table 2) compared with the right/contralateral ARM. When 
we stratified the postoperative group in groups, one with and one without 
parastomal hernia, the left ARM was thicker cranial and at the level of the 
colostomy in the parastomal hernia group but not in the group without 
parastomal hernia.
Table 2. Left ARM vs. right ARM data.
Left ARM* Right ARM* P-Value**
No PH (n = 33)
Postoperative 8cm above stoma 9.3 (2.1) 9.1 (2.3) 0.440
Postoperative 3cm above stoma 10.1 (3.3) 9.5 (3.2) 0.137
Postoperative level stoma 10.8 (3.1) 10.7 (3.4) 0.797
Postoperative 3cm below stoma 10.7 (2.8) 11.7 (3.6) 0.044
Postoperative 8cm below stoma 11.1 (3.6) 12 (3.7) 0.017
PH (n = 44)
Postoperative 8cm above stoma 7.9 (2.3) 7.4 (2.3) 0.036
Postoperative 3cm above stoma 9.6 (2.4) 8.8 (2.9) 0.024
Postoperative level stoma 10.2 (3.0) 9.3 (2.5) 0.004
Postoperative 3cm below stoma 10.2 (2.8) 10.1 (3.6) 0.677
Postoperative 8cm below stoma 9.9 (3.3) 10.6 (3.9) 0.151
* Values represent the means and standard deviation in mm
** P-values are two-sided. For continuous variables the paired student t-test was used.  
Caudal to the level of the colostomy, the left ARM was thinner than the right 
ARM. Again, the postoperative group was divided in two groups, one with and 
one without parastomal hernia. Caudal to the colostomy a thinner left ARM was 
observed in the group without parastomal hernia at 3cm caudal (10.7 +/-2.8 vs. 
11.7 +/-3.6 (p = 0.044) and 8 cm caudal (11.1 +/-3.6 vs. 12 +/-3.7 (p=0.017) . 
In the group with a parastomal hernia no significant differences in ARM were 
seen. 
Discussion
This is the first study to show that changes are present in the abdominal wall 
after colostomy creation. By using the I-Space® system, a midline shift was 
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seen to the right (contralateral) side of the colostomy. In addition differences 
were observed in the thickness of the ARM in the area near the colostomy.In 
literature, a decrease of the general thickness of the ARM in females and in 
older people has been described, and similar findings were observed in this 
study (20, 21). Little is known, however with regard to the effect of abdominal 
incisions on changes in the abdominal wall and even less is known regarding 
changes after colostomy creation (15, 22, 23). Two types of changes in the 
abdominal wall were observed in this study which might have an influence on 
wound healing and IH formation. 
Midline shift 
A significant shift to the contralateral side of the colostomy was observed 
when preoperative and postoperative CT-scans were compared. The observed 
midline shift appears to be caused by a decrease in restraining forces at the site 
of the colostomy. Without the pull of the abdominal wall muscles on the left 
(colostomy) side, a dysbalance of the muscles in favor of the muscles on the 
right (contralateral) side can result in the observed midline shift. This change 
would increase the force on some parts of the suture line. In addition, a curve 
instead of a straight wound line will also promote separation of the wound 
edges which is known to be a risk factor for IH (13). Although it is possible that 
in addition to the decrease in restraining forces, the excess of tissue due to 
colostomy creation might also induce a shift, this could not be tested in this 
study. During our initial mechanical modelling by testing using the Abdoman®, 
(the artificial abdomen of Erasmus University Medical Center and Technology 
University of Delft, the Netherlands) we observed that a midline shift also 
occurred without the excess volume of a colostomy and that the decrease 
in restraining forces were the main cause of midline shift. This findings are, 
however, preliminary and more research still needs to be conducted.
ARM measurements
Other observed findings were changes in ARM thickness. The left (colostomy) 
ARM at the level of the colostomy was significantly thicker postoperatively 
compared to the preoperative situation. On review of the CT-scans, it was 
more difficult to measure the ARM thickness in the vicinity of the colostomy; 
the medial part of the ARM seemed to fold over itself due to pressure of the 
colostomy, inducing the apparent observed increase in thickness. 
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A similar finding was observed when comparing the left (colostomy) ARM 
with the right ARM postoperatively. The left ARM was thicker at 8cm cranial, 3cm 
cranial and at the level of the colostomy. However, caudal to the colostomy, the 
left ARM was actually thinner. This change may be caused by left ARM atrophy 
due to the denervation or damage to the intercostal /subcostal nerve after 
colostomy creation. Colostomies created during abdominoperineal resection 
or Hartmann procedures are generally situated in the lower left quadrant 
and positioned at the level of the 12th intercostal nerve. The iliohypogastric 
nerve which travels caudal to the 12th intercostal nerve does not innervate 
the rectus muscle and cannot compensate for any potential damage. Injury 
to the intercostal nerve would induce atrophy of the left ARM at the level of 
the colostomy and caudal. This effect was partially obscured in this study due 
to overlap caused by the colostomy and possible herniation. The combination 
of an atrophy of the left ARM and the associated midline shift could be the 
cause of the increase of risk of IH observed in the PACIFIC-study(12). There has 
been discussion as to which position is preferential for colostomy placement. 
Currently, it is not known if colostomies should be placed through or lateral of 
the ARM. However, lateral of the ARM the intercostal nerves are less segmented 
and could be easier to detect and preserve (24). Additionally, a more cranial 
colostomy position could decrease atrophy to the ARM, because the 11th 
and 12th intercostal nerves are mainly responsible for ARM innervation (25). 
Furthermore, prophylactic mesh application at the level of the colostomy 
will decrease the chance of parastomal hernia formation and as a result will 
decrease possible long-term nerve damage due to compression(26). No 
literature, however, is currently available with regards to the effects of these 
prophylactic measures on ARM atrophy.
Limitations
The main weaknesses of this study are the retrospective design and the limited 
number of patients. Due to the limited number of available preoperative 
CT-scans in this cohort, we were not able to perform statistical analyses 
with regards to IH or parastomal hernia and the midline shift. In addition, it 
is unknown what the impact a 5mm shift would have on the forces on the 
abdominal wall. This is something that might be investigated in the future with 
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biomechanical experiments (for instance, using the Abdoman®). Currently our 
group is developing a Finite Element Model, in attempt to model the forces after 
incisions in the abdominal wall. Furthermore, it would have been interesting to 
have a preoperative CT-scan of all patients and standard follow-up CT-scans 
during the postoperative period and to see the development of the changes 
of the midline and the ARM. Also, measurement errors were minimized in 
this study by using the I-Space® program but could possibly be reduced even 
further by implementing a prospective study protocol. As stated before, it was 
difficult to measure the ARM in the vicinity of the colostomy due to folding 
of the ARM. The decrease in left ARM thickness caudal to the colostomy was 
apparent and in accordance with our hypothesis.
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Abstract 
Purpose
Incisional hernia (IH) is one of the most frequent postoperative complications. 
Of all patients undergoing IH repair, a vast amount have a hernia which can be 
defined as a large incisional hernia (LIH). The aim of this study is to identify the 
preferred technique for LIH repair.
Methods
A systematic review of the literature was performed and studies describing 
patients with IH with a diameter of 10cm or a surface of 100cm2 or more were 
included. Recurrence hazards per year were calculated for all techniques using 
a generalized linear model. 
Results 
Fifty-five articles were included, containing 3945 LIH-repairs. Mesh reinforced 
techniques displayed better recurrence rates and hazards than techniques 
without mesh reinforcement. Of all the mesh techniques, sublay repair, 
sandwich technique with sublay mesh and aponeuroplasty with intraperitoneal 
mesh displayed the best results (recurrence rates of <3.6%, recurrence hazard 
<0.5% per year). Wound complications were frequent and most often seen 
after complex LIH repair. 
Conclusions 
The use of mesh during LIH repair displayed the best recurrence rates and 
hazards. If possible mesh in sublay position should be used in cases of LIH 
repair.
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Introduction 
Incisional hernia (IH) is one of the most frequent complications after abdominal 
surgery with an incidence up to 20%(1-3), and in high risk patients incidences 
over 35% have been reported (4, 5). In the United States, 4 to 5 million abdominal 
surgeries are performed every year which means that a number as high as 
500.000 IH will develop annually. Within this group, a specific subcategory of 
patients with large incisional hernia (LIH) can be identified. The incidence of 
LIH is rising due to an increase in survival of intra-abdominal catastrophes and 
infections(6). Of all patients with IH 15-47% have a hernia which can be defined 
as a LIH (7). Patients with LIH often experience severe symptoms and associated 
co-morbidities. Patients with LIH may have complaints of severe back pain, 
disturbance of ventilatory function, chronic wounds or enterocutaneous 
fistulas, resulting in a major decrease in quality of life and daily activities(6, 
8-10). 
LIH repair is technically challenging and is associated with a longer hospital 
stay, impaired wound healing, a higher rate of reoperations and readmissions 
and increased recurrence rates(7, 11-14). In some cases approximation of the 
rectus fascia is not possible and the mesh can be used to bridge the defect or 
additional measures such as component separation or aponeuroplasty must 
be added. Bridging with the mesh in contact with the viscera increases the risk 
of postoperative complications such as adhesion formation, bowel obstruction 
and complicated reinterventions(15, 16). In the last decades laparoscopic LIH 
repair has been introduced, with an intraperitoneal onlay mesh (IPOM) bridging 
the defect. Using IPOM, augmentation of the abdominal wall is in most cases 
not performed and the entire mesh is in contact with the viscera, for which 
reason composite meshes are most often used to reduce adhesion formation. 
Randomized clinical trials have been conducted on the different repair 
techniques of small and medium sized ventral(17-20), but the treatment of LIH 
has not yet been properly addressed. There is no consensus, based on evidence, 
regarding the optimal treatment option. The treatment of LIH is in fact a major 
problem, with associated potentially life-threatening complications. The aim 
of this study is to identify the best possible technique(s) for LIH repair with 
regards to recurrence and complication rates.
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Methods 
In literature many different definitions of LIH are proposed but consensus 
is lacking, as shown in table 1. Commonly used parameters to define large 
abdominal hernia include width, length, transverse size and the surface 
calculation of an ellipse (½ length x ½ width x π). For this review LIH is defined 
as ventral incisional hernia with a fascial defect of 10cm or more in any direction 
according to the definition of the European Hernia Society(21) or a defect 
surface of 100cm2 or more.
Table 1. Definitions of large incisional hernias in the literature.
Author Definition of large hernia
Tanaka EY, 2010(22) ≥ 10 cm width or length
Muysoms FE, 2009(21) ≥ 10 cm width
Ammaturo C, 2005(23) ≥ 10 cm width
Dumanian GA, 2003(24) > 10-15 cm transverse size
Korenkov M, 2001(25) ≥ 10 cm width or length
Chevrel JP, 2000(26) ≥ 15 cm width
Search strategy
A systematic review of the literature was conducted to detect all treatment 
strategies of large incisional hernia. An electronic search of Embase, Pubmed 
and the Cochrane Central Register of Controlled Trials was performed on May 
2nd, 2014. Additionally, a cross-reference search of review articles in leading 
journals and manual research of reference lists of all included studies was 
conducted to identify articles published on the treatment of LIH. There was no 
restriction on language, study type or publication year. 
Study inclusion and exclusion criteria
Only treatment studies involving adult human subjects with LIH of the ventral 
abdominal wall were included. Ventral wall hernias include midline, transvers, 
subcostal, (para)umbilical and paramedian locations. LIH was defined as 
a fascial defect (hernial orifice) measuring 10cm or more in any direction or 
a surface of 100cm2 or more. The following study types were included: RCT, 
prospective and retrospective cohort studies, case-control studies and case 
series. 
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Studies with one of the following characteristics were excluded: a 
mean follow-up of less than one year, less than 75% completion of follow-up 
of at least one year, or reporting on repair with a commercially not available 
mesh. Studies reporting series or cohorts of fewer than 10 patients operated 
over 3 years were excluded to eliminate small case series that were likely to 
be influenced by learning curves, and to minimize selection and publication 
bias of ‘positive’ results. LIH in the iliac region or after lumbotomy were 
excluded. Studies were excluded if a full-text version was not available. 
Whenever multiple publications from institutions reporting the same cohort 
were encountered, only the most recent and complete article was included. 
Two reviewers independently assessed the titles and abstracts of all reports 
identified by electronic and manual searches. Any disagreement was resolved 
by discussion and consensus with the last author of this article. 
In the results discrimination between ‘simple’ and ‘complex’ LIH was 
made. Simple LIH was defined as a fascial defect over 10 cm (or surface over 
100cm2) with intact soft tissue and skin and, if recurrent, with a not-infected 
mesh in situ from previous repair, comparable to the ‘minor’ complex abdominal 
hernias from the classification system of Slater (27). Complex LIH was defined as 
a fascial defect over 10 cm (or surface over 100cm2) and associated problems of 
substantial loss of tissue, intra-abdominal infection, or if recurrent with infected 
mesh. LIH was also considered complex if during LIH repair a concomitant 
parastomal hernia was repaired. The category complex LIH includes most of 
the ‘moderate’ and ‘major’ complex abdominal hernias from the classification 
system of Slater(27). 
Statistical analysis
To compare recurrence rates between repair techniques a generalized linear 
model (GLM) is used(28). Since the occurrence of individual recurrence is not 
reported, the risk of getting a recurrence is assumed equal during each month 
of follow-up of the study for not-affected patients. Exponential survival curves 
are assumed, which are identical for all studies of a certain type of treatment, 
but which differ between treatments. Considering one study i, xi represents 
the sample size, ti the follow-up and yi the number of patients not experiencing 
the recurrence. The exponential survival curve is given by S(t)=exp(-at). 
a represents the angle of the slope of the curve and is estimated from the 
data of all inidividual studies reporting on one repair technique. The expected 
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value of yi  is µi=xi exp (_ati), or log µi=logxi_ati. To estimate a, the GLM is used, 
assuming for yi a Poisson distribution with expectation µi and a logarithmic 
link function. The linear predictor is hi=logxi+ati, with an offset log xi, and no 
intercept. Using the GLM function in the R system, a is estimated(29). A larger 
a  means a smaller probability per month follow-up of getting a recurrence. 
The hazard (a) is transformed from a monthly risk to a yearly risk of getting a 
recurrence during long-term follow-up. 
Results 
The systematic database search identified 1749 records and 80 additional 
records were identified through additional cross-referencing. After removal of 
all duplicates 1467 unique records remained. All abstracts were screened for 
eligibility and for 410 records the full-text article was assessed. Fifty-five articles 
containing 3945 patients met the inclusion criteria and were selected for review 
and included in GLM analysis. The PRISMA flow-chart of the selection of relevant 
studies can be found in figure 1(30). Three techniques of open reconstruction 
without mesh were described comprising 460 patients. Six different techniques 
of open reconstruction with mesh were described comprising 3002 patients 
and 483 patients were repaired by laparoscopic approach. An overview of the 
different LIH repair techniques and results are shown in table 2. 
1. Open reconstruction without mesh
a) Components Separation Technique (CST/Ramirez) 
CST was firstly described by Albanese in 1951(82) and named as such after 
the publication of Ramirez in 1990(8). During CST the abdominal wall is 
augmented by creating relaxing incisions in the external oblique aponeurosis 
and separating the external oblique from the internal oblique muscles and 
elevating the overlying rectus muscle from the posterior rectus sheath (figure 
2). In 7 studies, including one RCT, a total of 219 LIH were repaired using CST(9, 
11, 31-35). In, approximately 40% of cases, patients had a complex LIH.
Postoperative mortality was 1.3%, and postoperative complications 
occurred in almost 50%. Infection or necrosis of the wound occurred in 20%, 
hematoma in 8%, seroma in 9%, and pulmonary complications in 7%. In one 
patient a rupture of the abdominal wall at site of the relaxing incisions occurred 
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for which mesh augmentation was performed. Recurrence after CST occurred 
in 16% of patients after mean 12-52 months follow-up.
Figure 1. The PRISMA flow chart of the selection of relevant studies.
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Figure 2. Components Separation Technique; relaxing incisions external oblique fascia(1), separating 
the external oblique from the internal oblique(2), elevating overlying rectus fascia from posterior rectus 
sheath(3) and bringing fascia from both sides together in midline for closure(4). 
b) Aponeuroplasty
In 1941 Welti and Eudel introduced a technique which consists of incising both 
anterior rectus sheaths and suturing them overlapping together covering the 
hernia defect(83) (figure 3). In 3 studies a total of 195 LIH were repaired using 
aponeuroplasty(10, 36, 37). In 55% of cases, patients had a complex LIH (36, 37). 
In simple LIH cases postoperative seroma or hematoma formation developed 
in 6%. Recurrence occurred after aponeuroplasty in 2.2% of patients after a 
mean follow-up of over 4.5 year. In complex LIH patients the postoperative 
mortality after aponeuroplasty was 10.4% and 18.9% of patients developed 
postoperative wound infections. The recurrence rate after aponeuroplasty with 
complex LIH’s was 21% after 10 years follow-up. The overall recurrence rate of 
LIH’s repaired with aponeuroplasty was 12% after mean 4-10 years follow-up. 
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Figure 3. Aponeuroplasty technique; incising both anterior rectus sheaths and suturing them 
overlapping together. A mesh can additionally be implanted intraperitoneally (IPOM) (red dotted line) 
or onlay (blue dotted line).
c) Langenskiöld method 
In 1982 Smitten et al published the results of the ‘Langenskiöld’ method 
of hernia repair, using strips of the hernial sac passed through the opposite 
abdominal wall as pulling threads to approximate the rectus muscles in the 
midline(38). Disappointing results included wound infection in one third of all 
patients and 20 out of the 46 patients (44%) with LIH developed a recurrence 
after a mean follow-up of 6 years. 
2. Open reconstruction with mesh 
a) Open repair with sublay mesh (Rives-Stoppa technique) 
French surgeons pioneered the use of a synthetic mesh in LIH repair 
performing closure of the rectus fascia using the preperitoneal (Stoppa, 1973) 
or retromuscular plane (Rives, 1973) (figure 4) (84, 85). In 11 articles a total of 
762 LIH were repaired using the sublay technique.(10, 39-48). Currently sublay 
repair consists of dissection and closure of the posterior rectus sheath and 
placement of a non-absorbable mesh. Most authors report no problems with 
closing the posterior rectus sheath after dissecting the retrorectus plane. In a 
large hernia the defect can extend into the subumbilical abdominal wall (below 
the arcuate line) where no posterior rectus sheath is present and the mesh is 
(partly) positioned in the preperitoneal plane. Rosen extends the retromuscular 
dissection by incising the posterior rectus sheet just medial of the semilunar 
line and positioning the mesh in the retromuscular plain and more laterally in 
the preperitoneal plain (between the peritoneum and the transvers abdominis 
muscle)(47). In 26% of cases, patients had a complex LIH. Since not all studies 
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reported separately on the outcomes of simple and complex LIH, reported 
postoperative complications are of all patients with a sublay mesh. 
Postoperative mortality following sublay repair was 2.1%. Wound 
complications were reported in 11%, seroma in 9% and hematoma in 7%. In 
91 patients additional dermolipectomy or panniculectomy was performed, 
without increased complication rates(39, 41). Mesh infection or fistulas 
associated with wound infection developed in 4.7%, requiring removal of 
the mesh. In most cases of mesh infection, a polyester (PE) prosthesis was 
used(10). In contrast, mesh infection was observed in only 1 patient (<0.5%) 
after repair with polypropylene (PP)(40). After sublay repair some studies 
reported the occurrence of serious complications, such as respiratory failure 
or pulmonary infection in 4.8% (5/103 patients)(39, 41, 45) and prolonged ileus 
in 7.7% (5/65)(40) patients. The overall recurrence rate of LIH repair with sublay 
mesh reinforcement was 3.6% after follow-up from 1-8 years. Recurrence rates 
between simple and complex LIH did not differ. 
Figure 4. Position of meshes in relation to the abdominal wall; onlay (blue dotted line), retromuscular 
(green dotted line) and preperitoneal (red dotted line) position. In our review ‘sublay position’ consists 
of meshes in retromuscular or preperitoneal position.
b) Open repair by aponeuroplasty and intraperitoneal mesh (IPOM)
In 2 studies, consisting of 630 patients, additionally to IPOM placement, both 
anterior rectus sheaths were incised and sutured overlapping together (figure 
3) (49, 50). In all patients a (composite-)PE mesh was implanted. Neither of 
the articles reported the number of simple and complex LIH in their patient 
population. 
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Postoperative mortality was 0.5%. Seroma or hematoma formation 
was reported in 5% and wound infection in 4%. In 1.3% of patients the mesh 
infected, requiring removal of the mesh. The recurrence rate of LIH repair with 
IPOM and aponeuroplasty was 3.2% after 3-8 years follow-up.
c) Open repair with intraperitoneal mesh by bridging (IPOM) 
In cases were the hernia defect is too large or more complicated, IPOM as 
bridging technique can be used (figure 5). In 10 studies, a total of 514 LIH were 
repaired using the IPOM technique(11, 15, 46, 51-57). In one study a biological 
porcine mesh was used(57). Approximately 15% of patients had a complex LIH, 
but not all studies reported separately on the outcomes of simple and complex 
LIH repairs. 
Postoperative one death was reported (mortality 0.2%). Wound infection 
and skin necrosis were reported in 9% of patients and seroma or hematoma 
formation in 10%. In 3.5% of cases, mesh removal was necessary due to 
infection. In the RCT of de Vries Reiling 39% (7 out of 18) of intraperitoneal 
ePTFE meshes became infected and required removal of the mesh(11). The 
recurrence rate of LIH repair with biological mesh in intraperitoneal position 
was 15.8% (3 out of 19 patients) after a follow-up of 18 months(57). The overall 
recurrence rate of LIH repair with IPOM was 8.3% after 1 to 6 years follow-up.
Figure 5. Intraperitoneal onlay mesh technique (IPOM); position of the mesh in relation to the abdominal 
wall. 
d) CST with mesh (modified CST)
It can be opted to use an additional mesh during CST procedures. In the 
studies that investigated the modified CST (MCST), three variations on the 
classic CST were used for component separation, represented by the minimally 
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invasive, posterior and endoscopic CST. Minimally invasive CST uses tunnel 
incisions for external oblique aponeurosis release(58, 59). In endoscopic 
CST direct access to the ventral abdominal wall is provided by using balloon 
dissectors and laparoscopic visualization(60). In posterior CST the posterior 
rectus sheath is incised just medial to the intercostals nerves, exposing the 
transverses abdominis muscle and a release of the transverse abdominis is 
performed(61). In 8 articles a total of 511 LIH were repaired using the MCST(47, 
58-64). Conventional modified CST was performed in 339 patients, minimally 
invasive CST in 95 patients, endoscopic CST in 22 patients and posterior CST 
in 55 patients. In 57% of the patients a complex LIH was present. The mesh 
was positioned in sublay position in 52%(47, 59-63), in IPOM 28% (58, 61, 62), 
or in onlay position in 20% (62, 64). In 11.5% of all patients midline closure of 
the fascia was not completely achieved and the mesh was used in a partially 
bridging position.
Postoperative mortality was 1.8% and postoperative complications 
occurred in 55%. Infection or necrosis of the wound occurred in 33%, 
hematomas in 4%, seromas in 11%, and pulmonary complications in 16%. In 
one study 3 mesh infections requiring excision of part of the biological mesh 
were reported(62). The reported recurrence rate for LIH after MCST was 10.0% 
after 1-5 years follow-up. 
e) Open repair with onlay mesh
In 1979 Chevrel was one of the first who pioneered the use of a non-absorbable 
mesh on the anterior fascia of the rectus muscle as reinforcement of suture 
repair (figure 4)(86). In 6 articles a total of 454 LIH were repaired using the onlay 
mesh technique(53, 65-69). In 4% a complex LIH was present. In 26 patients 
additional relaxing incisions were used to achieve tension-free closure of the 
midline(67, 68). In 38 patients the defect was bridged with the onlay mesh(53, 
66). 
Postoperatively no mortality was reported. Wound infection occurred 
in 31% of patients and removal of the mesh was required in 1.7%. Seromas 
developed in 19% of patients, mainly in patients with a biological mesh. 
Respiratory and cardiovascular complications occurred in 6%. The overall 
recurrence rate of LIH repair with onlay mesh was 11.1% after a 15 to 77 months 
follow-up. 
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f ) The sandwich technique
In the ‘sandwich technique’ the hernia sac is used as an extension of the 
posterior rectus sheath and the anterior rectus sheath. A non-absorbable mesh 
is implanted in the sublay position to reinforce the repair (figure 6). In 5 studies 
a total of 131 LIH were repaired using the sandwich technique(53, 70-73). In 
approximately 10% a complex LIH was present. 
Postoperative complications of wound infection and seroma were 
reported in respectively 17% and 5% of simple LIH. One patient developed 
necrosis of both fascia and skin which led to mesh exposure and necessitated 
mesh explantation(73). In the small group of patients with complex LIH, no 
postoperative complications were reported. After a follow-up of 1 to 7 years, 
the only recurrence reported after the sandwich technique was of the patient 
needing mesh explantation. 
Figure 6. The ‘sandwich technique; a) half of the hernial sac (red) is used as an extension of the posterior 
rectus sheath and the contralateral half of the hernial sac as an extension of the anterior rectus sheath. 
b) A mesh is placed in retromuscular position (blue dotted line). 
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3. Laparoscopic repair
In the last decade the laparoscopic repair with intraperitoneal mesh (IPOM) 
has been gaining popularity (figure 5). In the included studies the mesh was 
positioned bridging the defect with an overlap ranging between at least 2 and 
5 cm. In 8 studies a total of 483 LIH were repaired using laparoscopy(74-81). No 
patients were defined as complex LIH. During repair non-absorbable ePTFE, 
PE- or PP-composite meshes were used. 
Postoperative wound complications were reported in 8% of patients; 6% 
of patients developing prolonged seroma (>6-8 weeks) and in 2 patients (0.4%) 
mesh infection was reported. The complication trocar site hernia was described 
by Ferrari in 2 out of 36 patients(74). Conversion to an open procedure due 
to dense adhesions, problems with fixation or enterotomy occurred in 5% of 
laparoscopic repair. Ji et al. describe a technique of adhesiolysis through an 
additional small (5-10cm) incision in case of dense adhesions as an alternative to 
complete conversion with good results.(79) The recurrence rate of laparoscopic 
LIH repair with intraperitoneal mesh was 5.6% after 14-62 months follow-up.
Table 3. Overview of recurrence hazards per year using GLM
Technique # Hazard (a) Std error Recurrence hazard per year (%)
Open without mesh
CST(9, 11, 31-35) 219 0.00392 0.00253 4.6
Aponeuroplasty(10, 36, 37) 195 0.00468 0.00251 5.5
Langenskiöld(38) 46 0.00771 0.00265 8.8
Open with mesh
Sublay(10, 39-48) 762 0.00043 0.00069 0.5
Aponeuroplasty + IPOM(49, 50) 630 0.00039 0.00053 0.5
IPOM (bridging)(11, 15, 46, 51-57) 514 0.00211 0.00093 2.5
MCST(47, 58-64) 511 0.00212 0.00155 2.5
Onlay(53, 65-69) 454 0.00288 0.00101 3.4
Sandwich(53, 70-73) 131 0.00028 0.00273 0.3
Laparoscopy
IPOM (bridging) (74-81) 483 0.00265 0.00181 3.1
4. Generalized linear model (GLM) of recurrence rates 
The hazards (a) for the different repair techniques are shown in table 3 and 
figure 7. The open repair techniques without mesh have a recurrence hazard 
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of between 4.6 to 8.8% per year; components separation technique having 
the lowest recurrence hazard. All open repair techniques with mesh had lower 
recurrence hazards than techniques without mesh, ranging from 0.3-3.4% per 
year. The lowest recurrence hazards were seen for sandwich technique (0.3% 
per year), aponeuroplasty with IPOM mesh (0.5% per year) and mesh in sublay 
position (0.5% per year). The open and laparoscopic intraperitoneal bridging 
techniques showed high recurrence hazards of 2.5 and 3.1% per year, only 
exceeded by onlay mesh repair with 3.4% per year recurrence hazard for mesh 
repair techniques. 
Figure 7. Data and curves of the recurrence percentage over time, as estimated by the generalized 
linear model. The large symbols represent the data; the curves are marked with the same symbols, but 
smaller.
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Discussion
Recurrence rate
This review on surgical repair of LIH shows better long-term recurrence rates 
and hazards for techniques with mesh reinforcement compared to techniques 
without mesh reinforcement. To exemplify this finding, it was discovered 
that mesh reinforced CST and aponeuroplasty reported lower recurrence 
rates compared to their conventional use and implementation without mesh 
reinforcement. These results are comparable to the repair of small and medium 
sized IH (17, 19). 
The best recurrence rates and hazards for LIH repair were reported 
after sandwich technique, sublay repair and aponeuroplasty with IPOM. After 
several years of follow-up the recurrence rates of these techniques were 
3.6% or lower. These exceptional low recurrence rates were even lower than 
reported recurrence rates of 9-14% for small hernias repaired with sublay or 
intraperitoneal mesh as reinforcement(18). This might partially be explained 
by the experience of surgeons who published these series on LIH(10, 49, 50). 
Due to the complexity of problem we believe that patients with a LIH should 
only be operated by experienced hernia surgeons. In case of mesh repair, the 
sublay technique might be the best option for LIH repair as it is already widely 
implemented and displayed good recurrence rates and hazards. The mesh can 
be positioned in the sublay position after closing the posterior rectus sheaths 
or after the sandwich technique, which uses a part of the hernia sac as an 
extension of the posterior rectus sheath to create an extraperitoneal (sublay) 
space for the mesh. Although the hernia sac seems not as strong as the anterior 
or posterior rectus sheath, results of the sandwich technique seem promising. 
The aponeuroplasty technique is only described by one group and is currently 
not widely used. However, mesh repair might not be possible because of 
complex abdominal wall anatomy due to fibrosis, and/or co-morbidities such 
as obesity, pulmonary disease and old age. These cases should be treated case 
by case, and the best option might be conservative treatment. 
Mortality
In the included studies the postoperative mortality of LIH repairs varied 
between 0.4% and 10.4%. Mortality was not associated with the used 
technique of repair. However, in patients with a simple LIH overall mortality 
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was 0.4%, increasing to 5.4% in patients with a complex LIH. The mortality 
after simple LIH repair is comparable to mortality of small incisional hernia 
repair (ranging 0.16-0.4%)(87-89). In patients with simple LIH or small hernias 
the cause of death is generally of cardiovascular origin. Patients with complex 
LIH frequently generally have more co-morbidities and mortality is related to 
multi-organ failure, bowel necrosis, bowel obstruction, mesh infection and 
sepsis(9, 31, 43, 45, 57, 62, 64). 
Wound complications
Infection, seroma, hematoma and skin necrosis were observed frequently 
after LIH repair. Between simple and complex LIH a sizeable difference in 
wound complications was found. The degree of intra-operative contamination 
increases the risk of prosthetic infection and often results in a chronic affection 
with sinus formation or loss of prosthesis. For these reasons, the majority of 
patients with a complex LIH were repaired with an open technique without 
mesh implantation and overall wound complications for these techniques 
ranged between 13 and 48%. One of the more frequently used open non-
mesh techniques in common practice is the CST. During CST the blood supply 
of the abdominal wall by the epigastric perforating arteries is endangered. 
Damage to these arteries may endanger the blood supply of the skin (then 
only depending on blood flow from the intercostal arteries) and interfere 
with wound healing and increase the risk of infection (6, 31, 90). Furthermore, 
the intercostal arteries might have been damaged during former operations, 
giving rise to even more complications(11, 90). Therefore, new endoscopic CST, 
minimally invasive CST and posterior CST have been developed and promising 
results of reduced wound infections and necrosis have been described(58-61).
Pulmonary complications
Postoperative pulmonary complications after LIH repair, such as insufficiency 
and pneumonia, were reported frequently, sometimes requiring reoperation 
or prolonged ventilatory support up to two weeks(9, 66). In patients with 
LIH lateral migration of the rectus muscles in conjunction with flank muscle 
contraction leads to a progressive decrease in the volume of the abdominal 
cavity and worsening protrusion of the viscera. Repositioning the viscera in 
a stiff abdominal cavity can lead to decreased perfusion of the intestine and 
elevation of the diaphragm, which in turn can lead to ventilatory difficulties 
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and rarely abdominal compartment syndrome(90, 91). The use of preoperative 
pneumoperitoneum or botox might be implemented in some cases although 
evidence is limited(44, 92-94). 
In LIH repair overall postoperative complications are higher compared 
to smaller incisional hernia repair. The increased morbidity is partly caused by 
patient characteristics, such as more serious and extensive primary diseases, 
systemic collagen disease and the increased intra-abdominal and pulmonary 
pressure after repair. Frequently a large wound bed is created, increasing the 
risk of wound complications. 
Limitations
The first limitation of this review is the lacking consensus on the definition of 
LIH (table 1). The criteria for LIH as proposed by the European Hernia Society 
(EHS)(21) were used: size of hernial orifice 10cm or more in any direction. 
Since some authors only report the hernia surface, articles describing hernias 
over 100cm2 were also included. Recently a consensus paper on definition of 
complex abdominal wall hernias is published, but these detailed criteria are 
often not mentioned in articles and are especially usable for (future) prospective 
studies(27). That’s why we used a more simple definition to differentiate 
between ‘simple’ and ‘complex’ LIH in this review. 
Secondly, the follow-up between the studies included in this review 
varied from 1 to 10 years. Due to the delay between hernia repair and the 
development of a recurrence the period of follow-up is important. Since 
short term follow-up might cause underestimation of recurrence rate, only 
articles with a mean follow-up of at least 1 year were included. Still, comparing 
techniques for recurrence rates is difficult with different follow-up periods. 
For this reason the recurrence hazard per year for every repair technique was 
calculated. This model assumes an equal hazard for getting a recurrence during 
each month of follow-up of the study. But this is not consistent with the natural 
pattern of recurrence, and as a consequence the monthly or yearly hazard does 
not resemble the true percentage of recurrence. Furthermore, the assumption 
in the GLM is that count follow Poisson distributions. Overdispersion is 
quite common, and so one has to keep in mind that standard errors will be 
too optimistic. However, we think that the GLM is a useful tool in comparing 
recurrence rates for studies with different follow-up periods. 
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In the vast majority of articles recurrence was determined by physical 
examination. The use of radiological examination in the diagnosis of hernias 
is very useful in obese patients and for the detecting of smaller hernias. The 
sensitivity and specificity of ultrasonography and CT-scan for incisional hernias 
is very high(95). Since radiological examination was not standard performed 
the recurrence rates might be underestimated.  
Another limitation was the availability of only a few prospective series 
and mainly retrospective series for inclusion. Postoperative complications 
are an important outcome parameter in comparing repair techniques but are 
likely to be underestimated, especially in retrospective studies(96). In addition 
possible patient selection bias and publication bias of good results might 
be present. Publication bias was reduced by excluding small series. For this 
reason not all possible techniques for large hernia repair are covered. Recently 
a systematic review was published which focussed on giant incisional hernia 
repair techniques(97). Although some of the conclusions drawn from that paper 
are similar to the conclusions made in this review, there are several limitations 
in that study. Firstly, a definition was used which does not correspond with 
the EHS guidelines. In addition, due to some of their exclusion criteria several 
articles were not included in their review. This resulted in them including only 
14 papers whereas this review included 55. Furthermore their conclusions 
are based mainly on their expert opinion, whereas this study’ conclusions are 
based on statistical analysis with a generalized linear model.
Also, the universal lacking consensus on terminology for mesh positions 
and the large variety of meshes for hernia repair on the market worldwide add 
difficulty in comparing repair techniques. Terms as ‘inlay’ ‘underlay’, ‘overlay’ 
and ‘subfascial’ are used without clarity about the position of the mesh to 
the abdominal wall. To minimize confusion the terminology proposed by the 
EuraHS working group was used (figure 4)(98). The choice of mesh material in 
abdominal wall repair is still debatable, especially in a complex LIH or infected 
environment. The studies included in this review reported more frequently 
mesh infections for PE meshes than PP meshes in LIH. This corresponds with 
the increased complication rate of PE meshes in smaller incisional hernia 
repair(99). The high rate of ePTFE mesh infections in complex LIH was the 
reason for premature termination of the RCT of the Vries Reilingh et al(11). 
Recently, biological meshes have been introduced into LIH repair which might 
induce better results with regards to infections and incorporation. The first 
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prospective trial has been conducted recently to evaluate their effectiveness in 
LIH repair and showed good results regarding mesh infection but a recurrence 
rate comparable to classic CST without mesh reinforcement(62). The ideal 
mesh for complex hernia surgery has still not been found and further research 
should be focus on this.
Finally, patient characteristics such as BMI, age and infection grade were 
often not described in the included studies and this could cause heterogeneity 
between groups. We tried to adjust for this limitation by excluding small series. 
However, this still poses a problem in this review and until new (randomized) 
trials become available the outcomes of this review should be interpreted 
critically. 
Conclusion
Research on the treatment of LIH is challenging. LIH must be considered a 
separate category of incisional hernia, posing more problems than the smaller 
variety. Because of the high incidence of LIH and possibly also by the lack of 
centers for this complex pathology many different approaches have been 
proposed and are applied in daily practice until now. This heterogeneity in 
surgical care makes any validation of techniques difficult. To make results more 
comparable for future research, a widely accepted classification of hernias and 
repair techniques is needed. A global online registration system for all hernia 
repair has been developed and launched (EuraHS)(98). 
Although available literature regarding LIH repair is relatively scarce, we 
feel that some of the limitations as previously discussed were adjusted for or 
reduced in this review due to its design and the statistics used. In this review it 
was observed that LIH repair with mesh reinforcement is superior with regards 
to long-term recurrence. Based on available literature sublay repair for LIH seems 
the preferred techniques it is already implemented widely and displayed good 
recurrence rates and yearly recurrence hazards. For all techniques increased 
postoperative complications were reported compared to smaller IH repair. IH 
repair, and especially LIH repair, is a surgical challenging procedure and in our 
opinion should be performed by specialists only. 
Chapter 8
178
References 
1. Hoer J, Lawong G, Klinge U, Schumpelick V. [Factors influencing the development of incisional 
hernia. A retrospective study of 2,983 laparotomy patients over a period of 10 years] Einflussfaktoren 
der Narbenhernienentstehung. Retrospektive Untersuchung an 2.983 laparotomierten Patienten 
uber einen Zeitraum von 10 Jahren. Chirurg. 2002;73(5):474-80.
2. Millbourn D, Cengiz Y, Israelsson LA. Effect of stitch length on wound complications after closure of 
midline incisions: a randomized controlled trial. Arch Surg. 2009;144(11):1056-9.
3. Mudge M, Hughes LE. Incisional hernia: a 10 year prospective study of incidence and attitudes. Br 
J Surg. 1985;72(1):70-1.
4. Adye B, Luna G. Incidence of abdominal wall hernia in aortic surgery. Am J Surg. 1998;175(5):400-2.
5. Stevick CA, Long JB, Jamasbi B, Nash M. Ventral hernia following abdominal aortic reconstruction. 
Am Surg. 1988;54(5):287-9.
6. de Vries Reilingh TS, Bodegom ME, van Goor H, Hartman EH, van der Wilt GJ, Bleichrodt RP. 
Autologous tissue repair of large abdominal wall defects. Br J Surg. 2007;94(7):791-803.
7. Helgstrand F, Rosenberg J, Kehlet H, Jorgensen LN, Bisgaard T. Nationwide prospective study of 
outcomes after elective incisional hernia repair. J Am Coll Surg. 2013;216(2):217-28.
8. Ramirez OM, Ruas E, Dellon AL. “Components separation” method for closure of abdominal-wall 
defects: an anatomic and clinical study. Plast Reconstr Surg. 1990;86(3):519-26.
9. Shestak KC, Edington HJ, Johnson RR. The separation of anatomic components technique for 
the reconstruction of massive midline abdominal wall defects: anatomy, surgical technique, 
applications, and limitations revisited. Plast Reconstr Surg. 2000;105(2):731-8; quiz 9.
10. Rives J, Pire JC, Flament JB. Reflections on large eventrations. Results of our experience (322 cases) 
and new therapeutic indications. Chirurgie - Memoires de l’Academie de Chirurgie. 1985;111(3):215-
25.
11. de Vries Reilingh TS, van Goor H, Charbon JA, Rosman C, Hesselink EJ, van der Wilt GJ, et al. Repair of 
giant midline abdominal wall hernias: “components separation technique” versus prosthetic repair 
: interim analysis of a randomized controlled trial. World J Surg. 2007;31(4):756-63.
12. Dragu A, Klein P, Unglaub F, Polykandriotis E, Kneser U, Hohenberger W, et al. Tensiometry as a 
decision tool for abdominal wall reconstruction with component separation. World J Surg. 
2009;33(6):1174-80.
13. Borud LJ, Grunwaldt L, Janz B, Mun E, Slavin SA. Components separation combined with abdominal 
wall plication for repair of large abdominal wall hernias following bariatric surgery. Plast Reconstr 
Surg. 2007;119(6):1792-8.
14. Hesselink VJ, Luijendijk RW, de Wilt JH, Heide R, Jeekel J. An evaluation of risk factors in incisional 
hernia recurrence. Surg Gynecol Obstet. 1993;176(3):228-34.
15. Oussoultzoglou E, Baulieux J, De la Roche E, Peyregne V, Adham M, Berthoux N, et al. [Long-term 
results of 186 patients with large incisional abdominal wall hernia treated by intraperitoneal mesh] 
Cure chirurgicale des grandes eventrations par prothese intra-peritoneale. A propos d’une serie de 
186 patients avec un long recul. Ann Chir. 1999;53(1):33-40.
16. Halm JA, de Wall LL, Steyerberg EW, Jeekel J, Lange JF. Intraperitoneal polypropylene mesh hernia 
repair complicates subsequent abdominal surgery. World J Surg. 2007;31(2):423-9; discussion 30.
17. Luijendijk RW, Hop WC, van den Tol MP, de Lange DC, Braaksma MM, JN IJ, et al. A comparison of 
suture repair with mesh repair for incisional hernia. N Engl J Med. 2000;343(6):392-8.
18. den Hartog D, Dur AH, Tuinebreijer WE, Kreis RW. Open surgical procedures for incisional hernias. 
Cochrane Database Syst Rev. 2008(3):CD006438.
19. Burger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J. Long-term follow-up 
of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg. 
2004;240(4):578-83; discussion 83-5.
20. Forbes SS, Eskicioglu C, McLeod RS, Okrainec A. Meta-analysis of randomized controlled trials 
comparing open and laparoscopic ventral and incisional hernia repair with mesh. Br J Surg. 
2009;96(8):851-8.
Review treatment large IH
179
8
21. Muysoms FE, Miserez M, Berrevoet F, Campanelli G, Champault GG, Chelala E, et al. Classification of 
primary and incisional abdominal wall hernias. Hernia. 2009;13(4):407-14.
22. Tanaka EY, Yoo JH, Rodrigues AJ, Jr., Utiyama EM, Birolini D, Rasslan S. A computerized tomography 
scan method for calculating the hernia sac and abdominal cavity volume in complex large 
incisional hernia with loss of domain. Hernia. 2010;14(1):63-9.
23. Ammaturo C, Bassi G. The ratio between anterior abdominal wall surface/wall defect surface: a new 
parameter to classify abdominal incisional hernias. Hernia. 2005;9(4):316-21.
24. Dumanian GA, Denham W. Comparison of repair techniques for major incisional hernias. Am J 
Surg. 2003;185(1):61-5.
25. Korenkov M, Paul A, Sauerland S, Neugebauer E, Arndt M, Chevrel JP, et al. Classification and 
surgical treatment of incisional hernia. Results of an experts’ meeting. Langenbecks Arch Surg. 
2001;386(1):65-73.
26. Chevrel JP, Rath AM. Classification of incisional hernias of the abdominal wall. Hernia. 2000;4:7-11.
27. Slater NJ, Montgomery A, Berrevoet F, Carbonell AM, Chang A, Franklin M, et al. Criteria for 
definition of a complex abdominal wall hernia. Hernia : the journal of hernias and abdominal wall 
surgery. 2014;18(1):7-17.
28. Dobson AJ, Barnett AG. An introduction to generalized linear model (3rd edition): CRC Press; 2008. 
320 p.
29. Team RDC. R: a language and environment for statistical computing. . Vienna, Austria: R Foundation 
for Statistical Computing; 2011.
30. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews 
and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
31. de Vries Reilingh TS, van Goor H, Rosman C, Bemelmans MH, de Jong D, van Nieuwenhoven EJ, et 
al. “Components separation technique” for the repair of large abdominal wall hernias. J Am Coll 
Surg. 2003;196(1):32-7.
32. Espinosa-de-los-Monteros A, Dominguez I, Zamora-Valdes D, Castillo T, Fernandez-Diaz OF, Luna-
Torres HA. Closure of midline contaminated and recurrent incisional hernias with components 
separation technique reinforced with plication of the rectus muscles. Hernia : the journal of hernias 
and abdominal wall surgery. 2013;17(1):75-9.
33. Mazzocchi M, Dessy LA, Ranno R, Carlesimo B, Rubino C. “Component separation” technique and 
panniculectomy for repair of incisional hernia. Am J Surg. 2011;201(6):776-83.
34. Saulis AS, Dumanian GA. Periumbilical rectus abdominis perforator preservation significantly 
reduces superficial wound complications in “separation of parts” hernia repairs. Plast Reconstr 
Surg. 2002;109(7):2275-80; discussion 81-2.
35. Yegiyants S, Tam M, Lee DJ, Abbas MA. Outcome of components separation for contaminated 
complex abdominal wall defects. Hernia : the journal of hernias and abdominal wall surgery. 
2012;16(1):41-5.
36. Loh A, Rajkumar JS, South LM. Anatomical repair of large incisional hernias. Ann R Coll Surg Engl. 
1992;74(2):100-5.
37. Sturniolo G, Versace GA, Gagliano E, Tonante A, Cacciola R, Fragomeni A, et al. Actuality of the 
overlapping suture in the therapy of aponeurotic and incisional hernias. Chirurgie - Memoires de 
l’Academie de Chirurgie. 1994;120(6-7):320-4.
38. Smitten VK, Heikel HVA, Sundell B. Repair of incisional hernias by F. Langenskiold’s operation. Acta 
Chirurgica Scandinavica. 1982;148(3):257-61.
39. Berry MF, Paisley S, Low DW, Rosato EF. Repair of large complex recurrent incisional hernias with 
retromuscular mesh and panniculectomy. Am J Surg. 2007;194(2):199-204.
40. Campanelli G, Bastazza M, Ruca A, Senni Buratti M, Casirani R, Nicolosi FM, et al. Surgical treatment 
of incisional hernias with marked loss of substance. Hernia : the journal of hernias and abdominal 
wall surgery. 2000;4(4):202-5.
41. Fernandez Lobato R, Fernandez Luengas D, Serantes A, Cerquella C, Fradejas JM, Moreno Azcoita 
M. Use of Histoatryl(registered trademark) for incisional hernia repair. Hernia : the journal of hernias 
and abdominal wall surgery. 2000;4(2):99-103.
42. Heisterkamp J, den Hoed PT, Kluin J, Weidema WF, van Steensel CJ. Long-term results after modified 
Gallie technique for incisional hernia repair: results in 19 patients. Hernia : the journal of hernias 
and abdominal wall surgery. 2005;9(1):12-5.
Chapter 8
180
43. Tonante A, Lo Schiavo MG, Bonanno L, D’Alia C, Taranto F, Gagliano E, et al. [Complications of open 
prosthetic surgery for large incisional hernias] Le complicanze della chirurgia protesica “open” dei 
grandi laparoceli. Chir Ital. 2004;56(5):629-37.
44. Toniato A, Pagetta C, Bernante P, Piotto A, Pelizzo MR. Incisional hernia treatment with progressive 
pneumoperitoneum and retromuscular prosthetic hernioplasty. Langenbecks Arch Surg. 
2002;387(5-6):246-8.
45. Trivellini G, Bagni CM, Sollini A, Senni M, Leone S, Contessini Avesani E. Repair of giant hernias using 
more prosthesis. Hernia : the journal of hernias and abdominal wall surgery. 2001;5(3):124-8.
46. Alexandre JH, Dupin P. Surgical treatment of complex abdominal wall hernias. Medecine et 
Chirurgie Digestives. 1983;12(6):423-6.
47. Rosen MJ, Reynolds HL, Champagne B, Delaney CP. A novel approach for the simultaneous 
repair of large midline incisional and parastomal hernias with biological mesh and retrorectus 
reconstruction. Am J Surg. 2010;199(3):416-20; discussion 20-1.
48. Ladurner R, Chiapponi C, Linhuber Q, Mussack T. Long term outcome and quality of life after open 
incisional hernia repair--light versus heavy weight meshes. BMC surgery. 2011;11:25.
49. Briennon X, Lermite E, Meunier K, Desbois E, Hamy A, Arnaud JP. Surgical treatment of large 
incisional hernias by intraperitoneal insertion of Parietex(R) composite mesh with an associated 
aponeurotic graft (280 cases). J Visc Surg. 2011;148(1):54-8.
50. Hamy A, Pessaux P, Mucci-Hennekinne S, Radriamananjo S, Regenet N, Arnaud JP. Surgical 
treatment of large incisional hernias by an intraperitoneal Dacron mesh and an aponeurotic graft. 
J Am Coll Surg. 2003;196(4):531-4.
51. Ammaturo C, Bassi UA, Bassi G. Outcomes of the open mesh repair of large incisional hernias using 
an intraperitoneal composite mesh: our experience with 100 cases. Updates Surg. 2010;62(1):55-
61.
52. Bernard C, Polliand C, Mutelica L, Champault G. Repair of giant incisional abdominal wall hernias 
using open intraperitoneal mesh. Hernia : the journal of hernias and abdominal wall surgery. 
2007;11(4):315-20.
53. Martinez DA, Vazquez JL, Pellicer E, Aguayo JL, Morales G, Moreno-Egea A. Results of expanded 
polytetrafluoroethylene patches in moderate and large incisional hernias. Hernia : the journal of 
hernias and abdominal wall surgery. 1999;3(3):149-52.
54. Moreno-Egea A, Mengual-Ballester M, Cases-Baldo MJ, Aguayo-Albasini JL. Repair of complex 
incisional hernias using double prosthetic repair: single-surgeon experience with 50 cases. 
Surgery. 2010;148(1):140-4.
55. Liu F, Li J. Repair of large abdominal wall defects using the Proceed surgical mesh with open intra-
peritonium onlay method. Saudi medical journal. 2011;32(5):504-9.
56. lo Monte AI, Damiano G, Palumbo VD, Zumbino C, Spinelli G, Sammartano A, et al. Eight-point 
compass rose underlay technique in 72 consecutive elderly patients with large incisional hernia. 
International Journal of Gerontology. 2011;5:161-5.
57. Shaikh FM, Giri SK, Durrani S, Waldron D, Grace PA. Experience with porcine acellular dermal 
collagen implant in one-stage tension-free reconstruction of acute and chronic abdominal wall 
defects. World J Surg. 2007;31(10):1966-72; discussion 73-4, 75.
58. Butler CE, Campbell KT. Minimally invasive component separation with inlay bioprosthetic mesh 
(MICSIB) for complex abdominal wall reconstruction. Plast Reconstr Surg. 2011;128(3):698-709.
59. Ghali S, Turza KC, Baumann DP, Butler CE. Minimally invasive component separation results in fewer 
wound-healing complications than open component separation for large ventral hernia repairs. J 
Am Coll Surg. 2012;214(6):981-9.
60. Harth KC, Rosen MJ. Endoscopic versus open component separation in complex abdominal wall 
reconstruction. Am J Surg. 2010;199(3):342-6; discussion 6-7.
61. Krpata DM, Blatnik JA, Novitsky YW, Rosen MJ. Posterior and open anterior components separations: 
a comparative analysis. Am J Surg. 2012;203(3):318-22; discussion 22.
62. Itani KM, Rosen M, Vargo D, Awad SS, Denoto G, 3rd, Butler CE, et al. Prospective study of single-
stage repair of contaminated hernias using a biologic porcine tissue matrix: the RICH Study. 
Surgery. 2012;152(3):498-505.
Review treatment large IH
181
8
63. Picazo-Yeste J, Morandeira-Rivas A, Moreno-Sanz C. Multilayer myofascial-mesh repair for giant 
midline incisional hernias: a novel advantageous combination of old and new techniques. Journal 
of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 
2013;17(9):1665-72.
64. Carbonell Tatay F, Bonafe Diana S, Garcia Pastor P, Gomez IGC, Baquero Valdelomar R. [New surgical 
technique in complex incisional hernias: Component Separation Technique (CST) with prosthesis 
and new muscle insertions] Nuevo metodo de operar en la eventracion compleja: separacion 
anatomica de componentes con protesis y nuevas inserciones musculares. Cir Esp. 2009;86(2):87-
93.
65. Rios A, Rodriguez JM, Munitiz V, Alcaraz P, Perez D, Parrilla P. Factors that affect recurrence after 
incisional herniorrhaphy with prosthetic material. Eur J Surg. 2001;167(11):855-9.
66. Rohr S, Vogt F, Thiry CL, Dai B, Meyer C. [Parietal prosthetic mesh in the treatment of large incisional 
hernias] Le pontage prothetique parietal dans le traitement des grandes eventrations. J Chir (Paris). 
1993;130(1):37-40.
67. Kingsnorth AN, Shahid MK, Valliattu AJ, Hadden RA, Porter CS. Open onlay mesh repair for major 
abdominal wall hernias with selective use of components separation and fibrin sealant. World J 
Surg. 2008;32(1):26-30.
68. Memon AA, Khan A, Zafar H, Murtaza G, Zaidi M. Repair of large and giant incisional hernia with 
onlay mesh: perspective of a tertiary care hospital of a developing country. International journal of 
surgery. 2013;11(1):41-5.
69. Tuveri M, Tuveri A, Nicolo E. Repair of large abdominal incisional hernia by reconstructing the 
midline and use of an onlay of biological material. Am J Surg. 2011;202(1):e7-11.
70. Bracci F, Pollicita S, Carnuccio P. “Open” abdominal surgery for large incisional hernias. Proposal of 
a personal technique. Chir Ital. 2008;60(3):439-43.
71. Matapurkar BG, Gupta AK, Agarwal AK. A new technique of “Marlex-peritoneal sandwich” in the 
repair of large incisional hernias. World J Surg. 1991;15(6):768-70.
72. Katsaragakis S, Manouras A, Stamou KM, Androulakis G. Modified technique for repairing large 
incisional hernias. Eur J Surg. 2001;167(6):458-60.
73. Malik A, Macdonald AD, de Beaux AC, Tulloh BR. The peritoneal flap hernioplasty for repair of 
large ventral and incisional hernias. Hernia : the journal of hernias and abdominal wall surgery. 
2014;18(1):39-45.
74. Ferrari GC, Miranda A, Sansonna F, Magistro C, Di Lernia S, Maggioni D, et al. Laparoscopic 
management of incisional hernias > or = 15 cm in diameter. Hernia : the journal of hernias and 
abdominal wall surgery. 2008;12(6):571-6.
75. Baccari P, Nifosi J, Ghirardelli L, Staudacher C. Short- and mid-term outcome after laparoscopic 
repair of large incisional hernia. Hernia : the journal of hernias and abdominal wall surgery. 2012.
76. Perrone JM, Soper NJ, Eagon JC, Klingensmith ME, Aft RL, Frisella MM, et al. Perioperative outcomes 
and complications of laparoscopic ventral hernia repair. Surgery. 2005;138(4):708-15; discussion 
15-6.
77. Raftopoulos I, Vanuno D, Khorsand J, Ninos J, Kouraklis G, Lasky P. Outcome of laparoscopic ventral 
hernia repair in correlation with obesity, type of hernia, and hernia size. J Laparoendosc Adv Surg 
Tech A. 2002;12(6):425-9.
78. Ferrari G, Bertoglio C, Magistro C, Girardi V, Mazzola M, Di Lernia S, et al. Laparoscopic repair for 
recurrent incisional hernias: a single institute experience of 10 years. Hernia : the journal of hernias 
and abdominal wall surgery. 2013;17(5):573-80.
79. Ji Y, Zhan X, Wang Y, Zhu J. Combined laparoscopic and open technique for the repair of large 
complicated incisional hernias. Surgical endoscopy. 2013;27(5):1778-83.
80. Moreno-Egea A, Carrillo-Alcaraz A. Management of non-midline incisional hernia by the 
laparoscopic approach: results of a long-term follow-up prospective study. Surgical endoscopy. 
2012;26(4):1069-78.
81. Wormer BA, Walters AL, Bradley JF, 3rd, Williams KB, Tsirline VB, Augenstein VA, et al. Does 
ventral hernia defect length, width, or area predict postoperative quality of life? Answers from a 
prospective, international study. The Journal of surgical research. 2013;184(1):169-77.
Chapter 8
182
82. Albanese AR. [Gigantic median xipho-umbilical eventration; method for treatment] Eventracion 
mediana xifoumbilical gigante; metodo para su tratamiento. Rev Asoc Med Argent. 1951;65(709-
710):376-8.
83. Welti H, Eudel F. Un Procede de cure radicale des eventrations postoperatoires par auto-etalement 
des muscles grands droits apres incision du feuillet anterieur de leur gaine. Chirurgie - Memoires 
de l’Academie de Chirurgie 1941;12:791-8.
84. Stoppa R. Les plasties de la paroi abdominale. Table ronde du 75eme Congres Francais de Chirurgie. 
Avec la participation de R Bourgeon, Ph Detrie Cl gautier-Benoit, A Milhaud, H Neidhardt, J Poilleux, 
J Rives, J Visset. In: Actualites Chirurgicales, Masson Paris. 1973:662-736.
85. Rives J, Lardennois B, Pire JC, Hibon J. [Large incisional hernias. The importance of flail abdomen and 
of subsequent respiratory disorders] Les grandes eventrations. Importance du “volet abdominal” et 
des troubles respiratoires qui lui sont secondaires. Chirurgie. 1973;99(8):547-63.
86. Chevrel JP. [The treatment of large midline incisional hernias by “overcoat” plasty and prothesis 
(author’s transl)] Traitement des grandes eventrations medianes par plastie en paletot et prothese. 
Nouv Presse Med. 1979;8(9):695-6.
87. Sharma A, Mehrotra M, Khullar R, Soni V, Baijal M, Chowbey PK. Laparoscopic ventral/incisional 
hernia repair: a single centre experience of 1,242 patients over a period of 13 years. Hernia : the 
journal of hernias and abdominal wall surgery. 2011;15(2):131-9.
88. Clarke JM. Incisional hernia repair by fascial component separation: results in 128 cases and 
evolution of technique. Am J Surg. 2010;200(1):2-8.
89. Bisgaard T, Kehlet H, Bay-Nielsen MB, Iversen MG, Wara P, Rosenberg J, et al. Nationwide study of 
early outcomes after incisional hernia repair. Br J Surg. 2009;96(12):1452-7.
90. de Vries Reilingh TS, van Geldere D, Langenhorst B, de Jong D, van der Wilt GJ, van Goor H, et al. 
Repair of large midline incisional hernias with polypropylene mesh: comparison of three operative 
techniques. Hernia : the journal of hernias and abdominal wall surgery. 2004;8(1):56-9.
91. Agnew SP, Small W, Jr., Wang E, Smith LJ, Hadad I, Dumanian GA. Prospective measurements of 
intra-abdominal volume and pulmonary function after repair of massive ventral hernias with the 
components separation technique. Ann Surg. 2010;251(5):981-8.
92. Zielinski MD, Goussous N, Schiller HJ, Jenkins D. Chemical components separation with botulinum 
toxin A: a novel technique to improve primary fascial closure rates of the open abdomen. Hernia : 
the journal of hernias and abdominal wall surgery. 2013;17(1):101-7.
93. Ibarra-Hurtado TR, Nuno-Guzman CM, Echeagaray-Herrera JE, Robles-Velez E, de Jesus Gonzalez-
Jaime J. Use of botulinum toxin type a before abdominal wall hernia reconstruction. World J Surg. 
2009;33(12):2553-6.
94. Sabbagh C, Dumont F, Fuks D, Yzet T, Verhaeghe P, Regimbeau JM. Progressive preoperative 
pneumoperitoneum preparation (the Goni Moreno protocol) prior to large incisional hernia 
surgery: volumetric, respiratory and clinical impacts. A prospective study. Hernia : the journal of 
hernias and abdominal wall surgery. 2012;16(1):33-40.
95. den Hartog D, Dur AH, Kamphuis AG, Tuinebreijer WE, Kreis RW. Comparison of ultrasonography 
with computed tomography in the diagnosis of incisional hernias. Hernia : the journal of hernias 
and abdominal wall surgery. 2009;13(1):45-8.
96. Dindo D, Hahnloser D, Clavien PA. Quality assessment in surgery: riding a lame horse. Ann Surg. 
2010;251(4):766-71.
97. Eriksson A, Rosenberg J, Bisgaard T. Surgical treatment for giant incisional hernia: a qualitative 
systematic review. Hernia : the journal of hernias and abdominal wall surgery. 2013.
98. Muysoms F, Campanelli G, Champault GG, Debeaux AC, Dietz UA, Jeekel J, et al. EuraHS: the 
development of an international online platform for registration and outcome measurement of 
ventral abdominal wall hernia repair. Hernia : the journal of hernias and abdominal wall surgery. 
2012.
99. Leber GE, Garb JL, Alexander AI, Reed WP. Long-term complications associated with prosthetic 
repair of incisional hernias. Arch Surg. 1998;133(4):378-82.

Chapter
Recommendations for reporting 
outcome results in abdominal 
wall repair. Results of a 
Consensus meeting in Palermo, 
Italy, 28-30 June 2012
F.E. Muysoms
E.B. Deerenberg
E. Peeters
F. Agresta
F. Berrevoet
G. Campanelli
W. Ceelen
G.G. Champault
F. Corcione
D. Cuccurullo
A.C. de Beaux
U.A. Dietz
R.J. Fitzgibbons Jr.
J.F. Gillion
R-D. Hilgers
J. Jeekel
I. Kyle-Leinhase
F. Köckerling
V. Mandala
A. Montgomery
S. Morales-Conde
R.K.J. Simmermacher
V. Schumpelick
M. Śmietański
M. Walgenbach
M. Miserez
Hernia 2013;17:423–433.
Chapter 9
186
Abstract
Background
The literature dealing with abdominal wall surgery is often flawed due to lack 
of adherence to accepted reporting standards and statistical methodology. 
Material and methods
The EuraHS Working Group (European Registry of Abdominal Wall Hernias) 
organized a consensus meeting of surgical experts and researchers with an 
interest in abdominal wall surgery, including a statistician, the editors of the 
journal Hernia and scientists experienced in meta-analysis. Detailed discussions 
took place to identify the basic ground rules necessary to improve the quality 
of research reports related to abdominal wall reconstruction. 
Results 
A list of recommendations was formulated including more general issues on 
the scientific methodology and statistical approach. Standards and statements 
are available, each depending on the type of study that is being reported: 
the CONSORT statement for the Randomized Controlled Trials, the TREND 
statement for non-randomized interventional studies, the STROBE statement 
for observational studies, the STARLITE statement for literature searches, the 
MOOSE statement for meta-analyses of observational studies and the PRISMA 
statement for systematic reviews and meta-analyses. 
A number of recommendations were made, including the use of 
previously published standard definitions and classifications relating to hernia 
variables and treatment; the use of the validated Clavien-Dindo classification 
to report complications in hernia surgery; the use of “time-to-event analysis” 
to report data on “freedom-of-recurrence” rather than the use of recurrence 
rates, because it is more sensitive and accounts for the patients that are lost to 
follow-up compared to other reporting methods.  
Conclusion 
A set of recommendations for reporting outcome results of abdominal wall 
surgery was formulated as guidance for researchers. It is anticipated that 
the use of these recommendations will increase the quality and meaning of 
abdominal wall surgery research. 
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Introduction
The EuraHS (European Registry for Abdominal Wall HerniaS) working group 
was formed under the auspices of the European Hernia Society (EHS) board 
in 2009. An online platform for registration and outcome measurement of 
operations for ventral abdominal wall hernias has been developed. For this, 
a set of definitions and classifications were proposed(1). The EuraHS working 
group organized a consensus meeting to prepare recommendations relating 
to the reporting of outcome results in abdominal wall hernia repair. At the 
initiative of the first author, Filip Muysoms, current chairman of the EuraHS 
working group, and of Vincenzo Mandala, current president of the European 
Hernia Society, a consensus meeting was organized in Palermo, Italy from 
June 28th till June 30th 2012. The participants to this consensus discussion and 
meeting were the EuraHS Working Group members and some other experts, 
editors and a statistician. The participants to the consensus discussions are the 
authors of this manuscript. 
Materials and methods
The scientific methodology of clinical studies including systematic reviews 
and meta-analyses were discussed with researchers and a statistician invited 
to the consensus meeting. Recommendations relating to study methodology, 
description of the patient population and statistical approach were proposed 
to research on abdominal wall surgery. For taxonomy of the statistical items two 
basic textbooks on medical statistics were used(2, 3). Specific recommendations 
on abdominal wall surgery for describing hernia variables, treatment variables 
and for reporting the outcome results in a uniform manner were formulated by 
consensus.
Results
Description of study methodology
A study describes a sample or cohort of patients. It is of utmost importance 
to know how the study population was decided upon, how the study was 
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conducted, what was the primary aim or endpoint of the study and how 
was the endpoint analysed. This knowledge is essential to know whether the 
results of this study can be extrapolated and generalized to the larger group 
of patients with the disease treated, so that the study result might influence 
the treatment of future patients. Knowledge of the sample procedures used to 
determine the study population from the screened patients allows the readers 
to identify potential sources of bias and thus assess the external validity of the 
study results. Some exemplary hernia-related different types of studies: cohort 
study by Dietz(4), comparative cohort study by Kurian(5), registry study by 
Helgstrand(6), randomized controlled trial by Bloemen(7), prospective non-
randomized clinical trial by Feliu(8), systematic review by Hansson(9) a meta-
analysis by Aslani(10). 
Study types
All reported studies should have a clear description of the study type, which 
should be mentioned in the title and/or the abstract of the manuscript. There 
is a fundamental distinction between observational studies or interventional 
studies (Figure 1). An outcome variable(s) (aka dependent variable) will be 
studied in relation to one or more predictor variables (aka independent 
variables; aka risk factors) in an observational study. Analysis will focus on the 
association of the predictor(s) with the outcome(s) over a defined time period. A 
cohort study is a type observational study in which a group (cohort) is defined, 
e.g. all patients undergoing a particular operation or having a certain type of 
hernia. Most publications on ventral abdominal wall repair are classified as 
non-comparative cohort studies because there is no control group in the study. 
Rather the results are discussed in relation to other studies published on similar 
patient populations. In a comparative cohort study or case-control study at least 
two different populations are compared within the study. A registry is a type of 
cohort study that has a specific purpose, defined in advance. The data entered 
are carefully crafted to answer important questions about the condition or 
symptom being studied. Results from registry studies are often very informative 
because such care is taken to assure consistent data definition, consistent data 
entry and the enrolment of a large number of patients in relationship to the 
total affected population. A cross-sectional study is an observational study, 
which by definition is not longitudinal because subjects are studied at a single 
point in time. An example would be a study investigating the impact of the 
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patients’ BMI on the incidence of incisional hernias in a population of patients 
with previous laparotomies. 
In an interventional study the result of an intervention on a specific 
outcome variable is examined. The patient samples compared in the study 
should ideally only differ in the predictor variable that is influenced by the 
intervention. Other variables, called confounders, should be equally distributed 
between the study groups. Randomization for the predictor variable in a 
randomized controlled trial (RCT) is the best method to ensure “equality” of the 
study groups provided the study population is large enough. For this reason 
RCT’s are assigned a high level of evidence because if the randomisation is 
performed adequately they have the smallest risk of bias between the study 
populations. In a comparative non-randomized clinical trial, it is less clear why a 
specific patient receives the intervention or not.
In a systematic review, a comprehensive literature research is performed 
on a specific topic and a qualitative critical appraisal of the individual 
studies is performed. Only data from studies that are considered of sufficient 
methodological quality are summarized. In a meta-analysis the quantitative 
data of the individual studies are pooled and statistically analysed. A meta-
analysis of RCT’s is considered the highest level of evidence and thus allows for 
the highest grade of recommendation. But meta-analyses have considerable 
limitations to detect differences as they usually have higher variances than 
single studies, and thus have limitations to detect differences with low 
incidences.
A case report or case series describes an observation or a treatment, which 
is considered by the authors as rare or novel and thus worthy of publishing in 
a manuscript.  
As shown in figure 1, guidelines are available on the web for specific 
types of studies which provide step by step instructions including a check 
list for authors to assure correct conduct and reporting of their work(11-16). 
The Cochrane Collaboration at www.cochrane.org summarizes the websites. 
Many journals only accept manuscripts that conform to these guidelines and 
require their reviewers and editors to use them when assessing the quality of 
submissions. Critical appraisal sheets to assess the quality of a study report 
can be found on the website of the Centre for Evidence Based Medicine from 
Oxford can be found to(17).
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Figure 1. Types of clinical studies: it is recommended to include the type of study clearly in the title and/
or the abstract of a manuscript. Reporting guidelines (colomn 3) are available on the web to help 
authors in preparing manuscripts for publication. 
a:  CONSORT statement: Consolidated standards of reporting trials. 
 www.consort-statement.org(11)
b:  TREND statement: Transparent Reporting of Evaluations with Non-
randomized Designs. http://www.cdc.gov/trendstatement/(12)
c:  STROBE statement: Strengthening the reporting of observational 
studies in epidemiology.  www.strobe-statement.org(13)
d:  STARLITE statement: Standards for reporting literature searches.(14)
e:  PRISMA statement: Preferred reporting items for systematic reviews 
and meta-analyses. www.prisma-statement.org(15)
f:  MOOSE statement: Meta-analysis of Observational Studies in 
Epidemiology.(16)
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Prospective versus retrospective studies
In a prospective study, a cohort of patients is observed for a period of time 
to look at outcome, e.g. complications, and then relate this to the predictor 
variables, e.g. type of surgical technique. Interventional studies are prospective 
studies focused on the outcome of a specific intervention that is controlled 
but different in the study groups that are compared. A study qualifies as 
prospective if the outcome measurement of the primary endpoint is decided 
before the start of the study, and the endpoint measurements are performed in 
the future after the start of the study. Prospective studies are methodologically 
superior to retrospective studies because the measurements can be controlled 
and standardized. Moreover the data gathered are usually more homogeneous 
and complete.
In a retrospective study the investigator looks backwards in time and 
examines exposure to possible risk or protective factors in relation to an 
outcome that is established before the start of the study. Thus the study looks 
at measurements made before the study was started and therefore the data 
will be less controlled and less homogeneous. 
The research question and the primary endpoint
The manuscript of an interventional study should clearly state the research 
question and/or aim of the study. This research question is translated into a 
scientific hypothesis that will be the basis for the study design and the number 
of patients required to answer the research question. A clinically relevant 
primary endpoint will be chosen for which the hypothesis is formulated. The 
primary endpoint or primary variable of a study is the outcome parameter to be 
measured and compared, either to the control group in a comparative study or 
to results from the literature in non-comparative studies. For abdominal wall 
repair, the primary endpoint is most often hernia recurrence, but many other 
outcome parameters are possible to formulate the hypothesis: acute or chronic 
pain, Quality of Life, complications, reoperation rates, wound infections, mesh 
infections, etc. A superiority study investigates if the intervention is superior in 
comparison to the control group. The results of the study will be compared to 
the null hypothesis (H0), that there is no difference between the groups in the 
primary endpoint measurement. The analysis has to be performed on Intention 
To Treat (ITT) basis. In ITT analysis, patient outcome is analysed according to the 
allocated treatment by randomization, regardless wether the patient actually 
Chapter 9
192
received the treatment or not(18). According to the International Conference 
on Harmonisation (ICH) guidelines of Good Clinical Practice (GCP) a statistical 
test decision of a study should be conservative. This is the rationale to use the 
ITT population for superiority studies and the PP population for equivalence 
studies. For non-inferiority trials the correspondence between ITT and PP 
should be used or a hybrid population. 
In some specific clinical situations, an equivalence or non-inferiority 
design is preferred. An equivalence study investigates whether a new treatment 
is not worse than the control. The analysis will be performed on the Per Protocol 
Population (PP), i.e. the patients who adhered strictly to the protocol and 
actually received the intervention called for by the protocol. These different 
types of analysis aid investigators in determining if a new treatment or device is 
better or as good as, but cheaper than what is now available. Like most clinical 
studies, the use of a biomedical statistician at both the study design and study 
analysis stage is recommended.
The sample size
When designing a clinical trial it is important to estimate the number of patients 
needed to answer the research question. Performing a clinical trial is time-
consuming and expensive. It is also ethically mandatory to keep the number 
of patients that allow for valid study results as small as possible. Therefore it is 
important to estimate the number of patients that should be included in the 
study at the onset to answer the clinical question and the scientific hypothesis 
the study is exploring. If the sample size is too small the study might not be 
able to reject the H0. In other words the study sample is too small to show 
a difference in the primary outcome, although in reality there is a difference 
(false negative; type II error). On the other hand if the sample size is too large, 
scares resources will be a spent unnecessarily. To calculate the sample size 
needed, there has to be agreement on several elements. First, the hypothesis 
type has to be clear: superiority, equivalence or non-inferiority. The expected 
mean value of the primary outcome parameter in the two groups and the 
difference in outcome considered clinically important has to be estimated, 
based on preliminary findings or results from similar studies in the literature. 
The significance level, i.e. the α or Type I error we accept (usually 5%) and the 
statistical power (usually 80% = 1- β, where β denotes the Type II error level) 
have to be defined. These assumptions will provide the number of patients 
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in each group needed to evaluate the primary endpoint. All studies have 
“dropouts”, because the patients are lost to follow-up, die, or are not willing to 
continue participation. Therefore, the number of patients to enter in the study 
should be increased in line with the number of “dropout” patients anticipated, 
often 10% to 20%.
Interim analysis
Prior to the onset of the study, the protocol of the study should state if an 
interim analysis will be conducted. An interim analysis is usually done for safety 
reasons. Therefore, an analysis of the patients “as treated” is the best approach. 
There are different interim analysis procedures and the procedure should be 
chosen carefully and described in the study protocol. 
During an interim analysis the progress of the study inclusions, the 
occurrence of serious adverse events and the quality of the raw data can also 
be evaluated. A decision can be made to prolong the inclusion time, to increase 
the sample size or to stop the trial prematurely. Ideally, an independent data 
monitoring committee (IDMC) takes such a decision. An example is the study by 
Itani et al. on ventral hernia repair comparing laparoscopic with conventional 
surgery(19). The infection rate was so much higher in the conventional group 
that the data safety monitoring board insisted the trial be stopped.
 
Description of patient population 
The ultimate goal of a study is to generalize the findings in the study to the 
larger population of which the study population is a sample. To assess the 
external validity of a study, the exact method of determining the study sample 
or study cohort has to be clear. 
Mono-centre versus multi-centre studies
There are advantages and disadvantages for both study strategies. Mono-
centre interventional studies have a greater chance of having two comparable 
groups by excluding the variations in the confounding variables that arise 
from including patients treated in different centres. Multi-centre studies have 
a greater chance of correct inference and generalization of the study results to 
the larger population in the community. But multi-centre studies are logistically 
more difficult to perform. Moreover the homogeneity and the quality of 
the raw data are often inferior in the participating centres compared to the 
Chapter 9
194
centre of the primary investigator. On the other hand including patients from 
several centres will create a larger group of eligible patients and thus a higher 
likelihood of achieving the sample size in a shorter time period. For some less 
common conditions, a multi-centre approach is prerequisite to enrol a large 
enough cohort of patients. It is essential that the authors report variations in 
expertise related to the surgical technique under investigation. 
Inclusion criteria, exclusion criteria and eligibility 
To minimize selection bias all consecutive eligible patients during the study 
period should be considered for inclusion. The reasons for non-inclusion in 
the trial and the number of these should be monitored and reported. To know 
which patients are eligible a clear and detailed description of inclusion and 
exclusion criteria should be given. If reporting a subset of hernia patients, for 
example only those undergoing laparoscopic surgery, then clear reasons for 
why the subgroup were selected for that particular intervention, and how 
many patients over the same study period had an alternative intervention.
Dropouts and lost to follow-up
Inevitably subjects will become lost to follow-up and will not be available 
for measurement of the primary endpoint. Some patients will not receive 
the allocated treatment according to the randomization because of errors, a 
preoperative surgical decision, an intraoperative change in therapy or because 
the patient withdraws consent to participate. Nevertheless a description of the 
entire Intention To Treat (ITT) population has to be provided and every patient 
accounted for, preferably in a flow diagram. This will make it clear to the reader 
which patients are included in the study analysis. The baseline data of the 
study population with the distribution of the predictor variables and possible 
confounding variables should be provided for the ITT population in the first 
table of the manuscript. This table will allow evaluation of the concordance 
between different groups in comparative studies. The variables should be listed 
with their frequency or mean value, their range and their standard deviation. 
For analysis of the primary and secondary endpoints of the study the decision 
about the use of the ITT or PP population, is based on the type of statistical 
hypothesis (superiority versus equivalence). 
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Description of the hernia variables, operative procedure and mesh variables
The literature dealing with the treatment of abdominal wall hernias would 
benefit from using a common standard for description of the hernias themselves, 
the operation performed and the mesh materials used. The European Hernia 
Society has previously published classifications for inguinal and ventral 
hernias(20, 21). Moreover during the development of the EuraHS platform 
for registration of ventral hernias many definitions and recommendations 
for describing variables of interest were proposed by consensus amongst 
the EuraHS working group members(1). A general recommendation of the 
consensus meeting in Palermo is to use these existing classifications and 
terminologies to describe the hernia patients included in a study.
Hernia variables
It is recommended to use the EHS classifications for inguinal and ventral hernias. 
Primary ventral hernias and incisional ventral hernias should be distinguished 
and classified accordingly. The hernia size of ventral hernias is preferably an 
intra-operative measurement and the width and length will be described in 
centimetres (cm) as the mean and the standard deviation. If the hernia defect 
surface is reported, the method of calculation of the defect size in cm2 should 
be given. By multiplying width and length, the true hernia defect size is smaller 
than the rectangle calculated and thus this value is an overestimation of the 
true abdominal wall defect size. Alternatively the formula of an ellipse can be 
used to get a better estimation of the true hernia defect size. For calculating 
the real surface area of a hernia defect or several defects of an incisional hernia 
many measurements are needed and calculations dependent on the form of 
the defect. Ammaturo and Bassi have published a method for calculating the 
wall defect surface and compare it to the surface of the anterior abdominal 
wall(22). This method involves the use of transparent paper, a computer 
scanner and software to calculate the exact surface. For routine use in surgical 
practice this is not practical. 
In order to classify the dimensions of an abdominal wall hernia the 
consensus is to use the terminology proposed in the previous classifications. 
For primary ventral hernias three groups are created using the hernia defect 
diameter: small (<2 cm), medium (≥ 2 - 4 cm) and large (≥ 4 cm). For incisional 
hernias, there is not a common standard yet. The consensus panel recommends 
using the EHS classification and thus the width of the incisional hernia is the 
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distinguishing parameter between groups: W1 (< 4 cm), W2 (≥ 4 - 10 cm) and 
W3 (≥ 10 cm). If descriptive terminology like “large, giant, huge” are used, a 
clear description of the definition should be given. However, the use of such 
adjectives to define the hernia size is discouraged.
Operative techniques and mesh variables
Surgical technique and their outcome is an important issue in surgical studies. A 
detailed description of the surgical techniques used is important for the readers 
to understand the procedure(s) used in the patients studied. It should allow to 
reproduce the technique in future patients. Authors should be encouraged to 
use clear terminology like those proposed by the EuraHS working group(1). For 
prosthetic materials, fixation devices and other equipment, we recommend 
using not only the generic name of the material but also providing the product 
and company name. When comparing different meshes the classification 
of meshes proposed by Klinge and Klosterhalfen is recommended(23). A 
complete description of the size of implanted mesh, the overlap of the hernia 
defect and the detailed technique used for fixation will help the reader to 
understand the procedure used.
Assessment of outcome: recurrences, complications and quality of life
Recurrences
The outcome parameter recurrence is the primary endpoint in most studies of 
abdominal wall hernia surgery. A hernia recurrence is defined as: “A protrusion 
of the contents of the abdominal cavity or preperitoneal fat through a defect 
in the abdominal wall at the site of a previous repair of an abdominal wall 
hernia.”(1). Recurrence is a categorical dichotomous variable, which means the 
outcome cannot be quantified, but is a yes or no response. The definition used 
in the study of what constitutes a recurrence should be given as well as the 
method of follow-up that is used to look for possible recurrence. If the primary 
endpoint of the study is recurrence, the consensus is that only clinical follow-
up will be considered adequate. In an interventional study, blinding of the 
evaluator to the treatment arm will minimize investigator bias and improve the 
quality of the data and is to be strongly encouraged. 
Basically, there are two options to describe the primary endpoint 
recurrence in a cohort of patients. The “recurrence rate” can be measured at 
a specific time point (Tx) during follow-up, as the number of patients of the 
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ITT population that have developed a recurrence between the operation date 
(T0) and Tx. This will leave us with the problem of what to do with the patients 
that were “lost to follow-up”. This uncertainty about the status, i.e. recurrence 
or no recurrence, of the lost to follow-up patients will cause serious bias in the 
estimation of the calculated recurrence rate. A specific cohort of patients has 
no fixed recurrence rate because the recurrence rate will increase over time 
with longer follow-up. The result of a study with a recurrence rate at a specific 
point in time during follow-up should include 95% confidence intervals. It is 
recommended that the statistical analysis of recurrence rates at a specified time 
in a comparative study be performed with the Fisher exact test and logistic 
regression to include prognostic factors. 
A more sensitive method of reporting the outcome is by “time-to-event 
analysis” as introduced by Kaplan and Meier several decades ago for survival 
analysis(24). The main reason to favour this approach is that patients lost to 
follow-up, the dropouts, are accounted for. In abdominal wall surgery, the event 
studied is most often recurrence and thus “survival rate” can be best described 
as the “freedom-of-recurrence”. For every patient in the study the time period 
of follow-up will be defined by the date of the hernia repair (T0) to the date of 
recurrence or the date of the last follow-up recorded without recurrence (T1). 
At T1 the status of the patient will be recorded: recurrence or no recurrence. The 
difference between T1 and T0 is the time the patient was at risk of development 
of a recurrence and was under “surveillance”. During the study period the 
number of patients at risk will gradually decrease with every patient that has 
a recurrence or that is lost to follow-up, i.e. censored cases. The outcome of 
time-to-event data for hernia recurrence is given by a Kaplan-Meier plot of 
the freedom-of-recurrence and by calculating freedom-of-recurrence rates 
at predetermined time endpoints. Statistical analysis of time-to-event data 
is performed using the log rank test or Cox’s regression model if prognostic 
factors are included. Time-to-event analysis is more powerful than comparing 
recurrence rates, thus requiring a smaller sample size to test a specific scientific 
hypothesis of an interventional study.
Complications
The consensus group recommends using the Clavien-Dindo classification as was 
proposed previously by the EuraHS working group(25-27). A clear definition of 
the different complications evaluated and reported must be given, preferably 
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using published classifications. Of specific interest for abdominal wall surgery 
is postoperative seroma. The seroma classification proposed by Morales-Conde 
is recommended(28). 
The method of follow-up
The method for assessment of the primary and other endpoints of the study 
should be described clearly in the manuscript. Indeed, the recurrence rate 
measured will be influenced by the method of follow-up. Figure 2 illustrates 
an increase in quality of follow-up which can range from the number of 
reoperations for recurrences seen to systematic investigation with medical 
imaging. The Palermo consensus group considered that follow-up without 
clinical examination of the patient is likely to give an important underestimation 
of the true recurrence rate and thus should be avoided. For other endpoints 
such as quality of life assessment, a follow-up by phone or mail might be 
adequate. 
For large registries like the Danish Hernia Database, the Swedish 
Hernia Registry and the Herniamed database a clinical follow-up of all patients 
is not practical and achievable(29, 30). In the population based Danish 
Ventral Hernia Database the reoperation rate for recurrence is the primary 
outcome measurement as a “surrogate for recurrence”. Helgstrand et al.(31) 
demonstrated using a questionnaire and subsequent selective request for 
clinical follow-up, that the reoperation rate underestimated the overall risk for 
recurrence by four- to fivefold. In the Herniamed registry patients are followed 
up using a questionnaire send to the patient at one, five and ten years(29). 
Patients reporting a problem are invited for an examination by a physician.
Blinding of the patient and the evaluator at the primary endpoint to 
the treatment group in an interventional study has some organisational and 
logistic difficulties, but should be considered when writing a study protocol 
because of the enhancement of the quality of the outcome data and the 
diminished risk of patient or investigator bias.
Ethical and financial considerations
Studies should be performed according to the guidelines of the International 
Conference on Harmonisation (ICH) of Good Clinical Practice (GCP)(18). This includes 
the approval by the ethical committee of the center where the study is performed. 
Informed consent of the patients to be included in the study is mandatory.
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Figure 2. The validity of data for recurrence after hernia repair is dependent on the method of follow-up 
performed. It is recommended to consider only follow-up including clinical investigation as adequate. 
Registration of the study protocol in an international database like www.
clinicaltrials.gov is recommended and is mandatory for acceptance in some 
peer reviewed journals. 
For studies of abdominal wall surgery it is very important that financial 
sponsors of the study are disclosed. The manuscript should state how the study 
was initiated: as an Investigator Initiated Study (IIS) or initiated by a commercial 
sponsor of the study. Conflicts of interest should be clearly stated at the end of 
the manuscript. If a research grant was received for the study, the name of the 
sponsoring organisation or company should be disclosed. Also the involvement 
of the sponsor in initiating or conducting the study and in reporting the results 
should be clearly delineated. 
The consensus group also encourages investigators to report negative 
trial results. If the study methodology is appropriate, a negative outcome 
should not hinder the acceptance for publication.
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Discussion
The literature dealing with abdominal wall surgery often fails to meet good 
reporting standards and statistical methodology. Moreover the terminology 
used to describe the hernias and their therapies is very heterogeneous, often 
due to the lack of commonly accepted standards and definitions. This was 
the impetus for the formation of the EuraHS working group. By organising a 
consensus meeting including the editors of Hernia - the World Journal of Hernia 
and Abdominal Wall Surgery - and some specialists in statistics or systematic 
reviews, the aim was to suggest a set of recommendations to provide a 
standard for investigators writing a study protocol and to authors preparing a 
manuscript for submission. The recommendations are listed in Table 1. 
The CONSORT statement is the common standard to use as guidance 
in performing and reporting RCT’s (www.consort-statement.org). However, for 
ventral hernia repair, RCT’s are not frequent and the majority of the literature is 
comparative retrospective studies or non-comparative cohort studies. For those 
studies the STROBE statement (STrengthening the Reporting of OBservational 
studies in Epidemiology) is the relevant guideline (www.strobe-statement.org) 
and the quality of the studies can be scored using the MINORS scale(32). 
We consider that an author checklist specifically targeted at abdominal 
wall surgery based on accepted statements and scoring systems would increase 
the quality of submissions. Editors and reviewers can use a similar checklist for 
their evaluations. 
The consensus panellists strongly believe that an effort is needed 
to increase the statistical and methodological basis of the abdominal wall 
research. Considering recurrence, which is the primary interest of most studies 
on hernia repair, it is recommended using time-to-event data of the freedom 
of recurrence to analyse and report study results. The number of dropouts from 
studies on hernia repair before the measurement of the primary endpoint is 
often high. Therefore the use of time-to-event data is more suitable in hernia 
repair studies. 
To reduce the heterogeneity of the description of the variables studied 
and the surgical techniques performed, we recommend using previously 
published terminology and definitions. Understanding the study population 
and the surgical technique is essential for the inference of the results to the 
larger population of which the study population is part. 
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Table 1. Summary of recommendations for reporting outcome results in abdominal wall surgery as 
formulated by the panel of a consensus meeting held by the EuraHS working group in Palermo, Italy, 
June 2012.
Topic Recommendation
Study type The title and/or the abstract of the manuscript should have a clear description 
of the study type.
Reporting 
guidelines
Use standardised reporting guidelines (CONSORT, TREND, STROBE, STARLITE, 
PRISMA, MOOSE) to prepare a study protocol or manuscript.
Prospective vs 
retrospective
The abstract should report whether the study is prospective or retrospective, i.e. 
whether the data for the primary endpoint is assessed prospectively.
Primary endpoint 
or variable
Clearly define the primary endpoint or variable of the study, including the 
population analysed (ITT or PP) and a detailed description of how, when and by 
whom this primary endpoint was assessed. 
Blinded 
assessment
State wether the evaluation of the primary endpoint was performed by a person 
blinded to the treatment group of the patient.
Sample size Describe the method used for calculating the sample size and the software used 
for it.
Inclusion criteria, 
exclusion criteria 
and eligibility
Give a clear description of the study population by listing the inclusion criteria 
and exclusion criteria. Report the number of eligible patients not included in the 
study and the reasons for non-inclusion.
Dropouts The percentage of patients not available for evaluation of the primary endpoint 
should be given, including the reasons for “lost to follow-up”. 
The use of a flow diagram of the patients in the study is recommended.
Classifications We recommend using the EHS classification for inguinal and ventral hernias.
Hernia size The width and the length of the hernia from an intraoperative measurement are 
most appropriate. 
When the hernia defect size is reported the method of calculating this size should 
be given.
Surgical technique The surgical techniques used in the study should be described in enough detail 
that the reader could perform the technique him or herself.
Meshes and 
devices
When referring to specific equipment items, we recommend the inclusion of the 
generic name (e.g. polypropylene), the product name and the manufacturer.
Mesh size and 
fixation
Report on the size of the implanted mesh, the overlap of the hernia defect and 
the fixation method in detail.
Time-to-event 
analysis
Time to event analysis using Kaplan-Meier estimates of “freedom of recurrence” 
is the preferred method for analysis of recurrences in hernia repair patients. 
Recurrence rate A recurrence rate should be given on the ITT population and reported with 95% 
confidence intervals. The duration of follow-up at which the recurrence rate was 
measured should be given.
Mean follow-up If a mean follow-up time is given, the range should be given as well.
Method of follow-
up
We recommend to consider only clinically evaluated patients as adequate follow-
up to evaluate recurrence.
In large patient registries clinical follow up in all patients is not achievable. 
Alternatively, follow-up with questionnaires and selective clinical follow-up is 
proposed.
Ethical 
considerations
Every study should mention the approval of the institutional ethical committee 
and informed consent of the patients. 
Financial 
disclosures
Financial support of the study or the investigators should be mentioned by name 
of the organisation or company. Distinguish “Investigator Initiated Studies” from 
studies initiated by a commercial sponsor of the study.
Negative trial 
results
Negative findings or outcome of a study should not be a reason not to submit 
a manuscript. If methodologically correct, negative results can be informative.
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The external validity of a study is the main goal of scientific research and 
exact description of the study parameters is thus important. 
Several clinicians and researchers feel that for most clinical questions 
we have, we will never get answers from RCT’s and meta-analyses because 
the amount of variables is too large. Their frustration is that at this moment 
guidelines are focused mainly on this type of EBM research. Registers may be 
an important source of information for health care. In our particular field of 
research, a population based register like the Danish Ventral Hernia Database or 
large surgical datasets of variables and outcomes like the Herniamed database 
and from the Würzburg Univesity, provides us with very interesting data(4, 29, 
30). However, the statements resulting from the analysis of register data, even 
by sound scientific multivariate statistical analysis, can be limited by various 
sources of bias. The selective inclusion of patients and their data may introduce 
selection bias. Some confounding variables may not be included in the dataset 
of the register and thus result in confounder bias. Nevertheless we think that in 
practice registers may be good to generate scientific hypotheses and consider 
safety questions.
The EuraHS working group encourages researchers in abdominal wall 
surgery to use of the EuraHS platform to gather the data of their patients(1). The 
platform can be used for clinical studies like RCT’s and observational studies 
or for prospective registration of consecutive patients. The platform can be 
used individually, as an institutional registry, or in groups of participants (e.g. 
as national registry). Use of the platform will conform to the recommendation 
of using the consensus-based definitions and classifications of the EuraHS 
working group.
Knowledge of study design and statistical issues is of minimal interest 
to many surgeons. We think that a series of short statistical reviews related 
specifically to abdominal wall surgery would be a good start to improve 
awareness of the importance of a sound statistical approach to hernia repair 
research. Moreover we would encourage the surgical societies to include 
courses on clinical research and statistical items in the program or in pre-
congress courses during meetings of the societies. 
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Abstract
Background
In laparoscopic incisional hernia repair, direct contact between the prosthesis 
and the abdominal viscera is inevitable, which may lead to an inflammatory 
reaction resulting in abdominal adhesion formation. This study compared 
five different synthetic and biologic meshes in terms of adhesion formation, 
shrinkage, incorporation, and histologic characteristics after a period of 30 
and 90 days.
Methods
In 85 rats, a mesh was positioned intraperitoneally in direct contact with 
the viscera. Five different meshes were implanted: Prolene (polypropylene), 
Parietex composite (collagen-coated polyester), Strattice (porcine dermis, 
non-cross-linked), Surgisis (porcine small intestine submucosa, non-cross-
linked), and Permacol (porcine dermis, cross-linked). The meshes were 
tested in terms of adhesion formation, shrinkage, and incorporation after a 
period of 30 and 90 days. Additionally, collagen formation after 90 days was 
determined.
Results
Significantly less adhesion formation was observed with Parietex composite 
(5 %; interquartile range [IQR], 2–5 %) and Strattice (5 %; IQR, 4–10 %) in 
the long term. In contrast, organs were attached to Permacol with four of 
seven meshes (57 %), and adhesion coverage of Surgisis mesh was present 
in 66 % (IQR, 0–100 %) of the cases. After 90 days, the best incorporation was 
seen with the Parietex composite mesh (79 %; IQR, 61–83 %). After 90 days, 
major alterations in adhesion formation were seen compared with 30 days. 
Histologically, Strattice and Parietex composite showed a new mesothelial 
layer on the visceral side of the mesh. Microscopic degradation and new 
collagen formation were seen in the Surgisis group.
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Conclusions
Parietex composite mesh demonstrated the best long-term results compared 
with all the other meshes. The biologic non-cross-linked mesh, Strattice, 
showed little adhesion formation and moderate shrinkage but poor 
incorporation. Biologic meshes are promising, but varying results require a 
more detailed investigation and demonstrate that biologic meshes are not 
necessarily superior to synthetic meshes. The significant changes that take 
place between 30 and 90 days should lead to careful interpretation of short-
term experimental results.
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Introduction
Incisional hernia remains a major clinical problem for 2–20 % of all patients 
undergoing abdominal surgery(1, 2). Even higher incidences reaching 30–37 % 
are reported among obese and aortic aneurysm patients(3, 4). Despite the high 
frequency of incisional hernia operations, long-term results remain disappointing.
Burger et al.(5) reported 10-year recurrence rates up to 63 % after primary 
suture repair and up to 32 % after mesh repair. In addition, the recurrence 
rates increase after each reoperation, underscoring the importance of the best 
evidence-based method at the first operation(6).
In recent years, laparoscopic incisional hernia repair has shown 
increased popularity. Although laparoscopic repair offers no advantages in 
terms of recurrence rates, it may be associated with a shorter hospital stay, 
lower perioperative complication rates, and a shorter mean operation time 
than open repair(7-9).
In laparoscopic hernia repair, direct contact between the prosthesis and 
the abdominal viscera is inevitable. This contact may lead to an inflammatory 
reaction resulting in abdominal adhesion formation(10), which can induce 
small bowel obstruction(11), chronic pain(12), infertility, enterocutaneous 
fistulas(13), and difficulties at reoperation(14). The latter is illustrated by 
Halm et al.(15), who showed that 21 % of patients with an intraperitoneal 
polypropylene mesh required small bowel resection for entrance to be gained 
into the abdomen at reoperation.
Currently, a wide variety of synthetic and biologic hernia reinforcement 
materials is available on the market, complicating the selection of an 
appropriate prosthesis(16, 17). The most commonly used meshes are made 
of polypropylene. This material is relatively inexpensive and easy to handle 
and does incorporate well into the abdominal wall. However, when placed in 
contact with the abdominal viscera, polypropylene meshes may be associated 
with severe adhesion formation(15). Therefore, intraperitoneal utilization 
should be avoided(18).
Alternatives can be found in composite and biologically derived 
prostheses. Composite meshes consist of a synthetic material and an anti-
adhesive layer or coating on the visceral side of the mesh. Biologic grafts are 
collagen meshes derived from bovine, porcine, human skin, or other tissue 
such as submucosa or pericardium.
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A recognizable difference exists between the meshes in performance 
characteristics such as cellular response, strength, biodegradability, and 
susceptibility to infection(19). Biologic meshes are thought to induce fewer 
adhesions because of increased “biocompatibility” and less foreign body 
reaction(16)]. On the other hand, these characteristics may result in less 
incorporation into the abdominal wall(19). Furthermore, some biologic grafts 
are chemically cross-linked to make them less prone to degradation in vivo. 
This progress should increase the strength and longevity of the mesh while 
providing the benefits of a biologic scaffold(20, 21).
This study aimed to help in the selection of the appropriate prosthesis 
from the wide choice of available hernia reinforcement materials. Therefore, 
we compared a commonly used synthetic mesh and a composite mesh with 
one cross-linked and two non-cross-linked biologic meshes in intraperitoneal 
position in a rat model. The meshes were tested in terms of adhesion formation, 
shrinkage, and incorporation after a period of 30 and 90 days. Additionally, 
collagen formation after 90 days was determined.
Materials and methods
Study design
In this study, 85 male Wistar rats were randomized into two groups: 50 animals 
in group A and 35 animals in group B. Both groups were in turn subdivided 
into five groups corresponding with the five meshes tested, thus resulting in 
10 animals per mesh in group A and 7 animals per mesh in group B. After the 
animals had been humanely killed (group A after 30 days and group B after 
90 days), adhesion formation, mesh incorporation, shrinkage, tissue response, 
and collagen formation were scored and compared.
Animals studied
Male inbred rats of the Wistar strain weighing 340–390 g were obtained from 
a licensed breeder in Harlan, The Netherlands and given 2 weeks to become 
customized to laboratory conditions before the start of the study. The animals 
were bred under specific pathogen-free conditions, kept under standard 
laboratory conditions in individually ventilated cages (temperature, 20–24 
°C; relative humidity, 50–60 %; 12-h light and 12-h dark cycles), and fed with 
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standard rat chow and water ad libitum during the whole study period. The 
protocol of the study was approved by the Animal Experiments Committee of 
the Erasmus University Rotterdam.
Materials
Table 1 presents the materials and the brand names of the five meshes tested. 
Before use, the biologic scaffolds Strattice (Lifecell, KCI, Branchburg, NJ) and 
Surgisis (Cook Biotech, West Lafayette, IN, USA) were rehydrated or soaked 
as directed by the manufacturer. Monofilament polypropylene 5-0 (Ethilon; 
Johnson & Johnson Medical, New Brunswick, NJ, USA) sutures were used for 
mesh fixation to the abdominal wall and closure. Multifilament polyglyconate 
5-0 sutures (Safil; Melsungen, Germany B. Braun) were used for closure of the 
skin.
Table 1. Meshes included in the study
Brand name Basic material Modification Manufacturer
Prolene Polypropylene None Ethicon, Johnson and Johnson 
(Somerville, NJ, USA)
Parietex Composite Polyester Collagen-polyethylene-
glycol-glycerol coating
Covidien Surgical 
(Dublin, Ireland)
Strattice Porcine dermis Non-crosslinked Lifecell, KCI  
(Branchburg, NJ, USA)
Surgisis Small intestinal 
submucosa
Non-crosslinked Cook Biotech (West 
Lafayette, IN, USA)
Permacol Porcine dermis Crosslinked Covidien Surgical 
(Dublin, Ireland)
Procedure
The study was performed under aseptic conditions using a modification of a 
validated rat model previously described by Burger et al. (14, 22). At the start 
of the study, the animals were anesthetized using isoflurane/O2 inhalation 
and buprenorphin analgesia (0.05 mg/kg) administered subcutaneously. The 
abdomen was shaved and cleaned with alcohol 70 %, after which a 5-cm midline 
skin incision was made and skin flaps were raised. Subsequently, the abdominal 
cavity was opened with a 4-cm midline incision through the linea alba. A sterile 
mesh measuring 2.5 × 3.5 cm was placed in an intraperitoneal position and 
fixed transmusculary with six nonabsorbable sutures. The abdominal wall and 
skin were both closed with a running absorbable suture.
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Measurements
Adhesion formation
After 30 days (group A) and 90 days (group B), the animals were anesthetized 
and the ventral abdominal wall was opened through a U-shaped incision 
(including skin) around the mesh. Pictures of the mesh and current adhesions 
were taken using a 5.0-megapixel digital camera (Sony Cybershot, Tokyo, Japan). 
Subsequently, the animals were killed by cardiac incision, adhesions were cut, 
and the abdominal wall including the mesh was removed. Two independent 
observers assessed the adhesion coverage of the mesh surface using a scoring 
system. A grid was placed over the mesh, dividing it into 24 equal squares and 
facilitating accurate estimation of adhesion formation. In case of interobserver 
variance, the mean was scored. For objective scoring of the severity of the 
adhesions, the Zühlke scoring system was used. This system has a four-degree 
classification of adhesions based on histologic and morphologic criteria (Table 
2). Adhesions merely attached to the mesh edge did not contribute to the total 
adhesion score. Finally, the animals were killed by cardiac incision.
Table 2. Zühlke score: macroscopic classification of abdominal adhesions.
Zühlke score Characteristics
1 Filmy adhesion, easy to separate by blunt dissection
2 Stronger adhesion; blunt dissection possible, partly sharp dissection necessary; 
beginning of vascularization
3 Stronger adhesion; lysis possible by sharp dissection only; clear vascularization
4 Very strong adhesion; lysis possible by sharp dissection only; organs strongly 
attached with severe adhesions; damage of organs hardly preventable
Incorporation
Mesh incorporation was defined as the amount of the mesh edge (in millimeters) 
incorporated into the abdominal wall as a percentage of the circumference. In 
case of interobserver variance, the mean was scored.
Mesh shrinkage
Mesh shrinkage was defined as the projection of the mesh surface and 
measured with a caliper by two independent observers. By measuring the 
projection, curling and wrinkling of the mesh were included in addition to the 
actual size of the mesh. Shrinkage was defined as the relative loss of surface (%) 
compared with the original size of the mesh.
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Tissue reaction
For each group, five meshes with the adjacent abdominal wall were fixed in 4 
% neutral buffered formalin. After routine tissue processing, sections were cut 
and stained with hematoxylin and eosin (H&E) or picrosirius red.
H&E staining
Paraffin sections were dewaxed and stained with hematoxylin (Sigma-Aldrich, 
Seelze, Germany). After washing in tap water and demiwater, the sections were 
stained with eosin (Sigma-Aldrich). Subsequently, the sections were dehydrated 
in alcohol and xylene and mounted with Entallan (Merck, Darmstadt, Germany). 
Slides were analyzed with a light microscope (Olympus, Tokyo, Japan).
Picrosirius red staining
Paraffin sections were dewaxed, rehydrated, and stained with 0.1 % Sirius Red 
F3BA (Direct Red 80; Fluka Chemie, Zwijndrecht, The Netherlands) in a saturated 
picric acid solution for 1 h. Brief washing in 0.1 % acetic acid was followed by 
rapid dehydration in 100 % alcohol.
After a xylene bath, the slides were mounted with Entellan (Merck). 
Subsequently they were analyzed using a polarized light microscope (Olympus) 
with polarization filters whereby the collagen fibers show birefringence. 
This technique allows the orientation of the collagen fibers to be visualized, 
indicating the amount of collagen new formation(23).
In the H&E-stained samples, the degree of inflammation was scored 
using the following grading scale: grade 1 (mild inflammatory reaction with a 
few giant cells, occasional lymphocytes, and plasma cells), grade 2 (moderate 
reaction with giant cells and increased numbers of admixed lymphocytes, 
plasma cells, eosinophils, and neutrophils), and grade 3 (severe inflammatory 
reaction with micro abscesses).
Statistical analysis
Because the data were not normally distributed, adhesion formation, 
incorporation, shrinkage, and tenacity were compared using nonparametric 
tests (Kruskal-Wallis, Mann–Whitney). Therefore, all results were presented using 
the median and the interquartile range (IQR). After the amount of adhesion 
formation and the percentage of incorporated mesh edge had been assessed, 
these parameters were used to determine the Spearman’s rank correlation 
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coefficient. All reported p values are two-sided and considered significant if 
lower than 0.05. Statistical analysis was performed using the PSAW 17 statistical 
software package (IBM SPSS statistics, Amsterdam, The Netherlands).
Results
During this study involving 85 animals, no animals died prematurely.
Adhesions
At 30 days, Parietex composite showed a significantly smaller percentage of 
mesh surface covered with adhesions (9 %; IQR, 3.0–12.8 %) than any of the 
other meshes. Permacol resulted in significantly more adhesions than any of 
the other meshes (87.5 %; IQR, 81–100 %), and adhesion coverage with the 
Prolene mesh was significantly higher than with Strattice (40 %; IQR, 24.1–61.5 
%) or Parietex composite meshes. Surgisis mesh showed 45 % coverage (IQR, 
7.4–77.5 %) of the mesh surface.
At 90 days, the smallest amount of adhesions was seen with Parietex 
composite (5 %; IQR, 2–5 %) and Strattice (5 %; IQR, 4–10 %), significantly less 
with either Prolene (42 %; IQR, 36.8–53.6 %) or Permacol (74.8 %; IQR, 37.9–82.7 
%) (Figure 1). Five Surgisis meshes showed 100 % adhesion coverage, whereas 
two meshes were completely adhesion free. Compared with the results at 30 
days, Prolene, Strattice, and Permacol showed a significant reduction in the 
amount of adhesions at 90 days (Figure 1). Figure 2 shows representative views 
of all the meshes at the long-term follow-up evaluation.
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Figure 1. Adhesion coverage at 30 days compared with coverage at the 90-day follow-up assessment. 
Values are median (interquartile range). At 30 days: *p < 0.050 versus Strattice and Parietex composite; 
§p < 0.050 versus all other meshes; ±p < 0.050 versus all other meshes. At 90 days: ❖p < 0.050 versus 
Permacol and Prolene; ◉p < 0.050 versus Permacol and Prolene. At 90 days, Prolene, Strattice, and 
Permacol showed a significant reduction compared with their status at 30 days (Mann–Whitney U test).
Mesh incorporation
At 30 days, no significant difference in mesh edge incorporation was seen 
between Parietex composite (70 %; IQR, 53–80 %), Prolene (50 %; IQR, 46.3–
56.1 %), Surgisis (34 %; IQR, 16.7–66.5 %), Strattice (23 %; IQR, 5–70 %), and 
Permacol (48 %; IQR, 34.3–69.6) meshes. At 90 days, the percentage of Parietex 
composite mesh incorporated (79 %; IQR, 61.2–83.0 %) was significantly 
higher than that of Prolene (53 %; IQR, 31.0–61.2 %), Strattice (40 %; IQR, 9.5–
57.4 %), or Permacol (21 %; IQR, 16.0–41.4). The percentage of Surgisis mesh 
edge incorporated was 66 % (IQR, 0–100 %). Five meshes showed complete 
incorporation, whereas two other meshes did not incorporate at all (Figures 2 
and 3). For each mesh, no significant differences were observed between 30 
and 90 days.
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Figure 2. Representative views at the 90-day follow-up assessment. Parietex composite adhesions 
merely to the mesh edge do not contribute to the total adhesion score. Permacol cecum adhered to the 
mesh. Surgisis I without adhesions and with minimal incorporation (2 of 7). Surgisis II complete coverage 
with adhesions and full incorporation (5 of 7). Dashed line marks the original size of the mesh.
Shrinkage
At 30 days, Surgisis showed significantly more shrinkage (39 %; IQR, 37.1–
50.6 %) than any of the other meshes. More shrinkage occurred with both 
Permacol (13.7 %; IQR, 8.6–22.6 %) and Strattice (16 %; IQR, 14.3–19.2 %) 
than with Parietex composite. No significant differences were seen between 
Prolene (11 %; IQR, 8.6–16.2 %) and Parietex composite (9 %; IQR, 5.7–13.6 
%). At 90 days, Surgisis resulted in significant more shrinkage than any of the 
other meshes (65 %; IQR, 42.4–74.3 %) (Figure 4). The percentage of shrinkage 
shown by Strattice (28 %; IQR, 22.9–28.0 %) was significantly higher than that 
shown by Prolene (16 %; IQR, 11.4–18.5 %). After 90 days, Parietex composite 
mesh demonstrated shrinkage of 23 % (IQR, 9.7–31.7 %), and Permacol 
exhibited shrinkage of 17.7 % (IQR, 12.2–23.8 %). All the meshes except Prolene 
and Permacol showed significantly more shrinkage at 90 days than at 30 days.
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Figure 3. Percentage of the mesh edge incorporated into the abdominal wall. At 30 days, no significant 
differences were found. Values are median (interquartile range). §p < 0.050 versus Prolene, Strattice, and 
Permacol. For each mesh, no significant differences were observed between 30 and 90 days (Mann–
Whitney U test).
Figure 4. Shrinkage of the mesh surface compared with the original size. At 30 days: §p < 0.050 versus all 
other meshes; ±p < 0.050 versus Permacol and Strattice. At 90 days: *p < 0.050 versus all other meshes; 
¶p < 0.050 versus Prolene. Compared with 30 days, Surgisis, Parietex composite, and Strattice showed 
significant more shrinkage (Mann–Whitney U test)
Tenacity of adhesions
At 30 days, the Zühlke score for adhesions to the Permacol mesh was significantly 
higher than the score for Prolene (p = 0.011), Parietex composite (p = 0.004), or 
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Surgisis (p = 0.007). Organs were attached (Zühlke 4) to Permacol in 6 of 10 cases 
(60 %) and to Strattice in 2 of 10 cases (20 %). At 90 days, the Zühlke score of 
Permacol was significantly higher than the score of Parietex composite, Surgisis, 
or Strattice. No organs were attached to any of the meshes except Permacol (4 
of 7, 57.1 %). The Zühlke scores for the Strattice (1; IQR, 1–2) and Surgisis (1; IQR, 
0–1) meshes were significantly lower than for Prolene (2; IQR, 2–2).
Correlation between adhesion formation and incorporation
At 30 days, Strattice showed a significant correlation between adhesion 
coverage of the mesh and incorporation of the mesh edge (ρ = 0.681; p = 0.030). 
At 90 days, only Surgisis showed a significant correlation coefficient (ρ = 0.828; 
p = 0.021). In both cases, the correlation coefficient indicated that an increase 
of incorporation was correlated with an increase in adhesion formation.
Tissue reaction
At 30 days, histologic evaluation after H&E staining of the meshes demonstrated 
a grade 1 (mild) foreign body reaction to all the meshes except Permacol. This 
mesh showed a grade 2 inflammatory reaction, resulting in a thick fibrous layer 
between the mesh and the abdominal wall. Additionally, in some cases, a fibrous 
layer was visible on the abdominal side of the mesh, generally combined with 
strong adhesions (Figure 5).
At 90 days, a grade 1 mild foreign body reaction was visible around all 
the meshes, with limited numbers of giant cells and lymphocytes present. 
Parietex composite meshes showed a larger influx of fibroblasts. Strattice and 
Parietex composite showed a new mesothelial layer on the visceral side of the 
mesh. On the Permacol mesh, a new mesothelial layer was alternating with a 
small layer of fibrous tissue.
Histologic samples after picrosirius red staining at 90 days are 
shown in Figure 6 Tissue surrounding the Prolene mesh indicates complete 
incorporation of the mesh by a layer of collagen around the Prolene fibers. All 
these collagen fibers have the same orientation and thickness. The collagen 
layer between mesh and muscles also was highly organized but in a different 
direction and with a different thickness because it is mostly of the same color.
In the case of Parietex composite, the mesh was completely covered 
with collagen in different orientations. The collagen directly surrounding the 
fibers has a different direction than the collagen of the layer between the 
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mesh and the muscles. In particular, the layer between material and muscles 
appeared to be very organized based on the homogeneity of color. The 
collagen fibers of the Permacol mesh itself showed a structured orientation 
of collagen fibers. The mesh and the muscle layer had almost no collagen 
between them, as indicated with a “c” in Figure 6. Furthermore, this layer 
was very organized in one direction. A small layer of collagen with fibers in 
several different orientations separated Strattice mesh from the abdominal 
muscles. Surgisis mesh was completely incorporated into connective tissue, 
with collagen fibers crossing the surrounding tissue and the Surgisis mesh 
(indicated by * in Figure 6).
Figure 5. Histologic sample of Permacol mesh at the 30-day follow-up assessment. The liver is strongly 
attached to the mesh. 1 Permacol mesh. 2 Fibrotic layer. 3 Liver.
!
"
#
Discussion
The current study analyzed five different meshes in terms of adhesion 
formation, incorporation, and shrinkage after 30 and 90 days. For these three 
parameters, Parietex composite mesh demonstrated the best long-term 
results compared with all the other meshes. The biologic non-cross-linked 
mesh, Strattice, showed little adhesion formation and moderate shrinkage 
but poor incorporation.
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Figure 6. Histologic samples after picrosirius red staining at 90 days. The collagen layer between mesh 
and abdominal wall is indicated by c. Collagen surrounding Surgisis mesh is shown by asterisk.
!
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Adhesions are formed during the inflammatory phase in the first 7 days 
after surgery(24). This period is followed by the proliferation phase until about 
day 30, when some regression is observed, whereas the remaining adhesions 
become more organized to fibrous and vascularized tissue. In general, previous 
opinion maintained that this succeeding phase of remodeling was temporary 
and that inert scar tissue was finally formed. However, findings recently have 
shown that even after months to years, macrophages, fibroblasts, mononuclear 
cells, and neovascularization can be identified in abdominal adhesion tissue, 
suggesting a dynamic and ongoing process of remodeling(25-27). This is 
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supported by our study showing major alterations in the results after 90 days 
compared with 30 days. The amount of adhesion formation to the Strattice 
and the Prolene meshes was significantly diminished, whereas the extent of 
adhesions to the Surgisis mesh increased at 90 days.
The fact that the anti-adhesive collagen layer of the Parietex composite 
mesh is absorbed within 30 days is not congruent with our findings that 
very few adhesions on this mesh occur even in the long term(28). These data 
support recent long-term studies in which Parietex composite resulted in 
minimal adhesion formation(29, 30). The mechanism of this phenomenon is 
not completely understood, but perhaps the formation of a new mesothelial 
layer plays a pivotal role in this process. Histologic examination of tissue 
samples after H&E supports this hypothesis showing a new mesothelial layer 
on the Parietex composite and Strattice meshes. On Permacol mesh, a new 
mesothelial layer was alternating with a small fibrous layer, the latter most 
probably the result of adhesion formation.
In addition to adhesion prevention on the visceral side of the mesh, a 
fundamental characteristic of a mesh for intraperitoneal use should be a good 
incorporation on the ventral side. A macroporous surface and a (mild) foreign 
body reaction might be necessary for sufficient incorporation, although Petter-
Puchner et al.(31) showed that macroscopic perforation of different biologic 
meshes did not improve incorporation. At 30 days, no significant differences in 
incorporation were seen between the meshes as a result of large variation in 
all the groups. At 90 days, however, Parietex composite showed a significantly 
higher percentage of incorporation than Strattice, Prolene, or Permacol. At this 
time point, Surgisis mesh resulted in a wide variation of results regarding all 
parameters. Five meshes were well incorporated and completely covered with 
adhesions, resulting in excessive shrinkage. In contrast, the other two meshes 
showed no incorporation or adhesion formation at all, with less shrinkage.
Further analysis showed a significant correlation between incorporation 
and adhesion formation. The cause of this correlation is a matter of speculation, 
although an explanation might be found in the foreign body reaction. This 
reaction necessary for ingrowth on the ventral side also can induce the 
formation of adhesions on the visceral side because this mesh does not have 
a specific anti-adhesive layer. As a consequence, limited adhesion formation 
goes with insufficient incorporation.
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The literature clearly shows that Surgisis manifests enhanced shrinkage 
and is absorbed completely by the body. However, the speed of degradation is 
a matter of discussion(19, 31-33).
One advantage attributed to biodegradable meshes is their ability 
to support regeneration of the original tissue, but when the mesh degrades 
before adequate cellular infiltration, differentiation, collagen deposition, and 
neovascularization, the overall quality and strength of the newly formed tissue 
probably will be insufficient for abdominal hernia repair(19, 34).
Histologic examination of Surgisis after picrosirius red staining showed 
a transition layer with collagen fibers organized in different directions crossing 
the border between Surgisis and surrounding tissue. Together with degradation 
of the mesh, this suggests an ongoing remodeling process. Unfortunately, 
from the results of this study, it is not possible to conclude what influence the 
remodeling process has on the strength of the mesh and underlying tissue.
In our study, a wide variation in adhesion formation to the mesh was 
seen in the Strattice group at 30 days. In two cases, less than 5 % of the surface 
was covered with adhesions, whereas in two additional cases, organs were 
attached to the Strattice mesh. Remarkably, the amount of adhesions attached 
to the mesh dropped dramatically from 40 % at 30 days to 5 % at 90 days. In 
combination with a significant lower tenacity of adhesions compared with the 
Prolene mesh at 90 days, this may suggest less severe adhesion formation to 
Strattice mesh in the long term. This may be explained by the histologic result 
similar to that of Parietex composite meshes, showing a new mesothelial layer 
at the visceral side of the mesh.
Our result of a wide variation at 30 days is consistent with that of Mulier 
et al.(35), who also found a wide distribution in adhesion formation. However, 
they did not mention whether any organs were involved or not. At 90 days, 
40 % of the Strattice mesh edge was incorporated into the abdominal wall. 
In contrast to the results at 30 days, correlation between adhesions and 
incorporation could not be found anymore because very few adhesions were 
seen. Histologic examination with picrosirius red staining showed almost no 
degradation of the mesh. Additionally, a small and sharply bordered layer of 
novel connective tissue was seen between the mesh and the abdominal wall, 
confirming the macroscopic observation of limited incorporation.
The amount of adhesions to Permacol mesh after 90 days (74.8 %) was 
significantly diminished compared with the amount after 30 days (87.5 %), 
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whereas the Zühlke score was not. This may be explained by the reduction in 
filmy adhesions, whereas, in contrast, bowel or liver adhered to 57 % of the 
meshes. In the literature, these extensive adhesions and limited adhesion 
formation to Permacol mesh are described(36, 37).
Mesh edge incorporation at 90 days was 21 %, and in contrast to Strattice 
and Surgisis, no correlation between adhesion formation and incorporation 
was found at either time point. Histologic examination after 30 days showed a 
substantial fibrotic layer between the Permacol mesh and the abdominal wall, 
and picrosirius red staining did not show a transition layer with degradation of 
the mesh or new collagen formation. Additionally, the macroscopic observation 
of liver adhered to the mesh was microscopically confirmed with a fibrotic 
reaction between liver and mesh (Figure 5).
These observations suggest that Permacol mesh placement results in a 
foreign body reaction comparable with that of synthetic meshes, resulting in 
formation of a fibrotic capsule rather than tissue regeneration. An explanation 
may be found in the chemical cross-linking process. The aim of this process is 
to increase the strength of the scaffold and to restrain the in vivo degradation 
process. A disadvantage may be that cross-linking results in biocompatibility, 
possibly leading to more adhesion formation. Therefore, based on results in this 
study, non-cross-linked mesh should be preferred to prevent strong adhesion 
formation.
We conclude from this study that biologic meshes are not necessarily 
superior to synthetic meshes with regard to adhesion formation, incorporation, 
or shrinkage. Our data confirm the outcome of earlier studies in which 
composite meshes showed clear advantages compared with other meshes 
on the market(38, 39). The difference in our results between 30 and 90 days 
appears to be highly significant and should lead to careful interpretation of 
short-term experimental results.
Biological mesh in hernia repair
225
10
References
1. Israelsson LA, Jonsson T. Incisional hernia after midline laparotomy: a prospective study. Eur J Surg. 
1996;162(2):125-9.
2. Read RC, Yoder G. Recent trends in the management of incisional herniation. Arch Surg. 
1989;124(4):485-8.
3. Bevis PM, Windhaber RA, Lear PA, Poskitt KR, Earnshaw JJ, Mitchell DC. Randomized clinical trial 
of mesh versus sutured wound closure after open abdominal aortic aneurysm surgery. Br J Surg. 
2010;97(10):1497-502.
4. Hoer J, Lawong G, Klinge U, Schumpelick V. [Factors influencing the development of incisional 
hernia. A retrospective study of 2,983 laparotomy patients over a period of 10 years] Einflussfaktoren 
der Narbenhernienentstehung. Retrospektive Untersuchung an 2.983 laparotomierten Patienten 
uber einen Zeitraum von 10 Jahren. Chirurg. 2002;73(5):474-80.
5. Burger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J. Long-term follow-up 
of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg. 
2004;240(4):578-83; discussion 83-5.
6. Luijendijk RW, Hop WC, van den Tol MP, de Lange DC, Braaksma MM, JN IJ, et al. A comparison of 
suture repair with mesh repair for incisional hernia. N Engl J Med. 2000;343(6):392-8.
7. Olmi S, Scaini A, Cesana GC, Erba L, Croce E. Laparoscopic versus open incisional hernia repair: an 
open randomized controlled study. Surg Endosc. 2007;21(4):555-9.
8. Sajid MS, Bokhari SA, Mallick AS, Cheek E, Baig MK. Laparoscopic versus open repair of incisional/
ventral hernia: a meta-analysis. Am J Surg. 2009;197(1):64-72.
9. Sauerland S, Walgenbach M, Habermalz B, Seiler CM, Miserez M. Laparoscopic versus open surgical 
techniques for ventral or incisional hernia repair. Cochrane Database Syst Rev. 2011(3):CD007781.
10. Luijendijk RW, de Lange DC, Wauters CC, Hop WC, Duron JJ, Pailler JL, et al. Foreign material in 
postoperative adhesions. Ann Surg. 1996;223(3):242-8.
11. Ellis H, Moran BJ, Thompson JN, Parker MC, Wilson MS, Menzies D, et al. Adhesion-related 
hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet. 
1999;353(9163):1476-80.
12. Stanciu D, Menzies D. The magnitude of adhesion-related problems. Colorectal Dis. 2007;9 Suppl 
2:35-8.
13. Leber GE, Garb JL, Alexander AI, Reed WP. Long-term complications associated with prosthetic 
repair of incisional hernias. Arch Surg. 1998;133(4):378-82.
14. Burger JW, Halm JA, Wijsmuller AR, ten Raa S, Jeekel J. Evaluation of new prosthetic meshes for 
ventral hernia repair. Surg Endosc. 2006;20(8):1320-5.
15. Halm JA, de Wall LL, Steyerberg EW, Jeekel J, Lange JF. Intraperitoneal polypropylene mesh hernia 
repair complicates subsequent abdominal surgery. World J Surg. 2007;31(2):423-9; discussion 30.
16. Gaertner WB, Bonsack ME, Delaney JP. Visceral adhesions to hernia prostheses. Hernia. 
2010;14(4):375-81.
17. Kingsnorth A, LeBlanc K. Hernias: inguinal and incisional. Lancet. 2003;362(9395):1561-71.
18. Ventral Hernia Working G, Breuing K, Butler CE, Ferzoco S, Franz M, Hultman CS, et al. Incisional 
ventral hernias: review of the literature and recommendations regarding the grading and 
technique of repair. Surgery. 2010;148(3):544-58.
19. Bellows CF, Alder A, Helton WS. Abdominal wall reconstruction using biological tissue grafts: 
present status and future opportunities. Expert Rev Med Devices. 2006;3(5):657-75.
20. Duan X, Sheardown H. Crosslinking of collagen with dendrimers. J Biomed Mater Res A. 
2005;75(3):510-8.
21. Melman L, Jenkins ED, Hamilton NA, Bender LC, Brodt MD, Deeken CR, et al. Early biocompatibility 
of crosslinked and non-crosslinked biologic meshes in a porcine model of ventral hernia repair. 
Hernia. 2011;15(2):157-64.
22. Alponat A, Lakshminarasappa SR, Yavuz N, Goh PM. Prevention of adhesions by Seprafilm, an 
absorbable adhesion barrier: an incisional hernia model in rats. Am Surg. 1997;63(9):818-9.
Chapter 10
226
23. Coleman R. Picosirius red staining revisited. Acta Histochemica. 2009;111:393-470.
24. Baptista ML, Bonsack ME, Felemovicius I, Delaney JP. Abdominal adhesions to prosthetic mesh 
evaluated by laparoscopy and electron microscopy. J Am Coll Surg. 2000;190(3):271-80.
25. Binnebosel M, Klinge U, Rosch R, Junge K, Lynen-Jansen P, Schumpelick V. Morphology, quality, and 
composition in mature human peritoneal adhesions. Langenbecks Arch Surg. 2008;393(1):59-66.
26. Epstein JC, Wilson MS, Wilkosz S, Ireland G, O’Dwyer ST, Herrick SE. Human peritoneal adhesions 
show evidence of tissue remodeling and markers of angiogenesis. Dis Colon Rectum. 
2006;49(12):1885-92.
27. Roy S, Clark CJ, Mohebali K, Bhatt U, Wallace WA, Nahman NS, et al. Reactive oxygen species and EGR-
1 gene expression in surgical postoperative peritoneal adhesions. World J Surg. 2004;28(3):316-20.
28. Schreinemacher MH, Emans PJ, Gijbels MJ, Greve JW, Beets GL, Bouvy ND. Degradation of 
mesh coatings and intraperitoneal adhesion formation in an experimental model. Br J Surg. 
2009;96(3):305-13.
29. Chelala E, Debardemaeker Y, Elias B, Charara F, Dessily M, Alle JL. Eighty-five redo surgeries after 
733 laparoscopic treatments for ventral and incisional hernia: adhesion and recurrence analysis. 
Hernia. 2010;14(2):123-9.
30. Zinther NB, Wara P, Friis-Andersen H. Intraperitoneal onlay mesh: an experimental study of 
adhesion formation in a sheep model. Hernia. 2010;14(3):283-9.
31. Petter-Puchner AH, Fortelny RH, Silic K, Brand J, Gruber-Blum S, Redl H. Biologic hernia 
implants in experimental intraperitoneal onlay mesh plasty repair: the impact of proprietary 
collagen processing methods and fibrin sealant application on tissue integration. Surg Endosc. 
2011;25(10):3245-52.
32. Poulose BK, Scholz S, Moore DE, Schmidt CR, Grogan EL, Lao OB, et al. Physiologic properties of 
small intestine submucosa. J Surg Res. 2005;123(2):262-7.
33. Clarke KM, Lantz GC, Salisbury SK, Badylak SF, Hiles MC, Voytik SL. Intestine submucosa and 
polypropylene mesh for abdominal wall repair in dogs. J Surg Res. 1996;60(1):107-14.
34. Connor J, McQuillan D, Sandor M, Wan H, Lombardi J, Bachrach N, et al. Retention of structural and 
biochemical integrity in a biological mesh supports tissue remodeling in a primate abdominal wall 
model. Regen Med. 2009;4(2):185-95.
35. Mulier KE, Nguyen AH, Delaney JP, Marquez S. Comparison of Permacol and Strattice for the repair 
of abdominal wall defects. Hernia. 2011;15(3):315-9.
36. Gaertner WB, Bonsack ME, Delaney JP. Experimental evaluation of four biologic prostheses for 
ventral hernia repair. J Gastrointest Surg. 2007;11(10):1275-85.
37. Stanwix MG, Nam AJ, Hui-Chou HG, Ferrari JP, Aberman HM, Hawes ML, et al. Abdominal ventral 
hernia repair with current biological prostheses: an experimental large animal model. Ann Plast 
Surg. 2011;66(4):403-9.
38. Schug-Pass C, Sommerer F, Tannapfel A, Lippert H, Kockerling F. The use of composite meshes 
in laparoscopic repair of abdominal wall hernias: are there differences in biocompatibily?: 
experimental results obtained in a laparoscopic porcine model. Surg Endosc. 2009;23(3):487-95.
39. Schug-Pass C, Tamme C, Tannapfel A, Kockerling F. A lightweight polypropylene mesh (TiMesh) for 
laparoscopic intraperitoneal repair of abdominal wall hernias: comparison of biocompatibility with 
the DualMesh in an experimental study using the porcine model. Surg Endosc. 2006;20(3):402-9.

Chapter
Experimental study on 
synthetic and biological 
mesh implantation in the 
contaminated environment
E.B. Deerenberg
I.M. Mulder
N. Grotenhuis
M. Ditzel
J. Jeekel
J.F. Lange
British Journal of Surgery 2012;99(12):1734-41.
Chapter 11
230
Abstract:
Background
Implantation of meshes in a contaminated environment can be complicated 
by mesh infection and adhesion formation.
Methods
The caecal ligation and puncture model was used to induce peritonitis in 144 
rats. Seven commercially available meshes were implanted intraperitoneally: 
six non-absorbable meshes, of which three had an absorbable coating, and 
one biological mesh. Mesh infection, intra-abdominal abscess formation, 
adhesion formation, incorporation and shrinkage were evaluated after 28 and 
90 days. Histological examination with haematoxylin and eosin and picrosirius 
red staining was performed.
Results
No mesh infections occurred in Sepramesh®, Omyramesh® and Strattice®. One 
mesh infection occurred in Parietene® and Parietene Composite®. Significantly 
more mesh infections were found in C-Qur® (15 of 16; P ≤ 0.006) and Dualmesh® 
(7 of 15; P ≤ 0.035). Sepramesh® showed a significant increase in adhesion 
coverage from 12.5 % at 28 days to 60.0 % at 90 days (P = 0.010). At 90 days 
there was no significant difference between median adhesion coverage of 
Parietene Composite® (35.0 %), Omyramesh® (42.5 %), Sepramesh® (60.0 %) 
and Parietene® (72.5 %). After 90 days the adhesion coverage of Strattice® was 
5.0 %, and incorporation (13.4 %) was significantly poorer than for other non-
infected meshes (P ≤ 0.009). Dualmesh® showed shrinkage of 63 % after 90 
days.
Conclusion
Parietene Composite® and Omyramesh® performed well in a contaminated 
environment. Strattice® had little adhesion formation and no mesh infection, 
but poor incorporation. Some synthetic meshes can be as resistant to infection 
as biological meshes.
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Introduction
Mesh reinforcement during ventral hernia repair drastically reduces 10-year 
recurrence rates(1, 2). Non-absorbable synthetic materials are currently the most 
commonly used prosthesis for reinforcement of ventral hernias. Advantages 
of synthetic meshes are low recurrence rates, ease of use and relatively low 
costs. However, implantation of synthetic meshes can be complicated by mesh 
infection and adhesion formation. Mesh infection is a feared complication and 
reported in up to 16% of patients after abdominal wall repair(3). The risk of 
mesh infection is increased in a contaminated environment, which makes the 
use of synthetic mesh debatable(4). Mesh infection after implantation often 
necessitates its removal, which leaves the patient with a contaminated field 
and an abdominal wall deficit that is often larger than the original hernia. 
Macroporous meshes have been preferred because large pores permit 
infiltration of macrophages and allow rapid fibroplasia and angiogenesis, with 
reduced infiltration and growth of bacteria(5, 6). The drawback of macroporous 
meshes is the increased risk of visceral adhesions to the site of the repair, with 
associated small bowel obstruction, pain, infertility and enterocutaneous 
fistula formation(5, 7, 8). These adhesions arise as a result of fibrin deposition in 
the abdominal cavity, with subsequent formation of adhesions. The presence 
of contamination increases fibrin deposition, leading to an increased amount 
and tenacity of adhesions intra-abdominally and to the mesh(9). In a clean 
environment antiadhesive coatings have proved to reduce adhesion formation 
to macroporous meshes(8, 10, 11). The aim of the study was to compare 
commercially available synthetic and biological meshes in terms of infection 
rate, adhesion formation, incorporation and shrinkage after implantation in a 
contaminated environment.
Methods
One hundred and forty-four male Wistar rats weighing 250–350 g were 
obtained from a licensed breeder (Harlan Laboratories, Boxmeer, The 
Netherlands). They were bred under specific pathogen-free conditions, kept 
under standard laboratory conditions in individually ventilated cages, and 
fed freely with standard rat chow and water throughout the experiment. The 
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protocol of the experiment was approved by the Ethical Committee on Animal 
Experimentation of Erasmus University Rotterdam.
Peritonitis model
Rats were anaesthetized by isoflurane/oxygen inhalation and received 
buprenorphine analgesia (0.05 mg/kg subcutaneously). The abdomen was 
shaved and the skin disinfected with 70 % alcohol, after which the abdominal 
cavity was opened through a 3-cm midline incision. To induce peritonitis, 
a caecal ligation and puncture (CLP) model was used(12). The caecum was 
carefully manipulated outside the abdominal cavity and ligated just distal to 
the ileocaecal valve with a monofilament non-absorbable suture (4/0 Ethilon®; 
Ethicon, Johnson & Johnson, Somerville, New Jersey, USA), maintaining the 
continuity of the bowel. The caecum was punctured distally to the ligation 
with an 18-G needle. The fascia and skin were closed with a running absorbable 
suture (5/0 Safil®; B. Braun, Melsungen, Germany). After 24 h the abdomen 
was reopened, a culture swab was taken to confirm peritonitis, the necrotic 
caecum was resected and the abdominal cavity was rinsed with at least 20 ml 
phosphate-buffered saline at 37°C. A sterile mesh, measuring 2.5 × 3 cm, was 
implanted intraperitoneally with three transmuscular nonabsorbable sutures 
(5/0 Ethilon®) on both sides of the incision in all mesh groups. No mesh was 
implanted in the control group. After administration of gentamicin (6 mg/kg 
intramuscularly) the abdominal wall and skin were closed separately with a 
running absorbable suture (5/0 Safil®).
Implanted meshes
The rats were divided into eight groups, a control group that received no 
mesh and groups in which one of the following seven meshes was implanted 
intraperitoneally: 
1. Non-cross-linked collagen (Strattice®; LifeCell, Branchburg, New 
Jersey, USA)
2. Polypropylene (Parietene®; Sofradim, Trevoux, France; part of 
Covidien, North Haven, Connecticut, USA)
3. Collagen–polyethyleneglycol–glycerol-coated polypropylene 
(Parietene Composite®; Sofradim)
4. Omega-3-fatty acid coated polypropylene (C-Qur®; Atrium, Hudson, 
New York,USA)
Meshes in a contaminated environment
233
11
5. Carboxymethylcellulose–sodium hyaluronate coated polypropylene 
(Sepramesh®; Bard, New Providence, New Jersey, USA)
6. Expanded polytetrafluoroethylene (PTFE) (Dualmesh®; Gore, 
Flagstaff, Arizona, USA)
7. Condensed PTFE (Omyramesh®; B. Braun)
Measurements
Half of the surviving animals were killed after 28 days and half after 90 days. The 
abdomen was shaved, disinfected and opened through a U-shaped incision 
extending laterally and caudally to the mesh. Directly after opening the 
abdomen, a swab of the abdominal cavity was taken for culture. Mesh infection 
was defined as the presence of abscesses of the mesh, and parts of the mesh 
were cultured for microbiological evaluation. Adhesions were scored using a 
grid placed over the mesh, dividing it into 30 equal squares. The tenacity of the 
adhesions was graded using the Zühlke score, a four-degree classification of 
adhesions based on histological and morphological criteria(13). Pictures of the 
abdominal wall with mesh and any adhesions were taken with a 5.0-megapixel 
digital camera. The abdominal cavity was inspected for abscesses; when 
present, these were scored and cultured at four sites: the liver, abdominal wall, 
bowel and omentum(14). Mesh incorporation was defined as the percentage 
of the mesh edge incorporated into the abdominal wall, taking into account 
any shrinkage. Shrinkage was defined as the relative loss of surface compared 
with the original size of the mesh, measured with a caliper. The animals were 
killed by cardiac cut. All measurements were carried out by two independent 
observers and disagreements reconciled by discussion.
Histological evaluation
At least two representative samples of macroscopically non infected meshes 
with adjacent abdominal wall were excised by full-thickness (mesh and 
abdominal wall muscle) biopsy punches of 5 mm diameter. The samples were 
embedded in Tissue-Tek® (Sakura, Alphen aan den Rijn, The Netherlands) and 
immediately frozen in liquid nitrogen. Frozen sections of 6 μm were made 
using a cryostat (Leica; Davis Instruments, Vernon Hills, Illinois, USA). Sections 
were stained with either haematoxylin and eosin or picrosirius red (Direct Red 
80; Fluka Chemie, Zwijndrecht, The Netherlands)(15). Samples were assigned 
a random number before evaluation and scored by two observers blinded to 
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the specific type of mesh. Fibrosis, lymphocyte infiltration and angiogenesis 
were scored macroscopically at 200× magnification using a light microscope 
(Olympus, Center Valley, Pennsylvania, USA). The following grading scale was 
used: 0, none present; 1, little; 2, moderate; and 3, extensive. The picrosirius 
red-stained sections were analysed for collagen and scored by means of the 
same scale for the presence of collagen around the mesh and abdominal wall.
Statistical analysis
Results are presented as median (interquartile range). Mesh infection, tenacity 
and percentage of adhesions, histological score, abscess formation, survival 
and weight were compared using Kruskal–Wallis, Mann–Whitney U, χ2 and 
Fisher’s exact tests as the data did not show a normal distribution. If the overall 
test showed differences, pairwise tests were done to determine the groups 
causing the overall significance. Exact methods for significance were used 
when computational limits allowed these. All reported P values are two-sided 
and P < 0.050 was considered statistically significant. In view of the numbers, it 
was not possible to adjust the P values using Bonferroni’s correction. Statistical 
analysis was performed using PSAW® statistical software package version 17 
(IBM, Armonk, New York, USA).
Results
During the first 2 days of the experiment 22 (15.3%) of the 144 rats died. 
Necropsy was performed and septicaemia was found to be the cause of 
death in all rats (Table 1). On day 13 one rat in the C-Qur® group died from 
intestinal obstruction due to severe adherence of the bowel to the infected 
mesh. Abdominal cultures on day 1 confirmed bacterial contamination in 
all animals with Gram-positive (Enterococcus, Staphylococcus, Streptococcus) 
and Gram-negative (Escherichia coli and Proteus) microorganisms. All animals 
exhibited symptoms of sepsis including apathetic behaviour, ocular exudates, 
piloerection, diarrhoea and weight loss. The maximum percentage weight 
loss varied between 11.1 and 14.2%, and was more pronounced in the C-Qur® 
group (P ≤ 0.048 compared with other groups).
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Table 1. Postoperative mortality and number of animals analysed at 28 and 90 days after surgery
No. analysed
Group Mesh material # Postoperative 
death
28 days 90 days
Control - 18 2 8 8
Strattice Non-crosslinked collagen 18 4 7 7
Parietene Polypropylene 18 2 8 8
Parietene 
composite
Collagen–polyethyleneglycol–
glycerol-coated polypropylene
18 4 7 7
Sepramesh Carboxymethylcellulose–sodium 
hyaluronate-coated polypropylene
18 2 8 8
C-Qur Omega-3-fatty acid-coated
polypropylene
18 2 8* 8
Dualmesh Expanded polytetrafluoroethylene 18 3 7 8
Omyramesh Condensed polytetrafluoroethylene 18 3 7 8
Total 144 22 60 62
*One rat in the C-Qur® group died after 13 days. The results for this rat were analysed together with those 
for rats killed after 28 days in the C-Qur® group.
Mesh infection
At the time of death macroscopic infection of the mesh was present in 24 
(22.6%) of 106 animals. The infection rate among C-Qur® meshes was high (15 
of 16 rats) compared with all other meshes (P ≤ 0.006) (Figure 1). Dualmesh® 
also showed a high infection rate (7 of 15 rats), significantly higher than all 
other groups apart from C-Qur® (P ≤ 0.035). All infected meshes became large 
fibrotic pseudotumours. No additional mesh infection was discovered by 
microbiological culture of the meshes.
Abscesses
Intra-abdominal abscesses were found in 37 rats (62%) after 28 days and 27 
(44%) after 90 days (P = 0.049).The majority of abscesses were located at the 
caecum or abdominal wall. There was no significant difference between groups 
in intra-abdominal abscesses (P = 0.482).
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Figure 1. Comparison of mesh infection rates (combined 28 and 90 days). Values are percentage of 
macroscopically infected meshes among surviving animals.
Adhesions
After 28 and 90 days the surfaces of all infected meshes were completely covered 
with adhesions. Owing to the high infection rate in C-Qur® and Dualmesh® the 
median adhesion coverage was 90–100% (Figure 2). After 28 days significantly 
less adhesion to the mesh surface was found for Strattice® (median 10.0 (5.0–
10.0) %) and Sepramesh® (12.5 (6.3–22.5) %) compared with all other meshes 
(P ≤ 0.004 and P ≤ 0.017 respectively). Median adhesion coverage was 45.0% 
for Parietene Composite®, 52.5% for Parietene® and 55.0% for Omyramesh®. 
Sepramesh® showed an increase in adhesion formation from a median of 
12.5% at 28 days to 60.0% at 90 days (P = 0.010). After 90 days Strattice® (5.0 
(5.0–10.0) %) had significantly less adhesion coverage than the other meshes 
(P ≤ 0.003). At 90 days there was no significant difference between median 
adhesion coverage of Parietene Composite® (35.0%), Omyramesh® (42.5%), 
Sepramesh® (60.0%) and Parietene® (72.5%).
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Figure 2. Comparison of percentage of mesh adhesions at 28 and 90 days’ follow-up. Values are median 
(interquartile range).* At 28 days Strattice® had less adhesions compared to  Parietene®, Parietene 
Composite®, C-Qur®, Dualmesh® and Omyramesh® (P<0.050), and §C-Qur® and †Dualmesh® more 
adhesions compared to Parietene® and Omyramesh®(P<0.050). **At 90 days Strattice had less adhesions 
than all other meshes (P<0.050); §§C-Qur® more adhesions compared to  Parietene®, Parietene 
Composite®, Sepramesh® and Omyramesh® (P<0.050); # and ## Sepramesh® increase in adhesions from 
28 to 90 days (P<0.050, all Mann–Whitney U test).
Incorporation
After 28 and 90 days C-Qur® showed no or very little incorporation into the 
abdominal wall owing to the high rate of mesh infection (Figure 3). Strattice® 
showed a poor incorporation of 22.7% at 28 days, which was lower than for 
Omyramesh® (47.1%; P = 0.004), Parietene Composite® (42.5%; P = 0.004) 
and Sepramesh® (35.6%; P = 0.004). The incorporation of Strattice® was not 
improved after 90 days (median 13.4%). This was significantly worse than the 
incorporation of Parietene Composite® (54.5%; P = 0.003), Omyramesh® (50.4%; 
P < 0.001), Parietene® (48.4%; P = 0.009) and Sepramesh® (40.9%; P = 0.002). At 
90 days, Dualmesh® (29.4%) was incorporated more poorly than Parietene® (P = 
0.020), Parietene Composite® (P = 0.009) and Omyramesh® (P = 0.002).
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Figure 3. Mesh edge incorporation at 28 and 90 days’ follow-up. Values are median (interquartile range). 
*P < 0•050 versus Parietene Composite®, Sepramesh®, C-Qur® and Omyramesh® at 28 days; #P < 0•050 
versus Parietene®, Parietene Composite®, Sepramesh® and Omyramesh® at 28 days; §P < 0•050 versus 
Parietene Composite® and Omyramesh® at 28 days; **P < 0•050 versus Parietene®, Parietene Composite®, 
Sepramesh®, C-Qur® and Omyramesh® at 90 days; ##P < 0•050 versus all other meshes at 90 days; §§P < 
0•050 versusParietene®, Parietene Composite®, C-Qur® and Omyramesh® at 90 days (Mann–Whitney 
Utest).
Shrinkage
The shrinkage of C-Qur® could not be determined owing to the formation of 
large fibrotic pseudotumours in all but one of the meshes. The non-infected 
Dualmesh® showed the highest percentage loss of mesh surface, of 63% after 
90 days (P ≤ 0.012 compared with other meshes). All other meshes had a median 
loss of mesh surface of between 0 and 10% after 28 days. Strattice showed 
a progressive median loss of surface from 0% at 28 days to 23% at 90 days 
(P = 0.003). After 90 days the purely synthetic Dualmesh®, Omyramesh® and 
Parietene® showed shrinkage of between 0 and 15%. Parietene Composite® and 
Sepramesh® did not shrink after 90 days (P ≤ 0.026 and P ≤ 0.014 respectively 
compared with all other meshes).
Histology
Fibrosis was observed in all mesh-surrounding tissues. This was especially 
pronounced for the four polypropylene based meshes and Omyramesh® 
(Figure 4). Dualmesh® showed a clear encapsulation of the mesh, almost 
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without cellular infiltration into it. A large number of vessels could be seen in 
the tissue surrounding Parietene Composite® and Omyramesh®. Because of 
wide intra-animal variation, no statistically difference was found for fibrosis, 
influx of lymphocytes, angiogenesis and collagen deposition (data not shown).
Figure 4. Histological samples after 90 days: a,c,e,g,i haematoxylin and eosin staining and b,d,f,h,j 
picrosirius red staining of histological samples after 90 days (original magnification ×40). a,b 
Polypropylene (Parietene®; Sofradim, Trevoux, France; part of Covidien, North Haven, Connecticut, USA); 
c,d collagen–polyethyleneglycol–glycerol-coated polypropylene (Parietene Composite®; Sofradim); e,f 
carboxymethylcellulose–sodium hyaluronate-coated polypropylene (Sepramesh®; Bard, New 
Providence, New Jersey, USA); g,h expanded polytetrafluoroethylene (Dualmesh®; Gore, Flagstaff, 
Arizona, USA); i,j condensed polytetrafluoroethylene (Omyramesh®; B. Braun, Melsungen, Germany); 
and k,l non-cross-linked collagen mesh (Strattice®; LifeCell, Branchburg, New Jersey, USA). The purple 
and pink cells in the haematoxylin and eosin-stained sections are fibroblasts and lymphocytes. The 
synthetic fibres of the Parietene® (a,b), Parietene Composite® (c,d), Sepramesh® (e,f) and Omyramesh® (i,j) 
are surrounded with fibrotic tissue with newly formed collagen. Around Dualmesh® (g,h) a cellular layer 
is observed, forming a capsule; cellular infiltration into the mesh is minimal. In the picrosirius red-
stained section of the Strattice® mesh (l) it is impossible to differentiate between the collagen of the 
mesh and newly formed collagen (C/F). M, abdominal wall muscle; F, mesh fibres, C, newly formed 
collagen layer. 
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Discussion
In this experimental contaminated environment, the collagen-coated 
polypropylene mesh Parietene Composite® and the condensed PTFE 
Omyramesh® had a low risk of infection, moderate adhesion formation and 
good incorporation. The biological Strattice® mesh did not become infected 
and showed remarkably little adhesion formation, but poor incorporation. 
If a mesh is used in a contaminated environment, consensus exists that a 
biological collagen mesh or a synthetic macroporous, monofilament mesh may 
be advantageous(5, 16-18). Biological collagen meshes have been developed 
specifically for a contaminated environment and Strattice® did not show any 
mesh infection in this experiment. Biological meshes, particularly Strattice®, 
have shown improved clearance of bacteria, which decreases the possibility 
of infection and formation of adhesions(19). A prospective multicentre study 
of contaminated ventral hernia repair with Strattice® reported a similar low 
infection rate with little need to remove the mesh(20). 
The macroporous Parietene®, Parietene Composite®, Sepramesh® 
and Omyramesh® had a low risk of infection. Large pores allow admission of 
macrophages, fibroplasia and angiogenesis, which improves the ability to clear 
infection(5, 6). In this study, however, the macroporous C-Qur® mesh showed a 
high infection rate. This polypropylene mesh is coated with anti-inflammatory 
omega-3 fatty acids. In an experimental clean environment macrophages 
were scarcely present in the mesh after implantation(11, 21). It might be 
hypothesized that the anti-inflammatory properties of the omega-3 fatty 
acid coating have prevented macrophage penetration, although no clinical 
or experimental literature on the characteristics of omega-3 fatty acids in the 
presence of bacteria has yet been published. 
Dualmesh® showed a high infection rate, probably because of its partially 
microporous structure (smaller than 10 μm). The increased risk of infection 
after surgery with Dualmesh®, and the need to remove the prosthesis in case of 
infection, is notorious in the clinical situation(22-24). Mesh infection is caused 
by infiltration and proliferation of bacteria within the pores and interstices of 
synthetic materials. Small pores prevent infiltration of immune cells and make 
microporous meshes more susceptible to infection(5, 25).Additionally, the 
hydrophobic visceral surface of Dualmesh® decreases adhesion of tissue cells, 
allowing bacteria a free passage to the implant surface(16). 
Chapter 11
242
Intra-abdominal adhesion and abscess formation are important causes 
of morbidity and mortality following contaminated abdominal surgery. During 
peritonitis fibrin is deposited in the abdominal cavity, inducing adhesion 
formation and providing possible niduses for abscess formation(9). Biological 
Strattice® mesh showed low adhesion formation after 90 days, confirming 
previous experimental results(26-28). Sepramesh® showed a significant 
increase in adhesion formation between 28 and 90 days, implying that the 
cellulose–hyaluronate coating is absorbed before a neoperitoneal layer is 
formed. These results confirm that adhesion formation in the presence of mesh 
is not complete after 7 days(8, 11). The surface of Parietene Composite® and 
Omyramesh® were least covered with adhesions after 90 days. Low adhesion 
formation on the collagen-coated Parietene Composite® has been described in a 
clean environment(8, 11). The present results suggest that the collagen coating 
remains present until a neoperitoneum has formed, even in a contaminated 
environment. The low adhesion formation on Omyramesh® confirms 
experimental findings with this relatively new mesh in a clean environment(29, 
30). The low adhesion formation might be explained by its smooth, monolayer, 
non-fibrous, macroporous structure. The plain polypropylene Parietene® mesh 
was largely covered with adhesions. Clinically, uncoated polypropylene meshes 
are known to induce severe adhesion formation with attachment of intestine 
to the mesh when implanted intraperitoneally(7, 31). In 21 % of patients with 
an intraperitoneal uncoated polypropylene mesh, adhesions made bowel 
resection necessary during re-exploration in one study(7). 
The non-infected, partially microporous, expanded PTFE Dualmesh® had 
an alarmingly high shrinkage rate (median 63 % after 90 days). Such shrinkage 
has frequently been reported experimentally, but this does not seem to be 
correlated with a higher recurrence rate clinically(8, 23, 32). A fibrous capsule 
surrounding the mesh was observed, almost without cellular infiltration into 
the mesh. Contraction of this capsule was probably the cause of shrinkage, 
which might have been more pronounced in the small meshes used in the 
present experiment compared with the much larger meshes used clinically. 
Of the macroporous meshes, the plain polypropylene Parietene® showed the 
most shrinkage (15 % after 90 days), confirming experimental results(32, 33). 
The biological Strattice® mesh had a 23 % loss of surface after 90 
days, probably caused by collagenase activity. Premature weakening of 
the biomechanical properties of the scaffold combined with insufficient 
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incorporation can possibly result in loss of the prosthesis and hernia 
recurrence(34). Until evidence of biomechanical strength after hernia repair 
with biological meshes has been provided, synthetic meshes are preferred for 
primary repair.
Translation of experimental results to the clinical situation should 
be done with caution. However, the CLP model is suitable for studying the 
behaviour of synthetic and biological meshes experimentally in a contaminated 
environment. In this model, as in clinical infections, peritonitis arises from a 
complex interaction of the immune system with inflammatory, haemodynamic 
and biochemical alterations similar to human sepsis, with a consistent increase 
in cytokine levels(35-38). Another advantage of this experimental model is the 
use of rats of the same age and sex, and specified pathogen-free bacterial status. 
This minimizes biological and microbiological variability, and makes it suitable 
for comparing characteristics of different meshes in a similar contaminated 
environment(38). A limitation of the model is the size of the mesh and mesh 
pores in relation to the abdominal wall, which is different between rats and 
humans. This might lead to an overestimation of shrinkage. The meshes 
in this experiment were fixated with six sutures. In humans the number of 
fixation points in relation to the mesh size would be much higher. This might 
have influenced incorporation, as described in previous experimental mesh 
studies(8, 11). Finally, the concentration of the antiadhesive coatings and its 
systemic effects during breakdown in this model might be different from the 
human situation. 
The experimental results of synthetic mesh implantation in a 
contaminated environment make strict contraindication in humans 
questionable. Although there are no meshes without disadvantages, certain 
permanent synthetic meshes might be somewhat infection-resistant and 
therefore useful for permanent hernia repair in a contaminated environment. 
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Abstract
Background
The use of meshes for abdominal hernia surgery in a contaminated environment 
is compromised due to a high risk of complications. Little is known about 
differences in the foreign body reaction between materials in contaminated 
environments. Therefore we compared the presence of macrophages and 
their attractors after implantation of different meshes in a contaminated 
environment in vivo.
Methods
28 and 90 days after implantation, biopsies of the abdominal wall with 
implanted meshes (Parietene®, Parietene Composite®, C-Qur®, Sepramesh®, 
Dualmesh® and Omyramesh®) were harvested from a peritonitis rat model. 
Biopsies were analysed with immunohistochemistry for macrophage markers 
CD68, iNOS, and CD206, and for T-cells with CD3. Toluidine-staining was used 
for mast cells.
Results
More CD3- and CD68-positive cells were found in samples with meshes than 
in the control group without a mesh. After 90 days, Parietene Composite® and 
Sepramesh® were surrounded by more iNOS-positive cells than the control 
group. C-Qur® and Dualmesh® were surrounded by more CD206-positive cells 
than the control group at day 28. The M1/M2 ratio was low for all meshes.
Conclusions
Mesh-specific cellular responses are evident in a contaminated environment 
and therefore these data can help the surgeon to select suitable meshes for 
implantation.
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Introduction
Meshes are occasionally used in a clean-contaminated or even in a contaminated 
environment, like fascial defects after bowel resection, near stomas or after 
removal of an infected mesh. Generally spoken, in clinical application the risk 
of complications like infection of the mesh is higher in a contaminated field 
and therefore surgeons are hesitant to use meshes in these cases(1, 2). The 
extent of the inflammatory response of the body, also known as foreign body 
reaction, depends on the type and consistency of the mesh(3-5). 
Using an in vitro model, we have recently described mesh-dependent 
reactions of macrophages in a contaminated environment(6). Many 
researchers investigate the foreign body reaction in a sterile environment. 
After implantation, all types of meshes used for abdominal wall hernia surgery 
induce a foreign body reaction. After implantation of the mesh, inflammatory 
cells, starting with neutrophils and mast cells are attracted to the wound 
site(3). Mast cells attract macrophages to the wound site and the number and 
degranulation of mast cells is important for the extend of the foreign body 
reaction. After implantation of the mesh, inflammatory cells, starting with 
neutrophils and mast cells are attracted to the wound site(3). Mast cells attract 
macrophages to the wound site and the number and degranulation of mast 
cells is important for the extend of the foreign body reaction(3, 4, 7, 8). Besides 
mast cells, T-cells are also important attractors of macrophages(3, 4, 9). 
After being recruited, macrophages will dominate the wound site(3, 
5). Macrophage phenotypes can range between pro-inflammatory (M1) and 
repair/anti-inflammatory (M2). M1-macrophages produce pro-inflammatory 
factors such as interleukin (IL)-6, tumor necrosis factor (TNF)α and express 
inducible nitric oxide synthase (iNOS)(10). M2-macrophages produce anti-
inflammatory factors such as IL-1 receptor antagonist (IL-1RA), chemokines 
such as CCL18, and growth factors such as vascular endothelial growth factor 
(VEGF). M2-macrophages express among others the surface protein CD206, 
which is the mannose receptor important for recognition of pathogens(10). 
How the foreign body reaction in a contaminated environment will 
depend on the type of material is not yet completely understood. In a 
contaminated environment, macrophages are expected to change mainly into 
the M1-phenotype because the infection and presence of bacteria needs to 
be eliminated(11). M1-macrophages negatively influence incorporation of the 
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mesh, by producing matrix degrading enzymes and inhibitors of extracellular 
matrix(5). Van Putten et al.(12) found that the foreign body reaction against 
collagen discs is delayed in the presence of bacterial cell wall components. 
Whether the presence of bacterial components also delays the foreign body 
reaction against synthetic meshes is not known.
Using an in vitro model, we have confirmed mesh-dependent reactions 
of macrophages in a contaminated environment(6). Previously we studied the 
in vivo behavior of seven commercially available meshes (1 biological and 6 
synthetic meshes) in a contaminated environment in rats and found differences 
in mesh infection, adhesions and incorporation of the biomaterial(13). In this 
experiment polypropylene was used, a mesh often used in patients and also 
polypropylene based meshes with a hydrophilic collagen-coating, omega 
3-fatty acid-coating, and a hyaluronate-carboxymethylcellulose coating, which 
are described to have a lower complication rate in a clean environment(14). 
Expanded (microporous) and condensed (macroporous) expanded 
polytetrafluoroethylene (PTFE) meshes were also included. Expanded PTFE has 
a high infection risk due to the small micropores whereas condensed PTFE is 
believed to have a good outcome in a contaminated environment due to its 
macroporous structure(15, 16). 
In this study, the cellular immune responses to different synthetic 
meshes in a contaminated environment in vivo are compared in more detail. 
As macrophages are the key players in the foreign body reaction, the presence 
of T-cells and mast cells as macrophage attractors and the phenotypes of 
macrophages with immunohistochemistry are investigated. This knowledge 
can help the surgeon to choose the best materials to use in an environment 
with high risk of contamination.
Materials and methods
Contaminated model in vivo
The rat experiment protocol is according to the Animal Research: Reporting 
In Vivo (ARRIVE) guidelines and was approved by the Ethical Committee on 
Animal Experimentation of Erasmus University Rotterdam, the Netherlands 
(EMC 2075-105-10-03). We used samples of an earlier presented study in 
which in 144 (8 groups, 9 rats per group, two time points) male Wistar rats 
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(Harlan Laboratories, Boxmeer, the Netherlands) weighing 250-350 grams a 
contaminated environment was created by caecum ligation and puncture(13). 
Briefly, the caecum was ligated just distally to the ileocaecal valve maintaining 
the continuity of the bowel and punctured distally to the ligation with an 18-G 
needle leading to leakage of fecal fluids with bacteria into the abdominal cavity 
to induce peritonitis. After 24 hours the abdomen was re-opened and peritonitis 
was confirmed by microbiological culture, resulting in a contaminated wound. 
One of the following meshes (2.5 x 3 cm) was implanted intraperitoneally with 
6 transmuscular non-absorbable sutures (5/0 Ethilon, Johnson & Johnson: New 
Brunswick, New Jersey, United States): 
1. Parietene® (polypropylene (PP), Covidien- Sofradim Production, 
Trevoux, France)
2. Parietene Composite® (PP with an onesided absorbable, hydrophilic 
collagen-coating, Covidien- Sofradim Production, Trevoux, France)
3. C-Qur® (PP with omega 3-fatty acid-coating and triglycerides, Atrium, 
Hudson, New York, USA)
4. Sepramesh® (PP, with a hyaluronate-carboxymethylcellulose coating, 
Bard, New Providence New Jersey, USA)
5. Dualmesh® (expanded polytetrafluoroethylene (PTFE), Gore, Flagstaff, 
Arizona, USA)
6. Omyramesh® (condensed PTFE, B Braun, Melsungen, Germany)
7. Strattice® (collagen derived from porcine skin, LifeCell, Branchburg, 
New Jersey, USA)
A control group was included following completely the same protocol, only no 
mesh was implanted after re-opening the abdomen. After implantation, all rats 
received one dose of gentamicin (6 mg/kg) intramuscularly. Two to four rats 
per group died from sepsis(13). 
Harvesting
At 28 days and 90 days after implantation of the materials, the animals were 
euthanized by cardiac cut and a swab was taken to culture bacteria; C-Qur® 
resulted in 95% (15 out of 16) of the samples positive for bacteria, Dualmesh® 
50% (7 out of 15) and Parietene® and Parietene Composite® both 5% (1 out of 
15), in the other groups no infections were found. One biopsy per animal was 
taken from the incorporated mesh with surrounding tissue. In the rats without 
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a biomaterial a biopsy of the abdominal wall was taken at the same place where 
in the other rats the mesh was implanted. In some animals, incorporation of the 
material was insufficient and because there was no adjacent tissue, no biopsy 
could be taken. For Strattice® at both time points, Sepramesh® at day 28 and 
C-Qur® and Omyramesh® at day 90 only 1 or 2 samples could be taken because 
of insufficient incorporation and therefore these conditions were excluded for 
analysis. Biopsies were snap-frozen in Tissue-Tekc (Sakura, Alphen, Rijn, The 
Netherlands) with liquid nitrogen and stored at -80oC till sectioning. Sections 
of 6 μm were cut on a cryostat (Leica; Davis Instruments, Vernon Hills, Illinois, 
USA) and stored at -80oC.
Staining
Immunohistochemistry
Frozen sections were defrosted and fixed in acetone. After fixation sections 
were washed in PBS and incubated with 10% normal goat serum (Sigma-
Aldrich, St Louis, MO, USA) to block non-specific binding. After incubation 
sections were washed with phosphate buffered saline and incubated with 
primary antibodies against CD206 (2.5 μg/mL, Abcam, 64693, Cambridge, UK), 
iNOS (2 μg/mL, Abcam, 15323), CD3 (1:100, Abcam, 16669), CD68 (5 ug/ml, Acris 
Antibodies GmbH, BM 4000, Herford, Germany). We choose the antibiodies 
based on literature(4, 10, 17). Irrelevant IgG was used as a negative control. 
Link biotinylated goat-anti-mouse (Biogenex, HK-325-UM, Fremont, CA, USA) 
was used at a second antibody, Label streptavidin-AP (Biogenex, HK-321-UK) as 
a tertiary antibody with neufuchsin as substrate. Sections were counterstained 
with hematoxylin (Sigma). Lung and spleen tissue were used as a positive 
controls. Sections were mounted with vectamount (Vector Laboratories, 
Burlingame, CA).
Toluidine blue (mast cells)
Sections were defrosted and fixated in acetone. After washing in demineralised 
water the sections were placed in a toluidine blue solution (1% Toluidin blue 
(Fluka (Sigma), 89640) in 50% isopropanol and 50% demineralised water) for 
30 minutes at 37°C. Sections were washed for 1 minute in pure isopropanol. 
Sections were air-dried and mounted with vectamount (Vector Laboratories).
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Analyses
Stained sections were analysed by light microscopy (Olympus, Tokyo, Japan). 
Per staining, sections were blinded and the number of cells in 5 areas at the 
interface of the mesh and tissue was ranked. In the case of the control group, 
cells were counted subcutaneously, at the place where in the other groups the 
mesh was implanted. Samples were ranked based on the number of positive 
cells, ranks were ranging from 1 to 58 (due to a total of 58 analysed samples). 
Control group day 28: 8 samples, day 90: 7 samples. Parietene® 8 and 5 samples 
respectively, Parietene Composite® 5 and 4 samples, C-Qur® day 28: 5 samples, 
Sepramesh® day 90: 4 samples, Dualmesh® day 28: 3 samples, day 90: 4 samples, 
Omyramesh® day 28: 5 samples. Ranking was performed by two independent 
observers (NG and NK). The ranking of one observer was compared with the 
ranking of the other observer. If there was a difference in ranking per sample of 
more than 15, the samples were analysed again. After that, the mean ranking 
per sample was calculated from the ranking of one observer and the other 
observer. Then the samples were unblinded and were used for further analysis. 
The number of iNOS-positive cells was divided by the number of CD206-
positive cells leading to an M1/M2 ratio. The natural logarithm of this ratio was 
calculated for visualisation. Data is presented as box plots with medians and 
whiskers showing the interquartile range.
Statistics
The medians of the groups were compared with a Kruskal-Wallis test 
(independent samples median test) and Mann-Whitney in SPSS (IBM Corp. 
Released 2011. IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM 
Corp.) False Discovery Rate was used for mathematical correction by multiple 
comparisons. p<0.05 was considered statistically significant.
Results
The number of mast cells and T-cells were analysed in the tissue adjacent to 
the meshes, since these two cells are the main attractors of macrophages. We 
found no significant differences in the numbers of mast cells between the 
biomaterials or compared to the control group (Figure 1a). 
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Figure 1. A) Analysis of the presence of mast cells at day 28 and day 90 after implantation of a mesh. 
Graphs show the mean rank per type of mesh, numbers behind the groups indicate sample size. An 
example of the toluidine staining is shown in which positive cells are indicated by arrows. M indicates 
mesh. B) Analysis of the presence of T-cells with antibodies against CD3 after 28 and 90 days. An example 
of the CD3 staining is shown in which positive cells are indicated by arrows. M indicates mesh. Graphs 
show the mean rank per type of mesh, p-values are indicated in the graphs, numbers behind the groups 
indicate sample size.
All meshes had more CD3-positive T-cells at day 28 than the control group 
(p= or < 0.03). There were also mesh-dependent differences: Parietene® was 
surrounded by less CD3- positive cells than Dualmesh® (p=0.03) and Parietene 
Composite® was surrounded by less CD3-positive cells than Omyramesh® 
(p=0.03). After 90 days still all samples with meshes contained more CD3-
positive cells than the control group (p=0.03) (Figure1b). To investigate the 
total number of attracted macrophages, samples were stained for CD68 as a 
general macrophage marker. After 28 days more macrophages were found 
adjacent in the groups with a mesh than in the control group (p= or < 0.015). 
The same finding was still observed after 90 days, but this was only statistically 
significant for Sepramesh® (p=0.02) and Dualmesh® (p=0.02) (Figure 2). 
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Figure 2. Analysis and ranking for the presence of CD68-positive macrophages 28 and 90 days after 
implantation of a mesh. An example of CD68-positive cells is shown in which positive cells are indicated 
by arrows. M indicates mesh. Graphs show the mean rank per type of mesh, p-values are indicated in the 
graphs, numbers behind the groups indicate sample size.
To investigate how the different meshes influence the macrophage 
phenotype, we stained the samples with antibodies against iNOS for M1-
macrophages and with antibodies against CD206 for M2-macrophages. At day 
28 we did not find significant differences between the conditions, however 
after 90 days, Parietene Composite® and Sepramesh® were surrounded by 
significantly more iNOS-positive cells than the control group (p=0.03). There 
were no statistically significant differences between the meshes (Figure 3a). 
After 28 days we found more CD206-positive cells surrounding C-Qur® and 
Dualmesh® than in the control group (p=0.045). After 90 days, no significant 
differences were observed (Figure 3b). To determine for each mesh whether 
it induces a more pro- or antiinflammatory reaction the M1/M2 ratio was 
calculated based on iNOS positive and CD206-positive cells (Fig.3c). All meshes 
except Parietene Composite® after 90 days, had a negative mean ratio, indicative 
for a predominant M2, or anti-inflammatory, reaction. However no statistically 
significant differences in M1/M2 ratios were observed between the meshes.
Chapter 12
256
Figure 3. A) Analysis and ranking for the presence of iNOS-positive M1 macrophages 28 and 90 days 
after implantation of a mesh. An example of iNOS-positive cells is shown in which positive cells are 
indicated by arrows. M indicates mesh. Graphs show the mean rank per type of mesh, p-values are 
indicated in the graphs, numbers behind the groups indicate sample size. B) Analysis and ranking for 
the presence of CD206-positive macrophages 28 and 90 days after implantation of a mesh. An example 
of CD206-positive cells is shown in which positive cells are indicated by arrows. M indicates mesh. 
Graphs show the mean rank per type of mesh, p-values are indicated in the graphs, numbers behind the 
groups indicate sample size. C) The M1/M2 ratio based on the number of iNOS- positive cells divided by 
the CD206-positive cells, the natural logarithm of this ratio was calculated for visualisation. p-values are 
indicated in the graph, numbers behind the groups indicate sample size.
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Discussion
Surgeons often hesitate to use biomaterials in a contaminated environment, 
like fascial defects after bowel resection, near stomas or after removal of an 
infected mesh. Nowadays, most used biomaterials in this environment are 
biologic materials, which are very expensive compared to synthetic biomaterials. 
However, a critical review describes that there is not enough evidence to state 
that biologic biomaterials perform better than synthetic biomaterials(1). 
Therefore a close look to synthetic biomaterials in a contaminated environment 
is needed. Little is known about the mesh-specific phenotypes and presence 
of macrophages after implantation of a mesh in a contaminated environment. 
In this study, different meshes were implanted in a rat model in a 
contaminated environment. The attractors of macrophages, namely T-cells and 
mast cells, and the different phenotypes of macrophages were analyzed. In these 
experiments mesh-specific cellular responses were seen. All meshes induced 
the influx of T-cells and macrophages, still present after 90 days compared 
with the control group without a mesh. High levels of T-cells and macrophages 
indicate a chronic inflammatory reaction when meshes were implanted in a 
contaminated environment(3, 4). Both PTFE-meshes were surrounded by the 
most T-cells whereas the polypropylene biomaterials Parietene® and Parietene 
Composite® had the lowest number of T-cells. The latter is indicative for 
resolution of the inflammatory reaction, possibly leading to a fibrotic reaction 
for Parietene® which is often seen in vivo. This macroscopically represents 
in a firm incorporation and shrinking of this mesh suggesting fibrosis(3, 13, 
18, 19). Parietene Composite® performed well macroscopically with a low 
amount of adhesions and a low percentage of infection in a contaminated 
environment(13), most likely due to the collagen layer which is known to 
reduce adhesions(14). 
We found high numbers of CD206-positive and iNOS-positive 
macrophages around C-Qur®-and Dualmesh®-samples after 28 days, indicative 
for a chronic inflammation reaction. Indeed macroscopically these meshes had 
the highest infection rate and a bad incorporation in the abdominal wall(13). 
This might be explained by the presence of endotoxins released by bacteria 
during the infection, which are known to delay the foreign body reaction(12). 
Dualmesh® is a partially microporous mesh with a higher risk of infection than 
PP and polyethylene(15, 20). This can be explained by the small pore size 
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allowing bacteria to infiltrate when macrophages cannot(21). Also small pores 
induce a M1 pro-inflammatory reaction, known to induce tissue turnover and 
thereby negatively influencing incorporation of meshes in the abdominal 
wall(5, 22). This was macroscopically confirmed(13). Higher numbers of M2 
macrophages are associated with a better outcome in wound healing than 
with a predominant M1-reaction(17, 23). We found high levels of CD206(M2)-
positive cells around Parietene Composite® and Sepramesh® which are meshes 
known for a good biocompatibility in vivo with low adhesion formation(14). 
C-Qur® is coated with triglycerides and Omega 3-fatty acids. 
Cardiovascular research showed that triglycerides can enhance an 
inflammatory response in endothelial cells. Whether this is also the case in 
the foreign body reaction is not investigated, however this can be a possible 
explanation for the found chronic inflammation reaction(24). We expected 
more distinguished differences between the meshes regarding the M1/M2 
ratio, however macrophages are a heterogeneous population of cells, M1 
and M2 being two extremes in the spectrum(25, 26). Subtle differences in 
this ratio might have been missed. Due to poor incorporation of some of the 
meshes we did not have equal group sizes leading to a lower probability of 
finding significant differences. Sepramesh® at day 28, C-Qur® and Omyramesh® 
at day 90, and Strattice® at both time points had a very low sample size due 
to no ingrowth in the surrounding tissues which made it impossible to draw 
conclusions. Therefore these meshes for these time points were not included 
in our analysis. No differences were found for mast cells. This is likely due to the 
time point of analysis for we did our first analysis 28 days after implantation. 
The amount and presence of mast cells is indicative for an acute inflammatory 
reaction(7, 27) and therefore differences could not be detected in these 
experiments. Future studies with increased sample numbers and time points 
are needed to obtain more insight in the precise foreign body reaction and 
thereby the different performances of meshes in a contaminated environment. 
For surgery in an environment at risk of contamination, the choice of a 
specific mesh is important. More insight in mesh-dependent cellular immune 
responses can help surgeons choose between the various commercially 
available meshes for implantation in a contaminated environment.
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Abstract
Background
Macrophages play an important role in the reaction to biomaterials, which 
sometimes have to be used in a surgical field at risk of contamination. The 
macrophage phenotype in reaction to
biomaterials in an inflammatory environment was evaluated in both an in vivo 
and in vitro setting.
Methods
In the in vivo setting, polypropylene (PP) biomaterial was implanted for 28 
days in the contaminated abdominal wall of rats, and upon removal analysed 
by routine histology as well as immunohistochemistry for CD68 (marker 
for macrophages), inducible nitric oxide synthase (iNOS – a marker for 
proinflammatory M1 macrophages) and CD206 (marker for anti-inflammatory 
M2 macrophages). For the in vitro model, human peripheral blood monocytes 
were cultured for 3 days on biomaterials made from PP, collagen (COL), 
polyethylene terephthalate (PET) and PET coated with collagen (PET+COL). 
These experiments were performed both with and without lipopolysaccharide 
and interferon γ stimulation. Secretion of both M1- and M2-related proteins 
was measured, and a relative M1/M2 index was calculated.
Results
In vivo, iNOS- and CD206-positive cells were found around the fibers of 
the implanted PP biomaterial. In vitro, macrophages on both PP and COL 
biomaterial had a relatively low M1/M2 index. Macrophages on the PET 
biomaterial had a high M1/M2 index, with the highest increase ofM1 cytokines 
in an inflammatory environment. Macrophages on the PET+COL biomaterial 
also had a high M1/M2 index.
Conclusion
Macrophages in an inflammatory environment in vitro still react in a 
biomaterial-dependent manner. This model can help to select biomaterials 
that are tolerated best in a surgical environment at risk of contamination.
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Introduction
Biomaterials are used widely in reparative and regenerative medicine. However, 
in an environment at risk of contamination, surgeons are reluctant to use 
biomaterials owing to a higher risk of complications. A feared postoperative 
complication of biomaterial implantation is infection of the biomaterial and 
surrounding tissue by bacteria, reported in up to 16 per cent of patients(1). The 
risk of infection is even higher in some circumstances, such as in surgery of the 
gastrointestinal tract or nasal cavity, as well as in the presence of peritonitis. 
The risk of infection also depends on the type of biomaterial, such as its 
configuration, hydrophobicity and whether it is made from monofilament or 
multifilament(1-3). All biomaterials elicit a foreign body reaction, and the degree 
of this reaction varies depending on the nature of the biomaterials. At present, 
the foreign body reaction in an environment with a high risk of contamination 
is not well characterized.
Macrophages play a pivotal role in the foreign body reaction(1, 4, 5). The 
phenotype of the macrophages can change in response to environmental 
factors, giving rise to different populations of macrophages with distinct 
functions, which can force the foreign body reaction into tolerance of the 
biomaterial or into a state of inflammation. Classically activated macrophages, 
or M1 macrophages, have been characterized and desribed most thoroughly. 
They propagate proinflammatory responses by producing cytokines such 
as interleukin (IL) 1b, tumour necrosis factor (TNF) a and IL-6(6-8). Another 
macrophage phenotype is represented by the alternatively activated 
macrophages, referred to as M2 macrophages. These cells can arise when 
exposed to IL-4 or immune complexes. They express scavenger receptors and 
IL-1 receptor antagonist (IL-1RA). M2 macrophages also produce IL-10 and 
chemokines, such as CCL18 and macrophage-derived chemokine (MDC, or 
CCL22)(6-8), and are able to produce growth factors, thus promoting angiogenesis 
and tissue repair(6). During wound healing, M1 macrophages are normally 
present from day 1, and accumulate and dominate the wound site after 2–3 
days. After cleaning the wound site by phagocytosis, macrophages change 
towards an M2 phenotype. Persistent inflammation can cause an imbalance of 
M1 to M2 macrophages and lead to fibrosis. Synthetic biomaterials can induce 
the formation of fibrous wound healing tissue within 2–4 weeks. Macrophages 
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cannot phagocytose this synthetic biomaterial, leading to the formation of 
giant cells situated at the biomaterial surface10.
In a contaminated environment macrophages adapt to an M1 
phenotype(9), needed for control of the acute infection by phagocytosis. 
However, prolonged M1 phenotype of macrophages can lead to tissue damage, 
and may compromise the integration of the material in the body by the release 
of inflammatory cytokines(10). Therefore, the foreign body reaction is altered 
in a contaminated environment.
New biomaterials should be developed for use in an environment where 
the risk of contamination of the biomaterial is high. Biological materials, such 
as collagen-based biomaterials processed from human or porcine dermis, 
are thought to be tolerated in an environment at high risk of contamination 
and have a low postoperative complication rate(11, 12). Biomaterials with low 
actual surface area, such as monofilament biomaterials, were well tolerated in 
a contaminated field in an experimental study2, and in several clinical studies 
have been associated with fewer postoperative infections(13, 14). However, 
there is no consensus yet, and only a few comparative studies13,14 are available. 
In a recent study15 employing an experimental rat model, the foreign body 
reaction in rats was biomaterial-dependent in a contaminated environment. 
Some biomaterials had poor incorporation into the abdominal wall with a 
high infection rate, whereas others, such as monofilament polypropylene 
biomaterials, had good incorporation into the abdominal wall and a low 
inflammatory reaction(15).
The aim of this study was to investigate the reaction of macrophages to 
biomaterials in an environment at risk of contamination. First, the phenotype 
of macrophages surrounding a monofilament polypropylene biomaterial was 
analysed in vivo, as this material has been shown previously to induce the 
mildest foreign body reaction(15). Second, the macrophage phenotype and 
reaction were characterized in more detail in an in vitro model. In this model 
bacterial contamination was simulated, thereby permitting comparison 
of the macrophage reaction in a contaminated and a clean environment. 
Contamination was simulated using a combination of lipopolysaccharide (LPS) 
and interferon (IFN) γ, and the macrophage reaction was studied by measuring 
a panel of proteins indicative of the macrophage phenotype.
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Methods
Rat peritonitis model and tissue collection
The protocol of the rat experiment was approved by the Ethical Committee 
on Animal Experimentation of Erasmus University Rotterdam, The Netherlands, 
and is in accordance with the Animal Research: Reporting In Vivo Experiments 
(ARRIVE) guidelines. A contaminated environment was created by the caecal 
ligature puncture model, in which the caecum is punctured to provide leakage 
of faecal fluid into the abdominal cavity, thus causing peritonitis. After 24 h the 
abdominal cavity was re-opened, peritonitis was confirmed by microbiological 
culture, and a monofilament polypropylene (PP) biomaterial (Parietene™; 
Covidien – Sofradim Production, Trévoux, France) was placed intraperitoneally 
in four rats(15). Some 28 days after implantation, a sample of the abdominal 
wall with the incorporated biomaterial was harvested using biopsy punches 
(5 mm diameter). As controls, abdominal walls from rats with peritonitis, but 
with no biomaterial, were collected. All tissue samples were fixed in 4 per cent 
formalin and embedded in paraffin.
Histology and immunohistochemistry
Tissue sections were cut and stained with haematoxylin and eosin in accordance 
with standard procedures. To identify macrophage types, immunohistochemical 
staining with the following antibodies were used; CD68, a general macrophage 
marker; CD206, a marker for M2 macrophages(8), and inducible nitric oxide 
synthase (iNOS) as a marker for M1 macrophages(10). Briefly, paraffin sections 
were dewaxed and, to block the sections for aspecific binding, the sections 
were pretreated with heat-mediated antigen retrieval solution (Target 
Retrieval Solution; Dako, Glostrup, Denmark) at 90°C for 20 min. Sections were 
incubated with CD68 (1 : 100; Acris, Herford, Germany), CD206 (1 : 100) or iNOS 
(1 : 50) (both Abcam, Cambridge, UK) for 60 min, and subsequently incubated 
with link and label (Concentrated MultiLink® and Concentrated HRP Label 
(peroxidase-conjugated streptavidin); BioGenex, Fremont, California, USA); 
3,3′-diaminobenzidine was used as substrate. Sections were dried overnight 
and mounted with VectaMount™ (Vector Laboratories, Burlingame, California, 
USA). Matching irrelevant isotype antibodies were used as negative controls, 
and tissues known to contain the specific markers were employed as positive 
controls. Sections were also Gram-stained to visualize potential bacteria. All 
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slides were analysed with an Olympus BX50 light microscope (Olympus, Tokyo, 
Japan).
Monocyte isolation
Ficoll density gradient (Ficoll-Paque™ PLUS; GE Healthcare, St Giles, UK) was used 
to isolate monocytes from the buffy coat of four healthy donors (men and women 
aged 25–65 years). All buffy coats were obtained from the blood bank (Sanquin, 
Rotterdam, The Netherlands). Some 30 ml of 1 : 5 diluted buffy coat with 0.1 
per cent bovine serum albumin (BSA) in phosphate-buffered saline (PBS) was 
layered on 15 ml Ficoll. After 15 min centrifugation at 1000g with no brake, the 
interphase band containing peripheral blood mononuclear cells was aspirated 
and washed in PBS/BSA 0.5 per cent 2 mmol/l EDTA and labelled with 100 μl anti-
CD14+ magnetic beads (CD14 microbeads human, MACS Separation columns 
LS and MidiMACS™ Separator; all from Miltenyi Biotec, Bergisch Gladbach, 
Germany), and isolated according to the manufacturer’s guidelines. This positive 
selection of monocytes will not activate the cells(16). Purity of the isolation was 
assessed by fluorescence-activated cell sorting (FACS) analysis, in which 1 × 106 
monocytes were incubated for 15 min at room temperature with the following 
antibodies: FITC-conjugated CD14 and peridinin chlorophyll protein complex 
(PerCP)-conjugated CD45 (all BD Biosciences, Franklin Lakes, New Jersey, USA). 
After incubation, cells were washed in PBS/BSA 0.1 per cent and FACS analysis 
was performed with CellQuest™ Pro on a FACSCalibur™ (both BD Biosciences); 
the purity of the freshly isolated CD14+ monocytes was above 95 per cent (data 
not shown). In the case of donors 1, 2 and 4, the yield of monocytes was not 
sufficient to allow for testing of all four biomaterials in the experiments.
Culturing macrophages on biomaterials
Four different biomaterials were chosen to study macrophage response 
in relation to the biomaterial (all from Covidien – Sofradim Production): a 
multifilament PP biomaterial (Parietene™), hydrophobic with a contact angle 
of 95°; a collagen-based material (COL) (Permacol™), processed from porcine 
skin and cross-linked with hexamethylene di-isocyanate; a multifilament 
polyethylene terephthalate (PET) biomaterial, hydrophilic with a contact angle 
of 80.9°; and a multifilament PET biomaterial with an absorbable, continuous 
and hydrophilic collagen film on one of its sides (PET+COL) (Parietex™ 
Composite). The PET and PP biomaterials have a similar weave (Figure 1).
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Figure 1. Detailed picture of wave pattern of polypropylene (A) and polyethylene terephthalate 
multifilaments (B)
The materials were cut into 1.5 × 1.5-cm pieces with a sterile scalpel. Before cell 
seeding, materials were incubated in 100 per cent non-heat-inactivated fetal 
calf serum (FCS) (Lonza, Verviers, Belgium) for 2 h to provide protein attachment. 
Freshly isolated monocytes were adjusted to a concentration of 0.7 × 106 cells/
ml in a total volume of 25 ml in a 50-ml PP tube (Falcon™; Becton, Dickinson, 
Franklin Lakes, New Jersey, USA). Twelve samples were incubated per 25 ml for 
2 h at 37°C. Subsequently, samples were placed in a 24-well non-adherent plate 
(NUNC™, non-treated multiplate; Thermo Scientific, Rochester, New York, USA) 
and cultured for 3 days in serum-free X-VIVO™ 15 medium with 20 per cent 
FCS (Lonza). To simulate an inflammatory environment caused by bacterial 
infection, macrophages on biomaterials were cultured with 10 ng/ml LPS 
(Sigma-Aldrich, St Louis, Missouri, USA) and 1 ng/ml recombinant human IFN-γ 
(PeproTech, Rocky Hill, New Jersey, USA), and compared with macrophages on 
the same materials without simulation. The medium was refreshed after 48 h 
of culturing, and after a further 24 h in culture the supernatant was harvested 
for protein analysis.
Analysis of the production of inflammatory and anti-inflammatory cytokines
Proteins were measured in 25 μl cell culture supernatant using a multiplex 
system (Millipore, Billerica, Massachusetts, USA)(17). IL-1β, IL-6, TNF-α, monocyte 
chemotactic protein (MCP) 3 and macrophage inflammatory protein (MIP) 
1α, IL-1RA, RANTES (regulated on activation, normal T cell expressed and 
secreted, or CCL5), and macrophage-derived chemokine (MDC, or CCL22) were 
measured according to manufacturer recommendations. The CCL18 DuoSet® 
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ELISA (R&D Systems, Minneapolis, Minnesota, USA) was used to analyse CCL18 
in 100 μl cell culture supernatant according to the manufacturer’s instructions. 
These nine proteins were selected based on previous experiments, where the 
read-out parameters were chosen after stimulation of macrophages towards 
either the M1 or M2 phenotype16. To correct for the numbers of macrophages 
on the different biomaterials, the cells were lysed in 0.1 per cent Triton in PBS 
(Sigma-Aldrich) and samples were frozen at −80°C before being analysed with 
CyQUANT® cell proliferation assay kit (Invitrogen, Carlsbad, California, USA). 
DNA content was measured according to the manufacturer’s recommendation.
Statistical analysis
The in vitro experiments were performed in triplicate with four different 
monocyte donors. All data are presented as scatterdot plots, with each dot 
representing an individual sample. The mean of the four donors is indicated by a 
line in the graphs. When evaluating the effect of an inflammatory environment, 
the data are presented as the ratio of the LPS/IFN-γ-stimulated condition 
versus the non-stimulated condition for each biomaterial. To calculate the 
ratio between LPS/IFN-γ-stimulated samples and non-stimulated samples, the 
stimulated samples were divided by the mean of the non-stimulated samples 
per donor. To compare the effect of the four biomaterials on the macrophage 
phenotype in an inflammatory environment, a relative M1/M2 index for each 
material was determined by calculating for each cytokine the percentage of 
production relative to the mean production on the four materials. This was 
followed by taking the mean of the percentages of the M1 cytokines (MIP-1α, 
TNF-α, MCP-3, IL-1β, IL-6) divided by the mean percentages of the M2 cytokines 
(MDC, RANTES, IL-1RA and CCL18) per sample. Groups were compared in SPSS® 
for Windows® version 20.0 (IBM, Armonk, New York, USA) using the Kruskal–
Wallis test (independent samples median test) and Mann–Whitney U test, 
because the data were not normally distributed. Correlation between proteins 
was analysed by Spearman correlation. The Bonferroni correction was used. 
Differences were considered statistically significant when P < 0.050.
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Results
Macrophage phenotype in vivo
The PP biomaterial was well integrated in the surrounding tissues 28 days after 
implantation into the contaminated abdominal wall of rats. On histological 
examination, all samples displayed dense tissue surrounding the fibres of 
the biomaterial, with many multinucleated CD206-positive giant cells. iNOS 
and CD206-positive cells were also observed in this dense layer. In addition, 
many blood vessels were observed in the connective tissue surrounding the 
biomaterial (Figure 2).
To investigate the influence of a biomaterial, samples of abdominal wall 
tissue from control rats with contamination but without implanted biomaterial 
were also stained with haematoxylin and eosin, CD68, CD206 and iNOS at 
28 days. These samples had no infiltration of lymphocytes and only a few 
macrophages, some of which were iNOS- or CD206-positive (Figure 2).
Biomaterial-dependent effect on macrophage phenotype in an in 
vitro model
LPS and IFN-γ were chosen to simulate bacterial infection in the in vitro model. 
LPS is a bacterial wall fragment and IFN-γ is known to activate the immune 
system and macrophages following bacterial infection22. To investigate 
how macrophages react on biomaterials in this simulated inflammatory 
environment in vitro, production of IL-1β, IL-6, TNF-α, MCP-3, MIP-1α, IL-1RA, 
RANTES, MDC and CCL18 was measured. The production of these proteins in 
an inflammatory environment was compared with that in a non-stimulated 
environment. Although the inflammatory environment increased the 
production of most proinflammatory proteins by macrophages, there were 
still differences in relation to the tested biomaterials (Figure 3). Macrophages 
on PET biomaterial induced the biggest increase in proinflammatory proteins. 
The stimulated versus non-stimulated ratio for anti-inflammatory proteins was 
approximately   1, indicating no increase in the production of these proteins 
in an inflammatory environment, except for RANTES, which was produced 
in greater amounts by macrophages on PET biomaterial in an inflammatory 
environment (Figure 4).
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Figure 2. a,d Haematoxylin and eosin (CD68 shown in inset), b,e inducible nitric oxide synthase (iNOS) 
and c,f CD206 staining 28 days after implantation of polypropylene (PP) in a contaminated environment 
in the rat. CD68-, iNOS- and CD206-positive macrophages can be seen surrounding the PP fibres. a–c PP 
biomaterial from a contaminated abdominal wall. d–f Abdominal wall without biomaterial from the 
same model. Representative sections and samples are shown. Brown colour represents positive staining; 
arrows indicate positive cells. GC, giant cell; V, vessels. (Original magnification ×200).
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Figure 3. Production of proinflammatory cytokines by macrophages seeded on different biomaterials in 
an inflammatory (as induced by lipopolysaccharide/interferon γ) compared with a non-stimulated 
environment after 3 days of culture. a Tumour necrosis factor (TNF) α, b interleukin (IL) 1β, c monocyte 
chemotactic protein (MCP) 3; d IL-6, e macrophage inflammatory protein (MIP) 1α. The dotted line 
indicates the basal level of expression, where there is no difference between stimulated and non-
stimulated environments, and the bars denote the mean value. Monocytes from a total of four donors 
were divided over the different biomaterials in triplicate samples. Cells from all donors could not be 
tested on every biomaterial owing to a low yield of monocytes. Protein production was corrected for 
DNA before comparison of stimulated and non-stimulated environments. PET+COL, polyethylene 
terephthalate with a collagen coating; COL, collagen; PET, polyethylene terephthalate; PP, polypropylene. 
*P < 0•001, †P < 0•050 (Kruskal–Wallis and Mann–Whitney U tests), indicating a significant increase in 
proinflammatory cytokines compared with baseline values.
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Figure 4. Production of anti-inflammatory cytokines by macrophages seeded on different biomaterials 
in an inflammatory environment (as induced by lipopolysaccharide/interferon γ) compared with a non-
stimulated environment after 3 days of culture. a CCL18, b interleukin 1 receptor antagonist (IL-1RA), c 
RANTES (regulated on activation, normal T cell expressed and secreted), d macrophage-derived 
chemokine (MDC). The dotted line indicates the basal level of expression, where there is no difference 
between stimulated and non-stimulated environments, and the bars denote the mean value. Monocytes 
from a total of four donors were divided over the different biomaterials in triplicate samples. Cells from 
all donors could not be tested on every biomaterial owing to a low yield of monocytes. Protein 
production was corrected for DNA before comparison of stimulated and non-stimulated environments. 
PET+COL, polyethylene terephthalate with a collagen coating; COL, collagen; PET, polyethylene 
terephthalate; PP, polypropylene. *P < 0•050 (Kruskal–Wallis and Mann–Whitney U tests), indicating a 
significant increase in anti-inflammatory cytokines compared with baseline values
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Figure 5. Comparison of secretion of proinflammatory cytokines by macrophages seeded on different 
biomaterials on the third day of culture with lipopolysaccharide/interferon γ, corrected for DNA. a 
Tumour necrosis factor (TNF) α, b interleukin (IL) 1β, c monocyte chemotactic protein (MCP) 3; d IL-6, e 
macrophage inflammatory protein (MIP) 1α. Monocytes from a total of four donors were divided over 
the different biomaterials in triplicate samples. Cells from all donors could not be tested on every 
biomaterial owing to a low yield of monocytes. PET+COL, polyethylene terephthalate with a collagen 
coating; COL, collagen; PET, polyethylene terephthalate; PP, polypropylene. a *P < 0•001 (PET+COL 
versus COL), †P < 0•050 (PET+COL versus PET), ‡P < 0.050 (COL versus PP); b †P < 0•050 (PET+COL versus 
COL and PET), ‡P < 0•050 (COL versus PET and PP); c *P < 0•001 (COL versus PET+COL and PET), †P < 0•050 
(COL versus PP); d †P < 0•050 (COL versus PET and PP); e *P < 0•001 (COL versus PET+COL and PP) (Kruskal–
Wallis and Mann–Whitney U tests)
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To compare the reaction of macrophages on the four different biomaterials in 
an inflammatory environment, the total amount of protein corrected for DNA is 
shown (Figure 5). The greatest induction of proinflammatory cytokines TNF-α, 
IL-1β, MCP-3 and MIP-1α was induced by macrophages on PET+COL biomaterial 
in the inflammatory environment. The lowest induction of proinflammatory 
and anti-inflammatory cytokine production was seen on the COL biomaterial 
(Figure 5). Macrophages on PP biomaterial produced significantly more CCL18 
and MDC than macrophages on other biomaterials, with the exception of 
MDC on PET+COL biomaterial. Macrophages on PET+COL biomaterial induced 
a significantly higher RANTES production compared with macrophages on 
COL (Figure 6). Macrophages on PP and COL biomaterial had the lowest M1/
M2 index, whereas macrophages on PET and PET+COL biomaterials had the 
highest M1/M2 index in the inflammatory environment (Figure 6).
Taking all the samples together, after correction for multiple testing, 
significant correlations with P < 0.050 were found between MCP-3 and MDC (r
s
 
= 0.80), IL-6 and IL-1β (r
s
 = 0.59), MIP-1α and MCP-3 (r
s
 = 0.64), MIP-1α and IL-1β 
(r
s
 = 0.60), TNF-α and IL-1β (r
s
 = 0.59), and MIP-1α and RANTES (r
s
 = 0.72).
Figure 6. Comparison of secretion of anti-inflammatory cytokines by macrophages seeded on different 
biomaterials at the third day of culture with lipopolysaccharide/interferon γ, corrected for DNA. a CCL18, 
b interleukin 1 receptor antagonist (IL-1RA), c RANTES (regulated on activation, normal T cell expressed 
and secreted), d macrophage-derived chemokine (MDC); e M1/M2 macrophage index. Monocytes from 
a total of four donors were divided over the different biomaterials in triplicate samples. Cells from all 
donors could not be tested on every biomaterial owing to a low yield of monocytes. The M1/M2 index 
for each sample was calculated as the percentage of the mean for each cytokine. The mean of M1 
cytokines (macrophage inflammatory protein 1α, tumour necrosis factor α, monocyte chemotactic 
protein 3, interleukin (IL) 1β, IL-6) was divided by the mean of M2 cytokines (MDC, RANTES, IL-1RA and 
CCL18). PET+COL, polyethylene terephthalate with a collagen coating; COL, collagen; PET, polyethylene 
terephthalate; PP, polypropylene. a †P < 0•050 (PP versus all other biomaterials); c †P < 0•050 (PET+COL 
versus COL); d *P < 0•001 (PP versus PET), †P < 0•050 (PP versus COL); e *P < 0•001 (PP versus PET+COL and 
PET), †P < 0•050 (COL versus PET+COL and PET) (Kruskal–Wallis and Mann–Whitney U tests).
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Discussion
As tolerance to biomaterials in surgical areas at risk of postoperative 
contamination is not understood completely, surgeons are reluctant to use 
biomaterials in these circumstances. Biomaterials should be explored for safer 
use in surgical environments prone to the development of postoperative 
infection. Macrophages are key players in the foreign body reaction, thus 
influencing the fate of biomaterials. In the present study the effect of 
biomaterials on macrophage phenotypes in an experimental model of 
postoperative contamination in rats, and in an in vitro model of inflammation, 
were studied.
Implantation of the monofilament PP biomaterial in a contaminated 
environment in the rat in vivo(15) revealed that PP fibres became surrounded 
by a small layer of dense tissue with many macrophages and other leucocytes. 
Compared with a contaminated abdominal wall without PP, which by day 28 
displayed only a few inflammatory cells, the implanted PP mesh appeared to 
extend the postoperative inflammatory reaction. No residual bacteria were 
observed on the Gram staining (data not shown), in agreement with previous 
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results of negative microbiological cultures of the biomaterial 28 days after 
implantation(15). This means that the extended inflammatory reaction is not 
caused by the presence of bacteria. The macrophages surrounding the PP 
mesh displayed mainly an M2 phenotype, which is associated with tissue repair 
and angiogenesis, thus indicating a remodelling phase of wound healing(10). 
In earlier in vivo rat studies, monofilament PP biomaterial evoked an anti-
inflammatory/fibrotic reaction with formation of fibrotic tissue around the 
mesh fibres, a low infection rate, and good incorporation into the abdominal 
wall, in both a contaminated(15, 18).
For the in vitro analysis, the M1/M2 index was calculated to summarize 
the effects of a biomaterial on macrophages. However, it should be appreciated 
that dividing macrophages into either M1 or M2 phenotypes is a simplification, 
as several intermediate states exist28. In the in vitro inflammatory environment, 
macrophages on the multifilament PP biomaterial induced the expression of 
anti-inflammatory proteins at a higher rate than the other biomaterials tested, 
thus resulting in a low M1/M2 index. The low M1/M2 index in the case of PP is 
caused mainly by a high protein production of CCL18, which is known for its 
association with fibrosis23.
Macrophages on the COL biomaterial produced a relatively low amount 
of proinflammatory and anti-inflammatory cytokines, indicative of a mild 
reaction to the biomaterial. A mild foreign body reaction against collagen-
based biomaterial has also been observed in vivo by others(11, 12, 14, 19).
Macrophages on the PET biomaterial had a relatively high M1/M2 index 
in the in vitro model, indicating a predominantly proinflammatory reaction of 
macrophages. PET and PP biomaterials are knitted according to similar weaves, 
resulting in comparable surfaces (figure 1). The difference in vitro is thus mainly 
in the contact angle/hydrophobicity, and therefore the proinflammatory 
reaction; thus the high M1/M2 index can be caused partly by the polymer type 
itself.
The PET+COL composite biomaterial tested is the mesh type generally 
preferred for intraperitoneal hernia surgery, as it minimizes the formation 
of postoperative tissue adhesions(20, 21). A high M1/M2 index was found for 
PET+COL biomaterial, indicating a high proinflammatory reaction in an 
inflammatory environment. In fact, this material evoked the highest absolute 
production of proinflammatory cytokines. This acute reaction can be explained 
by phagocytic activity of macrophages, trying to break down and digest 
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the thin collagen layer(22). A proinflammatory reaction was induced by the 
macrophages on PET+COL, even in a non-stimulated environment. When this 
environment was compared with an inflammatory environment in vitro, only a 
slight further increase in proinflammatory protein production was observed. 
This indicates that the PET+COL material itself has a great influence on the 
reaction of macrophages.
In a previous study16, the M1/M2 index in a sterile environment was 
analysed in vitro. Most interestingly, the present data indicate that the 
macrophage response remains biomaterial-specific even in an environment 
with simulated contamination. When comparing sterile and contaminated 
environments, the largest differences were observed for TNF-α production. 
TNF-α is an acute-phase protein, and reacts quickly in the present in vitro 
system. However, this does not indicate that the fourfold increases in MCP-3 
or the threefold increases in IL-6 are less relevant, as these factors might have a 
different potency or kinetics.
In vivo there is a great difference between multifilament and 
monofilament biomaterials, as the former allow for more cells to attach and 
fill the biomaterial. Monofilament biomaterials are less prone to infection 
because they provide fewer niches for bacterial infiltratration2,3. In the present 
study, monofilament biomaterials were not tested in the in vitro system owing 
to the low number of macrophages attaching to these in comparison with 
multifilament biomaterials.
The variation between macrophages isolated from different donors is 
not unexpected because it is known from clinical practice that patients respond 
differently to biomaterials. However, variations between the samples from one 
donor were also observed, which can be explained by the fact that monocytes 
are a heterogeneous population with different sensitivities to biomaterials 
or cytokines. However, taken together, distinct differences in macrophage 
reactions to biomaterials were observed.
The present study describes the very acute reaction to biomaterials, 
with analysis after 3 days of culture. The acute reaction is indicative of the 
subsequent outcome. It is obvious that the in vivo conditions are more complex 
than the in vitro situation. Most importantly, this study shows that an in vitro 
model system can be used to evaluate and simulate the foreign body reaction 
in an inflammatory environment, which can aid in selecting and developing 
new biomaterials that are well tolerated under conditions with a high risk of 
postoperative biomaterial infection.
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Abstract
Background
This experimental study investigates infectious complications and functional 
outcome of biological meshes in a contaminated environment.
Methods
In 90 rats peritonitis was induced, and after 24 hours, a biological mesh was 
implanted intraperitoneally including 2 non-crosslinked mesh groups (Strattice 
and Surgisis) and 2 crosslinked mesh groups (CollaMendFM and Permacol). 
Sacrifice was after 90 and 180 days.
Results
More mesh infections occurred in crosslinked meshes compared with non-
crosslinked meshes (70% vs 4%; P < 0.001). Mesh infection was the highest 
in crosslinked CollaMendFM (81.2%) and lowest in non-crosslinked Strattice 
groups (0%). Incorporation into the abdominal wall was poor in all meshes 
(0% to 39%). After 180 days no residue of non-crosslinked Surgisis mesh was 
found. After 180 days, shrinkage was 0.8% in crosslinked Permacol and 20% in 
Strattice groups. Strattice showed the least adhesion formation (median 5%).
Conclusions
Infection rate of biological meshes in a contaminated field was the highest in 
crosslinked meshes. All biological meshes showed poor incorporation, which 
makes long-term abdominal wall repair questionable.
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Introduction
Many factors are of influence on the functional outcome of abdominal wall 
repair, such as patient characteristics, site of implantation, the presence of 
contamination, and the chosen mesh material. Especially in the presence of 
bacterial contamination, repair of abdominal wall defects is a continuing 
challenge for surgeons. Contamination can be caused by intra-abdominal 
and surgical site infection, incarcerated and strangulated hernia, concomitant 
bowel surgery, the presence of a colostomy, acute evisceration, and open 
abdomen. Introduction of synthetic meshes in abdominal wall repair 
significantly decreased recurrence rates(1, 2). However, implantation of a 
synthetic prosthesis into a contaminated environment generates an increased 
risk for infection(3, 4). Mesh infection often necessitates removal of the mesh, 
leaving an abdominal wall deficit, sometimes larger than the original hernia, 
and closure can only be accomplished with contact of the mesh with the 
intra-abdominal content. Recommendations on mesh selection have been 
developed by the Ventral Hernia Work Group in 2008(5). In case of ventral 
hernia repair with mesh implantation in patients with grade-3 and -4 risk of 
surgical site infection, biological mesh is recommended. 
Biological meshes are extracellular scaffolds, processed from animal 
(bovine or porcine) small intestine submucosa, pericardium, or dermis. The 
donor tissue is said to be cleared of cells and immunogenic particles, after 
which a scaffold of extracellular matrix (ECM) remains. After implantation, the 
scaffold is gradually vascularized and remodelled into the host tissue while 
degradation of the ECM takes place(6, 7). To increase biomechanical strength, 
chemical crosslinking of the biological mesh can be conducted. Crosslinking 
stabilizes the 3- dimensional structure of the ECM. This improves withstanding 
of enzymatic degradation of the ECM, which can be accelerated because of 
inflammation or infection at the implantation site(8-10). Initial animal and 
clinical data seemed promising; however, compelling evidence is lacking as 
these data mainly report on clean cases and short follow-up with only a small 
portion in contaminated cases(11). Furthermore, recent clinical reports have 
been published on infectious complications of both non-crosslinked and 
crosslinked meshes(12-17).
The objective of this experimental study was to investigate the infectious 
complications and functional outcome of crosslinked and non-crosslinked 
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biological meshes in a contaminated environment in a model of abdominal 
wall repair in the rat.
Methods
Animals
Experimental protocols were approved by the Ethical Committee on Animal 
Experimentation of the Erasmus University Rotterdam. Ninety male rats of 
the outbred Wistar strain were obtained from a licensed breeder (Harlan, the 
Netherlands) and accustomed to laboratory conditions 2 weeks before the 
start of the experiment. The animals were bred under specific pathogen-free 
conditions, were kept under standard laboratory conditions in individually 
ventilated cages in pairs, and had free access to standard rat chow and water 
throughout the experiment.
Peritonitis model
Rats were anaesthetized with isoflurane and O2 inhalation (Pharmachemie, 
Haarlem, the Netherlands) and received buprenorfin analgesia 0.05 mg/
kg subcutaneously (Reckitt Benckiser Healthcare (UK) Limited, Kingston 
upon Thames, United Kingdom). Procedures were performed under aseptic 
conditions. The abdomen was shaved and the skin disinfected with 70% 
alcohol, after which the abdominal cavity was opened through a 3-cm midline 
incision through the skin and linea alba. To induce peritonitis, the cecal ligation 
puncture model was performed in all rats(18, 19). The cecum was carefully 
manipulated outside the abdominal cavity and ligated just distal to the ileocecal 
valve with a monofilament non-absorbable nylon suture (Ethilon 4-0; Ethicon, 
Somerville, NJ), maintaining the continuity of the bowel. Distally, the cecum was 
punctured once with an 18-ga needle. The fascia and the skin were closed with 
running absorbable polyglycolic acid sutures (Safil 5-0; B Braun, Melsungen, 
Germany). After 24 hours of recovery, the animals were re-anesthetized, the 
abdomen was reopened, a culture swab taken to confirm peritonitis, the 
necrotic cecum resected, and the abdominal cavity was rinsed with at least 20 
mL phosphate-buffered saline at 37°C. A sterile mesh, measuring 2.5 x 3 cm, 
was implanted intraperitoneally with 6 transmuscular non-absorbable sutures 
(Ethilon 5-0) in all mesh groups. In the control group no mesh was implanted. 
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After administration of gentamicin 6 mg/kg intramuscularly (Centrafarm, Etten 
Leur, the Netherlands), the abdominal wall and skin were separately closed 
with a running absorbable suture (Safil 5-0). Buprenorfin analgesia 0.05 mg/kg 
was administrated twice daily on the days animals were operated and the first 
day after mesh implantation.
Implanted meshes
The control group received no mesh, and in the mesh groups, 1 of 4 biological 
meshes was implanted within the peritoneal cavity. Prostheses were prepared 
according to the manufacturer’s instructions before implantation. Four 
commercially available biological meshes were implanted:
1. Non-crosslinked porcine dermis Strattice® (LifeCell, Branchburg, NJ)
2. Non-crosslinked porcine submucosa Surgisis® (Cook, Bloomington, 
IN)
3. Crosslinked porcine dermis CollaMendFM® (C.R. Bard [Davol, 
Inc],Warwick, RI)
4. Crosslinked porcine dermis Permacol® (Covidien, Norwalk, CT). 
Measurements
Animals were divided in groups according to implanted mesh and intended 
time of sacrifice, 90 or 180 days after implantation of the mesh. During the 
experiment, animals were weighed daily and scored for their wellness using an 
objective 12-point scoring system during the first 14 days of the experiment, 
thereafter once a week(20). In case of severe infectious complication, weight 
loss of 20% or more, or a wellness score of less than 5 out of 12 points, animals 
were euthanized before the intended end of the experiment and analyzed 
together with the surviving animals of the group. On all euthanized and 
deceased animals necropsy was performed. 
During sacrifice, the animals were anaesthetized with isoflurane 
and O2 inhalation; the abdomen was shaved, disinfected, and opened 
through a U-shaped incision extending laterally and caudally to the mesh. 
Macroscopically, mesh infection was defined as the presence of abscesses of 
the mesh. Parts of the mesh were cultured for microbiological evaluation. In all 
mesh groups, mesh surface and coverage of the mesh surface with adhesions 
were scored using a grid placed over the mesh, dividing it into 30 equal 
squares and facilitating accurate estimation of adhesion formation. Tenacity 
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of adhesions was scored using the Zühlke score, a 4-degree classification of 
adhesions based on histologic and morphologic criteria(21). Pictures of the 
abdominal wall with the mesh and the present adhesions were taken (5.0 
megapixels digital camera, Sony Cybershot, Tokyo, Japan). The abdominal 
cavity was inspected for abscesses, and when present, scored and cultured at 
4 sites of the peritoneum (liver, abdominal wall, bowel, and omentum) using 
an objective abscess size scoring system(22). Mesh incorporation was defined 
as percentage of the mesh edge incorporated into the abdominal wall, taking 
into account any surface reduction (Figure 1). If only the sutures secured the 
mesh to the abdominal wall and no ingrowth of the mesh was seen, ingrowth 
was scored as 0%. Surface reduction was defined as the relative loss of surface 
compared with the original size of the implanted mesh measured with a 
calliper. All measurements were performed by 2 independent observers and 
disagreements reconciled after discussion. The animals were euthanized by 
cardiac cut at the end of the experiment during anaesthesia.
Statistical analysis
Mesh infection, tenacity, and percentage of adhesions, abscess formation, 
survival, and weight were compared using nonparametric tests as the data did 
not show normal distribution (Kruskal-Wallis, Mann-Whitney, chi-square, and 
the Fisher exact tests). Therefore, all results are presented using the median 
and the interquartile range (IQR). In case the overall test showed differences, 
the pairwise tests were done to determine the groups causing the overall 
significance. 
Figure 1. Example of (absent) incorporation of the edge of biological mesh in the abdominal wall.
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Exact methods for significance were used when computational limits allowed 
these. All reported P values are 2-sided and considered significant if less than 
0.05. In view of the small sizes of the groups, it was not possible to adjust the P 
values using the Bonferroni correction. Statistical analysis was performed using 
PSAW statistical software package, version 17 (IBM SPSS statistics).
Results
During the 2 days after implantation of the mesh, 18 of the 90 rats (20%) were 
prematurely taken out of the experiment because of a low wellness score. 
Postoperative mortality was not statistically different between the groups. In all 
rats necropsy was performed and septicemia was found to be the cause of death. 
Abdominal cultures at day 1 confirmed bacterial contamination in all animals with 
gram-positive (Enterococcus, Staphylococcus, Streptococcus) and gram-negative 
microorganisms (Escherichia coli and Proteus). All animals demonstrated signs of 
sepsis including apathetic behaviour, ocular exudates, piloerection, diarrhea, and 
weight loss. Mortality in the groups is depicted in Table 1. Maximum percentage 
weight loss was significantly higher in CollaMendFM after postoperative day 5 
compared with the other groups (median: CollaMendFM, 12%; Strattice, 11%; 
Surgisis, 9%; Permacol, 9%; P < 0.020).
Table 1. postoperative mortality and animals analysed at both time points per group.
Group Material Animals Postoperative 
mortality
90 days 180 days
Control No mesh 18 2 8 8
Strattice Non-crosslinked dermis 18 4 7 7
Surgisis Non-crosslinked submucosa 18 5 6 7
Permacol Crosslinked dermis 18 5 7 6
CollaMendFM Crosslinked dermis 18 2 9 7
Total 90 18 37 35
*One rat in the Permacol group and 7 rats in the CollaMendFM group were euthanized before the 
intended end point. The results of these rats were analyzed together with the rats sacrificed at the 
intended end point.
Mesh infection and abdominal abscesses
Seven animals (44%) with a CollaMendFM mesh and 1 animal (7%) with a 
Permacol mesh were euthanized before the intended time point because 
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of clinically evident mesh infection with transcutaneous migration of the 
prosthesis. At sacrifice, macroscopic infection of the mesh was present in 
22 of 57 animals (39%). In Figure 2, the percentage of mesh infections per 
mesh group is shown. The mesh infection rate was significantly higher for 
crosslinked meshes compared with non-crosslinked meshes (70% vs 4%; P < 
0.001). In 16 animals, the mesh was encapsulated by a large abscess, and in 6 
animals, abscesses in parts of the mesh were found (Figure 3). No additional 
mesh infections were discovered by microbiological culture of the meshes 
performed during sacrifice. 
Figure 2. Comparison of combined percentage (90 and 180 days) of mesh infection. Values are 
percentages of macroscopically infected meshes of surviving animals. * non-crosllinked and § 
crosslinked meshes.
Intra-abdominal or abdominal wall abscesses were found in 42% of all 
surviving animals at sacrifice. Most abscesses were located at the ligation of 
the cecal stump. There was no significant difference in amount and size of 
intra-abdominally (non-mesh related) observed abscesses (P 5.321) between 
the meshes. Although when differentiated between crosslinked and non-
crosslinked meshes, more abscesses were observed in the animals with 
crosslinked meshes implanted (P =0.011).
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Figure 3. Macroscopic evaluation of mesh infection with meshoma of a Permacol mesh (A, B) and 
formation of mesh abscess in a Permacol mesh (C).
Surface reduction 
The 22 animals with infected meshes were excluded from this analysis because 
surface of the mesh could not be accurately measured. The CollaMendFM 
groups were excluded from analysis because, after excluding the animals 
with infected meshes, an insufficient number of animals were left to perform 
statistical testing. Loss of surface of Surgisis was significantly higher at both 
time points compared with Strattice and Permacol (P < 0.036). Both at 90 and 
180 days, only in 2 animals a very thin residue of the Surgisis mesh could be 
found macroscopically. Loss of surface after 90 days was significantly higher in 
the Strattice compared with the Permacol group (median [IQR], 23% [10 to 46] 
vs 3% [0 to 7]; P = 0.033). In the Strattice group, loss of surface after 180 days was 
median 20% (IQR, 10 to 41) and median 1% (IQR, 0 to 3) for the Permacol group 
(P = 0.075). After grouping the scaffolds by crosslinking, surface reduction 
of the mesh was lower in the crosslinked group (median [IQR], 2% [0 to 4]) 
compared with the non-crosslinked group (23% [10 to 46]; P < 0.001). 
Incorporation 
Overall incorporation of the biological meshes into the abdominal wall at 90 
and 180 days was poor (range, 0% to 39%). At 90 days, incorporation of all 
meshes was median 4% (IQR, 0 to 21) and at 180 days median 0% (IQR, 0 to 11). 
Due to the high infection rate, the CollaMendFM mesh showed incorporation 
of median 0% at 90 and 180 days (IQR, 0 to 24; IQR, 0 to 17, respectively). Most 
Surgisis meshes could not be identified at 90 and 180 days, leading to an overall 
incorporation of 0% (IQR, 0 to 0). Strattice showed incorporation of median 14% 
(IQR, 10 to 21) at 90 days, decreasing to median 10% (IQR, 6 to 12) at 180 days 
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(P = 0.128). Permacol was incorporated median 21% (IQR, 3 to 39) at 90 days, 
decreasing to 6% (IQR, 0 to 31) at 180 days (P = 0.320). At both time points, 
incorporation was not different between Strattice and Permacol (P = 0.513 and 
P 5.506). There was no difference in incorporation between crosslinked and 
non-crosslinked meshes (P = 0.537).
Figure 4. Comparison of the percentage of each mesh covered with adhesions after 90 and 180 days’ 
follow-up. Values represented as median (interquartile range). Strattice has significant lower adhesion 
formation than Surgisis, Permacol and Colla-MendFM at 90 and 180 days, *P < 0.05.
Adhesions
In the control group, 6 of 15 rats (40%) showed visceral adhesions to the 
midline scar with a maximum Zühlke score of 2. Adhesion coverage per mesh 
group is depicted in Figure 4. At 90 and 180 days, median 100% of the original 
implantation site of the Surgisis was covered with adhesions (90 days IQR, 76% 
to 100%; 180 days IQR, 100% to 100%). CollaMendFM was covered with median 
100% adhesions at 90 and 180 days (90 days IQR, 95% to 100%; 180 days IQR, 
100% to 100%). Strattice had little adhesion formation to the mesh at 90 and 
180 days (both time points median 5%; IQR, 5% to 10%), which was significantly 
lower than the other meshes (P < 0.038). At 90 days, median 68% (IQR, 48% to 
93%) of mesh surface of Permacol was covered by adhesions and at 180 days, 
median 42% (IQR 13% to 100%). Alteration in adhesion coverage between 
90 and 180 days in all mesh groups was not significantly different (P > 0.356). 
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Tenacity of adhesions was higher after 90 days for CollaMendFM (median 
Zühlke score, 4; IQR, 3 to 4) compared with Permacol (median Zühlke score, 3; 
3 to 3) and Strattice groups (median Zühlke score, 3; IQR, 3 to 3, respectively; 
P = 0.012 and P = 0.031). After 180 days, the tenacity of adhesions decreased 
and was lowest for Strattice (median Zühlke score, 2; IQR, 2 to 3), which was 
significantly lower than that for Permacol (median Zühlke score, 3; IQR, 3 to 
3), CollaMendFM (median Zühlke score, 3; IQR, 3 to 4) and Surgisis (median 
Zühlke score, 3; IQR, 3 to 3, respectively; P = 0.013, P = 0.007, and P = 0.008, 
respectively). After grouping the scaffolds by crosslinking, the percentage of 
the mesh covered with adhesions and the tenacity of the adhesions to the 
mesh were found to be higher in the crosslinked group (P = 0.01 and P = 0.024, 
respectively).
Comments
Crosslinked biological meshes were found to have a significantly higher 
percentage of mesh infection (70% vs 4%; P < 0.001) and intra-abdominal 
abscesses (P = 0.011) than non-crosslinked biological meshes. Infectious 
complications required euthanasia before the intended time point in almost 
half of animals in the crosslinked CollaMendFM group, as described in previous 
animal experiments(23-27).These results are in accordance with clinical reports 
of infectious complications of biological meshes instigating the debate on the 
indications for their clinical use(12-15, 17, 28, 29). The development of infection 
in crosslinked meshes seems comparable to mesh infection in microporous 
synthetic meshes by preclusion of immune cells(30). Crosslinking appears to 
decrease the pore size of biological meshes to a pore size small enough to 
provide a suitable housing for bacteria while preventing access of macrophages, 
fibroblasts, blood vessels, and collagen fibers into the pores(31, 32). This may 
lead to encapsulation rather than remodelling of the mesh(33, 34).
However, not all crosslinked meshes have similar densities of crosslinking 
because of differences in processing. Another interference of mesh integration 
could be the sterilization technique. CollaMendFM and Surgisis inhibiting 
tissue integration and reducing tensile strengths(35, 36).
However, the influence of sterilization techniques on these parameters 
is still largely untested. This could be of importance considering the differences 
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found in performance between the crosslinked meshes. In previous studies, the 
possible effect of crosslinking on the occurrence of infectious complications was 
not addressed. This experiment is the first step in acquiring more knowledge 
on the effect of crosslinking on the occurrence of infectious complications after 
implantation of biological meshes in a contaminated environment. 
In abdominal wall repair with a biological mesh, resistance to degradation 
is critical to prevent recurrence of hernia. During the remodelling process, 
after implantation a delicate balance exists between ECM degradation and 
deposition of host collagen. The donor material of the ECM seems to influence 
the rapidity of degradation of the mesh. High levels of hydroxyproline in 
collagenase assay suggest low resistance of the submucosa-based mesh to 
enzymatic degradation(37). This was illustrated in the present and previous 
experiments by the complete disappearance of the small intestine submucosa–
based Surgisis, which makes long-term hernia repair questionable(34, 38). 
Meshes derived from dermis were observed to have little surface reduction in 
the present experiment, with a 20% reduction in non-crosslinked Strattice and 
1% in crosslinked Permacol after 6 months. 
Chemical crosslinking is performed to make biological meshes more 
resistant to matrix metalloproteases and native and bacterial collagenase. 
Our experiment also showed decreased surface reduction in the crosslinked 
group; however, when only dermal meshes were investigated, there was no 
difference in surface reduction between non-crosslinked and crosslinked 
meshes. In the present experiment, under contaminated conditions, 
crosslinked meshes showed poor incorporation in the abdominal wall. The 
best incorporation was 21% by Permacol after 90 days, which was decreased 
to only 6% at 180 days. This disappointing incorporation of crosslinked meshes 
can be explained by delayed collagen degradation, leading to decreased 
angiogenesis and inflammation due to foreign body reaction resulting in 
poor tissue integration and adhesion formation(14, 24, 26, 27). This foreign 
body reaction can be provoked by exposure of antigenic epitopes known to 
hinder successful xenotransplantation. For example, galactose-alpha-1,3-
galactose (alpha-gal) is proven to be present in the ECM of non-crosslinked 
Surgisis(39). Crosslinking can initially mask these antigenic epitopes, but with 
mesh degradation, epitopes become exposed(40, 41). Exposure of epitopes 
leads to production of antibodies in humans and primates activating humoral 
immune and complement response(39, 42). Adhesion formation seems to be 
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related to foreign body reaction to the mesh and sutures and the presence of 
mesh infection in the present experiment. The amount of adhesions found in 
this experiment is consistent with earlier experimental reports(19, 26, 27). One 
clinical study evaluated adhesions by laparoscopic re-exploration after ventral 
hernia repair and found similar surface area and tenacity of adhesions in the 
biological meshes compared with synthetic meshes(43). 
To create a contaminated environment, we used the cecal ligation 
puncture model, which was originally designed as a sepsis model. In this 
model, as in clinical infections, peritonitis arises from a complex interaction 
of the immune system with inflammatory, hemodynamic, and biochemical 
alterations with a consistent increase of cytokine levels(44-47). Additionally, 
in this model genetically identical rats were used of the same age and sex 
and specified pathogen-free bacterial status. This minimalizes biological and 
microbiological variability and makes the model suitable for comparing the 
behaviour of various meshes in a contaminated environment but does not 
reflect daily practice(46). 
A limitation of the model in this experiment is that only a single dose 
of aminoglycoside is administrated, where this does not reflect the treatment 
of humans with abdominal sepsis. Administration of antibiotics in rats with 
fecal peritonitis does reduce bacteremia, bacteria concentration, and mortality 
rates(48). But previous experiments proposed a drawback regarding the use 
of antibiotics because of the possible marked bacterial cell death causing 
the release of toxic components against the immunologic system and the 
triggering of uncontrolled activation of this system(49-51). Previous animal 
experiments found that when antibiotics were added to the surgical treatment, 
the inflammatory response is minimized, but there is no difference in survival 
or amount of intra-abdominal abscesses(52, 53). Therefore, surgical control of 
the source of infection remains the most important treatment in abdominal 
sepsis. However, the adjunct of systemic antibiotics to surgical treatment is 
firmly established in the postoperative period in humans because it reduces 
the systemic effects of peritonitis and could influence late complications like 
abscess or fistula formation(54). Therefore, translation of experimental results 
to the clinic situation should be done with caution.
In the clinical setting, biological meshes are often implanted in the 
intraperitoneal or sublay position. A limitation of the present animal study is 
that thickness and size of the mesh in relation to the abdominal wall is dissimilar 
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between rats and humans. Furthermore, the chosen intraperitoneal placement 
of the mesh could have influenced incorporation of the mesh in the abdominal 
wall because the mesothelial layer of the peritoneum is less vascularized than 
the retromuscular space(55). On the other hand, closure of the peritoneal layer 
is often deficient when attempting sublay positioning of the mesh in humans, 
making the used model clinically relevant.
Conclusions
In conclusion, this experiment demonstrates a high infection rate and 
increased adhesion formation of crosslinked biological meshes (Permacol 
and CollaMendFM). Resistance to infection of non-crosslinked Strattice could 
allow implantation in the contaminated environment. However, the poor 
incorporation of all biological meshes and complete degradation of Surgisis 
makes long-term biomechanical strength of hernia repair questionable. 
Implantation of biological prostheses could be a valid choice in staged 
contaminated abdominal wall repair. Prevention of mesh infection associated 
with high costs for intensive care treatment, reoperation, and prolonged 
hospital stay might justify the high costs of a biological mesh.
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Abstract 
Background
This study investigates long-term incorporation, adhesion formation, mesh 
infection and shrinkage after implantation of biological meshes in non-
contaminated environment.
Methods
In 64 rats a mesh-model was used to implant various meshes intraperitoneally: 
2 non-crosslinked mesh groups (Strattice and Surgisis) and 2 crosslinked mesh 
groups (CollaMendFM and Permacol). Sacrifice was after 90 and 180 days. 
Results
High numbers of infectious complications were observed (12.5% transcutaneous 
prosthesis migration and 23.4% macroscopic mesh infection). Incorporation of 
meshes was poor (0% to 36.8%) on POD 180. Mesh shrinkage was highest in 
Surgisis (POD 90 57%, P<0.01). On POD 180, shrinkage did not differ between 
the meshes. Surgisis had the highest adhesion score on POD 90 (90%, P<0.023). 
Adhesions covering the mesh was least in Strattice (5%, P<0.029).
Conclusions
Experimental intraperitoneal implantation of biological meshes is accompanied 
by various infectious complications with little incorporation and will most likely 
not adequately prevent the formation of recurrent incisional hernia.
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Introduction
The number of patients undergoing elective abdominal wall hernia repair with 
mesh in the United States was approximately 48,000 in 2010(1). The subsequent 
economic burden is justified by the increased quality of life and core physiology 
after hernia repair(2, 3). Many different mesh types have been introduced on 
the market with different indications. Synthetic meshes are suggested to be 
contraindicated in clean-contaminated and contaminated fields following 
reports on increased susceptibility to infection, fistula formation and adhesion 
formation. Biological meshes were introduced aiming to reduce infectious 
complications by complete integration in the host tissue and ingrowth of 
mononucleair cells. Early short term results after implantation of biological 
meshes were promising, although mainly investigated in a clean environment. 
Thereafter reviews concluded that biological meshes should be incorporated 
in the surgeons armentarium which resulted in widespread implantation of 
these grafts(4-7). 
The Ventral Hernia Working Group of the European Hernia Society 
recommended use of biological mesh in case of a potentially contaminated or 
infected wound due to the risk of infectious complications. Consensus on the 
use of biological meshes has not been reached and surgeons over the world 
struggle with these recommendations in daily practice(8-10). In clinical studies 
with Strattice and Surgisis meshes recurrence of hernia was high which could 
be due to use of non-crosslinked meshes(11, 12). In a previous animal model 
infection rate was increased in crosslinked meshes and incorporation of all 
biological meshes was poor in a contaminated environment(13). Sustainable 
hernia repair and low rates of mesh infection when using biological meshes is 
essential to compete with synthetic meshes in a clean environment.
Long-term follow-up on biological meshes in clinical and animal 
studies is still scarce. This study aimed to compare two commercially available 
crosslinked with two non-cross-linked biological meshes in intra-peritoneal 
position in a rat model. The meshes were tested on infectious complications, 
adhesion formation, shrinkage and incorporation after a period of 90 and 180 
days. 
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Materials and methods
Animals
Sixty-four male rats of the outbred Wistar strain weighing 288-422 grams 
were obtained from a licensed breeder (Harlan, the Netherlands) and bred 
under specific pathogen-free conditions. The animals were accustomed to 
laboratory conditions one week before the start of the experiment. They were 
kept under standard laboratory conditions in individually ventilated cages and 
fed with standard rat chow and water ad libitum throughout the experiment. 
Experimental protocols were approved by the Ethical Committee on Animal 
Experimentation of the Erasmus University Rotterdam.
Implanted meshes
Animals were divided into 8 groups and 4 different commercially available 
biological meshes were implanted. Prostheses were prepared according to the 
manufacturer’s instructions before implantation.
1. Non-crosslinked porcine dermis Strattice (Lifecell, Branchburg, NJ)
2. Non-crosslinked porcine submucosa Surgisis (Cook, Bloomington, IN)
3. Crosslinked porcine dermis Permacol (Covidien, Norwalk, CT) 
4. Crosslinked porcine dermis CollamendFM  
(C.R. Bard/Davol, Inc, Warwick, RI). 
Mesh model
Rats were anaesthetized with isoflurane/O2 inhalation (Pharmachemie, 
Haarlem, the Netherlands) and received buprenorfin analgesia 0.05 mg/kg 
subcutaneously (Reckitt Benckiser healthcare limited, Kingston upon tames, 
United Kingdom). Procedures were performed under aseptic conditions. The 
abdomen was shaved and the skin disinfected with 70% alcohol, after which 
the abdominal cavity was opened through a 3 cm midline incision through 
the skin and linea alba. A sterile mesh, measuring 2.5x3 cm, was implanted 
intraperitoneally with three transmuscular non-absorbable sutures (Ethilon, 
5-0) on both sides of the incision in all mesh groups. Thereafter the abdominal 
wall and skin were separately closed with a running absorbable suture (Safil , 
5-0).
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Measurements
In case of severe infectious complications animals were euthanized before the 
intended endpoint. These animals were analysed together with the surviving 
animals sacrificed at the intended endpoint. Half of the surviving animals were 
sacrificed after 90 days and half after 180 days. During sacrifice the abdomen 
was shaved, disinfected and opened through a U-shaped incision extending 
lateral and caudal to the mesh. Mesh incorporation was defined as percentage 
of the mesh edge incorporated into the abdominal wall, taking into account any 
shrinkage (example in Figure 1). In all mesh groups mesh surface and coverage 
of the mesh surface with adhesions was scored using a grid placed over the 
mesh, dividing it into 30 equal squares and facilitating accurate estimation of 
adhesion formation. Tenacity of adhesions was scored using the Zühlke-score, 
a 4-degree classification of adhesions based on histological and morphological 
criteria(14). Pictures of abdominal wall with mesh and the present adhesions 
were taken (5.0 megapixels digital camera; Sony Cybershot). Macroscopically 
mesh infection was defined as the presence of abscesses of the mesh. Shrinkage 
was defined as the relative loss of surface compared with the original size of the 
implanted mesh measured with a calliper. All measurements were performed 
by 2 independent observers and disagreements reconciled after discussion. 
The animals were euthanized by cardiac cut. 
Statistical analysis
Incorporation, mesh infection, tenacity and percentage of adhesions, abscess 
formation, survival, weight and shrinkage were compared using non-parametric 
tests (Kruskal Wallis, Mann Witney, Chi-square, Fisher’s exact and Spearman’s 
rho) since the data did not show a normal distribution. Therefore all results 
are presented using the median and the interquartile range (IQR). In case the 
overall test showed differences, the pairwise tests were done to determine the 
groups causing the overall significance. Exact methods for significance were 
used when computational limits allowed these. All reported p-values are two-
sided and considered significant if less than 0.05. In view of the small sizes 
of the groups, it was not possible to adjust the p-values using Bonferroni’s 
correction. Statistical analysis was performed using PSAW statistical software 
package, version 17 (IBM SPSS statistics).
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Results
Mesh infection
During the experiment 8 animals were euthanized due to clinically evident 
mesh infection with transcutaneous migration of the prosthesis between day 
49 and 87. In all euthanized rats, 7 animals of the CollamendFM group and 1 of 
the Surgisis group, necropsy was performed and large mesh abscesses were 
found intra abdominally. In total 15 of 64 rats (23.4%) were found to have 
macroscopic infection of the mesh at time of sacrifice. In Figure 1 the amount 
of mesh infections per mesh-group is shown. Strattice had a significantly lower 
number of mesh infections compared to CollamendFM at 90 days (P<0.001). 
At 180 days CollamendFM showed a significantly higher rate of mesh infection 
compared to all other meshes (P<0.004). Maximum percentage of weight loss 
was significantly higher in CollamendFM compared to all other groups (median 
6, compared to Strattice 2; Surgisis 3; Permacol 3.5, P=0.001).
Mesh incorporation
Animals with mesh infection were not included in this analysis because no 
incorporation of the mesh was found in these animals. Incorporation of the 
meshes was not significantly different between the groups at 90 days (median 
13.2%, IQR 0-24.2%). Data per mesh is shown in Figure 2. No Surgisis meshes 
could be identified at 180 days and incorporation was scored as 0%. Therefore 
at 180 days the incorporation of Surgisis (0%, 0-0) was significantly lower than 
Strattice (13.7%, 10.3-22.4; P<0.001) and Permacol (20.7%, 5.7-24.5; P<0.001). 
For each mesh no difference in incorporation of the mesh was observed 
between 90 and 180 days. 
Adhesions
At 90 days Surgisis had the highest percentage of mesh adhesions to the mesh 
implantation site (90%, 32.5-100) which was significantly more than all other 
meshes (P<0.023). Data per mesh is shown in Figure 3. Strattice showed a 
significantly smaller percentage of mesh surface covered with adhesions (5.0%, 
5.0-5.0; median Zühlke 2) compared to all other meshes (P<0.029). When only 
considering non-infected meshes there was no longer a difference in adhesion 
coverage between Strattice and CollamendFM . 
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Figure 1. Comparison of combined percentage (90 and 180 days) of mesh infection. Values are 
percentage of macroscopically infected meshes of surviving animals. * Non-crosslinked and § 
crosslinked meshes.
Figure 2. Percentage of the mesh edge incorporated into the abdominal wall, only non-infected meshes 
included. Values are median (interquartile range). At 180 days: *no Surgisis mesh could be identified and 
P<0.001 compared to Strattice and Permacol (n=7). 
  
At 180 days CollamendFM had the highest rate of adhesions coverage 
(median 100, IQR 100-100; median Zühlke 3) of the mesh due to the high 
amount of infected meshes. This was significantly more than all other meshes 
(P<0.029). Adhesions were found at median 40% (IQR 11.2-63.7) of the size 
of the original implantation site of the Surgisis . Of the non-infected meshes 
Strattice had the least adhesions (5%, 5.0-5.0) which was significantly less than 
Surgisis (P<0.001) and Permacol (P<0.001).
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Figure 3. Comparison of percentage of each mesh covered with adhesions at the 90 and 180 days 
follow-up assessment. Values are median (interquartile range). *n=7. At 90 days: ± P<0.023 compared to 
all other meshes; ° P<0.029 compared to all other meshes. At 180 days: ∞ P<0.029 compared to all other 
meshes.
Shrinkage
Surface of the mesh could not be accurately measured in infected meshes 
therefore these were excluded from the analysis. Shrinkage of the mesh was 
highest in Surgisis at 90 days were a residue of median 43% of the original size 
was found (shrinkage 57%, IQR 37.0-69.5). Data per mesh is shown in Figure 4. 
This shrinkage of Surgisis was significantly higher than Strattice (33.0%, 22.5-
36.5; P=0.02), Permacol (3.0%, 0.0-7.0; P=0.003) and CollamendFM (0.0%, 0.0-
2.2; P=0.016). At 180 days there was no difference between the mesh groups. 
Figure 4. Percentage of shrinkage of the mesh surface, only non-infected meshes included. Values are 
median (interquartile range). At 90 days: *P<0.016 compared to all other meshes.
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Correlation between adhesion formation and incorporation
At 90 days CollamendFM showed a significant correlation between adhesion 
coverage of the mesh and incorporation of the mesh edge (ρ=-0.973; P=0.01). 
At 180 days there was no correlation. When the animals in group 90 days and 
180 days were combined CollamendFM showed a correlation coefficient of 
ρ=-0.612; P=0.05. This correlation coefficient indicates that in CollamendFM 
meshes increase of adhesion formation was correlated with a decrease of 
incorporation.
Discussion 
Based on the results of our long-term animal study we advocate more reluctance 
on implantation of biological meshes for abdominal wall repair. When biological 
meshes are implanted in an intraperitoneal position, incorporation in the 
abdominal wall is poor and adhesion formation and infection susceptibility 
remain a problem. The best results in our study were found with implantation of 
non-crosslinked Strattice. Adhesion coverage was low as 5%, but incorporation 
after 180 days was only 13.7%. Crosslinked Permacol had the better long-term 
incorporation (20.7%) but adhesion coverage of 15%. Worst results were found 
with crosslinked CollaMend and non-crosslinked Surgisis. After implantation 
of CollaMend infection of the mesh occurred in over 60% leading to a very 
low incorporation and increased adhesion formation. Non-crosslinked Surgisis 
dissolved completely within 180 days but induced substantial adhesion formation. 
These characteristics of biological meshes at long-term follow-up make the 
strength of the abdominal wall repair questionable. Moreover the adverse effects 
are comparable to intraperitoneally used (coated) synthetic meshes. 
It is a recurrent phenomenon in research where initial studies on new 
technology describe positive results (whether or not industry driven) and 
subsequently critical reviews are published only after years of trial and error. 
The first studies on biological meshes were mainly case series with large 
variation in sample size, mesh material, implantation technique, follow-up and 
study endpoints(7, 15). Although the majority of cases were implanted in a 
non-contaminated environment they have also led to recommendations for 
the use in contaminated surgical fields. In recent years authors have started to 
publish their doubts on biological meshes(15, 16).
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The aim of biological mesh implantation is to create a functional 
abdominal wall by deposition of native collagen during mesh degradation 
(‘remodelling’). In our current study incorporation of the mesh was highest in 
Permacol however with only 20.7% incorporation (20.7%, 5.7-24.5), followed 
by Strattice (13.7%, 10.3-22.4). The steps in this dynamic process include 
inflammatory response, cellular penetration and neovascularisation of the 
mesh, fibroblast infiltration and collagen deposition(17). It appears that all 
meshes induce varying levels of foreign body reaction and fibrosis. Multiple 
characteristics of the mesh influence this response: mesh material, weight, 
pore size, crosslinking and sterilisation technique. More data is becoming 
available on histopathologic responses to specific synthetic and biological 
meshes in animal models(16, 18, 19). Novitsky et al observed that crosslinked 
meshes caused extensive foreign body reaction with fibrous encapsulation 
and no evidence of integration or remodelling of the mesh(16). Dissimilarities 
have been found between crosslinked and non-crosslinked meshes suggesting 
that improved integration into host tissue in non-crosslinked matrix is due to 
a moderate mononucleair cell reaction(20). Possible cause of this foreign body 
reaction is due to presence of nucleair material in the mesh or exposure of 
antigentic epitopes following implantation(21-25). It is suggested that some 
crosslinking processes damage the extracellular matrix and negatively influence 
the host response leading to encapsulation, decreased fibroblast penetration 
in the matrix and little collagen synthesis(20, 23, 26-28). Similar results have 
been found in patients who underwent removal of porcine biologic mesh 
where no to little evidence of neovascularisation or neocellularisation was 
detected in crosslinked meshes(17). Non-crosslinked Strattice mesh showed 
highest degree of new collagen deposition and organization in the study by 
Novitsky et al. which is comparable to the results in our current study(28). 
Clinical studies like the multicentre RICH study showed similar results 
with a recurrence hernia rate of 19% after 1 year and 28% after 2 years(11). 
Likewise, Rosen et al recorded a recurrence rate of 31.3% with a follow-up 
of 21.7 months after implantation of biological mesh(29). These results can 
hardly be called sustainable hernia repairs and are not that dissimilar to 
synthetic meshes(6, 30). Increasingly synthetic meshes are being implanted 
in clean-contaminated and contaminated surgical field with quite favorable 
results(31-34) . Recent studies in grade II contaminated wounds showed lower 
recurrence rate after implantation of synthetic meshes compared to biological 
meshes with similar adverse event(35).
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Possible factors affecting the collagenesis and consequential recurrence 
rate of hernias are high rates of postoperative infectious adverse-events. 
Ambivalent results have been published previously: Basta et al reported a 51.4% 
incidence of wound complications leading to recurrence hernia rate of 18.9% 
with postoperative wound infection being the only predictor of recurrence 
with an odds ratio of 22.1(36). Increased infection rate of biological meshes 
could be due to bacterial niches in biomesh pores and bacterial formation of 
biofilms(37). 
Perhaps the advantage of biological meshes over synthetic material is the 
possibility of performing aggressive salvage procedures with removing parts 
of an infected mesh in situ to avert removal of all material with subsequently 
recurrence of hernia. 
An important factor when choosing a mesh are the associated costs. 
Biological meshes are substantially more expensive than synthetic meshes(4, 
6). However costs can be reduced when delayed primary closure with 
implantation of a biological mesh is possible during one hospital admission. 
In this way the number of admissions and in-hospital days can be reduced 
compared to staged repair(38). Additional benefit is earlier restoration of 
abdominal wall function which may lead to accelerated return to work. 
A limitation of our study might be the implantation of the mesh in an 
intraperitoneal position. After intraperitoneal placement of the mesh there 
is no close vascular supply to facilitate neovascularisation and fibroblasts 
have difficulty reaching the mesh(39). However in previous animal studies 
intraperitoneal or extraperitoneal implantation of the mesh did not affect 
host tissue incorporation or mesh degradation(19). Contact of the mesh with 
the intraperitoneal compartment can often not be avoided due to the large 
dimensions of the hernia defect(11, 36). In the retrospective analysis of the RICH 
study there was no difference in hernia recurrence rate when the retro-rectus 
plane was compared to intraperitoneal placement. In 2 trials sublay procedures 
are found to result in less wound complications and seromas compared to 
onlay procedures(40, 41). It is suggested that further randomized trials on the 
optimal placement is needed to guide decision-making(17, 38). 
Another limitation is that this research was performed in animals without 
any predisposing collagen disease or hernia defect. 
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Conclusions
We advocate more caution with implantation of biological meshes for 
abdominal wall repair. There seems to be no evidence for previously purported 
hypothesis that biological material enables ingrowth of cells and vessels 
resulting in a sustainable hernia repair. Implantation of biological mesh 
does not seem to reduce infection rate which is a significant factor for the 
recurrence of incisional hernia. Biological meshes might not have the required 
characteristics for implantation in clean environment with high infection rate 
and low incorporation of the mesh in the current experiment. 
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Abstract
Background
Recurrence is the most important complication of abdominal wall 
reconstruction. It is possible the repair itself is intact, but bulging or expansion 
of mesh causes recurrent swellings of the abdominal wall. 
Case summary
In this report, we present bulging of a polyester mesh due to central pore 
expansion. 
Discussion
Repetitive stress and variations in intra-abdominal pressure can change 
tensile strength and stretches mesh materials. Clinical distinction between 
recurrent hernia and mesh bulging is difficult but therapeutically irrelevant in 
symptomatic patients.
Conclusion
A swelling after abdominal wall repair can be caused by bulging of the mesh. 
A progressive bulging might be the result of failure of the mesh implant due 
to elongation. Mesh characteristics should be considered when choosing a 
feasible and suitable mesh for abdominal wall reconstruction. 
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Introduction
Recurrence is the most important complication of abdominal wall 
reconstruction. In order to reduce recurrence rates meshes are used as 
reinforcement of augmentation or bridging of large abdominal wall defects. 
Numerous meshes are available worldwide, differing in material, pore size, 
weight, tensile strength, elasticity and biocompatibility. These characteristics 
influence the risk of failure of repair. Swelling or bulge in the area of previous 
abdominal wall reconstruction is suggestive for recurrence, although not 
obligatory to be so(1, 2). It is possible that the repair is still intact and bulging 
of the mesh causes swelling. Bulging can be the result of an insufficient surgical 
technique. The problem is more frequently seen after repair of large defects(1), 
especially when mesh are used to bridge the defects(1, 3) and more frequent 
after laparoscopic repair(2-4). In this article we present the phenomenon of 
symptomatic bulging due to failure of a polyester mesh. 
Time-line
2004 necrotizing fasciitis
2005-2008 4-staged repair of abdominal wall with polyester mesh
2012 symptomatic bulging of repair due to enlargement of the mesh. Excision 
part of mesh.
2015 recurrent symptomatic bulging of the mesh. Excision polyester mesh and 
replacement by polypropylene mesh
Case 
A 43-year-old male was referred to the outpatient clinic with severe bulging of 
the complete right hemi abdomen. One year before he developed necrotizing 
fasciitis, extending from the right knee to the right thoracic wall resulted in a 
resection of the right abdominal wall. The patient was left with multiple scars 
from the right upper leg to the right thorax consisting mainly skin grafts. The 
abdominal wall consisted skin grafts and peritoneum. The patient experienced 
reduced quality of life and discomfort. A four-staged repair over three years 
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was performed in order to reconstruct the abdominal wall. Finally in 2008, the 
defect was closed in with two (sutured together) collagen-coated polyester 
meshes of 20*30cm (Parietex Composite®, Covidien, France). A coated mesh 
was implanted since contact with the visceral organs was inevitable with the 
loss of abdominal wall and bridging position of the mesh. The soft tissue defect 
was repaired at the sides of the hernia with skin obtained by using multiple 
tissue expanders. The soft tissue defect was covered with a free vascularized 
latissimus dorsi flap with large full thickness skin graft (figure 1). 
Four years after the final repair the patient returned to the outpatient 
department with progressive swelling of the right lower abdomen (figure 2). 
Figure 1. Abdominal wall after four-staged repair with Parietex Composite® mesh and latissimus dorsi 
flap (2008).
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Figure 2. Increased bulging of the abdominal wall four years after reconstruction (2012).
He suffered from abdominal pain and protrusion that interfered with his work. 
A CT-scan was performed, showing an intact repair, but enlargement of the 
mesh (figure 3). 
Figure 3. CT-scan of bulging mesh four years after reconstruction (2012).
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A surgical procedure was planned to repair the bulging abdominal wall. During 
surgery the bulging was found to be caused by expansion of an intact mesh. 
The elongation was caused by a striking central pore expansion from 1.5 to 2.5 
mm (figure 4). 
Figure 4. Pore size of explanted polyester mesh compared to original mesh (2102). (A) Pore size (1.5 mm) 
of original mesh (Parietex Composite®, Covidien, France). (B) Increased pore size (2.5 mm) of explanted 
mesh (Parietex Composite®, Covidien, France). 
Surgical excision of the central part of the mesh was performed to tighten the 
mesh and reduce the bulging. 30 months later the patient developed swelling 
of the right abdominal wall again. The patient was planned for repair. During 
the procedure the mesh was still in tact but there was ongoing expansion of 
the mesh. The mesh has been removed and replaced by a 20*30 polypropylene 
collagen-coated mesh (Parietene Composite®, Covidien, France) in bridging 
position. A heavy-weight polypropylene mesh was implanted to provide the 
maximum tensile strength to prevent failure of the repair(5). Follow-up of over 
1 year did not show any bulging. 
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Discussion
In this case symptomatic bulging at the hernia repair site was caused by 
elongations of the mesh due to pore enlargement. Each mesh used for hernia 
repair has certain features that determine the mechanical properties. During 
normal daily activities, mesh material is exposed to stress subsequent to 
changes in intra-abdominal pressure. The intra-abdominal pressure can raise 
up to 100 mmHg during coughing and can reach 250 mmHg during vomiting 
or jumping(6, 7). When abdominal wall defects are repaired using a bridging 
technique the material has to withstand the tensile stress at the borders. 
Normal daily activities require a tensile strength of 16 N/cm and 
strenuous activities a maximum tensile strength 42-47 N/cm(5, 8). Medium-
weight and heavy-weight meshes made of polyester, polypropylene or 
(expanded) polytetrafluoroethylene (ePTFE) provide the maximum tensile 
strength to prevent failure of the repair(5). In our patient polyester mesh was a 
valid choice for the first repair with regard to the tensile strength. The elasticity 
of a mesh should correspond to the elasticity of the abdominal wall to prevent 
foreign body sensation or discomfort of stiffness. Biomechanical studies have 
shown low stretch properties of meshes, only up to 3.5% during normal daily 
activities due to the very large diameter of the filaments(5). However, other 
biomechanical studies show that repetitive stress can change the tensile 
strength and stretches mesh materials(9). These studies did not test the 
polyester meshes, but in our case, elongation of polyester filaments is clearly 
demonstrated.  
Bulging is an important adverse effect after abdominal wall repair. 
Incidences of bulging vary from 1.6% to 17.4%(2-4). Clinical distinction 
between recurrence and bulging of mesh is difficult(1-3). Differentiation is 
therapeutically irrelevant in symptomatic patients, because both conditions 
surgical repair is indicated. Asymptomatic patients however do not require 
repair in the case of mesh bulging, except for cosmetic reasons. Radiologic 
imaging can be used to establish the right diagnosis. The use of CT-scans 
to distinguish between bulging or recurrence can be challenging because 
polypropylene meshes are visible lines with densities similar to adjacent 
muscle and can better be identified with ultrasound(10-12). When performing 
surgical repair for symptomatic bulging it is often not necessary to remove the 
implanted mesh, when incorporation is sufficient. With open approach the 
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mesh can be partly excised to tighten the repair or the mesh can be removed 
and replaced. In this case however, bulging was an ongoing process, that finally 
resulted in mesh explantation and placement of a new mesh. In asymptomatic 
patients a watchful waiting approach seems justified(2).
Conclusion
A swelling after abdominal wall repair can be caused by bulging of the mesh. 
A progressive bulging might be the result of failure of the mesh implant due 
to elongation. The distinction between a recurrence and bulging of the mesh 
remains difficult even with radiological examinations but is therapeutically 
irrelevant in symptomatic patients.
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General discussion
An attempt has been made to reduce the incidence of incisional hernia (IH) 
through optimizing all techniques for closing abdominal wall incisions. The 
STITCH trial confirmed the positive results of the Swedish research group of 
Israelsson, that developed the ‘small bites’ suture technique(1). Although in our 
systematic review and meta-analysis, a superior suture material for suturing 
the abdominal fascia could not be detected, evidence from earlier systematic 
reviews and meta-analyses demonstrated a combination of a continuous 
suture technique with a non-absorbable or slowly-absorbable suture material 
to be superior to an interrupted suture technique with a fast-absorbable suture 
on the incidence of IH(2, 3). Furthermore, a continuous technique is, of course, 
faster than an interrupted technique(2). 
Evaluating the evidence from the existing literature, the European Hernia 
Society formulated guidelines on the optimal method of closing abdominal 
wall incisions. It is advised to use a continuous suture technique with a slowly-
absorbable suture, since using a non-absorbable suture is associated with 
increased incidence of prolonged wound pain and suture sinus formation(3). 
Furthermore, a ‘small bites’ technique with a suture to wound length radio of 
at least 4:1 is recommended, in part based on the results of the STITCH trial, 
providing level 1 clinical evidence.
When taking into account the biology of wound healing, using a slowly- or 
non-absorbable suture to suture the fascia seems most logical. Fascial healing 
starts with  the recruiting of inflammatory cells. Two to five days after laparotomy, 
fibroblasts enter the wound side and start producing collagen. During the 
proliferation phase of the first three weeks, mainly type III collagen is produced 
and an extracellular matrix is created. Type III collagen consists of thin, weak 
fibres, and is replaced by strong and thick type I collagen during the following 
maturation phase(4, 5). The last part of the maturation phase is the remodeling 
or realignment of collagen fibres along tension lines – a process which can take 
years. The half-life tensile strength of absorbable sutures like polyglactin 910 
(Vicryl®) and polyglycolid acid (Dexon®) is around 2-3 weeks(6), suggesting an 
insufficient support of the healing linea alba after this time. The half-life tensile 
strength of the slowly-absorbable suture polydioxanone (PDS®) is 6 weeks(6). 
Since healing fascia needs at least 14 days to regain its strength(4, 7), using a fast-
absorbable suture will probably not provide support for long enough. 
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Since the research of Jenkins, it has been known that force distributions 
on the healing abdominal fascia play an important role in the development of 
IH(8). In patients that received an end colostomy during midline laparotomy, 
an increased prevalence of IH in those with parastomal hernia (PSH) was 
found after a mean follow-up of four years. A possible cause for this could be 
damage to the innervation of the abdominal wall during colostomy creation, 
leading in turn to atrophy of the abdominal rectus muscle. Furthermore, a 
non-symmetrical force distribution on the midline laparotomy wound occurs 
through the creation of a colostomy on the left side of the abdomen. The 
presence of PSH can increase the risk of the development of IH through both 
mechanisms. 
Unfortunately, optimizing all techniques for closing a midline laparotomy does 
not reduce the IH rate to zero; in high-risk patients, other interventions might 
be needed to further reduce its incidence. Prevention of the development of 
IH with the use of a prophylactic mesh has been investigated for this group. 
Patients with an abdominal aneurysm or obesity have been found to benefit 
from prophylactic mesh augmentation; the incidence of IH in these patients 
was significantly reduced, with an odds ratio of 0.25(9, 10). It is not clear if mesh 
augmentation in an onlay or sublay position is superior in the prevention of 
IH in high-risk patients. An RCT (PRIMA trial) was initiated to study the best 
mesh position for preventing IH in high-risk patients(11). Short-term results 
showed that primary mesh augmentation is safe, with an increase in seroma 
formation only, after onlay mesh augmentation, and without any increased risk 
in surgical site infection(12). The results on the incidence of IH after 2 years 
follow-up are expected in the near future. Since PSH is also a risk factor for IH, 
prevention of PSH will also reduce the incidence of IH. Another RCT (PREVENT 
trial) was initiated to investigate the use of a prophylactic mesh reinforcement 
of a colostomy on the incidence of PSH(13). In this trial, a retromuscular 
polypropylene mesh was put in place during colostomy creation. The results 
of 1-year follow-up show a significant reduction in the incidence of PSH – from 
24 to 4.5% – and no adverse events were found(14). Using prophylactic mesh 
augmentation of the abdominal wall during laparotomy or colostomy creation 
seems a safe and effective means of preventing hernias.
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An additional effect in reducing IH might come from influencing 
patient-related factors. Unfortunately, it is not (yet) possible to influence 
genetic susceptibility, or the connective tissue disorders that increase the 
risk of IH in some patients. However, influencing co-morbidities, nutritional 
status, and lifestyle choices is possible. As physicians, we should try to optimize 
patient factors that influence wound healing positively and negatively before 
performing surgery. In collaboration with other medical specialists, diabetes 
regulation should be optimized to improve wound healing; steroid use should 
be critically evaluated; and chronic pulmonary obstructive disease (COPD) 
and other lung pathologies should be optimized to minimize postoperative 
coughing, risk of pneumonia, and steroid use. Furthermore, the patient’s 
nutritional status should be evaluated in collaboration with a dietician. 
Optimization of metabolic state prior to major surgery leads to improved 
surgical outcomes by improving both wound healing and immune function(15). 
Patients with severe malnutrition and gastrointestinal dysfunction may benefit 
from preoperative parenteral nutrition. In morbidly obese patients, weight loss 
should be encouraged before elective surgery, since obesity is a risk factor for 
the development of IH(16-18). Lifestyle counselling should be provided, and 
patients should be strongly recommended to stop smoking – smoking is a risk 
factor for IH, has a detrimental effect on wound healing, increases the risk of 
surgical site infection, and is associated with increased coughing(19-21). 
An IH generally tends to become symptomatic and require treatment(22). For 
small and medium-sized hernias, the superiority of open mesh repair over 
suture repair has been proven by recurrence rates(23-25). However, for large 
hernias (over 10 cm in diameter), no consensus currently exists. The systematic 
review performed on the treatment of large ‘giant’ IHs revealed the best 
results for open repair with mesh in the sublay position. Large IH repair often 
requires some form of components separation technique (CST). During CST, 
the blood supply of the abdominal wall by the epigastric perforating arteries is 
endangered. Damage to these arteries may jeopardise the blood supply to the 
skin (which then depends solely on blood flow from the intercostal arteries) 
and thus interfere with wound healing and increase the risk of infection (26-
28). Furthermore, the intercostal arteries might have been damaged during 
former operations, giving rise to even more complications(26, 29). With this 
in mind, new endoscopic CST, minimally invasive CST, and posterior CST 
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have been developed, and promising results in terms of reduced wound 
infection and necrosis, have been described(30-33). In patients with a large 
IH, lateral migration of the rectus muscles in conjunction with flank muscle 
contraction, leads to a progressive decrease in the volume of the abdominal 
cavity and worsening protrusion of the viscera. Repositioning the viscera in 
a stiff abdominal cavity can lead to decreased perfusion of the intestine and 
elevation of the diaphragm, which in turn can lead to ventilatory difficulties – 
and rarely, abdominal compartment syndrome(26, 34). The use of preoperative 
pneumoperitoneum or botox might be indicated in some cases, although 
evidence is limited(35-38). 
These results are in accordance with the results of reviews and meta-
analyses on the subject for IH of all sizes(25, 39, 40). However, all authors report 
the same problem: the heterogeneity of the studies. Little evidence is available 
from RCTs on the subject of IH repair, and clear definitions of mesh positions, 
techniques, and outcome parameters are lacking, with substantial research 
flaws both methodologically and statistically. To improve the evidence-base 
for IH-surgery, the European Hernia Society Working Group has developed 
a classification for IH which takes in account the location, size, and possible 
recurrence of the IH(41). This classification system has, since its introduction 
in 2009, been widely accepted and used in scientific publications regarding 
IH. However, a solid comparison of research on abdominal wall surgery 
has remained elusive, due to the strong heterogeneity of reported study 
population characteristics and outcome measurements. To address this issue, 
improve research on hernia repair, and enable comparison of the literature, 
the EHS initiated a consensus meeting, and recommendations were duly 
formulated. Besides true recurrence, bulging is also an important adverse 
effect of abdominal wall repair, and the incidence of this is likely to have 
increased with the rise in laparoscopic hernia repairs(42). Clinical distinction 
between recurrence and bulging of mesh, is difficult(42-44). Differentiation is 
therapeutically irrelevant in symptomatic patients, because in both conditions 
surgical repair is indicated. Asymptomatic patients, however, do not require 
repair in the case of mesh-bulging, except for cosmetic reasons, and a watchful 
waiting approach seems justified in such cases(42).
The subject of a large part of the research on the treatment of IH 
is the search for the ideal mesh. Currently, a wide variety of synthetic and 
biological meshes are available on the market, complicating the selection of an 
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appropriate prosthesis. The most commonly used meshes in hernia repair are 
made of non-absorbable materials, in particular polypropylene and polyester. 
These materials are relatively inexpensive, easy to handle, and incorporate well 
into the abdominal wall. However, when placed in contact with the abdominal 
viscera, complications of adhesion formation can occur, associated with 
abdominal pain, small bowel obstruction, bowel erosion, enterocutaneous 
fistulas, and complicated future abdominal surgery(45-48). Contact with viscera 
is more common in laparoscopic repair and during the repair of complex or 
large abdominal wall hernias, with loss of domain or the inability to close 
the fascia completely. Furthermore, mesh infection can follow either open 
or laparoscopic hernia repair. Incidences of mesh infection after open repair 
range between 6-10%; and 0-4% after laparoscopic repair(49-51). Implantation 
of a mesh in a contaminated environment increases the risk of surgical site 
infections, including mesh infection(50, 52). For mesh use  intraperitoneally or 
in contaminated fields, alternatives can be found in composite and biological 
meshes. Composite meshes are synthetic meshes with an additional layer 
or coating on the visceral side of the mesh. Biological meshes are collagen 
scaffolds derived from human or animal donors. 
The results of the experiments described in part 2 of this thesis show a wide 
range of performance for biological meshes between clean and contaminated 
environments. Besides the infection susceptibility of some biological meshes, 
incorporation is found to be a problem for all biological meshes. This poor 
incorporation makes sustainable hernia repair questionable. The results of our 
animal experiments are in accordance with published results of recurrence 
rates of up to 80% in human hernia repair with biological meshes(53-59). 
Human studies reporting on the outcomes for biological meshes in hernia 
repair are scarce, report small numbers, are mostly single-institution based, and 
vary widely in follow-up time, operative technique, and patient selection(53). 
Furthermore, conflict of interest statements are often not reported(53). A 
limitation of our experiments might be the implantation of biological meshes 
in an intraperitoneal position. After intraperitoneal placement of a mesh, there 
is no close vascular supply to facilitate neovascularisation, and fibroblasts 
have difficulty reaching the mesh(60). However, in previous animal studies 
intraperitoneal or extraperitoneal implantation of the mesh did not affect host 
tissue incorporation or mesh degradation(61). In the retrospective analysis of 
the RICH study, there was no difference found in hernia recurrence rate when 
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the retro-rectus plane was compared to intraperitoneal placement of non-
crosslinked biological Strattice® mesh in patients(56).
Biological meshes can roughly be divided into non-crosslinked and 
crosslinked meshes. After implantation, the scaffold of extracellular matrix (ECM) 
is gradually vascularised and remodelled into the host tissue while degradation 
of the ECM takes place(62, 63). To increase biomechanical strength, chemical 
crosslinking of the biological mesh can be conducted. In the experiments in 
this thesis, a high incidence of mesh infection of crosslinked biological meshes 
was found. These results are in accordance with clinical reports of infectious 
complications with use of biological meshes(54, 64-69). The development 
of infection in crosslinked biological meshes seems comparable to mesh 
infection in microporous synthetic meshes by preclusion of immune cells(70). 
The crosslinking of meshes appears to involve the decreasing of pore size in 
biological meshes such that it promotes a suitable housing for bacteria, while 
preventing access of macrophages, fibroblasts, blood vessels, and collagen 
fibres into the pores. The greater the percentage of crosslinking, the more a 
biological mesh behaves like a microporous mesh. Additionally, crosslinking 
may lead to encapsulation rather than remodelling of the mesh. It is suggested 
that some crosslinking processes damage the extracellular matrix and 
negatively influence the host response, leading to encapsulation, decreased 
fibroblast penetration into the matrix, and little collagen synthesis(71-75). 
Similar results have been found in patients who have undergone removal of 
porcine biologic meshes, where little or no evidence of neovascularisation or 
neocellularisation was detected in crosslinked meshes(76). 
The first studies on biological meshes were mainly case series, with 
large variations in sample size, mesh material, implantation technique, 
follow-up, and study endpoints(52, 77). Although the majority of cases were 
implanted in a non-contaminated environment, these studies have also led to 
recommendations for use in contaminated surgical fields. In 2010, the Ventral 
Hernia Working Group (VHWG) recommended use of a biological mesh in cases 
of a potentially contaminated or infected wound, due to the risk of infectious 
complications(52). This publication, among other optimistic reports, led to the 
incorporation of biological meshes into the surgeon’s armentarium, which 
resulted in widespread implantation of these grafts(52, 78-80). In recent years, 
authors have started to publish their doubts on biological meshes(53, 59, 77, 
81). Biological meshes are often used when a hernia defect must be closed 
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in a contaminated environment: grade 3 and 4 hernia repairs of VHWG(52). 
Although no high-quality evidence exists to support the use of biological 
meshes in these situations, this decision can be defended. However, the use of 
biological meshes in clean or clean/contaminated environments – grade 1 and 
2 of VHWG(52) – cannot be justified by the evidence. Recent studies on grade 
2 hernia repairs showed a lower recurrence rate after implantation of synthetic 
meshes compared to biological meshes, with similar adverse events(82). 
Furthermore, several synthetic meshes have been shown to be infection-
resistant in these circumstances(58). An important factor when choosing a 
mesh is the associated cost; biological meshes are substantially more expensive 
than synthetic meshes(53, 78, 80). The mean price of a biological mesh in 2016 
was $19.15 per cm2 ; and the mean price of a non-biological mesh was $5.41 
per cm2 – an average of 3,5-fold less cost(53). The 2016 costs of the biological 
meshes used in the experiments in this thesis were: Strattice® $30.29 per cm2; 
Permacol® $18.24 per cm2; Surgisis® $13.42 per cm2; and CollaMendFM® $13.25 
per cm2(53). However, in VHWG grades 3 and 4(52), costs can be reduced when 
delayed primary closure with implantation of a biological mesh is possible 
during one hospital admission. In this way, the number of admissions and in-
hospital days can be reduced, compared to staged repair(83). An additional 
benefit is earlier restoration of abdominal wall function, which may lead to 
accelerated return to work. 
Future perspectives
Prevention of IH is a very important issue, and one that deserves a great deal 
more attention in the surgical community. As Hans Jeekel wisely stated during 
the 2016 EHS conference: “Don’t judge a surgeon before you’ve seen him or 
her close the abdomen”. Proper opening and closing of the abdominal wall 
should become a mandatory part of surgical training. Anatomical education 
and detailed instructions on the best evidence-based closing techniques will 
improve the general skills of surgical residents and reduce incidence rates of IH. 
Improvements in anatomical knowledge of the abdominal wall will also benefit 
laparoscopically oriented surgeons. Since laparoscopic abdominal surgery 
requires placement of trocars, there is a risk of vascular or nerve injury, and the 
development of an incisional hernia, or so-called trocar site hernia – especially 
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when the closure is with quickly absorbable sutures and trocars exceeding 5 mm 
in diameter(84, 85). To further prevent IH in high-risk patients, a prophylactic 
mesh seems a useful option. Ongoing research on the use of prophylactic mesh 
augmentation of the abdominal wall in high-risk patients is likely to provide 
high quality evidence regarding the best position of the mesh in the abdominal 
wall(11). Additionally, research on the improvement of fascial wound healing to 
prevent IH should be performed. Interesting ideas about the use of stem cells 
and growth factors are currently being investigated(86-88). 
The surgical treatment of IH is complex, and individual patient-, 
surgical technique-, and mesh-related issues should be addressed for each 
patient. Every incisional hernia is different, and a CT-scan should be used to 
preoperatively evaluate the dimensions of the hernia, loss of domain, and 
quality of remaining abdominal wall muscles and tissues. The complexity of 
hernia repair necessitates a dedicated and certified abdominal wall surgeon 
and surgical team. Many incisional hernia repairs benefit from techniques 
where planes in the abdominal wall are used or mobilized, which requires in-
depth knowledge of the abdominal wall and experience in abdominal wall 
surgery. To improve evidence-based surgery in hernia repair, an international 
collaboration should be established, with the involvement of dedicated 
hernia surgeons in international studies. Only in this manner can high-quality 
research, with adequate patients numbers, be accomplished. A very important 
parameter in hernia research is the length and method of follow-up. Patient 
follow-up should exceed one year, and radiological imaging is essential in 
establishing recurrence rates. A national, or (preferably) international, registry 
of hernia patients would be helpful. EuraHS and the Danish Hernia Registry are 
excellent examples of this, and are used to answer various research questions 
that require large cohort studies of patients(89-92). 
Even for dedicated IH surgeons, it is almost impossible to make an 
educated selection of a mesh from the hundreds of available types and 
brands on the market. It is therefore advised that the positive and negative 
experiences of hernia surgeons should be ‘bundled’ through international 
collaboration. Research should not be performed on specific brands of meshes, 
but rather on generic characteristics of each type of mesh. The initiative of the 
research group Matthews and Deeken on this subject should be applauded. An 
interesting concept might be some sort of ‘certificate of approval’ for a mesh, 
granted by an international committee of experts from the scientific societies 
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of hernia surgery. Combining the results of biomechanical studies, animal 
experiments, and clinical data, this committee could hand out such a certificate 
to certain meshes, and help other surgeons make an educated selection of 
mesh prostheses. 
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In Chapter 1 the subject of this thesis, incisional hernia (IH), is introduced. IH 
is the most frequent complication following abdominal surgery, and has great 
impact on patients’ lives, as well as being a burden in terms of healthcare costs. 
Several patient factors and technical aspects play a role in the development of 
IH. As stated back in 1914 by Sir Victor Horsley, the radical cure of a hernia is 
best represented by its prevention. 
Part 1. Prevention and incidence of incisional hernia
In the first part of the thesis, research is presented which determines the 
technical aspects of surgery that influence the development of IH. 
Chapter 2 describes the design of a multicentre randomized controlled 
trial (RCT) – the STITCH trial – to compare the upcoming ‘small bites’ suture 
technique to the generally performed ‘large bites’ suture technique of the 
midline fascia after laparotomy. Across 10 participating hospitals, 560 patients 
were randomly allocated to these two techniques. The ‘small bites’ technique 
consisted of a running suture with small tissue bites of 5 mm and a stitch every 
5 mm, performed with a 2-0 polydioxanone (PDS®) suture, with a 31 mm needle. 
The ‘large bites’ technique consisted of a running suture with large tissue bites 
of 1 cm and a stitch every 1 cm, performed with a 1 double loop PDS® suture, 
with a 48 mm needle. 
In Chapter 3, the results of the STITCH trial are presented. Patients in the 
small bites group had fascial closures sutured with significantly more stitches 
than those in the large bites group (mean number of stitches 45 [SD 12] vs 25 
[10]); a significantly higher ratio of suture length to wound length (5.0 [1.5] vs 
4.3 [1.4]); and a significantly longer closure time (14 [6] vs 10 [4] min). During 
follow-up, radiological imaging of the abdominal wall was performed in 76% 
of patients. At 1-year follow-up, 57 (21%) of the 277 patients in the large bites 
group, and 35 (13%) of the 268 patients in the small bites group, had developed 
IH (p=0.0220, covariate adjusted odds ratio 0.52, 95% Confidence Interval 0.31–
0.87; p=0.0131). Rates of adverse events did not differ significantly between 
the two groups. 
Chapter 4 presents the findings of a systematic review and meta-analysis 
performed to analyze the evidence from RCTs on the optimal method or suture 
material for closing the midline fascia. When using the same suture technique, 
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no significant differences between suture materials regarding the incidence of 
IH were found. When using the same suture material, the ‘small bites’ technique 
had a significantly lower rate of IH than the ‘large bites’ technique. No significant 
differences were found between the continuous ‘large bites’ technique and a 
technique with interrupted sutures.
In Chapter 5, the European Hernia Society (EHS) guidelines on the 
closure of abdominal wall incisions are reported on. In these guidelines, it is 
recommended to close a midline incision with a continuous suture technique; 
to avoid fast-absorbable sutures; to perform fascial closure in one layer; and to 
not close the peritoneum separately. It is advised to use a slowly-absorbable 
suture and a ‘small bites’ technique, with a suture to wound length ratio of at 
least 4:1. 
In Chapter 6, the incidence of IHs, and their correlation with parastomal 
hernias (PSH), is explored through examination of a cross-sectional study of 
150 patients with left-sided colostomies. Patients with a PSH were found to 
have a 7-times greater occurrence of midline IH. Most of the IHs developed at 
the level of the colostomy. 
In Chapter 7, the possible causes of the increased incidence of IH 
reported in Chapter 6 are further investigated. Seventy-seven patients with 
both a preoperative and postoperative abdominal CT-scan were selected from 
the cross-sectional study. The CT-scans of these patients were uploaded to 
the I-Space® system and three-dimensionally visualized and projected using 
V-scope® software. In the I-Space®, shift in the linea alba and thickness of the 
abdominal rectus muscles were measured. A thinner abdominal rectus muscle 
was found in patients with PSH, compared to those without. Furthermore, a 
shift of the midline to the right was found after colostomy creation. Both 
observations change the forces on the healing linea alba and likely contribute 
to the development of IH. 
Part 2. Surgical treatment of incisional hernia
In the second part of this thesis, research on the surgical treatment of IH is 
presented. 
In Chapter 8, the results of a systematic review on the surgical repair 
of IH are presented. Since evidence from RCTs was scarce, a meta-analysis 
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could not be performed. The results of cohort studies and non-randomized 
trials are compared with a generalized linear model, to determine the yearly 
recurrence risk for every technique. The surgical treatment options could 
broadly be divided into: open techniques without mesh; open techniques 
with mesh; and laparoscopic techniques with mesh. The open techniques with 
mesh augmentation performed best in terms of recurrence rates. Comparing 
individual techniques on yearly recurrence risk showed the best results for 
open repair with mesh in the sublay position.
In Chapter 9, the recommendations of the EHS for reporting outcomes 
of abdominal wall surgery can be found. It is recommended to use existing 
standards and statements available for the type of study that is being reported, 
i.e. the CONSORT, TREND, STROBE and PRISMA statements. Furthermore, 
recommendations are made to use standard definitions and classifications 
relating to hernia variables and treatment, and clear terminology proposed 
by the EHS and EuraHS. Likewise, the use of the validated Clavien-Dindo 
classification to report complications is recommended. An important proposal 
is to use ‘time-to-event analysis’ to report data on ‘freedom-of-recurrence’ rather 
than the use of recurrence rates, since this is more sensitive and accounts for 
patients lost to follow-up. 
In Chapter 10, synthetic, composite, and biological meshes are compared 
in terms of adhesion formation and incorporation after 90 days in an animal 
model. The polyester composite mesh (Parietex composite®) demonstrated 
the best long-term results, with good incorporation and very little adhesion 
formation. The best performing biological mesh was non-crosslinked Strattice®, 
with very little adhesion formation, but only moderate incorporation. 
Chapter 11 describes the implanting and comparing of several 
synthetic, composite, and biological meshes in a contaminated environment 
animal model. Polypropylene-based (Parietene®, Parietene composite® and 
Sepramesh®), condensed polytetrafluoroethylene (c-PTFE, Omyramesh®) 
synthetic and non-crosslinked biological (Strattice®) meshes developed none 
or very few mesh infections. Adhesion formation after 90 days was very slight 
with the biological mesh Strattice®, followed by the synthetic meshes Parietene 
composite® and Omyramesh®. However, incorporation of the biological mesh 
Strattice® was very poor after 90 days. 
In Chapter 12, the cellular immune responses to the synthetic meshes 
investigated in Chapter 11 are examined. All meshes induced the influx of 
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T-cells and macrophages, and these cells were still found after 90 days. Both 
PTFE-based meshes (Omyramesh® and Dualmesh®) were mostly surrounded by 
T-cells, indicative of a chronic inflammatory reaction. Polypropylene meshes 
(Parietene® and Parietene composite®) had the lowest number of T-cells, 
indicative of resolution of the inflammatory reaction. 
In Chapter 13, an in vitro model to study the biomaterial-dependent 
reaction of macrophages in an inflammatory environment is presented. The 
results are compared to an in vivo experiment with polypropylene mesh 
implantation in a contaminated environment. Macrophages were found to 
react in a similar biomaterial-dependent manner in the in vitro model as in the 
in vivo model. 
In Chapter 14, the investigation of several biological meshes for infection 
susceptibility in a contaminated environment animal model, is presented. 
Crosslinked biological meshes (Permacol® and CollaMendFM®) demonstrated 
an infection rate of 70% compared to 4% in non-crosslinked biological meshes 
(Strattice® and Surgisis®). Incorporation in the abdominal wall after 180 days was 
poor in all meshes, and no residue of non-crosslinked Surgisis® could be found. 
In Chapter 15, the study of long-term incorporation of biological 
meshes in a clean environment is presented. Even in this clean environment, 
cross-linked CollaMendFM® demonstrated a high infection rate, and only non-
crosslinked Strattice® did not show any mesh infection. Incorporation of the 
non-infected meshes into the abdominal wall after 180 days was poor: 14% in 
Strattice® and 21% in Permacol®. No residue of any Surgisis® meshes could be 
identified at 180 days. 
Chapter 16 of this thesis describes the relatively new phenomenon 
of mesh-bulging. A clinical case is presented in which a bulging Parietex 
composite® mesh was explanted and measured, and compared to the original 
implanted mesh. A striking expansion of the pores as the cause of bulging is 
demonstrated. 
Conclusion
To prevent the development of IH, the abdominal wall can best be closed 
with a continuous ‘small bites’ suture technique, using a slowly-absorbable 
suture. Reducing the rates of PSH will likely reduce the incidence of IH. When 
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performing large hernia repair, mesh augmentation reduces recurrence rates. 
Several intraperitoneal-implanted synthetic composite meshes showed 
good incorporation and low adhesion formation. Even in the contaminated 
environment, some synthetic composite meshes did not show any mesh 
infection. Between clean and contaminated environments, the various brands 
of biological meshes behave very differently. Infection susceptibility and poor 
incorporation remain problematic with the majority of biological meshes. Only 
one non-crosslinked biological mesh was found to have no mesh infections 
and very little adhesion formation, but incorporation into the abdominal wall 
was insufficient for an intraperitoneal position.
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Hoofdstuk 1 beschrijft het onderwerp van dit proefschrift: de preventie en 
behandeling van littekenbreuken. Na de ontdekking en introductie van asepsis 
en anesthesie in de 19e eeuw nam de abdominale chirurgie een grote vlucht. 
Met de toename van het aantal abdominale ingrepen werd de littekenbreuk 
een veel voorkomende complicatie en de incidentie is tot op de dag van 
vandaag onaanvaardbaar hoog. Littekenbreuken hebben een negatieve 
invloed op de kwaliteit van leven van patiënten en de manier waarop zij hun 
eigen lichaam boordelen. Het chirurgisch herstel brengt hoge kosten met zich 
mee en gaat gepaard met complicaties en recidieven. Het voorkomen van het 
ontstaan van een littekenbreuk is daarom ook van essentieel belang. Wanneer 
een littekenbreuk zich na abdominale chirurgie ontwikkelt wordt deze meestal 
symptomatisch en behoeft herstel. De chirurgische behandeling van een 
littekenbreuk heeft een hoog recidief percentage als er geen mat gebruikt 
wordt. De laatste jaren zijn er nieuwe synthetisch en biologische matten 
ontwikkeld voor het herstel van littekenbreuken. Voor kleine en middelgrote 
breuken is herstel met een mat eerste keus. Voor grote (‘giant’) littekenbreuken, 
met een defect van 10 centimeter of meer, bestaat nog geen consensus over 
de optimale manier van herstel.
Deel 1. Preventie en incidentie van littekenbreuken
Het eerste deel van dit proefschrift richt zich op de preventie en incidentie van 
littekenbreuken.
In Hoofdstuk 2 is de opzet van de STITCH-trial gedetailleerd beschreven. 
In deze multicentrische gerandomiseerde-gecontroleerde-studie (RCT) werd 
de beste methode voor het hechten van de fascie van de linea alba onderzocht. 
In beide groepen werd de fascie gesloten met een voortlopende hechting 
van poydioxanone (PDS®). De meest gebruikte “large bites’-hechttechniek van 
de fascie (per centimeter een hechting met 1cm afstand van de fascierand) 
met een PDS 1-loop werd vergeleken met de veelbelovende ‘small bites’-
hechttechniek (per 5mm een hechting met 5mm afstand van de fascierand) 
met PDS 2-0. Na 1 jaar werd door middel van lichamelijk onderzoek en 
radiologische beeldvorming geëvalueerd of er een littekenbreuk was ontstaan. 
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In Hoofdstuk 3 zijn de resultaten van de STITCH-trial gerapporteerd. 
In 10 deelnemende ziekenhuizen werden 560 patiënten die een laparotomie 
ondergingen, gerandomiseerd in twee groepen. Patiënten in de ‘small bites’-
groep werden gesloten met meer steken (gemiddeld 45 vs 25), een hogere 
‘suture length to wound length ratio’ van 4:1 en het sluiten van de fascie 
duurde langer (14 vs 10 min). De ‘small bites’-techniek blijkt een significante 
vermindering van het aantal littekenbreuken na 1 jaar te geven met een 
verschil in incidentie van 13 tegenover 21%. De ‘small bites’-techniek zal de 
nieuwe gouden standaard voor het sluiten van de buik worden. 
In Hoofdstuk 4 zijn de uitkomsten van een systematisch review en 
meta-analyse beschreven van alle RCT’s, waarin separaat hechttechnieken 
of hechtmaterialen zijn onderzocht op de incidentie van littekenbreuken. 
Het bleek dat bij dezelfde hechttechniek het soort hechtdraad dat gebruikt 
wordt geen significant verschil toonde met betrekking tot de incidentie van 
littekenbreuken. Bij het gebruik van dezelfde hechtdraad liet de ‘small bites’-
techniek een lagere incidentie littekenbreuken zien dan de ‘large bites’-
techniek, maar tussen de ‘large bites’-techniek en een techniek met staande 
hechtingen werd geen significant verschil gevonden. 
Hoofdstuk 5 betreft de richtlijn over de optimale manier van het 
sluiten van de buik van de European Hernia Society. Voor electieve mediane 
laparotomieën wordt geadviseerd om de fascie te sluiten met een voortlopende 
techniek, het gebruik van een snel-oplosbare hechting te vermijden, de fascie 
in één laag te sluiten zonder separate sluiting van het peritoneum en een ‘small 
bites’-techniek te gebruiken met een minimaal 4 maal zo lange hechting als de 
wond lang is (suture length to wound length ratio > 4:1). 
In Hoofdstuk 6 is de incidentie van littekenbreuken en parastomale 
hernia’s (PSH) en hun correlatie onderzocht in een cross-sectionele studie. 
In deze studie van 150 patiënten met een eindstandig linkszijdig stoma, 
bleken patienten met een PSH een 7 maal zo hoog risico te hebben op een 
littekenbreuk. De meeste littekenbreuken ontwikkelen zich in de linea alba op 
het niveau van het stoma. Een reden hiervoor zou kunnen zijn dat het plaatsen 
van een stoma voor verminderde innervatie van de buikwand zorgt, waardoor 
atrofie van de m. rectus abdominis (MRA) op kan treden. Tevens ontstaat een 
niet-symmetrische krachtverdeling op het mediane laparotomielitteken als 
gevolg van het aanleggen van het stoma door de linker zijde van de buikwand 
heen. 
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In Hoofdstuk 7 zijn 77 patiënten met een preoperatieve en 
postoperatieve CT-scan van de buik uit de cross-sectionele studie geselecteerd 
om deze werkingsmechanismen verder te onderzoeken. De CT-scans van deze 
patiënten werden onderzocht in de I-Space® door middel van V-scope® software. 
Hiermee konden de CT-scans als 3D-hologrammen worden geprojecteerd en 
verschuiving van de linea alba en de dikte van de MRA gemeten worden. Uit 
de resultaten bleek dat patiënten met een PSH een dunnere MRA hebben 
vergeleken met patiënten zonder PSH. Daarnaast ontstaat er bij de aanleg van 
een stoma een verschuiving van de linea alba naar rechts. Beide bevindingen 
veranderen de kracht op de genezende linea alba en dragen waarschijnlijk bij 
aan het ontstaan van littekenbreuken.
Deel 2. Chirurgische behandeling van littekenbreuken
Het tweede deel van dit proefschrift richt zich op de chirurgische behandeling 
van littekenbreuken.
In Hoofdstuk 8 wordt een systematisch review van de literatuur 
beschreven, gericht op de beste techniek om een grote littekenbreuk te 
herstellen. Helaas waren er weinig gerandomiseerde prospectieve studies 
beschikbaar en was een meta-analyse van de data niet mogelijk. Om de 
verschillende technieken vergelijkbaar te maken voor recidieven werd 
een gegeneraliseerd lineair model gebruikt om het jaarlijks recidief risico 
voor alle technieken te berekenen. De beschreven chirurgische technieken 
werden onderverdeeld in open herstel zonder mat, open herstel met mat en 
laparoscopisch herstel met mat. De open technieken zonder mat hadden de 
hoogste recidief percentages. De open technieken, met matten in verschillende 
posities ten opzichte van de buikwand, lieten de beste resultaten zien. De 
geadviseerde positie voor de mat in de buikwand is de sublay positie gezien 
de lage recidiefkans op lange termijn en het lage jaarlijkse recidiefrisico.
In Hoofdstuk 9 staan de aanbevelingen van de European Hernia Society 
ten aanzien van het rapporteren van uitkomsten van buikwandchirurgie. Er 
wordt geadviseerd om de bestaande richtlijnen en statements te gebruiken 
bij het rapporteren van de studie karakteristieken, zoals de CONSORT, STROBE 
en PRISMA statements. Verder wordt aanbevolen om de EHS-definities en 
classificaties voor buikwandbreuken en de Clavien-Dindo classificatie voor 
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het rapporteren van complicaties te gebruiken. Verder wordt voorgesteld om 
als uitkomstmaat ‘afwezigheid-van-recidief’ te gebruiken in plaats van het 
recidiefpercentage, omdat dit een meer gevoelige uitkomstmaat is en ook 
rekening houdt met patiënten, die ‘lost to follow-up’ zijn. 
Hoofdstuk 10 beschrijft het vergelijk van synthetische en biologische 
matten met betrekking tot ingroei en adhesievorming na 90 dagen in een 
diermodel. De synthetische matten van polyester en polypropyleen lieten, 
in tegenstelling tot de biologische matten, goede ingroei zien. Synthetische 
composite mat Parietex composite® en biologische mat Strattice® gaven bijna 
geen aanleiding tot adhesievorming. 
In Hoofdstuk 11 rapporteren we de eigenschappen van synthetische 
en biologische matten in een gecontamineerd milieu in een diermodel. 
Zowel enkele synthetische (Parietene®, Parietene composite®, Sepramesh® 
en Omyramesh®) als biologische matten (Strattice®) bleken bestand tegen 
infectie. Na 90 dagen was de mate van adhesievorming op biologische mat 
Strattice® het laagst, gevolgd door synthetische matten Parietene composite® 
en Omyramesh®, maar waren de synthetische matten beter ingegroeid. 
In Hoofdstuk 12 werden de matten uit het gecontamineerde milieu 
aanvullend onderzocht op vreemdlichaamreactie. Bij alle matten werd na 90 
dagen nog een influx van T-cellen en macrofagen gezien, indicatief voor een 
chronisch inflammatoire reactie. Wel waren er duidelijk verschillen tussen de 
matten te zien. Beide matten van PTFE (Omyramesh® en Dualmesh®) waren 
het meest omgeven door T-cellen. Bij de polypropyleen-matten (Parietene® 
en Parietene composite®) werden de laagste aantallen T-cellen gevonden, wat 
duidt op het uitdoven van deze reactie.
In Hoofdstuk 13 presenteren we een nieuw in vitro model waarin 
de eigenschappen van synthetische matten kunnen worden vergeleken. 
De resultaten van het in vivo experiment met polypropyleen-matten in 
gecontamineerd milieu uit hoofdstuk 12 werden vergeleken het nieuwe in 
vitro model. De macrofagen in het in vitro model bleken op een vergelijkbare 
manier te reageren op verschillende biomaterialen als in vivo. 
In Hoofdstuk 14 onderzochten we de infectiegevoeligheid van 
verschillende biologische matten in een diermodel. Na implantatie in een 
gecontamineerd milieu trad bij 70% van de gecrosslinkte matten (Permacol® 
en CollaMendFM®) een matinfectie op, tegenover 4% van de niet-gecrosslinkte 
matten (Strattice® and Surgisis®). Na 180 dagen bleek niet-gecrosslinkt Surgisis® 
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volledig verdwenen te zijn en was de ingroei in de buikwand van de andere 
matten slecht tot matig. 
In Hoofdstuk 15 richten we ons op de ingroei van biologische matten 
in de buikwand. Dezelfde collageen matten werden geïmplanteerd in een 
schoon milieu. Zelfs in het schone milieu werd bij CollaMendFM® een hoog 
infectiepercentage gevonden en werd alleen bij Strattice® geen enkele 
matinfectie gevonden. Na 180-dagen werd bij alle collageen matten opnieuw 
een matige ingroei in de buikwand gevonden (Strattice® 14% en Permacol® 
21%) en was niet-gecrosslinkt Surgisis® volledig verdwenen.
In Hoofdstuk 16 beschrijven we een 'bulging mesh', een recent bekend 
geworden complicatie na littekenbreukherstel. Hierbij is er wel zwelling van 
de buikwand, maar geen sprake van een waar recidief en dekt de mat nog 
steeds het buikwanddefect af, echter hernieert de mat mee door het defect 
naar buiten. In deze casus wordt voor het eerst het uitrekken van de poriën van 
een polyester mat bewezen bij een patiënt als oorzaak van deze complicatie. 
Conclusie
Om het ontwikkelen van een littekenbreuk te voorkomen kan het beste de 
fascie gesloten worden met een voortlopende langzaam oplosbare hechting 
in een ‘small bites’ techniek. Het aanwezig zijn van PSH geeft een hogere kans 
op een littekenbreuk. Indien een grote littekenbreuk hersteld wordt kan het 
beste een mat gebruikt worden om het recidief percentage te verlagen. Enkele 
synthetische matten laten een goede ingroei en lage adhesievorming zien 
indien ze geïmplanteerd worden in een intraperitoneale positie. Zelfs in het 
geïnfecteerde milieu blijken sommige synthetische matten infectieresistent. 
Het gedrag van verschillende biologische matten in zowel schoon als 
geïnfecteerd milieu is uiteenlopend. Slechte ingroei in de buikwand en 
matinfecties blijken problematisch bij de meeste soorten biologische matten. 
Slechts één soort niet-gecrosslinkte biologische mat liet geen matinfecties en 
een lage adhesiegevoeligheid zien, maar ook deze mat vertoonde een matige 
ingroei in de buikwand wanneer hij werd geïmplanteerd in een intraperitoneale 
positie. 
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